Blueprint
As filed with the Securities and Exchange Commission on October 10,
2018
Registration No. 333-_______
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
IMAGEWARE SYSTEMS,
INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
|
7372
|
33-0224167
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(Primary
standard industrial
classification code number)
|
(I.R.S. Employer
Identification Number)
|
10815 Rancho Bernardo Road, Suite 310
San Diego, California 92127
(858) 673-8600
(Address, Including Zip Code, and Telephone Number, Including Area
Code, of Registrant’s Principal Executive
Offices)
S. James Miller, Jr.
President and Chief Executive Officer
ImageWare Systems, Inc.
10815 Rancho Bernardo Road, Suite 310
San Diego, California 92127
(858) 673-8600
(Name, Address, Including Zip Code, and Telephone Number, Including
Area Code, of Agent for Service)
Copies to
Daniel W. Rumsey, Esq.
Jessica R. Sudweeks, Esq.
Disclosure Law Group, a Professional Corporation
600 West Broadway, Suite 700
San Diego, CA 92101
(619) 272-7050
Approximate date of
commencement of proposed sale to the public: From time to time after this registration
statement becomes effective, as determined by market conditions and
other factors.
If
any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, other than securities offered only in
connection with dividend or interest reinvestment plans, check the
following box. [X]
If
this form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same offering. [ ]
If
this form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same
offering. [ ]
If
this form is a post-effective amendment filed pursuant to Rule
462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same
offering. [ ]
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated
filer,” “smaller reporting company,” and
“emerging growth company” in Rule 12b-2 of the Exchange
Act. (Check one):
Large accelerated filer
|
|
[ ]
|
|
Accelerated
filer
|
|
[X]
|
|
|
|
|
|
|
Non-accelerated
filer
|
|
[ ]
|
|
Smaller reporting company
|
|
[X]
|
|
|
|
|
|
|
|
|
|
|
|
Emerging
growth company
|
|
[ ]
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 7(a)(2)(B) of the Securities Act. [
]
CALCULATION OF REGISTRATION FEE
Title of each class of securities to
be registered
|
Amount to be Registered(1)
|
Proposed Maximum Aggregate
Offering Price(2)
|
Amount of Registration
Fee
|
Common
Stock, par value $0.01 per share
|
11,031,000(3)
|
$10,920,690
|
$1,323.59
|
(1)
|
In
accordance with Rule 416 under the Securities Act of 1933, as
amended (the “Securities
Act”), the shares being registered hereunder include
such indeterminate number of shares of common stock as may be
issuable with respect to the shares being registered hereunder as a
result of stock splits, stock dividends or similar
transactions.
|
(2)
|
Estimated
solely for the purpose of calculating the registration fee for the
offering pursuant to Rule 457(c) under the Securities Act, based on
the average of the high and low prices of the Registrant’s
common stock on the OTCQB Marketplace on October 4,
2018.
|
(3)
|
Includes
(i) 10,000,000 shares of common stock issuable upon the conversion
of shares of the Company’s Series C Convertible Preferred
Stock, par value $0.01 per share (“Series C Preferred”) held by the
selling stockholders (“Conversion Shares”), and (ii) an
estimated 1,031,000 shares of common stock issuable as payment of
accrued dividends on shares of Series C Preferred held by selling
stockholders within 12 months from the date of this Registration
Statement (any shares of common stock issuable as dividends on
shares of Series C Preferred, the “Dividend Shares”). The number of
Dividend Shares issuable over the next 12 months are estimated
based on the closing price of the Registrant’s common stock
on October 4, 2018, as reported on the OTCQB
Marketplace.
|
The Registrant hereby amends this registration statement on such
date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically
states that this registration statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of
1933 or until the registration statement shall become effective on
such date as the Commission, acting pursuant to said section 8(a),
may determine.
|
|
|
|
The information in this prospectus is not complete and may be
changed. The selling stockholders may not sell these securities
until the registration statement filed with Securities and Exchange
Commission is effective. This prospectus is not an offer to sell
these securities and is not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.
|
|
|
|
|
Subject to completion, dated October 10, 2018
PRELIMINARY PROSPECTUS
11,031,000
SHARES
COMMON STOCK
This
prospectus relates to the sale from time to time of up to
11,031,000 shares of our common stock, par value $0.01 per share
(“Common
Stock”) by the selling stockholders identified in this
prospectus, which amount includes (i) 10,000,000 shares of Common
Stock that that may be issued to them from time to time upon
conversion of shares of our Series C Convertible Preferred Stock,
par value $0.01 per share ( “Series C Preferred”) (the
“Conversion
Shares”), and (ii) an estimated 1,031,000 shares of
Common Stock issuable as payment of accrued dividends on shares of
Series C Preferred held by selling stockholders within 12 months
from the date of this prospectus (any shares of Common Stock
issuable as dividends on shares of Series C Preferred, the
“Dividend
Shares”). We issued the Series C Preferred shares to
the selling stockholders in private placement transactions
completed on September 10, 2018 and September 21, 2018.
The prices at which the selling
stockholders may sell the shares will be determined by the
prevailing market price for the shares or in negotiated
transactions.
We are registering the Conversion Shares and
Dividend Shares to provide the selling stockholders with freely
tradable securities. This prospectus does not necessarily mean that
the selling stockholders will offer or sell those shares. Up to
11,031,000 shares may be sold from time to time after the
effectiveness of the registration statement, of which this
prospectus forms a part. See “Description of Private
Placement”
on page 15 below for more
information.
We
will not receive proceeds from the sale of the shares by the
selling stockholders. All selling and other expenses incurred by
the selling stockholders will be paid by the selling stockholders,
except for certain legal fees and expenses, which will be paid by
us.
Our
Common Stock is quoted on the OTCQB Marketplace under the symbol
“IWSY.” The last reported sale price of our common
stock on October 10, 2018 was $0.96 per share.
Our business and investing in our securities involves significant
risks. You should review carefully the risks and uncertainties
referenced under the heading “Risk
Factors” beginning on
page 6 of this prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal
offense.
The date of this prospectus is
,
2018
IMAGEWARE SYSTEMS, INC.
|
|
|
|
|
PAGE
|
|
|
|
|
|
1
|
|
|
|
|
|
2
|
|
|
|
|
|
6
|
|
|
|
|
|
13
|
|
|
|
|
|
14
|
|
|
|
|
|
15
|
|
|
|
|
|
16
|
|
|
|
|
|
17
|
|
|
|
|
|
19
|
|
|
|
|
|
21
|
|
|
|
|
|
22
|
|
|
|
|
|
24
|
|
|
|
|
|
38
|
|
|
|
|
|
61
|
|
|
|
|
|
72
|
|
|
|
|
|
75
|
|
|
|
|
|
77
|
|
|
|
|
|
77
|
|
|
|
|
|
77
|
|
|
|
ABOUT THIS PROSPECTUS
This prospectus is part of a
registration statement on Form S-1 that we filed with the
Securities and Exchange Commission (the “SEC”). Under this registration statement, the
selling stockholders may, from time to time, sell up to an
aggregate of 11,031,000 shares of our Common Stock, which includes
(i) 10,000,000 shares that may be issued upon conversion of
outstanding shares of our Series C Preferred, and (ii) an estimated
1,031,000 shares of Common Stock issuable as payment of accrued
dividends on shares of Series C Preferred held by selling
stockholders within 12 months from the date of this
prospectus. The registration statement
we filed with the SEC, of which this prospectus forms a part,
includes exhibits that provide more detail of the matters discussed
in this prospectus. You should read this prospectus and the related
exhibits filed with the SEC before making your investment
decision.
You
should rely only on the information contained in this
prospectus. Neither we nor the selling stockholders have
authorized any other person to provide you with different
information. If anyone provides you with different or
inconsistent information, you should not rely on it. Neither
we nor the selling stockholders are making offers to sell or
solicitations to buy the securities in any jurisdiction in which an
offer or solicitation is not authorized, or in which the person
making that offer or solicitation is not qualified to do so or to
anyone to whom it is unlawful to make an offer or
solicitation. You should not assume that the information in
this prospectus is accurate as of any date other than its
respective date. Our business, financial condition,
results of operations and prospects may have changed since those
dates.
|
This summary highlights information contained elsewhere in this
prospectus or incorporated by reference herein. This summary does
not contain all of the information you should consider before
investing in our securities. Before deciding to invest in our
securities, you should read this entire prospectus carefully,
including the section of this prospectus entitled “Risk
Factors” beginning on page 6.
Overview
We
develop mobile and cloud-based identity management solutions
providing biometric, secure credential and law enforcement
technologies. Our patented biometric product line includes our
flagship product, the IWS Biometric Engine®, a hardware and
algorithm independent multi-biometric engine that enables the
enrollment and management of unlimited population sizes. Our
identification products are used to manage and issue secure
credentials, including national IDs, passports, driver licenses and
access control credentials. Our digital booking products provide
law enforcement with integrated mug shots, fingerprint LiveScan and
investigative capabilities. We also provide comprehensive
authentication security software using biometrics to secure
physical and logical access to facilities or computer networks or
internet sites. We are headquartered in San Diego, California,
with offices in Portland, Oregon, Mexico and Ottawa,
Ontario.
We are also a leading developer of mobile and
cloud-based identity management solutions providing patented
biometric authentication solutions for the enterprise. We deliver
next-generation biometrics as an interactive and scalable
cloud-based solution. We bring together cloud and mobile technology
to offer multi-factor authentication for smartphone users, for the
enterprise, and across industries. We have introduced a set of
mobile and cloud solutions to provide biometric user
authentication, including the GoVerifyID® mobile application
and cloud-based SaaS solutions. These solutions include GoMobile
Interactive (“GMI”), which provides patented, secure, dynamic
messaging. More recently we have introduced GoVerifyID®
Enterprise Suite, which provides turnkey integration with Microsoft
Windows, Microsoft Active Directory, and security products from CA,
HPE, IBM, and SAP. These solutions are marketed and sold to
businesses across many industries. For the healthcare industry, we
also developed and market a patented, FDA-Cleared,
biometrically-secured, enterprise-level platform for patient
engagement and medication adherence.
Historically,
we have marketed our products to government entities at the
federal, state and local levels; however, the emergence of cloud
based computing, a mobile market that demands increased security
and interoperable systems, and the proven success of our products
in the government markets, has enabled us to enlarge our target
market focus to include the emerging consumer and non-government
enterprise marketplace.
Our biometric technology is a core software
component of an organization’s security infrastructure and
includes a multi-biometric identity management solution for
enrolling, managing, identifying and verifying the identities of
people by the physical characteristics of the human body. We
develop, sell and support various identity management capabilities
within government (federal, state and local), law enforcement,
commercial enterprises, and transportation and aviation markets for
identification and verification purposes. Our IWS Biometric Engine
is a patented biometric identity management software platform for
multi-biometric enrollment, management and authentication, managing
population databases of virtually unlimited sizes. It is hardware
agnostic and can utilize different types of biometric
algorithms. It allows different types of biometrics to be
operated at the same time on a seamlessly integrated
platform. It is also offered as a Software Development Kit
(“SKD”) based search engine, enabling developers
and system integrators to implement a biometric solution or
integrate biometric capabilities into existing applications without
having to derive biometric functionality from pre-existing
applications. The IWS Biometric Engine combined with our
secure credential platform, IWS EPI Builder, provides a
comprehensive, integrated biometric and secure credential solution
that can be leveraged for high-end applications such as passports,
driver licenses, national IDs, and other secure
documents.
Our
law enforcement solutions enable agencies to quickly capture,
archive, search, retrieve, and share digital images, fingerprints
and other biometrics as well as criminal history records on a
stand-alone, networked, wireless or web-based platform. We develop,
sell and support a suite of modular software products used by law
enforcement and public safety agencies to create and manage
criminal history records and to investigate crime. Our IWS Law
Enforcement solution consists of five software modules: Capture and
Investigative modules, which provide a criminal booking system with
related databases as well as the ability to create and print mug
photo/SMT image lineups and electronic mug-books; a Facial
Recognition module, which uses biometric facial recognition to
identify suspects; a Web module, which provides access to centrally
stored records over the Internet in a connected or wireless
fashion; and a LiveScan module, which incorporates LiveScan
capabilities into IWS Law Enforcement providing integrated
fingerprint and palm print biometric management for civil and law
enforcement use. The IWS Biometric Engine is also available to
our law enforcement clients and allows them to capture and search
using other biometrics such as iris or DNA.
|
|
|
|
|
|
Our
secure credential solutions empower customers to create secure and
smart digital identification documents with complete ID systems. We
develop, sell and support software and design systems which utilize
digital imaging and biometrics in the production of photo
identification cards, credentials and identification systems. Our
products in this market consist of IWS EPI Suite and IWS EPI
Builder. These products allow for production of digital
identification cards and related databases and records and can be
used by, among others, schools, airports, hospitals, corporations
or governments. We have added the ability to incorporate multiple
biometrics into the ID systems with the integration of IWS
Biometric Engine to our secure credential product
line.
Our GoVerifyID products support multi-modal
biometric authentication including, but not limited to, face,
voice, fingerprint, iris, palm, and more. All the biometrics can be
combined with or used as replacements for authentication and access
control tools, including tokens, digital certificates, passwords,
and PINS, to provide the ultimate level of assurance,
accountability, and ease of use for corporate networks, web
applications, mobile devices, and PC desktop environments.
GoVerifyID provides patented multi-modal biometric identity
authentication that can be used in place of passwords or as a
strong second factor authentication method. GoVerifyID is provided
as a cloud-based Software-as-a-Service (“SaaS”) solution; thereby, eliminating complex IT
deployment of biometric software and eliminating startup costs.
GoVerifyID works with existing mobile devices, eliminating the need
for specialized biometric scanning devices typically used with most
biometric solutions.
GoVerifyID
was built to work seamlessly with our patented technology
portfolio, including GoMobile Interactive®, the secure dynamic
messaging system, and the ultra-scalable IWS Biometric Engine that
provides anonymous biometric matching and storage. GoVerifyID is
secure, simple to use, and designed to provide instant identity
authentication by engaging with the biometric capture capabilities
of each user’s mobile device. GoVerifyID also provides a
fully open SDK for organizations that require the utmost in
flexibility.
Our
GoVerifyID Enterprise Suite for Windows easily and seamlessly
integrates with a user’s existing Microsoft
ecosystem/infrastructure to support the user’s extended
workforce. GoVerifyID Enterprise Suite secures corporate networks
from end-to-end – both applications and data – on
client, server, and cloud systems with flexible user login policies
to address varied trust requirements. Our GoVerifyID Enterprise
Suite works with the smart devices that the workforce already uses,
including iOS/Android smartphones and tablets.
Our GoVerifyID Enterprise Suite for Windows
provides biometric authentication for the Microsoft ecosystem that
secures enterprise security without compromising agility,
productivity, or user experience. Its comprehensive architecture
offers biometric authentication for the complete range of
enterprise stakeholders, delivering secure enterprise applications
and workspaces to internal employees, partners, suppliers and
vendors, even customers. Out-of-band authentication is provided via
universally available devices, such as smartphones and tablets.
In-band authentication can be enabled via fingerprint readers, iris
scanners, and any Windows Biometric Framework compatible device.
The server component provides easy centralized management of
biometric authentication policies for all users, using a standard
Snap-In to the Microsoft Management Console. It provides greater
user assurance and Single Sign-On (“SSO”) convenience for all corporate systems and
cloud applications. There is no compromise in agility or user
experience.
GoVerifyID Enterprise Suite also provides options
for seamless integration with leading Enterprise Identity and
Access Management (“IAM”) solutions including CA SSO, IBM Security
Access Manager (“ISAM”), SAP Cloud Platform, and HPE’s
Aruba ClearPass. These turnkey integrations provide multi-modal
biometric authentication to replace or augment passwords for use
with enterprise and consumer class systems.
Our
Pillphone® Platform:
●
Improves
medication adherence and manages chronic conditions by enriching
the relationship between the care team and the patient via its
enterprise level, mobile communication platform;
●
Digitally
connects healthcare providers with patients and provides support
when the patients are outside of the medical facility;
●
Streamlines
workflows and improves care team communication and collaboration
with the patient by offering personalized, two-way interactive,
secure messaging and real-time remote medication monitoring;
and
●
Enhances
the human connection of the care team that is essential for quality
patient-centered care.
|
|
|
|
|
|
Risk Factors
Our business is subject to substantial risk.
Please carefully consider the section titled
“Risk
Factors” beginning on
page 6 of this prospectus for a discussion of the factors you
should carefully consider before investing in our
securities.
Additional
risks and uncertainties not presently known to us or that we
currently deem immaterial may also impair our business operations.
You should be able to bear a complete loss of your
investment.
Corporate Information
We were
incorporated in the state of Delaware in 2005, and previously
incorporated in California in 1987 as a California corporation. Our
principal place of business is located at 10815 Rancho Bernardo
Road, Suite 310, San Diego, California 92127. Our telephone number
is (858) 673-8600. We maintain a corporate website
at http://www.iwsinc.com. The information
contained on our website is not, and should not be interpreted to
be, a part of this prospectus.
Private Placements
On September 10, 2018 (the
“Closing
Date”), we entered into
securities purchase agreements with certain accredited investors
(the “Investors”), pursuant to which we sold a total of 890
shares of our Series C Preferred at a purchase price of $10,000 per
share (the “Stated
Value”), and on September
21, 2018, we entered into securities purchase agreements with
additional Investors, pursuant to which we sold an additional 110
shares of Series C Preferred (together, the
“Series C
Financing”). Shares of
Series C Preferred accrue dividends at a rate of 8% per annum
if paid in cash, or 10% per annum if paid by the issuance of shares
of the Common Stock, and are payable on a quarterly basis
(“Dividend
Shares”). In addition,
each share of Series C Preferred is convertible into that number of
shares of the Company’s Common Stock
(“Conversion
Shares”) equal to the
Stated Value, divided by $1.00, which conversion rate is subject to
adjustment in accordance with the terms of the Certificate of
Designations, Preferences, and Rights of Series C Convertible
Preferred Stock.
In connection with the sale of the Series C
Preferred, we granted certain registration rights to the Investors
with respect to the Conversion Shares and Dividend Shares, pursuant
to a Registration Rights Agreement by and among us and the
Investors (the “Registration Rights
Agreement”), each of whom
are also the selling stockholders identified in this prospectus in
the section titled “Selling
Stockholders.” We are
filing the registration statement, of which this prospectus forms a
part, pursuant to the terms of the Registration Rights Agreement
requiring us to file a registration statement no later than 30 days
after the Closing Date to register the Conversion Shares and the
Dividend Shares.
|
|
|
|
|
THE OFFERING
|
|
|
The following summary contains
general information about this offering. The summary is not
intended to be complete. You should read the full text and more
specific details contained elsewhere in this prospectus.
|
|
|
|
|
|
|
|
Common Stock being offered by selling stockholders
|
|
Up to 11,031,000 shares.
|
|
|
|
|
|
|
|
Common Stock outstanding as of October 4, 2018
|
|
96,727,726 shares.
|
|
|
|
|
|
|
|
Use of Proceeds
|
|
The selling stockholders will receive all of the proceeds from the
sale of the shares of Common Stock offered for sale under this
prospectus. We will not receive any proceeds from the sale of
shares of our Common Stock by the selling
stockholders.
|
|
|
|
|
|
|
|
Plan of Distribution
|
|
The selling stockholders may sell the shares of Common
Stock from time-to-time on the principal market on which the shares
of Common Stock are traded at the prevailing market price or in
negotiated transactions. See “Plan of
Distribution.”
|
|
|
|
|
|
|
|
Risk Factors
|
|
An investment in our securities involves a high degree of risk. See
“Risk Factors” for a discussion of factors you should
consider carefully before making an investment
decision.
|
|
|
|
|
|
|
|
OTCQB Trading Symbol
|
|
IWSY
|
|
|
|
|
|
|
|
The
number of shares of our Common Stock outstanding is based on
96,727,726 shares of Common Stock outstanding as of October 4,
2018, and excludes:
●
7,264,843
shares of our Common Stock issuable upon the exercise of stock
options outstanding at a weighted-average exercise price of $1.33
per share;
●
1,763,856
shares of Common Stock issuable upon the exercise of warrants at a
weighted-average exercise price of $0.16 per
share;
●
770,177 shares of Common Stock reserved for future
issuance under our 1999 Stock Award Plan (the
“1999
Plan”);
●
32,616,575 shares of Common Stock issuable upon
conversion of 37,468 outstanding shares of Series A Convertible
Preferred Stock
(“Series A
Preferred”);
●
47,043 shares of Common Stock issuable upon
conversion of 239,400 outstanding shares of Series B Convertible
Preferred Stock
(“Series B
Preferred”);
and
●
10,010,959 shares of Common Stock issuable upon
conversion of 1,000 outstanding shares of Series C Convertible
Preferred Stock
(“Series C
Preferred”).
Unless otherwise indicated, all information in this
prospectus assumes:
●
no conversion of outstanding shares of Series A
Preferred;
●
no conversion of outstanding shares of Series B
Preferred;
●
no conversion of outstanding shares of Series C
Preferred; and
●
no exercise of outstanding warrants or the
outstanding stock options issued under the 1999 Plan, as described
above.
|
|
Investing in our Common Stock involves a high degree of risk. You
should consider carefully the risks and uncertainties described
below, together with all of the other information in this
prospectus, including our financial statements and related notes,
before deciding whether to purchase shares of our Common Stock. If
any of the following risks are realized, our business,
financial condition, results of operations and prospects could be
materially and adversely affected. In that event, the price of our
Common Stock could decline and you could lose part or all of your
investment.
Risks Related to Our Business
We have a history of significant recurring losses totaling
approximately $177.7 million at June 30, 2018 and
$170.5 million at December 31, 2017, and these losses may
continue in the future.
As of June 30, 2018 and December 31, 2017, we had
an accumulated deficit of approximately $177.7 million and
$170.5 million,
respectively, and these losses may continue in the future. We
expect to continue to incur significant sales and marketing,
research and development, and general and administrative expenses.
As a result, we will need to generate significant revenues to
achieve profitability, and we may never achieve
profitability.
Our operating results have fluctuated in the past and are likely to
fluctuate significantly in the future.
Our
operating results have fluctuated in the past. These
fluctuations in operating results are the consequence of, amongst
others:
●
varying
demand for and market acceptance of our technology and
products;
●
changes
in our product or customer mix;
●
the
gain or loss of one or more key customers or their key customers,
or significant changes in the financial condition of one or more of
our key customers or their key customers;
●
our
ability to introduce, certify and deliver new products and
technologies on a timely basis;
●
the
announcement or introduction of products and technologies by our
competitors;
●
competitive
pressures on selling prices;
●
costs
associated with acquisitions and the integration of acquired
companies, products and technologies;
●
our
ability to successfully integrate acquired companies, products and
technologies;
●
our
accounting and legal expenses; and
●
general
economic conditions.
These
factors, some of which are not within our control, will likely
continue in the future. To respond to these and other factors, we
may need to make business decisions that could result in failure to
meet financial expectations. If our quarterly operating results
fail to meet or exceed the expectations of securities analysts or
investors, our stock price could drop suddenly and significantly.
Most of our expenses, such as employee compensation
and inventory, are relatively fixed in the short term.
Moreover, our expense levels are based, in part, on our
expectations regarding future revenue levels. As a result, if our
revenue for a particular period was below our expectations, we
would not be able to proportionately reduce our operating expenses
for that period. Any revenue shortfall would have a
disproportionately negative effect on our operating results for the
period.
We depend upon a
small number of large system sales ranging from $100,000 to in
excess of $2,000,000 and we may fail to achieve one or more large
system sales in the future.
Historically,
we have derived a substantial portion of our revenues from a small
number of sales of large, relatively expensive systems, typically
ranging in price from $100,000 to $2,000,000. If we fail to receive
orders for these large systems in a given sales cycle on a
consistent basis, our business could be significantly harmed.
Further, our quarterly results are difficult to predict because we
cannot predict in which quarter, if any, large system sales will
occur in a given year. As a result, we believe that
quarter-to-quarter comparisons of our results of operations are not
a good indication of our future performance. In some future
quarters, our operating results may be below the expectations of
securities analysts and investors, in which case the market price
of our common stock may decrease significantly.
Our lengthy sales
cycle may cause us to expend significant resources for one year or
more in anticipation of a sale to certain customers, yet we still
may fail to complete the sale.
When
considering the purchase of a large computerized identity
management system, potential customers may take as long as eighteen
months to evaluate different systems and obtain approval for the
purchase. Under these circumstances, if we fail to complete a sale,
we will have expended significant resources and received no revenue
in return. Generally, customers consider a wide range of issues
before committing to purchase our products, including product
benefits, ability to operate with their current systems, product
reliability and their own budgetary constraints. While potential
customers are evaluating our products, we may incur substantial
selling costs and expend significant management resources in an
effort to accomplish potential sales that may never occur. In times
of economic recession, our potential customers may be unwilling or
unable to commit resources to the purchase of new and costly
systems.
A significant
number of our customers and potential customers are government
agencies that are subject to unique political and budgetary
constraints and have special contracting requirements, which may
affect our ability to obtain new and retain current government
customers.
A
significant number of our customers are government agencies. These
agencies often do not set their own budgets and therefore have
little control over the amount of money they can spend from
quarter-to-quarter or year-to-year. In addition, these agencies
experience political pressure that may dictate the manner in which
they spend money. Due to political and budgetary processes and
other scheduling delays that may frequently occur relating to the
contract or bidding process, some government agency orders may be
canceled or substantially delayed, and the receipt of revenue or
payments from these agencies may be substantially delayed. In
addition, future sales to government agencies will depend on our
ability to meet government contracting requirements, certain of
which may be onerous or impossible to meet, resulting in our
inability to obtain a particular contract. Common requirements in
government contracts include bonding requirements, provisions
permitting the purchasing agency to modify or terminate at will the
contract without penalty, and provisions permitting the agency to
perform investigations or audits of our business practices, any of
which may limit our ability to enter into new contracts or maintain
our current contracts.
One customer accounted for approximately 43% of our total revenues
during the six months ended June 30, 2018, and approximately 25% of
our total revenues during the year ended December 31, 2017. In the
event of any material decrease in revenue from this customer, or if
we are unable to replace the revenue through the sale of our
products to additional customers, our financial condition and
results from operations could be materially and adversely
affected.
During the six months ended
June 30, 2018 and year ended December 31, 2017, one customer
accounted for approximately 43% or $1,121,000 of our total revenue, and 25% or $1,089,000 of
our total revenue, respectively. If this customer were to
significantly reduce its relationship with the Company, or in the
event the we are unable to replace the revenue through the sale of
our products to additional customers, our financial condition and
results from operations could be negatively impacted, and such
impact would be material.
We occasionally
rely on systems integrators to manage our large projects, and if
these companies do not perform adequately, we may lose
business.
We
occasionally act as a subcontractor to systems integrators who
manage large projects that incorporate our systems, particularly in
foreign countries. We cannot control these companies, and they may
decide not to promote our products or may price their services in
such a way as to make it unprofitable for us to continue our
relationship with them. Further, they may fail to perform under
agreements with their customers, in which case we might lose sales
to these customers. If we lose our relationships with these
companies, our business, financial condition and results of
operations may suffer.
We are dependent upon third parties for the successful integration
of our products, and/or the launch of our products. Any delay in
the integration of our products or the launch of third-party
products may materially affect our results from operations and
financial condition.
Our current marketing
strategy involves the distribution of our products through larger
product partners and/or resellers that will either resell our
product alongside theirs, OEM a white label version of our
products, or sell our products fully integrated into their
offerings. Our strategy leaves us largely dependent upon the
successful rollout of our products by our distribution partners. We
have experienced delays in the rollout of our products due to these
factors during the years ended December 31, 2016 and 2017, and no
assurances can be given that we will not experience delays in the
future. Any delays negatively affect our results from operations
and financial condition.
If the patents we
own or license, or our other intellectual property rights, do not
adequately protect our products and technologies, we may lose
market share to our competitors and our business, financial
condition and results of operations would be adversely
affected.
Our success depends significantly on our ability
to protect our rights to the technologies used in our products. We
rely on patent protection, trade secrets, as well as a combination
of copyright and trademark laws and nondisclosure, confidentiality
and other contractual arrangements to protect our technology.
However, these legal means afford only limited protection and may
not adequately protect our rights or permit us to gain or keep any
competitive advantage. In addition, we cannot be assured that any
of our current and future pending patent applications will result
in the issuance of a patent to us. The U.S. Patent and Trademark
Office (“PTO”) may deny or require significant narrowing
of claims in our pending patent applications, and patents issued as
a result of the pending patent applications, if any, may not
provide us with significant commercial protection or may not be
issued in a form that is advantageous to us. We could also incur
substantial costs in proceedings before the PTO. These proceedings
could result in adverse decisions as to the claims included in our
patents.
Our
issued and licensed patents and those that may be issued or
licensed in the future may be challenged, invalidated or
circumvented, which could limit our ability to stop competitors
from marketing related products. Additionally, upon expiration of
our issued or licensed patents, we may lose some of our rights to
exclude others from making, using, selling or importing products
using the technology based on the expired patents. We also must
rely on contractual rights with the third parties that license
technology to us to protect our rights in the technology licensed
to us. Although we have taken steps to protect our intellectual
property and technology, there is no assurance that competitors
will not be able to design around our patents. We also rely on
unpatented proprietary technology. We cannot assure you that we can
meaningfully protect all our rights in our unpatented proprietary
technology or that others will not independently develop
substantially equivalent proprietary products or processes or
otherwise gain access to our unpatented proprietary technology. We
seek to protect our know-how and other unpatented proprietary
technology with confidentiality agreements and intellectual
property assignment agreements with our employees. However, such
agreements may not provide meaningful protection for our
proprietary information in the event of unauthorized use or
disclosure or other breaches of the agreements or in the event that
our competitors discover or independently develop similar or
identical designs or other proprietary information. In addition, we
rely on the use of registered and common law trademarks with
respect to the brand names of some of our products. Our common law
trademarks provide less protection than our registered trademarks.
Loss of rights in our trademarks could adversely affect our
business, financial condition and results of
operations.
Furthermore,
the laws of foreign countries may not protect our intellectual
property rights to the same extent as the laws of the United
States. If we fail to apply for intellectual property protection or
if we cannot adequately protect our intellectual property rights in
these foreign countries, our competitors may be able to compete
more effectively against us, which could adversely affect our
competitive position, as well as our business, financial condition
and results of operations.
If third parties
claim that we infringe their intellectual property rights, we may
incur liabilities and costs and may have to redesign or discontinue
selling certain products.
Whether a product infringes a patent involves
complex legal and factual issues, the determination of which is
often uncertain. We face the risk of claims that we have infringed
on third parties’ intellectual property rights. Searching for
existing intellectual property rights may not reveal important
intellectual property and our competitors may also have filed for
patent protection, which is not yet a matter of public knowledge,
or claimed trademark rights that have not been revealed through our
availability searches. Our efforts to identify and avoid infringing
on third parties’ intellectual property rights may not always
be successful. Any claims of patent or other intellectual property
infringement, even those without merit,
could:
●
increase
the cost of our products;
●
be
expensive and time consuming to defend;
●
result
in us being required to pay significant damages to third
parties;
●
force
us to cease making or selling products that incorporate the
challenged intellectual property;
●
require
us to redesign, reengineer or rebrand our products;
●
require
us to enter into royalty or licensing agreements in order to obtain
the right to use a third party’s intellectual property, the
terms of which may not be acceptable to us;
●
require
us to indemnify third parties pursuant to contracts in which we
have agreed to provide indemnification to such parties for
intellectual property infringement claims;
●
divert
the attention of our management; and
●
result
in our customers or potential customers deferring or limiting their
purchase or use of the affected products until the litigation is
resolved.
In
addition, new patents obtained by our competitors could threaten a
product’s continued life in the market even after it has
already been introduced.
If our security measures or those of our third-party data center
hosting facilities, cloud computing platform providers, or
third-party service partners, are breached, and unauthorized access
is obtained to a customer’s data, our data or our IT systems,
or authorized access is blocked or disabled, our services may be
perceived as not being secure, customers may curtail or stop using
our services, and we may incur significant legal and financial
exposure and liabilities.
Our
services involve the storage and transmission of our
customers’ and our customers’ customers’
proprietary and other sensitive data, including financial
information and other personally identifiable information. While we
have security measures in place, they may be breached as a result
of efforts by individuals or groups of hackers and sophisticated
organizations, including state-sponsored organizations or
nation-states. Our security measures could also be compromised by
employee error or malfeasance, which could result in someone
obtaining unauthorized access to, or denying authorized access to
our IT systems, our customers’ data or our data, including
our intellectual property and other confidential business
information. Additionally, third parties may attempt to
fraudulently induce employees or customers into disclosing
sensitive information such as user names, passwords or other
information to gain access to our customers’ data, our data
or our IT systems.
We
take extraordinary measures to ensure identity authentication of
users who access critical IT infrastructure, including but not
limited to, two-factor, multi-factor and biometric identity
verification. This substantially reduces the threat of unauthorized
access by bad actors using compromised user
credentials.
Because
the techniques used to breach, obtain unauthorized access to, or
sabotage IT systems change frequently, grow more complex over time,
and generally are not recognized until launched against a target,
we may be unable to anticipate or implement adequate measures to
prevent against such techniques.
Our
services operate in conjunction with and are dependent on products
and components across a broad ecosystem and, as illustrated by the
recent Spectre and Meltdown threats, if there are security
vulnerabilities in one of these components, a security breach could
occur. In addition, our internal IT systems continue to evolve and
we are often early adapters of new technologies and new ways of
sharing data and communicating internally and with partners and
customers, which increases the complexity of our IT systems. These
risks are mitigated by our ability to maintain and improve business
and data governance policies and processes and internal security
controls, including our ability to escalate and respond to known
and potential risks.
In
addition, our customers may authorize third-party technology
providers to access their customer data, and some of our customers
may not have adequate security measures in place to protect their
data that is stored on our servers. Because we do not control our
customers or third-party technology providers, or the processing of
such data by third-party technology providers, we cannot ensure the
integrity or security of such transmissions or processing.
Malicious third parties may also conduct attacks designed to
temporarily deny customers access to our services.
A
security breach could expose us to a risk of loss or inappropriate
use of proprietary and sensitive data, or the denial of access to
this data. A security breach could also result in a loss of
confidence in the security of our services, damage our reputation,
negatively impact our future sales, disrupt our business and lead
to legal liability. Finally, the detection, prevention and
remediation of known or potential security vulnerabilities,
including those arising from third-party hardware or software may
result in additional direct and indirect costs, for example
additional infrastructure capacity to mitigate any system
degradation that could result from remediation
efforts.
We operate in
foreign countries and are exposed to risks associated with foreign
political, economic and legal environments and with foreign
currency exchange rates.
We
have significant foreign operations. As a result, we are exposed to
risks, including among others, risks associated with foreign
political, economic and legal environments and with foreign
currency exchange rates. Our results may be adversely affected by,
among other things, changes in government policies with respect to
laws and regulations, anti-inflation measures, currency
conversions, collection of receivables abroad and rates and methods
of taxation.
We depend on key personnel, the loss of any of whom could
materially adversely affect future operations.
Our
success will depend to a significant extent upon the efforts and
abilities of our executive officers and other key personnel. The
loss of the services of one or more of these key employees and any
negative market or industry perception arising from the loss of
such services could have a material adverse effect on us and the
trading price of our Common Stock. Our business will also be
dependent upon our ability to attract and retain qualified
personnel. Acquiring and keeping these personnel could prove more
difficult or cost substantially more than estimated and we cannot
be certain that we will be able to retain such personnel or attract
a high caliber of personnel in the future.
We may have additional tax liabilities.
We are subject to income taxes in the United
States. Significant judgments are required in determining our
provisions for income taxes. In the course of preparing our tax
provisions and returns, we must make calculations where the
ultimate tax determination may be uncertain. Our tax returns are
subject to examination by the Internal Revenue Service
(“IRS”) and state tax authorities. There
can be no assurance as to the outcome of these examinations. If the
ultimate determination of taxes owed is for an amount in excess of
amounts previously accrued, our operating results, cash flows, and
financial condition could be adversely
affected.
We face competition from companies with greater financial,
technical, sales, marketing and other resources, and, if we are
unable to compete effectively with these competitors, our market
share may decline and our business could be
harmed.
We
face competition from other established companies. A number of our
competitors have longer operating histories, larger customer bases,
significantly greater financial, technological, sales, marketing
and other resources than we do. As a result, our competitors
may be able to respond more quickly than we can to new or changing
opportunities, technologies, standards or client requirements, more
quickly develop new products or devote greater resources to the
promotion and sale of their products and services than we
can. Likewise, their greater capabilities in these areas may
enable them to better withstand periodic downturns in the identity
management solutions industry and compete more effectively on the
basis of price and production. In addition, new companies may
enter the markets in which we compete, further increasing
competition in the identity management solutions
industry.
We
believe that our ability to compete successfully depends on a
number of factors, including the type and quality of our products
and the strength of our brand names, as well as many factors beyond
our control. We may not be able to compete successfully against
current or future competitors, and increased competition may result
in price reductions, reduced profit margins, loss of market share
and an inability to generate cash flows that are sufficient to
maintain or expand the development and marketing of new products,
any of which would adversely impact our results of operations and
financial condition.
Risks Related to Our Securities
Our Common Stock
is subject to “penny stock” rules.
Our
Common Stock is currently defined as a “penny stock”
under Rule 3a51-1 promulgated under the Exchange Act. “Penny
stocks” are subject to Rules 15g-2 through 15g-7 and Rule
15g-9, which impose additional sales practice requirements on
broker-dealers that sell penny stocks to persons other than
established customers and institutional accredited investors. Among
other things, for transactions covered by these rules, a
broker-dealer must make a special suitability determination for the
purchaser and have received the purchaser’s written consent
to the transaction prior to sale. Consequently, these rules may
affect the ability of broker-dealers to sell our Common Stock and
affect the ability of holders to sell their shares of our Common
Stock in the secondary market. To the extent our Common Stock is
subject to the penny stock regulations, the market liquidity for
our shares will be adversely affected.
Our stock price
has been volatile, and your investment in our Common Stock could
suffer a decline in value.
There
has been significant volatility in the market price and trading
volume of equity securities, which is unrelated to the financial
performance of the companies issuing the securities. These broad
market fluctuations may negatively affect the market price of our
Common Stock. You may not be able to resell your shares at or above
the price you pay for those shares due to fluctuations in the
market price of our Common Stock caused by changes in our operating
performance or prospects and other factors.
Some
specific factors that may have a significant effect on our Common
Stock market price include:
●
actual
or anticipated fluctuations in our operating results or future
prospects;
●
our
announcements or our competitors’ announcements of new
products;
●
the
public’s reaction to our press releases, our other public
announcements and our filings with the SEC;
●
strategic
actions by us or our competitors, such as acquisitions or
restructurings;
●
new
laws or regulations or new interpretations of existing laws or
regulations applicable to our business;
●
changes
in accounting standards, policies, guidance, interpretations or
principles;
●
changes
in our growth rates or our competitors’ growth
rates;
●
developments
regarding our patents or proprietary rights or those of our
competitors;
●
our
inability to raise additional capital as needed;
●
substantial
sales of Common Stock underlying warrants and preferred
stock;
●
concern
as to the efficacy of our products;
●
changes
in financial markets or general economic conditions;
●
sales
of Common Stock by us or members of our management team;
and
●
changes
in stock market analyst recommendations or earnings estimates
regarding our Common Stock, other comparable companies or our
industry generally.
Our future sales
of our Common Stock could adversely affect its price and our future
capital-raising activities could involve the issuance of equity
securities, which would dilute shareholders’ investments and
could result in a decline in the trading price of our Common
Stock.
We
may sell securities in the public or private equity markets if and
when conditions are favorable, even if we do not have an immediate
need for additional capital at that time. Sales of substantial
amounts of our Common Stock, or the perception that such sales
could occur, could adversely affect the prevailing market price of
our Common Stock and our ability to raise capital. We may issue
additional Common Stock in future financing transactions or as
incentive compensation for our executive management and other key
personnel, consultants and advisors. Issuing any equity securities
would be dilutive to the equity interests represented by our
then-outstanding shares of Common Stock. The market price for our
Common Stock could decrease as the market takes into account the
dilutive effect of any of these issuances. Furthermore, we may
enter into financing transactions at prices that represent a
substantial discount to the market price of our Common Stock. A
negative reaction by investors and securities analysts to any
discounted sale of our equity securities could result in a decline
in the trading price of our Common Stock.
The holders of our
preferred stock have certain rights and privileges that are senior
to our Common Stock, and we may issue additional shares of
preferred stock without stockholder approval that could have a
material adverse effect on the market value of the Common
Stock.
Our Board of Directors has the authority to issue
a total of up to four million shares of preferred stock and to fix
the rights, preferences, privileges, and restrictions, including
voting rights, of the preferred stock, which typically are senior
to the rights of the Common Stock, without any further vote or
action by the holders of our Common Stock. The rights of the
holders of our Common Stock will be subject to, and may be
adversely affected by, the rights of the holders of the preferred
stock that have been issued, or might be issued in the future.
Preferred stock also could have the effect of making it more
difficult for a third party to acquire a majority of our
outstanding voting stock. This could delay, defer, or prevent a
change in control. Furthermore, holders of preferred stock may have
other rights, including economic rights, senior to the Common
Stock. As a result, their existence and issuance could have a
material adverse effect on the market value of the Common Stock. We
have in the past issued, and may from time to time in the future
issue, preferred stock for financing or other purposes with rights,
preferences, or privileges senior to the Common Stock. As of
October 4, 2018 we had three series of preferred stock outstanding,
Series A Convertible Preferred Stock (“Series A
Preferred”), Series B
Convertible Preferred Stock (“Series B
Preferred”) and Series C
Convertible Preferred Stock (“Series C
Preferred”).
The
provisions of our Series A Preferred prohibit the payment of
dividends on our Common Stock unless the dividends on our preferred
shares are first paid. In addition, upon a liquidation, dissolution
or sale of our business, the holders of our Series A Preferred will
be entitled to receive, in preference to any distribution to the
holders of Common Stock, initial distributions of $1,000 per share,
plus all accrued but unpaid dividends. As of June 30, 2018 and
December 31, 2017, we had cumulative undeclared dividends on our
Series A Preferred of $0.
The
provisions of our Series B Preferred prohibit the payment of
dividends on our Common Stock unless the dividends on our preferred
shares are first paid. In addition, upon a liquidation, dissolution
or sale of our business, the holders of our Series B Preferred will
be entitled to receive, in preference to any distribution to the
holders of Common Stock, initial distributions of $2.50 per share,
plus all accrued but unpaid dividends. As of June 30, 2018 and
December 31, 2017, we had cumulative undeclared dividends on our
Series B Preferred of approximately $8,000.
The
provisions of our Series C Preferred prohibit the payment of
dividends on our Common Stock unless the dividends on our preferred
shares are first paid. In addition, upon a liquidation, dissolution
or sale of our business, the holders of our Series C Preferred will
be entitled to receive, in preference to any distribution to the
holders of Common Stock, initial distributions of $10,000 per
share, plus all accrued but unpaid dividends. As of June 30, 2018
and December 31, 2017, there were no shares of Series C Preferred
outstanding; therefore, there were no cumulative undeclared
dividends on our Series C Preferred as of such dates.
Certain
large shareholders may have certain personal interests that may
affect the Company.
As a result of the securities issued to Goldman
Capital Management and related entities controlled by Neal Goldman,
a member of our Board of Directors (together,
“Goldman”), Goldman beneficially owns, in the
aggregate, approximately 39.9% of the Company’s outstanding
voting securities as of October 4, 2018. As a result,
Goldman has the potential ability to exert influence over both the
actions of the Board of Directors and the outcome of issues
requiring approval by the Company’s shareholders. This
concentration of ownership may have effects such as delaying or
preventing a change in control of the Company that may be favored
by other shareholders or preventing transactions in which
shareholders might otherwise recover a premium for their shares
over current market prices.
Our corporate
documents and Delaware law contain provisions that could
discourage, delay or prevent a change in control of the
Company.
Provisions
in our certificate of incorporation and bylaws may discourage,
delay or prevent a merger or acquisition involving us that our
stockholders may consider favorable. For example, our certificate
of incorporation authorizes preferred stock, which carries special
rights, including voting and dividend rights. With these rights,
preferred stockholders could make it more difficult for a third
party to acquire us.
We
are also subject to the anti-takeover provisions of Section 203 of
the Delaware General Corporation Law. Under these provisions, if
anyone becomes an “interested stockholder,” we may not
enter into a “business combination” with that person
for three years without special approval, which could discourage a
third party from making a takeover offer and could delay or prevent
a change of control. For purposes of Section 203, “interested
stockholder” means, generally, someone owning 15% or more of
our outstanding voting stock or an affiliate of ours that owned 15%
or more of our outstanding voting stock during the past three
years, subject to certain exceptions as described in Section
203.
We do not expect
to pay cash dividends on our Common Stock for the foreseeable
future.
We
have never paid cash dividends on our Common Stock and do not
anticipate that any cash dividends will be paid on the Common Stock
for the foreseeable future. The payment of any cash dividend by us
will be at the discretion of our Board of Directors and will depend
on, among other things, our earnings, capital, regulatory
requirements and financial condition. Furthermore, the terms of our
Series A Preferred, Series B Preferred and Series C Preferred
directly limit our ability to pay cash dividends on our Common
Stock.
CAUTIONARY NOTES REGARDING FORWARD-LOOKING
STATEMENTS
This
prospectus contains forward-looking statements that involve
substantial risks and uncertainties. All statements contained in
this prospectus other than statements of historical facts,
including statements regarding our strategy, future operations,
future financial position, future revenue, projected costs,
prospects, plans, objectives of management and expected market
growth, are forward-looking statements. These statements involve
known and unknown risks, uncertainties and other important factors
that may cause our actual results, performance or achievements to
be materially different from any future results, performance or
achievements expressed or implied by the forward-looking
statements.
The
words “anticipate,” “believe,”
“estimate,” “expect,” “intend,”
“may,” “plan,” “predict,”
“project,” “target,”
“potential,” “will,” “would,”
“could,” “should,” “continue,”
and similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain
these identifying words. These forward-looking statements include,
among other things, statements about:
●
the
availability of capital to satisfy our working capital
requirements;
●
the
accuracy of our estimates regarding expenses, future revenues and
capital requirements;
●
anticipated
trends and challenges in our business and the markets in which we
operate;
●
our
ability to anticipate market needs or develop new or enhanced
products to meet those needs;
●
our
expectations regarding market acceptance of our
products;
●
the
success of competing products by others that are or become
available in the market in which we sell our products;
●
our
ability to protect our confidential information and intellectual
property rights;
●
our
ability to manage expansion into international
markets;
●
our
ability to maintain or broaden our business relationships and
develop new relationships with strategic alliances, suppliers,
customers, distributors or otherwise;
●
developments
in the U.S. and foreign countries; and
●
other risks and uncertainties, including
those described under
“Risk
Factors” and elsewhere
in this prospectus.
These
forward-looking statements are only predictions and we may not
actually achieve the plans, intentions or expectations disclosed in
our forward-looking statements, so you should not place undue
reliance on our forward-looking statements. Actual results or
events could differ materially from the plans, intentions and
expectations disclosed in the forward-looking statements we make.
We have based these forward-looking statements largely on our
current expectations and projections about future events and trends
that we believe may affect our business, financial condition and
operating results. We have included important factors in the
cautionary statements included in this prospectus, as well as
certain information incorporated by reference into this prospectus,
that could cause actual future results or events to differ
materially from the forward-looking statements that we make. Our
forward-looking statements do not reflect the potential impact of
any future acquisitions, mergers, dispositions, joint ventures or
investments we may make.
You
should read this prospectus with the understanding that our actual
future results may be materially different from what we expect. We
do not assume any obligation to update any forward-looking
statements whether as a result of new information, future events or
otherwise, except as required by applicable law.
SELECTED CONSOLIDATED FINANCIAL
DATA
The
summary consolidated statement of operations and balance sheet data
for the years ended and as of December 31, 2017 and December 31,
2016 presented below are derived from our audited consolidated
financial statements included elsewhere in this prospectus. The
selected consolidated statement of operations data for the six
months ended June 30, 2018 and June 30, 2017 and the selected
consolidated balance sheet data as of June 30, 2018 have been
derived from our unaudited consolidated interim financial
information included elsewhere in this prospectus, which, in the
opinion of our management, includes all adjustments necessary to
present fairly our results of operations and financial condition at
the dates and for the periods presented. The results for the six
months ended June 30, 2018 are not necessarily indicative of the
results that you should expect for the entire year ending December
31, 2018, or any other period.
This
financial information should be read in conjunction with
“Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” and our consolidated financial statements,
including the notes thereto, included elsewhere in this
prospectus.
Statements
of Operations Data:
(dollars in thousands, except for per share data
figures)
|
Six Months Ended
June 30,
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
Product
|
$1,279
|
$680
|
$1,614
|
$1,249
|
Maintenance
|
1,322
|
1,309
|
2,679
|
2,563
|
|
2,601
|
1,989
|
4,293
|
3,812
|
Cost of revenue:
|
|
|
|
|
Product
|
165
|
90
|
152
|
243
|
Maintenance
|
390
|
423
|
839
|
827
|
Gross
profit
|
2,046
|
1,476
|
3,302
|
2,742
|
|
|
|
|
|
Operating expense:
|
|
|
|
|
General
and administrative
|
2,190
|
1,934
|
4,192
|
3,722
|
Sales
and marketing
|
1,680
|
1,463
|
2,816
|
3,021
|
Research
and development
|
3,664
|
3,096
|
5,953
|
5,332
|
Depreciation
and amortization
|
24
|
38
|
68
|
129
|
|
7,558
|
6,531
|
13,029
|
12,204
|
Loss
from operations
|
(5,512)
|
(5,055)
|
(9,727)
|
(9,462)
|
|
|
|
|
|
Interest
expense, net
|
356
|
264
|
591
|
245
|
Other
income, net
|
—
|
(50)
|
(125)
|
(201)
|
Loss
before income taxes
|
(5,868)
|
(5,269)
|
(10,193)
|
(9,506)
|
Income
tax expense (benefit)
|
1
|
7
|
(124)
|
21
|
Net
loss
|
(5,869)
|
(5,276)
|
(10,069)
|
(9,527)
|
Preferred
dividends
|
(1,489)
|
(1,021)
|
(2,400)
|
(1,347)
|
Preferred
stock exchange
|
-
|
-
|
(1,245)
|
-
|
Net
loss available to common shareholders
|
$(7,358)
|
$(6,297)
|
$(13,714)
|
$(10,874)
|
|
|
|
|
|
Basic and diluted loss per common share
|
|
|
|
|
Net
loss
|
$(0.06)
|
$(0.06)
|
$(0.11)
|
$(0.10)
|
Preferred
dividends
|
(0.02)
|
(0.01)
|
(0.03)
|
(0.02)
|
Preferred
stock exchange
|
-
|
-
|
(0.01)
|
-
|
Basic
and diluted loss per share available to common
shareholders
|
$(0.08)
|
$(0.07)
|
$(0.15)
|
$(0.12)
|
Basic
and diluted weighted-average shares outstanding
|
94,749,904
|
92,203,567
|
92,816,723
|
94,426,783
|
(1) See Note 2 to our
audited consolidated financial statements included elsewhere in
this prospectus for an explanation of the method used to calculate
basic and diluted net loss per common share and the
weighted-average number of shares used in the computation of the
per share amounts.
Consolidated Balance Sheet Data:
(dollars in thousands)
|
June
30,
2018
(unaudited)
|
|
Cash
|
$2,213
|
$7,317
|
Total
assets
|
6,676
|
11,604
|
Accounts
payable, deferred revenue and accrued expenses
|
1,723
|
2,131
|
Accrued
interest payable to related parties
|
791
|
527
|
Convertible
lines of credit to related parties, net of discount
|
5,871
|
5,774
|
Pension
obligation
|
2,039
|
2,024
|
Total
liabilities
|
10,424
|
10,456
|
Total
stockholders’ (deficit) equity
|
(3,748)
|
1,148
|
Total
liabilities and shareholders’ equity (deficit)
|
6,676
|
11,604
|
|
|
|
DESCRIPTION OF PRIVATE PLACEMENT
TRANSACTIONS
On September 10, 2018, we entered into securities
purchase agreements with certain Investors, pursuant to which we
sold a total of 890 shares of our Series C Preferred at a purchase
price of $10,000 per share (the “Stated
Value”), and on September
21, 2018, we entered into securities purchase agreements with
additional Investors pursuant to which we sold an additional 110
shares of Series C Preferred (together, the
“Series C
Financing”). The issuance
of the Series C Preferred over the course of the Series C Financing
resulted in gross proceeds to the Company of $10.0
million.
Shares of Series C Preferred accrue dividends
at a rate of 8% per annum if paid in cash, or 10% per annum if paid
by the issuance of shares of the Common Stock, and are payable on a
quarterly basis (“Dividend
Shares”). Each share of
Series C Preferred has a liquidation preference equal to the
greater of (i) the Stated Value plus all accrued and unpaid
dividends, and (ii) such amount per share as would have been
payable had each share been converted into Common Stock immediately
prior to the occurrence of a Liquidation Event or Deemed
Liquidation Event (as such terms are defined in the Certificate of
Designations, Preferences, and Rights of Series C Convertible
Preferred Stock (“Series C
COD”)) (the
“Liquidation Preference
Amount”). Each share of
Series C Preferred is convertible into that number of shares of the
Company’s Common Stock (“Conversion
Shares”) equal to the
Stated Value, divided by $1.00, which conversion rate is subject to
adjustment in accordance with the terms of the Series C COD.
Holders of Series C Preferred may elect to convert shares of Series
C Preferred into Conversion Shares at any time. Holders of the
Series C Preferred may also require the Company to redeem all or
any portion of such holder’s shares of Series C Preferred at
any time from and after the third anniversary of the issuance date
or in the event of the consummation of a Change of Control (as such
term is defined in the Series C COD). Subject to the terms and
conditions set forth in the Series C COD, in the event the
volume-weighted average price of the Company’s Common Stock
is at least $3.00 per share (subject to adjustment in accordance
with the terms of the Series C COD) for at least 20 consecutive
trading days, the Company may convert all, but not less than all,
issued and outstanding shares of Series C Preferred into Conversion
Shares. In addition, in the event of a Change of Control, the
Company will have the option to redeem all, but not less than all,
issued and outstanding shares of Series C Preferred for 115% of the
Liquidation Preference Amount per share. Holders of Series C
Preferred will have the right to vote, on an as-converted basis,
with the holders of the Company’s Common Stock on any matter
presented to the Company’s stockholders for their action or
consideration. Shares of Series C Preferred rank senior to the
Company’s Common Stock and Series A Convertible Preferred
Stock, and junior to the Company’s Series B Convertible
Preferred Stock.
In connection with the sale of the Series C
Preferred, we granted certain registration rights to the Investors
(each of whom is also a selling stockholder identified in this
prospectus in the section titled “Selling
Stockholders”) with
respect to the Conversion Shares and Dividend Shares, pursuant to a
Registration Rights Agreement by and among us and the Investors
(the “Registration Rights
Agreement”). Under the
terms of the Registration Rights Agreement we agreed to file a
registration statement no later than 30 days after the Closing Date
in order to register the Conversion Shares and the Dividend
Shares, and are filing the registration statement, of which
this prospectus forms a part, in satisfaction of that obligation
under the Registration Rights Agreement.
The
Common Stock to be offered and sold using this prospectus will be
offered and sold by the selling stockholders named in this
prospectus. Accordingly, we will not receive any proceeds from any
sale of shares of our Common Stock in this offering.
This prospectus relates to the sale from
time to time by the selling
stockholders of up to 11,031,000 shares of our Common Stock, of
which 10,000,000 shares are issuable as Conversion Shares and an
estimated 1,031,000 may be issued as Dividend Shares within 12
months from the date of this prospectus. Both the Conversion Shares
and the Dividend Shares are issuable to the selling stockholders
pursuant to certain rights associated with shares of Series C
Preferred purchased by the selling stockholders during the Series C
Financing, which shares of Series C Preferred were issued and
outstanding prior to the original date of filing of the
registration statement of which this prospectus forms a
part.
Selling Stockholders Table
The table below presents information as of October
4, 2018, regarding the selling stockholders and the shares of
Common Stock the selling stockholders may offer and sell from time
to time under this prospectus, including an aggregate of
10,000,000 shares of Common Stock that that may be issued to them
from time to time as Conversion Shares and an estimated 1,031,000
shares of Common Stock that may be issued as Dividend Shares within
12 months from the date of this prospectus. More specifically, the following table sets
forth as to the selling stockholders:
●
|
the
number of shares of our Common Stock that the selling stockholders
beneficially owned prior to this offering;
|
●
|
the
total number of shares of our Common Stock that the selling
stockholders may offer for resale
pursuant to this prospectus; and
|
●
|
the
number and percent of shares of our Common Stock beneficially held
by the selling stockholders after this offering, assuming all of
the resale shares of Common Stock are sold by the selling
stockholders and that the selling stockholders do not acquire any
other shares of our Common Stock prior to their assumed sale of all
of the resale shares.
|
The table is prepared based on information
supplied to us by the selling stockholders. Although we have
assumed for purposes of the table below that the selling
stockholders will sell all of the securities offered by this
prospectus, because the selling stockholders may offer from time to
time all or some of their securities covered under this prospectus,
or in another permitted manner, no assurances can be given as to
the actual number of securities that will be resold by the selling
stockholders or that will be held by the selling stockholders after
completion of the resales. In addition, the selling stockholders
may have sold, transferred or otherwise disposed of the securities
in transactions exempt from the registration requirements of the
Securities Act of 1933, as amended (the “Securities
Act”), since the date the
selling stockholders provided the information regarding their
securities holdings. Information covering the selling stockholders
may change from time to time and changed information will be
presented in a supplement to this prospectus if and when necessary
and required.
Except
as described above, there are currently no agreements, arrangements
or understandings with respect to the resale of any of the
securities covered by this prospectus.
The
applicable percentages of ownership are based on an aggregate of
96,727,726 shares of our Common Stock issued and outstanding on
October 4, 2018. The number of shares Common Stock beneficially
owned by the selling stockholders is determined under rules
promulgated by the Securities and Exchange Commission.
|
|
Maximum
Shares
Being Offered
Hereby
|
Shares
Beneficially Owned
After the
Offering
|
Name of Selling
Stockholder
|
Owned Prior to
the Offering (1)(2)
|
|
|
Number(1)(4)
|
|
Blackwell Partners
LLC – Series A (6)
|
1,287,570
|
1,280,000
|
131,968
|
-
|
*
|
Geode Capital
Management LP(7)
|
1,002,817
|
1,000,000
|
103,100
|
-
|
*
|
Lane Ventures,
Inc.(8)
|
100,282
|
100,000
|
10,310
|
-
|
*
|
Nantahala Capital
Partners Limited
Partnership (6)
|
543,194
|
540,000
|
55,674
|
-
|
*
|
Nantahala Capital
Partners II Limited Partnership (6)
|
1,126,624
|
1,120,000
|
115,472
|
-
|
*
|
Nantahala Capital
Partners SI, LP(6)
|
3,993,478
|
3,970,000
|
409,307
|
-
|
*
|
Shellback
Financial, LLC(9)
|
1,005,914
|
1,000,000
|
103,100
|
-
|
*
|
Silver Creek CS
SAV, L.L.C. (6)
|
593,490
|
590,000
|
60,829
|
-
|
*
|
Stadlin Trust,
dated 5/25/01(10)
|
100,592
|
100,000
|
10,310
|
-
|
*
|
Weintraub Capital
Management, LP(11)
|
406,775(12)
|
300,000
|
30,930
|
105,000(12)
|
*
|
_______________
*
|
Denotes
a percentage less than one percent.
|
(1)
|
Includes
shares owned prior to the private placement transactions, which
shares are not being offered pursuant to this
prospectus.
|
(2)
|
Includes
shares of Common Stock that may be issued as Conversion Shares
within 60 days of October 10, 2018 and shares of
Common Stock issued as Dividend Shares on September 30,
2018, but does not include shares of Common Stock that may
be issued as Dividend Shares after September 30, 2018, as such
amount was not determinable on October 10, 2018. Assumes complete
conversion of all Series C Preferred convertible within 60 days of
October 10, 2018, without regard to any limitations on conversions
or exercise.
|
(3)
|
Per the
Series C COD, the number of shares of Common Stock issuable as
Dividend Shares are calculated by dividing the value of the
dividend payable on a particular payment date by the VWAP for
the five consecutive trading days immediately preceding the payment
date, as reported on the OTCQB Marketplace.
Because
the aggregate number of Dividend Shares issuable within the 12
month period following the date of this prospectus is not currently
known, this column identifies shares of Common Stock estimated to
be issuable as Dividend Shares within 12 months of October 10,
2018, based on the closing price of the Company’s Common
Stock on October 4, 2018, as reported on the OTCQB Capital
Market.
|
(4)
|
Assumes
that each selling stockholder will sell all Conversion Shares and
Dividend Shares offered by it under this prospectus.
|
(5)
|
This
number represents the percentage of Common Stock to be owned by the
selling stockholder after completion of the offering based on the
number of shares of Common Stock outstanding on October 4, 2018, as
adjusted to reflect the assumption that all 1,000 shares of Series
C Preferred are converted into the corresponding number of shares
of Common Stock so that there will be an aggregate of 106,727,726
shares of Common Stock outstanding.
|
(6)
|
Nantahala
Capital Management, LLC is a Registered Investment Adviser and has
been delegated the legal power to vote and/or direct the
disposition of securities on behalf of these entities as a General
Partner or Investment Manager and would be considered the
beneficial owner of such securities. The above shall not be deemed
to be an admission by the record owners or these selling
stockholders that they are themselves beneficial owners of these
shares of securities for purposes of Section 13(d) of the Exchange
Act or any other purpose.
|
(7)
|
Mr.
Jeffrey S. Miller, Chief Operating Officer of Geode Capital
Management LP, may be deemed to hold
voting and dispositive power over the shares identified
herein.
|
(8)
|
Mr.
Joseph Hammer, President of Lane Ventures, Inc., may be deemed to
hold voting and dispositive power over
the shares identified herein.
|
(9)
|
Mr.
Shawn D. Messner, President and Founder of Shellback Financial,
LLC, may be deemed to hold voting and
dispositive power over the shares identified
herein.
Mr. Messner is affiliated with Northland Capital Markets, which is
the trade name for certain capital markets and investment banking
services of Northland Securities, Inc., member FINRA/SIPC, and has
advised the Company that the securities were received solely as an
investment and not with a view to or for resale or
distribution.
|
(10)
|
Mr.
David Stadlin, Trustee for the Stadlin Trust, dated 5/25/01, may be
deemed to hold voting and dispositive
power over the shares identified herein.
|
(11)
|
Mr.
Jerald M. Weintraub, President of Weintraub Capital Management,
L.P., may be deemed to hold voting and
dispositive power over the shares identified
herein.
|
(12)
|
In
addition to Dividend Shares issued on September 30, 2018, inludes
(i) 91,350 shares of Common Stock held by Weintraub Capital
Management, LP;(ii) 1,575 shares of Common Stock held by Weintraub
Capital Management Profit Sharing Plan FBO Jerald Weintraub; (iii)
1,575 shares of Common Stock held by Weintraub Capital Management
Profit Sharing Plan FBO Nancy DeSchane; (iv) 3,150 shares of Common
Stock held by Ben Victor Weintraub 2012 Irrevocable Trust DTD
12/19/12; (v) 3,150 shares of Common Stock held by Max Jacob
Weintraub 2012 Irrevocable Trust DTD 12/19/12; and (vi) 4,200
shares of Common Stock held by Melody Howe Weintraub 2012
Irrevocable Living Trust.
|
We are
registering the shares of Common Stock issuable to the selling
stockholders as Conversion Shares upon conversion of the Series C
Preferred and as Dividend Shares issuable as payment of accrued
dividends on shares of Series C Preferred to permit the resale of
these securities by such holders of the securities from time to
time. We will not receive any of the proceeds from the sale by the
selling stockholders of the securities. We will bear all fees and
expenses incident to our obligation to register the
securities.
The
selling stockholders may sell all or a portion of the securities
beneficially owned by them and offered hereby from time to time
directly or through one or more underwriters, broker-dealers or
agents. If the securities are sold through underwriters or
broker-dealers, the selling stockholders will be responsible for
underwriting discounts or commissions or agent’s commissions.
The securities may be sold on any national securities exchange or
quotation service on which the securities may be listed or quoted
at the time of sale, in the over-the-counter market or in
transactions otherwise than on these exchanges or systems or in the
over-the-counter market and in one or more transactions at fixed
prices, at prevailing market prices at the time of the sale, at
varying prices determined at the time of sale, or at negotiated
prices. These sales may be effected in transactions, which may
involve crosses or block transactions. The selling stockholders may
use any one or more of the following methods when selling
securities:
●
ordinary brokerage
transactions and transactions in which the broker-dealer solicits
purchasers;
●
block trades in
which the broker-dealer will attempt to sell the shares as agent
but may position and resell a portion of the block as principal to
facilitate the transaction;
●
purchases by a
broker-dealer as principal and resale by the broker-dealer for its
account;
●
an exchange
distribution in accordance with the rules of the applicable
exchange;
●
privately
negotiated transactions;
●
settlement of short
sales entered into after the effective date of the registration
statement of which this prospectus is a part;
●
broker-dealers may
agree with the selling stockholders to sell a specified number of
such securities at a stipulated price per share;
●
through the writing
or settlement of options or other hedging transactions, whether
such options are listed on an options exchange or
otherwise;
●
a combination of
any such methods of sale; and
●
any other method
permitted pursuant to applicable law.
The
selling stockholders also may resell all or a portion of the
securities in open market transactions in reliance upon Rule 144
under the Securities Act, as permitted by that rule, or
Section 4(1) under the Securities Act, if available, rather
than under this prospectus, provided that they meet the criteria
and conform to the requirements of those provisions.
Broker-dealers
engaged by the selling stockholders may arrange for other
broker-dealers to participate in sales. If the selling stockholders
effect such transactions by selling securities to or through
underwriters, broker-dealers or agents, such underwriters,
broker-dealers or agents may receive commissions in the form of
discounts, concessions or commissions from the selling stockholders
or commissions from purchasers of the securities for whom they may
act as agent or to whom they may sell as principal. Such
commissions will be in amounts to be negotiated, but, except as set
forth in a supplement to this prospectus, in the case of an agency
transaction will not be in excess of a customary brokerage
commission in compliance with NASD Rule 2440; and in the case of a
principal transaction a markup or markdown in compliance with NASD
IM-2440.
In
connection with sales of the securities or otherwise, the selling
stockholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn
engage in short sales of the securities in the course of hedging in
positions they assume. The selling stockholders may also sell
securities short and if such short sale shall take place after the
date that the registration statement of which this prospectus is a
part is declared effective by the SEC, the selling stockholders may
deliver securities covered by this prospectus to close out short
positions and to return borrowed shares in connection with such
short sales. The selling stockholders may also loan or pledge
securities to broker-dealers that in turn may sell such shares, to
the extent permitted by applicable law. The selling stockholders
may also enter into option or other transactions with
broker-dealers or other financial institutions or the creation of
one or more derivative securities which require the delivery to
such broker-dealer or other financial institution of shares offered
by this prospectus, which shares such broker-dealer or other
financial institution may resell pursuant to this prospectus (as
supplemented or amended to reflect such transaction).
Notwithstanding the foregoing, the selling stockholders have been
advised that they may not use shares of Common Stock registered on
this registration statement to cover short sales of our securities
made prior to the date the registration statement, of which this
prospectus forms a part, has been declared effective by the
Securities and Exchange Commission (the “SEC”).
The
selling stockholders may, from time to time, pledge or grant a
security interest in some or all of the securities owned by them
and, if they default in the performance of their secured
obligations, the pledgees or secured parties may offer and sell the
securities from time to time pursuant to this prospectus or an
amendment to this prospectus or the registration statement,
amending, if necessary, the list of selling stockholders to include
the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus. The selling stockholders also
may transfer and donate the securities in other circumstances in
which case the transferees, donees, pledgees or other successors in
interest will be the selling beneficial owners for purposes of this
prospectus.
The
selling stockholders and any broker-dealer or agents participating
in the distribution of the securities may be deemed to be
“underwriters” within the meaning of Section 2(11)
of the Securities Act in connection with such sales. In such event,
any commissions paid, or any discounts or concessions allowed to,
any such broker-dealer or agent and any profit on the resale of the
shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Selling
stockholders who are “underwriters” within the meaning
of Section 2(11) of the Securities Act will be subject to the
applicable prospectus delivery requirements of the Securities Act
and may be subject to certain statutory liabilities of, including
but not limited to, Sections 11, 12 and 17 of the Securities Act
and Rule 10b-5 under the Securities Exchange Act of 1934, as
amended (“Exchange
Act”).
Each
selling stockholder has informed us that it is not a registered
broker-dealer and does not have any written or oral agreement or
understanding, directly or indirectly, with any person to
distribute the securities. Certain of the selling stockholders are
affiliates of broker-dealers. Each such selling stockholder has
represented to us that it acquired the securities to be resold
pursuant to this prospectus in the ordinary course of its business
and, at the time of the acquisition, such selling stockholder had
no agreements or understandings, directly or indirectly, with any
person to distribute the securities. Upon being notified in writing
by a selling stockholder that any material arrangement has been
entered into with a broker-dealer for the sale of securities
through a block trade, special offering, exchange distribution or
secondary distribution or a purchase by a broker or dealer, we will
file, if required, an amendment to this prospectus pursuant to Rule
424(b) under the Securities Act or an amendment to the registration
statement, disclosing (1) the name of each such selling
stockholder and of the participating broker-dealer(s), (2) the
number of shares involved, (3) the price at which such
securities were sold, (4) the commissions paid or discounts or
concessions allowed to such broker-dealer(s), where applicable,
(5) that such broker-dealer(s) did not conduct any
investigation to verify the information set out or incorporated by
reference in this prospectus, and (6) other facts material to
the transaction. In no event shall any broker-dealer receive fees,
commissions and markups, which, in the aggregate, would exceed
eight percent.
Under
the securities laws of some states, the securities may be sold in
such states only through registered or licensed brokers or dealers.
In addition, in some states the securities may not be sold unless
such securities have been registered or qualified for sale in such
state or an exemption from registration or qualification is
available and is complied with.
There
can be no assurance that any selling stockholder will sell any or
all of the securities registered pursuant to the shelf registration
statement, of which this prospectus forms a part.
Each
selling stockholder and any other person participating in such
distribution will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including,
without limitation, to the extent applicable, Regulation M of the
Exchange Act, which may limit the timing of purchases and sales of
any of the securities by the selling stockholder and any other
participating person. To the extent applicable, Regulation M
may also restrict the ability of any person engaged in the
distribution of the securities to engage in market-making
activities with respect to the securities. All of the foregoing may
affect the marketability of the securities and the ability of any
person or entity to engage in market-making activities with respect
to the securities. We will pay all expenses of the registration of
the securities pursuant to a registration rights agreement,
including, without limitation, SEC filing fees and expenses of
compliance with state securities or “blue sky”
laws; provided, however, that each selling stockholder
will pay all underwriting discounts and selling commissions, if
any. We will indemnify the selling stockholders against certain
liabilities, including some liabilities under the Securities Act,
in accordance with the registration rights agreement, or the
selling stockholders will be entitled to contribution. We may be
indemnified by the selling stockholders against civil liabilities,
including liabilities under the Securities Act, that may arise from
any written information furnished to us by the selling stockholders
specifically for use in this prospectus, in accordance with the
related registration rights agreements, or we may be entitled to
contribution.
MARKET PRICE OF COMMON STOCK AND OTHER
STOCKHOLDER MATTERS
Market Information
Our
Common Stock does not trade on an established securities exchange.
Our Common Stock is quoted under the symbol “IWSY” on
the OTCQB marketplace. The following table sets forth the high and
low sale prices for our Common Stock for each quarter in 2018, 2017
and 2016:
2018 Fiscal Quarters
|
|
|
First
Quarter
|
$2.24
|
$1.50
|
Second
Quarter
|
$1.90
|
$1.09
|
Third
Quarter
|
$1.44
|
$0.86
|
Fourth
Quarter (through October 4, 2018)
|
$1.00
|
$0.90
|
2017 Fiscal Quarters
|
|
|
First
Quarter
|
$1.39
|
$0.98
|
Second
Quarter
|
$1.24
|
$0.81
|
Third
Quarter
|
$1.50
|
$0.83
|
Fourth
Quarter
|
$1.62
|
$1.25
|
2016 Fiscal Quarters
|
|
|
First
Quarter
|
$1.49
|
$0.85
|
Second
Quarter
|
$1.52
|
$1.06
|
Third
Quarter
|
$1.47
|
$1.12
|
Fourth
Quarter
|
$1.35
|
$0.95
|
Holders
As
of October 4, 2018, we had approximately 187 registered holders of
record of our Common Stock. A significant number of our shares of
Common Stock were held in street name and, as such, we believe that
the actual number of beneficial owners of our Common Stock is
significantly higher.
Dividends
We
have never declared or paid cash dividends on our Common Stock. We
currently intend to retain all available funds and any future
earnings for use in the operation of our business and do not
anticipate paying any cash dividends in the foreseeable future. Any
future determination to declare cash dividends will be made at the
discretion of our Board of Directors and will depend on our
financial condition, results of operations, capital requirements,
general business conditions and other factors that our Board of
Directors may deem relevant.
As
of June 30, 2018, December 31, 2017 and 2016, the Company had
cumulative undeclared dividends of approximately $0 relating to our
Series A Preferred, $8,000 relating to our Series B Preferred and
$0 related to our Series C Preferred.
Securities Authorized for Issuance under Equity Compensation
Plans
The Amended and Restated 1999 Stock Award Plan
(the “1999 Plan”) was adopted by the Company’s Board
of Directors on December 17, 1999. Under the terms of the 1999
Plan, the Company could, originally, issue up to 350,000
non-qualified or incentive stock options to purchase Common Stock
of the Company. During the year ended December 31, 2014, the
Company subsequently amended and restated the 1999 Plan, whereby it
increased the share reserve for issuance to approximately 7.0
million shares of the Company’s Common Stock. Subsequently,
in February 2018, the Company amended and restated the 1999 Plan,
whereby it increased the share reserve for issuance by an
additional 2.0 million shares. The 1999 Plan prohibits the grant of
stock option or stock appreciation right awards with an exercise
price less than fair market value of Common Stock on the date of
grant. The 1999 Plan also generally prohibits the
“re-pricing” of stock options or stock appreciation
rights, although awards may be bought-out for a payment in cash or
the Company’s stock. The 1999 Plan permits the grant of
stock-based awards other than stock options, including the grant of
“full value” awards such as restricted stock, stock
units and performance shares. The 1999 Plan permits the
qualification of awards under the plan (payable in either stock or
cash) as “performance-based compensation” within the
meaning of Section 162(m) of the Internal Revenue Code. The number
of authorized shares available for issuance under the plan at June
30, 2018 was 703,927.
DESCRIPTION OF
SECURITIES
The
Company’s Certificate of Incorporation, as amended,
authorizes the issuance of two classes of stock to be designated
“Common Stock” and “Preferred Stock.” The
Preferred Stock may be divided into such number of series and with
the rights, preferences, privileges and restrictions as the Board
of Directors may determine.
Series A Convertible Preferred Stock
On
September 15, 2017, the Company filed the Certificate of
Designations of the Series A Preferred with the Delaware Secretary
of State, designating 31,021 shares of the Company’s
preferred stock, par value $0.01 per share, as Series A Preferred.
Shares of Series A Preferred accrue dividends at a rate of 8% per
annum if the Company chooses to pay accrued dividends in cash, and
10% per annum if the Company chooses to pay accrued dividends in
shares of Common Stock. Each share of Series A Preferred has a
liquidation preference of $1,000 per share and is convertible, at
the option of the holder, into that number of shares of the
Company’s Common Stock equal to the Liquidation Preference,
divided by $1.15. Each holder of the Series A Preferred is entitled
to vote on all matters, together with the holders of Common Stock,
on an as converted basis.
Holders of Series A Preferred may elect to convert
shares of Series A Preferred into Conversion Shares at any time. In
the event the volume-weighted average price
(“VWAP”) of the Company’s Common Stock is at
least $2.15 per share for at least 20 consecutive trading days, the
Company may elect to convert one-half of the shares of Series A
Preferred issued and outstanding, on a pro-rata basis, into
Conversion Shares, or, if the VWAP of the Company’s Common
Stock is at least $2.15 for 80 consecutive trading days, the
Company may convert all issued and outstanding shares of Series A
Preferred into Conversion Shares. In addition, in the event of a
Change of Control, the Company will have the option to redeem all
issued and outstanding shares of Series A Preferred for 115% of the
Liquidation Preference per share.
On
September 18, 2017, the Company offered and sold a total of 11,000
shares of Series A Preferred at a purchase price of $1,000 per
share. The total gross proceeds to the Company from the Series A
Financing was approximately $10.9 million.
Concurrently with the Series A Financing, the
Company entered into exchange agreements with holders of all
outstanding shares of the Company’s Series E Convertible
Preferred Stock, all outstanding shares of the Company's Series F
Convertible Preferred Stock and all outstanding shares of the
Company's Series G Convertible Preferred Stock (collectively
“Exchanged
Preferred”) pursuant to
which the holders thereof agreed to cancel their respective shares
of Exchanged Preferred in exchange for shares of Series A
Preferred. As a result of the Preferred Stock Exchange, the Company
issued to the holders of the Exchanged Preferred an aggregate total
of 20,021 shares of Series A Preferred.
The Company evaluated the Preferred Stock Exchange
and determined that the Preferred Stock Exchange was both an
induced conversion and an extinguishment transaction. Using the
guidance in ASC 260-10-S99-2, Earnings Per Share – SEC
Materials – SEC Staff Announcement: The Effect on the
Calculations of Earnings Per Share for a Period That Includes the
Redemption or Induced Conversion of Preferred Stock and
ASC 470-50, Debt – Modifications and
Extinguishments, the Company
recorded the fair value differential of the Exchanged Preferred as
adjustments within Shareholders’ Deficit and in the
computation of Net Loss Available to Common Shareholders in the
computation of basic and diluted loss per share. The Company
utilized the services an independent third-party valuation firm to
perform the computation of the fair value of the Exchanged
Preferred. Based on the fair value using these methodologies, the
Company recorded approximately $1,245,000 in fair value
differential as adjustments within Shareholders’ Deficit in
the Company’s Consolidated Balance Sheet for the year ended
December 31, 2017 and in the computation of basic and diluted loss
per share in the Company’s Consolidated Statement of
Operations for the year ended December 31,
2017.
On September 10, 2018, concurrently with the
Series C Financing, the Company entered into exchange agreements
with Neal Goldman and Charles Crocker, pursuant to which Messrs.
Goldman and Crocker agreed to exchange approximately $6.3 million
and $0.6 million, respectively, of outstanding debt (including
accrued and unpaid interest) owed under the terms of their
respective lines of credit for an aggregate of 6,896 shares of
Series A Preferred (the “Debt Exchange”). As a result of the Debt Exchange, all
indebtedness, liabilities and other obligations arising under the
respective lines of credit were terminated, cancelled and deemed
satisfied in full.
On September 10, 2018 the Company’s Board of
Directors also declared a special dividend (the
“Special
Dividend”) for holders of
the Series A Preferred (each a “Holder”), pursuant to which each Holder receive a
warrant (“Dividend
Warrant”) to purchase
39.87 shares of Common Stock for every share of Series A Preferred
held, which resulted in the issuance of Dividend Warrants to the
Holders as a group to purchase an aggregate of 1,493,856 shares of
Common Stock. Each Dividend Warrant has an exercise price of $0.01
per share, and is exercisable immediately upon
issuance; provided,
however, that a Dividend
Warrant may only be exercised concurrently with the conversion
of shares of Series A Preferred held by a Holder into shares of
Common Stock. In addition, each Dividend Warrant held by a Holder
shall expire on the earliest to occur of (i) the conversion of all
Series A Preferred held by such Holder into Common Stock, (ii) the
redemption by the Company of all outstanding shares of Series A
Preferred held by such Holder, (iii) the Dividend Warrant no longer
representing the right to purchase any shares of Common Stock, and
(iv) the tenth anniversary of the date of
issuance.
The Company had 30,571 shares, 31,021 shares and 0
shares of Series A Preferred outstanding as of June 30, 2018,
December 31, 2017 and December 31, 2016, respectively. At
December 31, 2017, the Company had cumulative undeclared dividends
of $0. During the six months ended June 30, 2018 certain
holders of Series A Preferred converted 450 shares of Series A
Preferred into 391,304 shares of the Company’s Common
Stock. There were no conversions of Series A Preferred into
Common Stock during the year ended December 31, 2017. During
the year ended December 31, 2017 and the six month ended June 30,
2018, the
Company issued the holders of Series A Preferred 585,058 and
1,121,258 shares of Common Stock, respectively, as payment of
dividends due.
Series B Convertible Preferred Stock
The Company had 239,400 shares of Series B
Convertible Preferred Stock (“Series B
Preferred”) outstanding
as of June 30, 2018, December 31, 2017 and December 31, 2016. At
June 30, 2018, December 31, 2017 and December 31, 2016, the Company
had cumulative undeclared dividends of approximately $8,000 ($0.03
per share). There were no conversions of Series B Preferred into
Common Stock during the six months ended June 30, 2018, or during
the years ended December 31, 2017 and 2016. The Company paid
dividends of approximately $51,000 to the holders of our Series B
Preferred in 2017, and approximately $25,500 during the six month
ended June 30, 2018.
Series C Convertible Preferred Stock
On September 10, 2018, the Company filed the
Certificate of Designations, Preferences, and Rights of Series C
Preferred with the Secretary of State for the State of Delaware
– Division of Corporations, designating 1,000 shares of the
Company’s preferred stock, par value $0.01 per share, as
Series C Preferred. Shares of Series C
Preferred accrue dividends
cumulatively and are payable quarterly at a rate of 8% per annum if
paid in cash, or 10% per annum if paid by the issuance of shares of
Common Stock. Each share of Series C Preferred has a liquidation
preference equal to the greater
of (i) the Stated Value plus all accrued and unpaid dividends, and
(ii) such amount per share as would have been payable had each
share been converted into Common Stock immediately prior to the
occurrence of a Liquidation Event or Deemed Liquidation Event. Each
share of Series C Preferred is convertible into that number of
shares of the Company’s Common Stock equal to the Stated
Value, divided by $1.00, which conversion rate is subject to
adjustment in accordance with the terms of the Series C COD.
Holders of Series C Preferred may elect to convert shares of Series
C Preferred into Conversion Shares at any time. Holders of the
Series C Preferred may also require the Company to redeem all or
any portion of such holder’s shares of Series C Preferred at
any time from and after the third anniversary of the issuance date
or in the event of the consummation of a Change of Control (as such
term is defined in the Series C COD). Subject to the terms and
conditions set forth in the Series C COD, in the event the
volume-weighted average price of the Company’s Common Stock
is at least $3.00 per share (subject to adjustment in accordance
with the terms of the Series C COD) for at least 20 consecutive
trading days, the Company may convert all, but not less than all,
issued and outstanding shares of Series C Preferred into Conversion
Shares. In addition, in the event of a Change of Control, the
Company will have the option to redeem all, but not less than all,
issued and outstanding shares of Series C Preferred for 115% of the
Liquidation Preference Amount per share. Holders of Series C
Preferred will have the right to vote, on an as-converted basis,
with the holders of the Company’s Common Stock on any matter
presented to the Company’s stockholders for their action or
consideration. Shares of Series C Preferred rank senior to the
Company’s Common Stock and Series A Convertible Preferred
Stock, and junior to the Company’s Series B Convertible
Redeemable Preferred Stock.
On
September 10, 2018, the Company offered and sold a total of 890
shares of Series C Preferred at a purchase price of $10,000 per
share, and on September 21, 2018, the Company offered and sold an
additional 110 shares of Series C Preferred at a purchase price of
$10,000 per share. The total gross proceeds to the Company from the
Series C Financing were approximately $10.0 million.
The Company had 1,000 shares of Series C Preferred outstanding as
of October 4, 2018.
ImageWare Systems, Inc., a Delaware corporation
since 2005 and previously incorporated in California in 1987 as a
California corporation, has its principal place of business at
10815 Rancho Bernardo Road, Suite 310, San Diego, California 92127.
We maintain a corporate website at http://www.iwsinc.com.
Our Common Stock is currently listed for quotation on the OTCQB
marketplace under the symbol “IWSY.” As used in
this prospectus, “we,” “us,” “our,” “ImageWare,” “ImageWare
Systems,”
“Company” or “our Company” refers to ImageWare Systems, Inc. and all
of its subsidiaries.
Overview
The
Company is a pioneer and leader in the emerging market for
biometrically enabled software-based identity management solutions.
Using those human characteristics that are unique to us all, the
Company creates software that provides a highly reliable indication
of a person’s identity. The Company’s
“flagship” product is the patented IWS Biometric
Engine®. The Company’s products are used to manage and
issue secure credentials, including national IDs, passports, driver
licenses and access control credentials. The Company’s
products also provide law enforcement with integrated mug shot,
fingerprint LiveScan and investigative capabilities. The Company
also provides comprehensive authentication security software using
biometrics to secure physical and logical access to facilities or
computer networks or internet sites. Biometric technology is now an
integral part of all markets the Company addresses and all of the
products are integrated into the IWS Biometric
Engine.
The Company is also a leading developer of mobile
and cloud-based identity management solutions providing patented
biometric authentication solutions for the enterprise. The Company
delivers next-generation biometrics as an interactive and scalable
cloud-based solution. The Company brings together cloud and mobile
technology to offer multi-factor authentication for smartphone
users, for the enterprise, and across industries. The Company has
introduced a set of mobile and cloud solutions to provide biometric
user authentication, including the GoVerifyID® mobile
application and cloud-based SaaS solutions. These solutions include
GoMobile Interactive (“GMI”), which provides patented, secure, dynamic
messaging. More recently the Company has introduced
GoVerifyID® Enterprise Suite, which provides turnkey
integration with Microsoft Windows, Microsoft Active Directory, and
security products from CA, HPE, IBM, and SAP. These solutions are
marketed and sold to businesses across many industries. For the
healthcare industry, The Company also developed and markets a
patented, FDA-Cleared, biometrically-secured, enterprise-level
platform for patient engagement and medication
adherence.
Historically,
we have marketed our products to government entities at the
federal, state and local levels; however, the emergence of
cloud-based computing, a mobile market that demands increased
security and interoperable systems, and the proven success of our
products in the government markets, has enabled us to enlarge our
target market focus to include the emerging consumer and
non-government enterprise marketplace.
Our biometric technology is a core software
component of an organization’s security infrastructure and
includes a multi-biometric identity management solution for
enrolling, managing, identifying and verifying the identities of
people by the physical characteristics of the human body. We
develop, sell and support various identity management capabilities
within government (federal, state and local), law enforcement,
commercial enterprises, and transportation and aviation markets for
identification and verification purposes. Our IWS Biometric Engine
is a patented biometric identity management software platform for
multi-biometric enrollment, management and authentication, managing
population databases of virtually unlimited sizes. It is hardware
agnostic and can utilize different types of biometric algorithms.
It allows different types of biometrics to be operated at the same
time on a seamlessly integrated platform. It is also offered as a
Software Development Kit (“SDK”) based search engine, enabling developers
and system integrators to implement a biometric solution or
integrate biometric capabilities into existing applications without
having to derive biometric functionality from pre-existing
applications. The IWS Biometric Engine combined with our secure
credential platform, IWS EPI Builder, provides a comprehensive,
integrated biometric and secure credential solution that can be
leveraged for high-end applications such as passports, driver
licenses, national IDs, and other secure
documents.
Our
law enforcement solutions enable agencies to quickly capture,
archive, search, retrieve, and share digital images, fingerprints
and other biometrics as well as criminal history records on a
stand-alone, networked, wireless or web-based platform. We develop,
sell and support a suite of modular software products used by law
enforcement and public safety agencies to create and manage
criminal history records and to investigate crime. Our IWS Law
Enforcement solution consists of five software modules: Capture and
Investigative modules, which provide a criminal booking system with
related databases as well as the ability to create and print mug
photo/SMT image lineups and electronic mug-books; a Facial
Recognition module, which uses biometric facial recognition to
identify suspects; a Web module, which provides access to centrally
stored records over the Internet in a connected or wireless
fashion; and a LiveScan module, which incorporates LiveScan
capabilities into IWS Law Enforcement providing integrated
fingerprint and palm print biometric management for civil and law
enforcement use. The IWS Biometric Engine is also available to our
law enforcement clients and allows them to capture and search using
other biometrics such as iris or DNA.
Our
secure credential solutions empower customers to create secure and
smart digital identification documents with complete ID systems. We
develop, sell and support software and design systems which utilize
digital imaging and biometrics in the production of photo
identification cards, credentials and identification systems. Our
products in this market consist of IWS EPI Suite and IWS EPI
Builder. These products allow for production of digital
identification cards and related databases and records and can be
used by, among others, schools, airports, hospitals, corporations
or governments. We have added the ability to incorporate multiple
biometrics into the ID systems with the integration of IWS
Biometric Engine to our secure credential product
line.
Our GoVerifyID products support multi-modal
biometric authentication including, but not limited to, face,
voice, fingerprint, iris, palm, and more. All the biometrics can be
combined with or used as replacements for authentication and access
control tools, including tokens, digital certificates, passwords,
and PINS, to provide the ultimate level of assurance,
accountability, and ease of use for corporate networks, web
applications, mobile devices, and PC desktop environments.
GoVerifyID provides patented multi-modal biometric identity
authentication that can be used in place of passwords or as a
strong second factor authentication method. GoVerifyID is provided
as a cloud-based Software-as-a-Service (“SaaS”) solution; thereby, eliminating complex IT
deployment of biometric software and eliminating startup costs.
GoVerifyID works with existing mobile devices, eliminating the need
for specialized biometric scanning devices typically used with most
biometric solutions.
GoVerifyID
was built to work seamlessly with our patented technology
portfolio, including GoMobile Interactive®, the secure dynamic
messaging system, and the ultra-scalable IWS Biometric Engine that
provides anonymous biometric matching and storage. GoVerifyID is
secure, simple to use, and designed to provide instant identity
authentication by engaging with the biometric capture capabilities
of each user’s mobile device. GoVerifyID also provides a
fully open SDK for organizations that require the utmost in
flexibility.
Our
GoVerifyID Enterprise Suite for Windows easily and seamlessly
integrates with a user’s existing Microsoft
ecosystem/infrastructure to support the user’s extended
workforce. GoVerifyID Enterprise Suite secures corporate networks
from end-to-end – both applications and data – on
client, server, and cloud systems with flexible user login policies
to address varied trust requirements. Our GoVerifyID Enterprise
Suite works with the smart devices that the workforce already uses,
including iOS/Android smartphones and tablets.
Our GoVerifyID Enterprise Suite for Windows
provides biometric authentication for the Microsoft ecosystem that
secures enterprise security without compromising agility,
productivity, or user experience. Its comprehensive architecture
offers biometric authentication for the complete range of
enterprise stakeholders, delivering secure enterprise applications
and workspaces to internal employees, partners, suppliers and
vendors, even customers. Out-of-band authentication is provided via
universally available devices, such as smartphones and tablets.
In-band authentication can be enabled via fingerprint readers, iris
scanners, and any Windows Biometric Framework compatible device.
The server component provides easy centralized management of
biometric authentication policies for all users, using a standard
Snap-In to the Microsoft Management Console. It provides greater
user assurance and Single Sign-On (“SSO”) convenience for all corporate systems and
cloud applications. There is no compromise in agility or user
experience.
GoVerifyID Enterprise Suite also provides options
for seamless integration with leading Enterprise Identity and
Access Management (“IAM”) solutions including CA SSO, IBM Security
Access Manager (“ISAM”), SAP Cloud Platform, and HPE’s
Aruba ClearPass. These turnkey integrations provide multi-modal
biometric authentication to replace or augment passwords for use
with enterprise and consumer class systems.
Our
Pillphone® Platform:
●
Improves
medication adherence and manages chronic conditions by enriching
the relationship between the care team and the patient via its
enterprise level, mobile communication platform;
●
Digitally
connects healthcare providers with patients and provides support
when the patients are outside of the medical facility;
●
Streamlines
workflows and improves care team communication and collaboration
with the patient by offering personalized, two-way interactive,
secure messaging and real-time remote medication monitoring;
and
●
Enhances
the human connection of the care team that is essential for quality
patient-centered care.
Industry Background
Biometrics and Secure Credential Markets
The identity and access management market is
expected to grow from $7.2 billion in 2015 to $12.78 billion by
2020, at an expected Compound Annual Growth Rate
(“CAGR”) of 12.2%. This growth is based on a
growing demand for compliance management requirements and
increasing trends in mobility devices and applications. The main
drivers are:
●
Banking,
Financial Services & Insurance
Audit
and regulation compliance is a key driving force in the market; it
is growing at the highest rate and will likely continue to grow
through 2020.
Identity
management solutions are rapidly moving into risk-based programs
focused on enforcement of access control and entitlement
management. The enterprise is achieving major benefits from costs,
but still lacks the capability to manage time-sensitive processes,
including manual approvals and provisioning.
Cloud
services to date, though increasing, still suffer from a perceived
lack of security. However, large enterprises are rapidly adopting
cloud models, especially in centralizing the management of
identities. This adoption is being done by still using on premise
identity management solutions, but also venturing into the cloud as
well. This means that the hybrid model, utilizing both cloud and
in-house identity management solutions, is increasing.
We
believe the biometric identity management market will continue to
grow as the role of biometrics becomes more widely adopted for
enhancing security and complying with government regulations and
initiatives and as biometric capture devices become increasingly
mobile, robust and cost effective. Our biometric and secure
credentialing solutions are meeting the requirements and standards
for true multi-modal biometric identity management systems, as well
as providing scalability to support evolving
functionality.
Some
of the industries that can benefit from biometric-based identity
management and are a major part of our examples
include:
Healthcare
●
Access
to patient health records
●
Sharing
patient records with other staff
●
Remote
access to clinical portals
●
Entering Certified Physician Order Entry
(“CPOE”) systems
●
Submitting electronic prescriptions
(“e-Rx”)
Banking
●
Login
for online banking
●
Verifying
transactions made on a banking website
Retail/e-Commerce
●
Login
for a mobile store with a mobile device
●
Verifying
purchases on a website or at mobile stores
●
Sending
coupons & offers to mobile devices
Government
●
Internet
access on trains & planes
Law Enforcement and Public Safety Markets
The
United States law enforcement and public safety markets are
composed of federal, state and local law enforcement
agencies. Our target customers include local police and
sheriff’s departments, primary state law enforcement
agencies, prisons, special police agencies, county constable
offices, and federal agencies such as the Department of Homeland
Security, FBI, DEA and ICE.
In
addition, police agencies in foreign countries have shown interest
in using the full range of IWS Law Enforcement products to meet the
growing need for a flexible yet robust booking/investigative
solution that includes the routine use of IWS Facial Recognition as
well as the ability to use other biometrics. We continue to target
agencies in foreign countries for our biometric and law enforcement
solutions.
Law
enforcement customers require demanding end-to-end solutions that
incorporate robust features and functionalities such as biometric
and secure credentialing capabilities, as well as instant access to
centrally maintained records for real time verification of identity
and privileges. Law enforcement has long used the multiple
biometrics of fingerprint and face in establishing an
individual’s identity record. More recently, law enforcement
is seeking capability to utilize additional biometrics such as iris
and DNA. The Company’s multi-biometric platform product,
the IWS Biometric Engine, allows company customers to use as many
and different biometrics as desired all on a single, integrated
platform.
Agencies
are also moving toward a more shared experience where specific
pieces of suspect/arrest data may be viewed by outside agencies
allowing a suspect’s identity to be quickly defined with the
end goal being the swift apprehension of the subject.
Products and Services
Our
identity management solutions are primarily focused around
biometrics and secure credentials providing complete,
cross-functional and interoperable systems. Our biometric and
secure credentialing products provide complete and interoperable
solutions with features and functions required throughout the
entire identity management life cycle, enabling users the
flexibility to make use of any desired options, such as identity
proofing and enrollment, card issuance, maintenance and access
control. Our solutions offer a significant benefit that one
vendor’s solution is used throughout the various stages, from
establishing an applicant’s verified identity, to issuance of
smart card-based credentials, to the usage and integration to
physical and logical access control systems.
These
solutions improve global communication, the integrity and
authenticity of access control to facilities and information
systems, as well as enhance security, increase efficiency, reduce
identity fraud, and protect personal privacy.
We
categorize our identity management products and services into three
basic markets: (i) Biometrics, (ii) Secure Credential, and (iii)
Law Enforcement and Public Safety. We offer a series of
modular products that can be seamlessly integrated into an
end-to-end solution or licensed as individual
components.
Biometrics
Our
biometric product line consists of the following:
GoMobile InteractiveTM
In July 2013, the Company introduced its mobile
biometric identity management platform, GoMobile
InteractiveTM
(“GMI”). Based upon acquired patented
messaging platform technology combined with the Company’s
patented IWS Biometric Engine®, GMI allows global business,
service and content providers to offer users biometric security for
their products, services and content on the Android or iPhone
operating systems. GMI includes a standalone application that can
be used as a turnkey solution, as well as an SDK, enabling
integration with existing mobile applications for Android and
iPhone. Targeted verticals for the product include mobile
banking and value transfer, retail, healthcare and entertainment
services. By supporting multi-modal biometrics on a mobile device,
the Company is able to offer an out-of-band security solution that
is far superior to traditional password or PIN protection, which
are now failing and costing businesses billions of dollars. In
addition, the GMI service supports dynamic information gathering,
allowing clients to learn about their users through the use of
interactive surveys that can be secured using
biometrics.
IWS Biometric Engine
This
is a biometric identity management platform for multi-biometric
enrollment, management and authentication, managing population
databases of unlimited sizes without regard to hardware or
algorithm. Searches can be 1:1 (verification), 1:N
(identification), X:N (investigative) and N:N (database integrity).
IWS Biometric Engine is technology and biometric agnostic, enabling
the use of biometric devices and algorithms from any vendor, and
the support of the following biometric types: finger, face, iris,
hand geometry, palm, signature, DNA, voice, 3D face and retina. IWS
Biometric Engine is a second-generation solution from the Company
that is based on field-proven ImageWare technology solutions that
have been used to manage millions of biometric records since 1997
and is ideal for a variety of applications, including: criminal
booking, background checks (civil and criminal), watch list,
visa/passport and border control (air, land and sea), physical and
logical access control, and other highly-secure identity management
environments. The Company believes that this product will be
very attractive to the emerging commercial and consumer markets as
they deploy biometric identity management systems.
Our
IWS Biometric Engine is scalable, and biometric images and
templates can be enrolled either live or offline. Because it
stores the enrolled images, a new algorithm can be quickly
converted to support new or alternate algorithms and capture
devices. The IWS Biometric Engine is built to be hardware
“agnostic,” and currently supports over 100 hardware
capture devices and over 70 biometric algorithms.
The
IWS Biometric Engine is available as an SDK, as well as a platform
for custom configurations to meet specific customer requirements.
The added suite of products provides government, law enforcement,
border management and enterprise businesses a wide variety of
application-specific solutions that address specific government
mandates and technology standards. It also provides the ability to
integrate into existing legacy systems and expand based upon
specific customer requirements. This enables users to integrate a
complete solution or components as needed. The application suite of
products includes packaged solutions for:
●
HSPD-12
personal identity verification
●
Applicant
identity vetting
●
Physical
access control
●
Single-Sign-On
and logical access control
IWS PIV Management
Application. The
Company provides a set of Enterprise Server products within our
complete PIV solution, and these software products supply
server-based features and functions, while the use case for PIV
requires client-based presentation of PIV data and
workflow. The IWS PIV Management Application supplies the
web-based graphical user interface that presents the user or client
interface to the various server functions. Since the
server-based applications perform specific functions for specific
phases of the PIV life cycle, these server-based applications need
to be bound together with additional workflow processes. The
IWS PIV Management Application meets this need with software
modules that interface and interconnect the server-based
applications.
IWS PIV
Middleware. The IWS
PIV Middleware product, which is NIST certified and listed on the
GSA approved product list, is a library of functions that connect a
card reader & PIV card on the hardware side with a software
application. The library implements the specified PIV Middleware
API functions that support interoperability of PIV Cards. This
software has been developed in conformance with the FIPS-201
specification, and the software has been certified by the NIST
Personal Identification Verification Program
(“NPIVP”) Validation Authority as being
compliant.
IWS Background
Server. The IWS
Background Server is a software application designed specifically
for government and law enforcement organizations to support the
first stage of biometric identity management functions such as
identity proofing and vetting. IWS Background Check Server
automatically processes the submission of an applicant’s
demographic and biographic data to investigative bureaus for
background checks prior to issuing a
credential.
IWS Desktop
Security. IWS
Desktop Security is a highly flexible, scalable and modular
authentication management platform that is optimized to enhance
network security and usability. This architecture provides an
additional layer of security to workstations, networks and systems
through advanced encryption and authentication technologies.
Biometric technologies (face, fingerprint, iris, voice or
signature), can be seamlessly coupled with TPM chips to further
enhance corporate security. USB tokens, smart cards and RFID
technologies can also be readily integrated. Additional features include:
●
Support for multiple authentication tools,
including Public Key Infrastructure (“PKI”) within a uniformed platform and Privilege
Management Infrastructure (“PMI”) technology, to provide more advanced
access control services and assure authentication and data
integrity;
●
Integration
with IWS Biometric Engine for searching and match capabilities
(1:1, 1:N and X:N);
●
Integration
with IWS EPI Builder for the production and management of secure
credentials;
●
Support
for both BioAPI and BAPI standards;
●
Supports
a Single Sign-On feature that securely manages Internet Explorer
and Windows application ID and password information;
●
Supports
file and folder encryption features; and
●
Supports
various operating systems, including Microsoft Windows 2000,
Windows XP, and Windows Server 2003.
IWS Biometric Quality
Assessment & Enhancement (“IWS Biometric
IQA&E”). The IWS Biometric IQA&E is a biometric image
enhancement and assessment solution that assists government
organizations with the ability to evaluate and enrich millions of
biometric images automatically, saving time and costs associated
with biometric enrollment while maintaining image and database
integrity.
The IWS Biometric IQA&E improves the accuracy
and effectiveness of biometric template enrollments. The software
may be used stand-alone or in conjunction with the IWS Biometric
Engine. IWS Biometric IQA&E provides automated image quality
assessment with respect to relevant image quality standards from
organizations such as International Civil Aviation Organization,
National Institute of Standards and Technology
(“NIST”), International Organization for Standards
(“ISO”) and American Association of Motor Vehicle
Association (“AAMVA”). IWS Biometric IQA&E also enables
organizations to conduct multi-dimensional facial recognition,
which further enhances accuracy for numerous applications,
including driver licenses, passports and watch
lists.
IWS
Biometric IQA&E automatically provides real-time biometric
image quality analysis and feedback to improve the overall
effectiveness of biometric images, thus increasing the biometric
verification performance, and maintaining database and image data
integrity. IWS Biometric IQA&E provides a complete platform
that includes an image enhancement library for biometric types
including face, finger and iris.
Secure Credential
Our
secure credential products consist of the following:
GoVerifyID®. On
November 14, 2016, the Company introduced GoVerifyID®
Enterprise Suite, a multi-modal,
multi-factor biometric authentication solution for the enterprise
market. An algorithm-agnostic solution, GoVerify ID Enterprise
Suite is an end-to-end biometric platform that seamlessly
integrates with an enterprise’s existing Microsoft
infrastructure, offering businesses a turnkey biometric solution
for quick deployment. The Company feels that this product has the
potential to dramatically accelerate adoption of its biometric
solution due to the worldwide prevalence of enterprise use of the
Microsoft infrastructure. Working across the entire enterprise ecosystem,
GoVerifyID Enterprise Suite offers a consistent user experience and
centralized administration with the highest level of security,
flexibility, and usability. GoVerifyID Enterprise Suite embodies
the following characteristics:
●
Mobile-workforce
friendly—With GoVerifyID Enterprise Suite user authentication
logins are possible for a tablet or laptop even when disconnected
from the corporate network. Additionally, GoVerifyID Enterprise
Suite offers a consistent user authentication experience across all
login environments;
●
Hybrid
cloud— GoVerifyID Enterprise Suite is linked from the cloud
to an enterprise’s Microsoft infrastructure and is backward
compatible with Windows 7, 8 and 10. Additionally, because the
solution is SaaS-based, it can easily scale to process hundreds of
millions of transactions and store just as many biometrics;
and
●
Seamless
integration—GoVerifyID Enterprise Suite is a snap-in to the
Microsoft Management console and can be centrally managed at the
server. Additionally, the solution allows for seamless movement as
it integrates with Active Directory using an organization’s
existing Microsoft security infrastructure.
IWS Card
Management. The IWS
Card Management System (“CMS”) is a comprehensive solution to support
and manage the issuance of smart cards complete with the following
capabilities:
●
Biometric
enrollment and identity proofing with Smart Card encoding of
biometrics;
●
Flexible
models of central or distributed issuance of
credentials;
●
Customizable
card life-cycle workflow managed by the CMS; and
●
Integration
of the CMS data with other enterprise solutions, such as physical
access control and logical access control (i.e.
Single-Sign-On).
IWS EPI
Suite. This is an ID
software solution for producing, issuing, and managing secure
credentials and personal identification cards. Users can
efficiently manage large amounts of data, images and card designs,
as well as track and issue multiple cards per person, automatically
populate multiple cards and eliminate redundant data entry. IWS EPI
Suite was designed to integrate with our customers’ existing
security and computing infrastructure. We believe that this
compatibility may be an appealing feature to corporations,
government agencies, transportation departments, school boards and
other public institutions.
IWS EPI
Builder. This is an
SDK and a leading secure credential component of identity
management and security solutions, providing all aspects of ID
functionality from image and biometric capture to the enrollment,
issuance and management of secure documents. It contains components
which developers or systems integrators can use to support and
produce secure credentials, including national IDs, passports,
International Civil Aviation Office -compliant travel documents,
smart cards and driver licenses. IWS EPI Builder enables
organizations to develop custom identification solutions or
incorporate sophisticated identification capabilities into existing
applications including the ability to capture images, biometric and
demographic data; enable biometric identification and verification
(1:1 and 1:X); as well as support numerous biometric hardware and
software vendors. It also enables users to add electronic
identification functionality for other applications, including
access control, tracking of time and attendance, point of sale
transactions, human resource systems, school photography systems,
asset management, inventory control, warehouse management,
facilities management and card production
systems.
IWS EPI
PrintFarm. While it
is the last stage of PIV Card Issuance, the PIV smart card printing
process is by no means the least important stage. Production
printing of tens of thousands of PIV cards requires a significant
investment and a well-engineered system. The IWS EPI PrintFarm
software offers a cost-effective, yet high-performance method for
high-volume card printing.
IWS PIV
Encoder. PIV smart
cards must be programmed with specific mandatory data, digital
signatures and programs in order to maintain the interoperability
as well as the security features specified for the cards. The IWS
PIV Encoder could be considered to be a complex device driver that
properly programs the PIV smart cards. The Encoder interacts
with the CMS for data payload elements. It interacts with the
Certificate Authority to encrypt or sign the PIV smart card data
with trusted certificates. Finally, it acts as the
application-level device driver to make the specific PIV smart card
encoding system properly program the smart card, regardless if the
system is a standalone encoding system or one integrated into a
card printer.
Law Enforcement and Public Safety
We believe our integrated suite of software
products significantly reduces the inefficiencies and expands the
capabilities of traditional booking and mug shot systems. Using our
products, an agency can create a digital database of thousands of
criminal history records, each including one or more full-color
facial images, finger and palm prints, biographic text information
and images of other distinctive physical features such as scars,
marks and tattoos (“SMT’s”). This database can be quickly searched
using text queries, or biometric technology that can compare
biometric characteristics of an unknown suspect with those in the
database.
Our
investigative software products can be used to create, edit and
distribute both mug photo and SMT photo lineups of any
size. In addition, electronic mug books display hundreds of
images for a witness to review and from which electronic selections
are made. The Witness View software component records the viewing
of a lineup (mug photo or SMT) detailing the images provided for
viewing along with the image or images selected. In addition to a
printed report, the Witness View module provides a non-editable
executable file (.exe) that may be played on any computer for court
exhibit viewing purposes.
Our
IWS Law Enforcement solution consists of software modules, which
may also be purchased individually. The IWS Law Enforcement Capture
and Investigative modules make up our booking system and database.
Our add-on modules include LiveScan, Facial Recognition, Law
Enforcement Web and Witness View as well as the IWS Biometric
Engine.
IWS Law
Enforcement. IWS Law
Enforcement is a digital booking, identification and investigative
solution that enables users to digitally capture, store, search and
retrieve images and demographic data, including mug shots,
fingerprints and SMT’s. Law enforcement may choose between
submitting fingerprint data directly to the State Automated
Fingerprint Identification System (“AFIS”), FBI criminal repository, or other
agencies as required. Additional features and functionality include
real-time access to images and data, creation of photo lineups and
electronic mug books, and production of identification cards and
credentials. IWS Law Enforcement also uses off-the-shelf
hardware and is designed to comply with open industry standards so
that it can operate on an array of systems ranging from a
stand-alone personal computer to a wide area network. To avoid
duplication of entries, the system can be integrated easily with
several other information storage and retrieval systems, such as a
records/jail management system (“RMS/JMS”) or an automated fingerprint
identification system.
Capture. This
software module allows users to capture and store a variety of
images (facial, SMT and others such as evidence photos) as well as
biographical text information. Each record includes images and text
information in an easy-to-view format made up of fields designed
and defined by the individual agency. Current customers of this
module range from agencies that capture a few thousand mug shots
per year to those that capture hundreds of thousands of mug shots
each year.
LiveScan. This
software module is FBI certified and complies with the FBI
Integrated Automated Fingerprint Identification System
(“IAFIS”) Image Quality Specifications
(“IQS”) while utilizing FBI certified LiveScan
devices from most major vendors. LiveScan allows users to capture
single to ten prints and palm data, providing an integrated
biometric management solution for both civil and law enforcement
use. By adding LiveScan capabilities, law enforcement organizations
further enhance the investigative process by providing additional
identifiers to identify suspects involved in a crime. In
addition, officers no longer need to travel to multiple booking
stations to capture fingerprints and mug shots. All booking
information, including images, may be located at a central
designation and from there routed to the State AFIS or FBI criminal
history record repository.
Investigative. This
software module allows users to search the database created with
IWS Law Enforcement. Officers can conduct text searches in many
fields, including file number, name, alias, distinctive features,
and other information, such as gang membership and criminal
history. The Investigative module creates a catalogue of possible
matches, allowing officers or witnesses to save time by looking
only at mug shots that closely resemble the description of the
suspect. This module can also be used to create a line-up of
similar facial images from which a witness may identify the
suspect.
Facial
Recognition. This
software module uses biometric facial recognition and retrieval
technology to help authorities identify possible suspects. Images
taken from surveillance videos or photographs can be searched
against a digital database of facial images to retrieve any desired
number of faces with similar characteristics. This module can also
be used at the time of booking to identify persons using multiple
aliases. Using biometrics-based technology, the application can
search through thousands of facial images in a matter of seconds,
reducing the time it would otherwise take a witness to flip through
a paper book of facial images that may or may not be similar to the
description of the suspect. The Facial Recognition module then
creates a selection of possible matches ranked in order of
similarity to the suspect, and a percentage confidence level is
attributed to each possible match. The application incorporates
search engine technology, which we license from various facial
recognition algorithm providers.
LE
Web. This software
module enables authorized personnel to access and search agency
booking records stored in IWS Law Enforcement through a standard
web browser from within the agency’s intranet. This module
allows remote access to the IWS Law Enforcement database without
requiring the user to be physically connected to the
customer’s network. This application requires only that the
user have access to the Internet and authorization to access the
law enforcement agency’s intranet.
EPI Designer for Law
Enforcement. The EPI
Designer for LE software is a design solution created for the IWS
Law Enforcement databases based on the IWS EPI Suite
program. This program allows integration with various IWS
databases for the production of unique booking/inmate reports,
wristbands, photo ID cards, Wanted or BOLO fliers, etc., created
from the information stored in booking records. Designs can be
created in minutes and quickly added to the IWS Law Enforcement
system, allowing all users with appropriate permissions immediate
access to the newly added form.
Maintenance and Customer Support
We
offer software and hardware support to our customers. Customers can
contract with us for technical support that enables them to use a
toll-free number to speak with our technical support center for
software support and general assistance 24 hours a day, seven days
a week. As many of our government customers operate around the
clock and perceive our systems as critical to their day-to-day
operations, a very high percentage contract for technical
support. For the six months ended June 30, 2018 and the
years ended December 31, 2017 and 2016, maintenance revenues
accounted for approximately 51%, 62% and 67% of our total revenues,
respectively.
Software Customization and Fulfillment
We
directly employ computer programmers and retain independent
programmers to develop our software and perform quality control. We
provide customers with software that we specifically customize to
operate on their existing computer system. We work directly with
purchasers of our system to ensure that the system they purchase
will meet their unique needs. We configure and test the system
either at our facilities or on-site and conduct any customized
programming necessary to connect the system with any legacy systems
already in place. We can also provide customers with a
complete computer hardware system with our software already
installed and configured. In either case, the customer is provided
with a complete turnkey solution, which can be used immediately.
When we provide our customers with a complete solution including
hardware, we use off-the-shelf computers, cameras and other
components purchased from other companies such as Dell or Hewlett
Packard. Systems are assembled and configured either at our
facilities or at the customer’s location.
Customers
We have a wide variety of domestic and
international customers. Most of our IWS Law Enforcement customers
are government agencies at the federal, state and local levels in
the United States. Our secure credential products are also being
used in Australia, Canada, the United Arab Emirates, Kuwait, Saudi
Arabia, Mexico, Colombia, Costa Rica, Venezuela, Singapore,
Indonesia and the Philippines. For the six months ended June 30, 2018, one
customer accounted for approximately 43% or $1,121,000 of our total
revenue and had trade receivables at June 30, 2018 of $0, as
compare to one customer that accounted for approximately 19% or
$368,000 of our total revenue and had trade receivables at June 30,
2017 of $0. For the year ended December 31, 2017, one customer
accounted for approximately 25% or $1,089,000 of total revenue and
had $201,000 trade receivables as of the end of the year, as
compared to two customers that accounted for approximately 30% or
$1,162,000 of total revenue and had $78,000 trade receivables as of
the end of the December 31, 2016.
Our Strategy
Our
strategy is to provide patented open-architected identity
management solutions including multi-biometric, secure credential
and law enforcement technologies that are stand alone, integrated
and/or bundled with key partners including channel relationships
and large systems integrators such as, United Technology Security,
GCR, Unisys, Lockheed Martin, IBM and Fujitsu, among others. Key
elements of our strategy for growth include the
following:
Fully Exploit the Biometrics, Access Control and Identification
Markets
The
establishment of the Department of Homeland Security coupled with
the movement by governments around the world to authenticate the
identity of their citizens, employees and contractors has
accelerated the adoption of biometric identification systems that
can provide secure credentials and instant access to centrally
maintained records for real-time verification of identity and
access (physical and logical) privileges. Using our products, an
organization can create secure credentials that correspond to
records, including images and biographic data, in a digital
database. A border guard or customs agent can stop an individual to
quickly and accurately verify his identity against a database of
authorized persons, and either allow or deny access as required.
Our technology is also standards based and applied to facilitate
activities such as federal identification mandates while complying
with personal identification verification standards such as
HSPD-12, International Civil Aviation Organization standards,
American Association of Motor Vehicle Administrators driver
licenses, voter registration, immigration control and welfare fraud
identification. We believe that these or very similar
standards are applicable in markets throughout the
world.
With
the identity management market growing at a rapid pace, biometric
identifiers are becoming recognized and accepted as integral
components to the identification process in the public and private
sectors. As biometric technologies (facial recognition,
fingerprint, iris, etc.) are adopted, identification systems must
be updated to enable their use in the field. We have built our
solutions to enable the incorporation of one or multiple
biometrics, which can be associated with a record and stored both
in a database and on a card for later retrieval and verification
without regard to the specific hardware employed. We believe
the increasing demand for biometric technology will drive demand
for our solutions. Our identity management products are built
to accommodate the use of biometrics and meet the demanding
requirements across the entire identity life cycle.
Expand Law Enforcement and Public Safety Markets
We
intend to use our successful installations with customers such as
the Arizona Department of Public Safety and the San Bernardino
County Sheriff’s Department as reference accounts, and to
market IWS Law Enforcement as a superior technological solution.
Our recent addition of the LiveScan module and support for local
AFIS to our IWS Law Enforcement will enhance its functionality and
value to the law enforcement customer as well as increase the
potential revenue the Company can generate from a system
sale. We primarily sell directly to the law enforcement
community. Our sales strategy is to increase sales to new and
existing customers, including renewing supporting maintenance
agreements. We have also established relationships with large
systems integrators such as Sagem Morpho to OEM our law enforcement
solution utilizing their worldwide sales force. We will focus our
sales efforts in the near term to establish IWS Law Enforcement as
the integrated mug shot and LiveScan system adopted in as many
countries, states, large counties and municipalities as possible.
Once we have a system installed in a region, we intend to then sell
additional systems or retrieval seats to other agencies within the
primary customer’s region and in neighboring regions. In
addition, we plan to market our integrated investigative modules to
the customer, including Facial Recognition, Web and WitnessView. As
customer databases of digital mug shots grow, we expect that the
perceived value of our investigative modules, and corresponding
revenues from sales of those modules, will also grow.
Software as a Service Business Model
With the advent of cloud-based computing and the
proliferation of smart mobile devices, which allow for reliable
biometric capture and the need to secure access to data, products
and services, the Company believes that the market for
multi-biometric solutions will expand to encompass significant
deployments of biometric systems in the commercial and consumer
markets. The Company therefore intends to leverage the strength of
its experience servicing existing government clients who have
deployed the Company’s products for large populations, as
well as its foundational patent portfolio in the field of
multi-modal biometrics and the fusion of multiple biometric
algorithms, to address the growing commercial and consumer market.
As part of its marketing plan, the Company offered new versions of
its product suite on a Software as a Service
(“SaaS”) model during 2016. This new business
model, which is intended to supplement the Company’s existing
business model, will allow new commercial and consumer clients to
biometrically verify identity in order to access data, products or
services from mobile and desktop devices. We have received significant interest and have
entered into a number of proof of concept arrangements with
customers and partners who we anticipate will initiate programs
prior to the end of 2018.
Mobile Applications
The
Company strengthened its patent portfolio in June 2012 with the
purchase of four U.S. patents relating to wireless technology from
Vocel. These patents, combined with the Company’s existing
foundational patents in the areas of biometric identification,
verification, enrollment and fusion, provide a unique and protected
foundation on which to build interactive mobile applications that
are secured using biometrics.
The
combination of our biometric identification technologies and
wireless technologies has led to the development of the IWS
Interactive Messaging System, which is a push application platform
secured by biometrics that transforms mobile devices into a
complete mobile ID, enabling companies to create applications that
allow a range of unprecedented activities, from secure sharing of
sensitive information to biometrically securing a mobile wallet.
Identity authentication, using multi-modal biometrics gives users
the confidence that their personal information is secure while the
push marketing capabilities of the technology allow companies
unparalleled interactivity that can be personalized to the needs
and interests of their customers.
Sales and Marketing
We
market and sell our products through our direct sales force and
through indirect distribution channels, including systems
integrators. As of December 31, 2017, we had sales and account
representatives based domestically in the District of Columbia,
California, Colorado, Oregon and internationally in Mexico.
Geographically, our sales and marketing force consisted of six
persons in the United States, and one person in Mexico as of
December 31, 2017.
Our direct
sales organization is supported by technical experts. Our
technical experts are available by telephone and conduct on-site
customer presentations in support of our sales
professionals.
The
typical sales cycle for IWS Biometric Engine and IWS Law
Enforcement includes a pre-sale process to define the potential
customer’s needs and budget, an on-site demonstration and
conversations between the potential customer and existing
customers. Government agencies are typically required to purchase
large systems by including a list of requirements in a Request for
Proposal, known as an “RFP,” and by allowing several
companies to openly bid for the project by responding to the RFP.
If our response is selected, we enter into negotiations for the
contract and, if successful, ultimately receive a purchase order
from the customer. This process can take anywhere from a few months
to over a year.
Our
Biometric and ID products are also sold to large integrators,
direct via our sales force and to end users through distributors.
Depending on the customer’s requirements, there may be
instances that require an RFP. The sales cycle can vary from a few
weeks to a year.
In
addition to our direct sales force, we have developed relationships
with a number of systems integrators who contract with government
agencies for the installation and integration of large computer and
communication systems. By acting as a subcontractor to these
systems integrators, we are able to avoid the time consuming and
often-expensive task of submitting proposals to government
agencies, and we also gain access to large clients.
We
also work with companies that offer complementary products, where
value is created through product integration. Through teaming
arrangements, we are able to enhance our products and to expand our
customer base through the relationships and contracts of our
strategic partners.
We
plan to continue to market and sell our products internationally.
Some of the challenges and risks associated with international
sales include the difficulty in protecting our intellectual
property rights, difficulty in enforcing agreements through foreign
legal systems and volatility and unpredictability in the political
and economic conditions of foreign countries. We believe we can
work to successfully overcome these challenges.
Competition
The Law Enforcement and Public Safety Markets
Due
to the fragmented nature of the law enforcement and public safety
market and the modular nature of our product suite, we face
different degrees of competition with respect to each IWS Law
Enforcement module. We believe the principal bases on which we
compete with respect to all of our products are:
●
the
unique ability to integrate our modular products into a complete
biometric, LiveScan, imaging and investigative system;
●
our
reputation as a reliable systems supplier;
●
the
usability and functionality of our products; and
●
the
responsiveness, availability and reliability of our customer
support.
Our
law enforcement product line faces competition from other companies
such as DataWorks Plus and 3M. Internationally, there are
often a number of local companies offering solutions in most
countries.
Secure Credential Market
Due
to the breadth of our software offering in the secure credential
market space, we face differing degrees of competition in certain
market segments. The strength of our competitive position is based
upon:
●
our
strong brand reputation with a customer base, which includes small
and medium-sized businesses, Fortune 500 corporations and large
government agencies;
●
the
ease of integrating our technology into other complex applications;
and
●
the
leveraged strength that comes from offering customers software
tools, packaged solutions and web-based service applications that
support a wide range of hardware peripherals.
Our
software faces competition from Datacard Corporation, a privately
held manufacturer of hardware, software and consumables for the ID
market, as well as small, regionally based companies.
Biometric Market
The
market to provide biometric systems to the identity management
market is evolving and we face competition from a number of
sources. We believe that the strength of our competitive position
is based on:
●
our
ability to provide a system which enables the enrollment,
management and authentication of multiple biometrics managing
population databases of unlimited sizes;
●
searches
can be 1:1 (verification), 1:N (identification), X:N
(investigative), and N:N (database integrity); and
●
the
system is technology and biometric agnostic, enabling the use of
biometric devices and algorithms from any vendor, and the support
of the following biometric types: finger, face, iris, hand
geometry, palm, DNA, signature, voice, and 3D face and
retina.
Our
multi-biometric product faces competition from French-based Safran,
Irish-based Daon, 3M and Aware Inc., none of which have offerings
with the scope and flexibility of our IWS Biometric Engine and its
companion suite of products or relevant patent
protection.
Intellectual Property
We
rely on trademark, patent, trade secret and copyright laws and
confidentiality and license agreements to protect our intellectual
property. We have several federally registered trademarks,
including the trademark ImageWare and IWS Biometric Engine, as well
as trademarks for which there are pending trademark registrations
with the United States, Canadian and other International Patent
& Trademark Offices.
We hold several issued patents and have several
other patent applications pending for elements of our products. We
believe we have the foundational patents regarding the use of
multiple biometrics and continue to be an IP leader in the
biometric arena. It is our belief that this intellectual property
leadership will create a sustainable competitive advantage. We
are an early pioneer in the first to file patents related to
multi-modal biometrics and currently are the worldwide leader in
multi-modal biometric patents, with 22 patents worldwide and 19
patents pending. These
technologies allow biometric matching using any type of
biometric modality for identity verification while protecting the
privacy of an individual. It is our belief that such technology
will be critical to providing biometric management solutions for
the consumer market where privacy protection has been a historical
issue and barrier to biometric adoption.
The
Company strengthened its patent portfolio in June 2012 with the
purchase of four U.S. patents relating to wireless technology from
Vocel. These patents, combined with the Company’s existing
foundational patents in the areas of biometric identification,
verification, enrollment and fusion, provide a unique and protected
foundation on which to build interactive mobile applications that
are secured using biometrics.
We
regard our software as proprietary and retain title to and
ownership of the software we develop. We attempt to protect
our rights in the software primarily through patents and trade
secrets. We have not published the source code of most of our
software products and require employees and other third parties who
have access to the source code and other trade secret information
to sign confidentiality agreements acknowledging our ownership and
the nature of these materials as our trade secrets.
Despite
these precautions, it may be possible for unauthorized parties to
copy or reverse-engineer portions of our products. While our
competitive position could be threatened by disclosure or reverse
engineering of this proprietary information, we believe that
copyright and trademark protection are less important than other
factors, such as the knowledge, ability, and experience of our
personnel, name recognition and ongoing product development and
support.
Our
software products are licensed to end users under a perpetual,
nontransferable, nonexclusive license that stipulates which modules
can be used and how many concurrent users may use them. These
forms of licenses are typically not signed by the licensee and may
be more difficult to enforce than signed agreements in some
jurisdictions.
Research and Development
Our
research and development team consisted of 40 and 32 programmers,
engineers and other employees as June 30, 2018 and December 31,
2017, respectively. We also contract with outside programmers for
specific projects as needed. We spent approximately $3.7 million
and $6.0 million on research and development in the periods ended
June 30, 2018 and December 31, 2017, respectively. We continually
work to increase the speed, accuracy, and functionality of our
existing products. We anticipate that our research and development
efforts will continue to focus on new technology and products for
the identity management markets.
Employees
We
had a total of 70 and 64 full-time employees as of June 30,
2018 and December 31, 2017, respectively. Our employees are not
covered by any collective bargaining agreement, and we have never
experienced a work stoppage. We believe that our relations with our
employees are good.
Environmental Regulation
Our
business does not require us to comply with any particular
environmental regulations.
Legal Proceedings
There is currently no action, suit, proceeding, inquiry or
investigation before or by any court, public board, government
agency, self-regulatory organization or body pending or, to the
knowledge of the executive officers of the Company or any of our
subsidiaries, threatened against or affecting the Company, our
Common Stock, any of our subsidiaries or of the Company’s or
our subsidiaries’ officers or directors in their capacities
as such, in which an adverse decision could have a material adverse
effect.
Description of Property
Our
corporate headquarters are located in San Diego, California, where
we occupy 9,927 square feet of office space. This facility is
leased through October 2018 at a cost of approximately $30,000 per
month. In addition to our corporate headquarters, we also occupied
the following spaces at In addition to our corporate headquarters,
we also occupied the following spaces at June 30,
2018:
●
1,508
square feet in Ottawa, Province of Ontario, Canada, at a cost of
approximately $3,000 per month until the expiration of the lease on
March 31, 2021;
●
9,720
square feet in Portland, Oregon, at a cost of approximately $22,000
per month until the expiration of the lease on February 28, 2023;
and
●
304
square feet of office space in Mexico City, Mexico, at a cost of
approximately $3,000 per month until November 30,
2018.
In July
2018, the Company entered in a new leasing arrangement for 8,511
square feet of office space for its San Diego headquarters. The new
lease commences on November 1, 2018 and terminates on April 30,
2025. Annual base rent over the lease term approximates $361,000
per year.
MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following discussion should be read in conjunction with our
consolidated financial statements and the related notes and other
financial information appearing elsewhere in this prospectus.
Readers are also urged to carefully review and consider the various
disclosures made by us which attempt to advise interested parties
of the factors which affect our business, including (without
limitation) the disclosures made under the captions
“Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and “Risk
Factors,” and in the audited consolidated financial
statements and related notes included in this
prospectus.
Overview
The
Company is a pioneer and leader in the emerging market for
biometrically enabled software-based identity management solutions.
Using those human characteristics that are unique to us all, we
create software that provides a highly reliable indication of a
person’s identity. Our “flagship” product is our
patented IWS Biometric Engine®. Scalable for small city
business or worldwide deployment, our IWS Biometric Engine is a
multi-biometric software platform that is hardware and algorithm
independent, enabling the enrollment and management of unlimited
population sizes. It allows a user to utilize one or more
biometrics on a seamlessly integrated platform. Our products are
used to manage and issue secure credentials, including national
IDs, passports, driver licenses and access control credentials. Our
products also provide law enforcement with integrated mug shot,
LiveScan fingerprint and investigative capabilities. We also
provide comprehensive authentication security software using
biometrics to secure physical and logical access to facilities or
computer networks or Internet sites. Biometric technology is now an
integral part of all markets we address and all of our products are
integrated into the IWS Biometric Engine.
With
the advent of cloud-based computing and the proliferation of smart
mobile devices, which allow for reliable biometric capture and the
need to secure access to data, products and services, the Company
believes that the market for multi-biometric solutions will expand
to encompass significant deployments of biometric systems in the
commercial and consumer markets. The Company therefore intends to
leverage the strength of its experience servicing existing
government clients who have deployed the Company’s products
for large populations, as well as its foundational patent portfolio
in the field of multi-modal biometrics and the fusion of multiple
biometric algorithms, to address the growing commercial and
consumer market.
Our
biometric technology is a core software component of an
organization’s security infrastructure and includes a
multi-biometric identity management solution for enrolling,
managing, identifying and verifying the identities of people by the
physical characteristics of the human body. We develop, sell and
support various identity management capabilities within government
(federal, state and local), law enforcement, commercial
enterprises, and transportation and aviation markets for
identification and verification purposes. Our IWS Biometric Engine
is a patented biometric identity management software platform for
multi-biometric enrollment, management and authentication, managing
population databases of virtually unlimited sizes. It is hardware
agnostic and can utilize different types of biometric algorithms.
It allows different types of biometrics to be operated at the same
time on a seamlessly integrated platform. It is also offered as an
SDK based search engine, enabling developers and system integrators
to implement a biometric solution or integrate biometric
capabilities into existing applications without having to derive
biometric functionality from pre-existing applications. The IWS
Biometric Engine combined with our secure credential platform, IWS
EPI Builder, provides a comprehensive, integrated biometric and
secure credential solution that can be leveraged for high-end
applications such as passports, driver licenses, national IDs, and
other secure documents.
Our
law enforcement solutions enable agencies to quickly capture,
archive, search, retrieve, and share digital images, fingerprints
and other biometrics as well as criminal history records on a
stand-alone, networked, wireless or web-based platform. We develop,
sell and support a suite of modular software products used by law
enforcement and public safety agencies to create and manage
criminal history records and to investigate crime. Our IWS Law
Enforcement solution consists of five software modules: Capture and
Investigative modules, which provide a criminal booking system with
related databases as well as the ability to create and print mug
photo/SMT image lineups and electronic mugbooks; a Facial
Recognition module, which uses biometric facial recognition to
identify suspects; a Web module, which provides access to centrally
stored records over the Internet in a connected or wireless
fashion; and a LiveScan module, which incorporates LiveScan
capabilities into IWS Law Enforcement providing integrated
fingerprint and palm print biometric management for civil and law
enforcement use. The IWS Biometric Engine is also available to our
law enforcement clients and allows them to capture and search using
other biometrics such as iris or DNA.
Our
secure credential solutions empower customers to create secure and
smart digital identification documents with complete ID systems. We
develop, sell and support software and design systems which utilize
digital imaging and biometrics in the production of photo
identification cards, credentials and identification systems. Our
products in this market consist of IWS EPI Suite and IWS EPI
Builder. These products allow for the production of digital
identification cards and related databases and records and can be
used by, among others, schools, airports, hospitals, corporations
or governments. We have added the ability to incorporate multiple
biometrics into the ID systems with the integration of IWS
Biometric Engine to our secure credential product
line.
Our enterprise authentication software includes
the IWS Desktop Security product, which is a comprehensive
authentication management infrastructure solution providing added
layers of security to workstations, networks and systems through
advanced encryption and authentication technologies. IWS Desktop
Security is optimized to enhance network security and usability,
and uses multi-factor authentication methods to protect access,
verify identity and help secure the computing environment without
sacrificing ease-of-use features such as quick login. Additionally,
IWS Desktop Security provides an easy integration with various
smart card-based credentials including the Common Access Card
(“CAC”), Homeland Security Presidential Directive
12 (“HSPD-12”), Personal Identity Verification
(“PIV”) credential, and Transportation Worker
Identification Credential (“TWIC”) with an organization’s access
control process. IWS Desktop Security provides the crucial
end-point component of a Logical Access Control System
(“LACS”), and when combined with a Physical Access
Control System (“PACS”), organizations benefit from a complete
door to desktop access control and security
model.
Critical Accounting Estimates
The discussion and analysis of our consolidated
financial condition and results of operations are based on our
consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the
United States of America (“GAAP”). The preparation of these consolidated
financial statements in accordance with GAAP requires us to utilize
accounting policies and make certain estimates and assumptions that
affect the reported amounts of assets and liabilities, the
disclosure of contingencies as of the date of the consolidated
financial statements and the reported amounts of revenues and
expenses during a fiscal period. The SEC considers an accounting
policy to be critical if it is important to a company’s
financial condition and results of operations, and if it requires
significant judgment and estimates on the part of management in its
application.
Significant
estimates include the allowance for doubtful accounts receivable,
inventory carrying values, deferred tax asset valuation allowances,
accounting for loss contingencies, recoverability of goodwill and
acquired intangible assets and amortization periods, assumptions
used in the Black-Scholes model to calculate the fair value of
share based payments, assumptions used in the application of fair
value methodologies to calculate the fair value differential of the
Preferred Stock Exchange, revenue and cost of revenue recognized
under the percentage of completion method and assumptions used in
the application of fair value methodologies to calculate the fair
value of pension assets and obligations.
The
following are our critical accounting policies because we believe
they are both important to the portrayal of our financial condition
and results of operations and require critical management judgments
and estimates about matters that are uncertain. If actual results
or events differ materially from those contemplated by us in making
these estimates, our reported financial condition and results of
operations for future periods could be materially
affected.
Revenue
Recognition. Effective
January 1, 2018, we adopted Accounting Standards Codification
(“ASC”), Topic 606, Revenue from Contracts with
Customers (“ASC 606”), using the modified retrospective
transition method.
In
accordance with ASC 606, revenue is recognized when control of the
promised goods or services is transferred to our customers, in an
amount that reflects the consideration we expect to be entitled to
in exchange for those goods or services.
The
core principle of the standard is that we should recognize revenue
to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which we expect to
be entitled in exchange for those goods or services. To achieve
that core principle, we apply the following five step
model:
1.
Identify
the contract with the customer;
2.
Identify
the performance obligation in the contract;
3.
Determine
the transaction price;
4.
Allocate
the transaction price to the performance obligations in the
contract; and
5.
Recognize
revenue when (or as) each performance obligation is
satisfied.
At
contract inception, we assess the goods and services promised in a
contract with a customer and identify as a performance obligation
each promise to transfer to the customer either: (i) a good or
service (or a bundle of goods or services) that is distinct or (ii)
a series of distinct goods or services that are substantially the
same and that have the same pattern of transfer to the customer. We
recognize revenue only when we satisfy a performance obligation by
transferring a promised good or service to a customer.
Determining
the timing of the satisfaction of performance obligations as well
as the transaction price and the amounts allocated to performance
obligations requires judgement.
We
disclose disaggregation of our customer revenue by classes of
similar products and services as follows:
●
Software licensing and
royalties;
●
Sales of computer hardware and identification
media;
●
Post-contract
customer support.
Software licensing and royalties
Software
licenses consist of revenue from the sale of software for identity
management applications. Our software licenses are functional
intellectual property and typically provide customers with the
right to use our software in perpetuity as it exists when made
available to the customer. We recognize revenue from software
licensing at a point in time upon delivery, provided all other
revenue recognition criteria are met.
Royalties
consist of revenue from usage-based arrangements and guaranteed
minimum-based arrangements. We recognize revenue for royalty
arrangements at the later of (i) when the related sales occur, or
(ii) when the performance obligation to which some or all of the
royalty has been allocated has been satisfied.
Computer hardware and identification media
We
generate revenue from the sale of computer hardware and
identification media. Revenue for these items is recognized upon
delivery of these products to the customer, provided all other
revenue recognition criteria are met.
Services
Services
revenue is comprised primarily of software customization services,
software integration services, system installation services and
customer training. Revenue is generally recognized upon completion
of services and customer acceptance provided all other revenue
recognition criteria are met.
Post-contract customer support (“PCS”)
Post contract customer support consists of
maintenance on software and hardware for our identity management
solutions. We recognize PCS revenue from periodic maintenance
agreements. Revenue is generally recognized ratably over the
respective maintenance periods provided no significant obligations
remain. Costs related to such contracts are expensed as
incurred.
Arrangements with multiple performance obligations
A
performance obligation is a promise in a contract to transfer a
distinct good or service to the customer. In addition to selling
software licenses, hardware and identification media, services and
post-contract customer support on a standalone basis, certain
contracts include multiple performance obligations. For such
arrangements, we allocate revenue to each performance obligation
based on our best estimate of the relative standalone selling
price. The standalone selling price for a performance obligation is
the price at which we would sell a promised good or service
separately to a customer. The primary methods used to estimate
standalone selling price are as follows: (i) the expected cost-plus
margin approach, under which we forecast our expected costs of
satisfying a performance obligation and then add an appropriate
margin for that distinct good or service and (ii) the percent
discount off of list price approach.
Contract costs
We
recognize an asset for the incremental costs of obtaining a
contract with a customer if we expect the benefit of those costs to
be longer than one year. We apply a practical expedient to expense
costs as incurred for costs to obtain a contract when the
amortization period is one year or less.
Other items
We
do not offer rights of return for our products and services in the
normal course of business.
Sales
tax collected from customers is excluded from revenue.
Allowance
for Doubtful Accounts. We provide an allowance for our accounts
receivable for estimated losses that may result from our
customers’ inability to pay. We determine the amount of
allowance by analyzing historical losses, customer concentrations,
customer creditworthiness, current economic trends, and the age of
the accounts receivable balances and changes in our customer
payment terms when evaluating the adequacy of the allowance for
doubtful accounts.
Valuation
of Goodwill, Other Intangible and Long-Lived
Assets. The Company
accounts for its intangible assets under the provisions of ASC 350,
“Intangibles - Goodwill and
Other.” In accordance
with ASC 350, intangible assets with a definite life are analyzed
for impairment under ASC 360-10-05 and intangible assets with an
indefinite life are analyzed for impairment under ASC 360. In
accordance with ASC 350, goodwill, or the excess of cost over fair
value of net assets acquired is tested for impairment using a fair
value approach at the “reporting unit” level. A
reporting unit is the operating segment, or a business one level
below that operating segment (referred to as a component) if
discrete financial information is prepared and regularly reviewed
by management at the component level. The Company’s reporting
unit is at the entity level. The Company recognizes an impairment
charge for any amount by which the carrying amount of a reporting
unit’s goodwill exceeds its fair value. The Company uses fair
value methodologies to establish fair
values.
We
assess impairment of goodwill and identifiable intangible assets
whenever events or changes in circumstances indicate that the
carrying value may not be recoverable. Factors we consider
important which could trigger an impairment review include the
following:
●
Significant
underperformance relative to historical or expected future
operating results;
●
Significant
changes in the manner of our use of the acquired assets or the
strategy of our overall business; and
●
Significant
negative industry or economic trends.
The
Company annually, or more frequently if events or circumstances
indicate a need, tests the carrying amount of goodwill for
impairment. The Company performs its annual impairment test in the
fourth quarter of each year. A two-step impairment test is used to
first identify potential goodwill impairment and then measure the
amount of goodwill impairment loss, if any. The first step was
conducted by determining and comparing the fair value, employing
the market approach, of the Company’s reporting units to the
carrying value of the reporting unit. The Company determined that
its only reporting unit is Identity Management. Based on the
results of this impairment test, the Company determined that its
goodwill assets were not impaired as of December 31,
2017.
The
Company evaluates long-lived assets for impairment whenever events
or changes in circumstances indicate their net book value may not
be recoverable. When such factors and circumstances exist, the
Company compares the projected undiscounted future cash flows
associated with the related asset or group of assets over their
estimated useful lives against their respective carrying amount.
Impairment, if any, is based on the excess of the carrying amount
over the fair value, based on market value when available, or
discounted expected cash flows, of those assets and is recorded in
the period in which the determination is made. The Company’s
management currently believes there is no impairment of its
long-lived assets. There can be no assurance, however, that market
conditions will not change or demand for the Company’s
products under development will continue. Either of these could
result in future impairment of long-lived assets.
There
are many management assumptions and estimates underlying the
determination of an impairment loss, and estimates using different,
but reasonable, assumptions could produce significantly different
results. Significant assumptions include estimates of future levels
of revenues and operating expenses. Therefore, the timing and
recognition of impairment losses by us in the future, if any, may
be highly dependent upon our estimates and assumptions. There can
be no assurance that goodwill impairment will not occur in the
future.
Stock-Based
Compensation. At
December 31, 2017, the Company had one stock-based compensation
plan for employees and nonemployee directors, which authorizes the
granting of various equity-based incentives including stock options
and restricted stock.
The Company estimates the fair value of its stock
options using a Black-Scholes option-pricing model, consistent with
the provisions of ASC 718, “Compensation – Stock
Compensation.” The fair
value of stock options granted is recognized to expense over the
requisite service period. Stock-based compensation expense for all
share-based payment awards is recognized using the straight-line
single-option method. Stock-based compensation expense is reported
in general and administrative, sales and marketing, engineering and
customer service expenses based upon the departments to which
substantially all of the associated employees report and credited
to additional paid-in capital.
ASC 718 requires the use of a valuation model to
calculate the fair value of stock-based awards. For the years ended
December 31, 2017 and 2016, the Company has elected to use the
Black-Scholes option-pricing model, which incorporates various
assumptions including volatility, expected life, and interest
rates. The Company is required to make various assumptions in the
application of the Black-Scholes option-pricing model. The Company
has determined that the best measure of expected volatility is
based on the historical weekly volatility of the Company’s
Common Stock. Historical volatility factors utilized in the
Company’s Black-Scholes computations for options granted
during the years ended December 31, 2017 and 2016 ranged
from 58% to 103%.
The Company has elected to estimate
the expected life of an award based upon the SEC approved
“simplified method” noted under the provisions of Staff
Accounting Bulletin No. 110. The expected term used by the
Company to value the grants issued in 2017 and 2016 as computed by
this method was 5.17 years. The effect of the difference between
the actual historical expected life and the simplified method was
immaterial. The interest rate used is the risk-free interest
rate and is based upon U.S. Treasury rates appropriate for the
expected term. Interest rates used in the Company’s
Black-Scholes calculations were 2.6% for the years ended December
31, 2017 and 2016. Dividend yield is zero, as the Company does
not expect to declare any dividends on the Company’s common
shares in the foreseeable future.
In
addition to the key assumptions used in the Black-Scholes model,
the estimated forfeiture rate at the time of valuation is a
critical assumption. The Company has estimated an annualized
forfeiture rate of approximately 0% for corporate officers, 4.1%
for members of the Board of Directors and 6.0% for all other
employees. The Company reviews the expected forfeiture rate
annually to determine if that percent is still reasonable based on
historical experience.
Income
Taxes. The Company accounts for
income taxes in accordance with ASC 740, “Accounting for Income
Taxes.”
Deferred income taxes are recognized
for the tax consequences related to temporary differences between
the carrying amount of assets and liabilities for financial
reporting purposes and the amounts used for tax purposes at each
year-end, based on enacted tax laws and statutory tax rates
applicable to the periods in which the differences are expected to
affect taxable income. A valuation allowance is established when
necessary based on the weight of available evidence, if it is
considered more likely than not that all or some portion of the
deferred tax assets will not be realized. Income tax expense is the
sum of current income tax plus the change in deferred tax assets
and liabilities.
ASC
740-10 requires a company to first determine whether it is
more-likely-than-not (defined as a likelihood of more than fifty
percent) that a tax position will be sustained based on its
technical merits as of the reporting date, assuming that taxing
authorities will examine the position and have full knowledge of
all relevant information. A tax position that meets this
more-likely-than-not threshold is then measured and recognized at
the largest amount of benefit that is greater than fifty percent
likely to be realized upon effective settlement with a taxing
authority.
We
recognize and measure uncertain tax positions in accordance with
GAAP, pursuant to which we only recognize the tax benefit from an
uncertain tax position if it is more likely than not that the tax
position will be sustained on examination by the taxing
authorities, based on the technical merits of the position. Any tax
benefits recognized in the consolidated financial statements from
such positions are then measured based on the largest benefit that
has a greater than fifty percent likelihood of being realized upon
ultimate settlement. We report a liability for unrecognized tax
benefits resulting from uncertain tax positions taken or expected
to be taken in a tax return. GAAP further requires that a change in
judgment related to the expected ultimate resolution of uncertain
tax positions be recognized in earnings in the quarter of such
change. We recognize interest and penalties, if any, related to
unrecognized tax benefits in income tax expense.
We
file annual income tax returns in multiple taxing jurisdictions
around the world. A number of years may elapse before an uncertain
tax position is audited and finally resolved. While it is often
difficult to predict the final outcome or the timing of resolution
of any particular uncertain tax position, we believe that our
analysis of income tax reserves reflects the most likely outcome.
We adjust these reserves, if any, as well as the related interest,
in light of changing facts and circumstances. Settlement of any
particular position could require the use of cash.
Significant
judgment is required in evaluating the Company’s uncertain
tax positions and determining the Company’s provision for
income taxes. No assurance can be given that the final tax outcome
of these matters will not be different from that which is reflected
in the Company’s historical income tax provisions and
accruals. The Company adjusts these items in light of changing
facts and circumstances. To the extent that the final tax
outcome of these matters is different than the amounts recorded,
such differences will impact the provision for income taxes in the
period in which such determination is made.
The Internal Revenue Code (the
“Code”) limits the availability of certain tax
credits and net operating losses that arose prior to certain
cumulative changes in a corporation’s ownership resulting in
a change of control of the Company. The Company’s use of
its net operating loss carryforwards and tax credit carryforwards
will be significantly limited because the Company believes it
underwent “ownership changes,” as defined under Section
382 of the Internal Revenue Code, in 1991, 1995, 2000, 2003, 2004,
2011 and 2012, though the Company has not performed a study to
determine the limitation. The Company has reduced its deferred
tax assets to zero relating to its federal and state research
credits because of such limitations. The Company continues to
disclose the tax effect of the net operating loss carryforwards at
their original amount as the actual limitation has not yet been
quantified. The Company has also established a full valuation
allowance for substantially all deferred tax assets due to
uncertainties surrounding its ability to generate future taxable
income to realize these assets. Since substantially all deferred
tax assets are fully reserved, future changes in tax benefits will
not impact the effective tax rate. Management periodically
evaluates the recoverability of the deferred tax assets. If it is
determined at some time in the future that it is more likely than
not that deferred tax assets will be realized, the valuation
allowance would be reduced accordingly at that
time.
Fair-Value
Measurements. The Company
accounts for fair value measurements in accordance with ASC 820,
“Fair
Value Measurements and Disclosures,” which defines fair value, establishes a
framework for measuring fair value in generally accepted accounting
principles, and expands disclosures about fair value
measurements.
ASC
820 establishes a fair value hierarchy that prioritizes the inputs
to valuation techniques used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3
measurements). The three levels of the fair value hierarchy under
ASC 820 are described below:
|
Level 1
|
Unadjusted quoted prices in active markets that are accessible at
the measurement date for identical, unrestricted assets or
liabilities.
|
|
|
|
|
Level 2
|
Applies to assets or liabilities for which there are inputs other
than quoted prices included within Level 1 that are observable for
the asset or liability such as quoted prices for similar assets or
liabilities in active markets; quoted prices for identical assets
or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in
which significant inputs are observable or can be derived
principally from, or corroborated by, observable market
data.
|
|
|
|
|
Level 3
|
Prices or valuation techniques that require inputs that are both
significant to the fair value measurement and unobservable
(supported by little or no market activity).
|
Assessing
the significance of a particular input to the fair value
measurement requires judgment, considering factors specific to the
asset or liability. Determining whether a fair value
measurement is based on Level 1, Level 2, or Level 3 inputs is
important because certain disclosures are applicable only to those
fair value measurements that use Level 3 inputs. The use of
Level 3 inputs may include information derived through
extrapolation or interpolation which involves management
assumptions.
For
a detailed discussion on the application of these and other
accounting policies, see Note 2 in the Notes to the Consolidated
Financial Statements.
Results of Operations
This
management’s discussion and analysis of financial condition
and results of operations should be read in conjunction with the
consolidated financial statements and related notes contained
elsewhere in this prospectus.
Comparison of Results for Fiscal Years Ended December 31, 2017 and
2016
Product Revenue
Net Product Revenue
|
Year
Ended
December 31,
2017
|
Year
Ended
December
31,
2016
|
|
|
|
|
|
|
|
Software
and royalties
|
$1,248
|
$857
|
$391
|
46%
|
Percentage of total net product revenue
|
77%
|
69%
|
|
|
Hardware
and consumables
|
$94
|
$68
|
$26
|
38%
|
Percentage of total net product revenue
|
6%
|
5%
|
|
|
Services
|
$272
|
$324
|
$(52)
|
(16)%
|
Percentage of total net product revenue
|
17%
|
26%
|
|
|
Total
net product revenue
|
$1,614
|
$1,249
|
$365
|
29%
|
Software and royalty revenue increased 46% or
approximately $391,000 during the year ended December 31, 2017 as
compared to the corresponding period in 2016. This increase is due
to higher project related sales of our identity management software
of approximately $397,000, higher sales of boxed identity
management software sold through our distribution channel of
approximately $5,000, higher law enforcement project revenue of
approximately $8,000 offset by lower royalty revenue of
approximately $19,000.
Revenue from the sale of hardware and consumables
increased 38% or approximately $26,000 during the year ended
December 31, 2017 as compared to the corresponding period in
2016. This increase resulted
from higher sales of hardware and consumables in project
solutions.
Services revenue is comprised primarily of
software integration services, system installation services and
customer training. Such revenue decreased 16% or approximately
$52,000 during the year ended December 31, 2017 as compared to the
corresponding period in 2016, due primarily to the
completion of the service element in identity management project
solutions in the 2015 period.
We believe that the period-to-period fluctuations
of identity management software revenue in project-oriented
solutions are largely due to the timing of government procurement
with respect to the various programs we are pursuing. Although
no assurances can be given, based on management’s current
visibility into the timing of potential government procurements and
potential partnerships and current pilot programs, we
believe that we will see an increase in government procurement and
implementations with respect to identity management initiatives
during 2018; however, government procurement initiatives,
implementations and pilots are frequently delayed and extended, as
was the case in the year ended December 31, 2017, and we cannot
predict the timing of such initiatives.
During
the year ended December 31, 2017, we continued our efforts to move
the Biometric Engine into cloud and mobile markets and to expand
our end-user market into non-government sectors including
commercial, consumer and healthcare applications. Our approach to the
markets we serve is to partner with larger integrators as resellers
who have both the infrastructure and resources to sell into the
worldwide market. We rely upon these partners for guidance as to
when they expect revenues for our products to begin to ramp. For
those opportunities that are approaching implementation, we are
being told by our partners that we should expect revenues to
commence in the first quarter of 2018.
Maintenance Revenue
Net Maintenance Revenue
|
Year Ended
December 31,
2017
|
Year Ended
December
31,
2016
|
|
|
|
|
|
|
|
Maintenance
Revenue
|
$2,679
|
$2,563
|
116
|
5%
|
Maintenance revenue was approximately $2,679,000
for the year ended December 31, 2017, as compared to approximately
$2,563,000 and $2,577,000 for the corresponding periods in 2016 and
2015, respectively. For the year ended December 31, 2017,
identity management maintenance revenue was approximately
$1,311,000 as compared to $1,181,000 for the comparable period in
2016. The increase in identity management maintenance revenue
of approximately $130,000 reflects the expansion of our installed
base. Law enforcement maintenance revenue was approximately
$1,368,000 for the 12 months ended December 31, 2017 as compared to
$1,382,000 for the comparable period in 2016. This decrease of
approximately $14,000 is primarily due to the expiration of certain
law enforcement maintenance contracts.
We
anticipate growth of our maintenance revenue through the retention
of existing customers combined with the continued expansion of our
installed base resulting from the completion of project-oriented
work, however we cannot predict the timing of this anticipated
growth.
Cost of Product Revenue
Cost of Product
Revenue
|
Year Ended
December 31,
2017
|
Year Ended
December 31,
2016
|
|
|
|
|
|
|
|
Software
and royalties
|
$39
|
$78
|
$(39)
|
(50)%
|
Percentage of software and royalty product revenue
|
3%
|
9%
|
|
|
Hardware
and consumables
|
$64
|
$43
|
$21
|
49%
|
Percentage of hardware and consumables product revenue
|
68%
|
63%
|
|
|
Services
|
$49
|
$122
|
$(73)
|
(60)%
|
Percentage of services product revenue
|
18%
|
39%
|
|
|
Total
cost of product revenue
|
$152
|
$243
|
$(91)
|
(37)%
|
Percentage of total product revenue
|
9%
|
20%
|
|
|
The
cost of software and royalty product revenue decreased
approximately $39,000 during the year ended December 31, 2017 as
compared to the corresponding period in 2016. The cost of software
and royalty revenue decreased approximately $11,000 during the year
ended December 31, 2016 as compared to the corresponding period in
2015. This decrease is due primarily to decreases in third
party software costs despite higher sales of software. In addition
to changes in costs of software and royalty product revenue caused
by revenue level fluctuations, costs of products can vary as a
percentage of product revenue from period to period depending upon
level of software customization and third-party software license
content included in product sales during a given
period.
The cost of product
revenue for our hardware and consumable sales during the year ended
December 31, 2017 increased approximately $21,000 as compared to
the corresponding period in 2016, due primarily to higher hardware
and consumable revenue of approximately $26,000. During the year ended
December 31, 2016, our cost of product revenue for our hardware and
consumable sales decreased by approximately $2,000, as compared to the
corresponding period in 2015 despite higher hardware and consumable
revenue of approximately $34,000 primarily due to the 2015 period
containing approximately $21,000 in hardware equipment written off
due to substantial doubt as to recoverability.
Cost of services
revenue decreased approximately $73,000 during the year ended
December 31, 2017 as compared to the corresponding period in 2016.
This decrease reflects lower professional service revenue of
approximately $52,000. Costs of service revenue can vary depending
upon the complexity of the project solution and the mix of labor
resources utilized to complete the service
element.
Cost of Maintenance Revenue
Maintenance cost
of revenue
|
Year Ended
December 31,
2017
|
Year Ended
December 31,
2016
|
|
|
|
|
|
|
|
Total
maintenance cost of revenue
|
$839
|
$827
|
$12
|
1%
|
Percentage of total maintenance revenue
|
31%
|
32%
|
|
|
Cost
of maintenance revenue increased approximately $12,000 during the
year ended December 31, 2017 as compared to the corresponding
period in 2016, resulting principally from higher labor costs
driven primarily by the utilization of more expensive labor
resources required to fulfill maintenance contract obligations for
the year ended December 31, 2017 as compared to the corresponding
period in 2016.
Product Gross Profit
Product gross profit
|
Years
Ended
December 31,
2017
|
Years
Ended
December 31,
2016
|
|
|
|
|
|
|
|
Software
and royalties
|
$1,209
|
$779
|
$430
|
55%
|
Percentage of software and royalty product revenue
|
97%
|
91%
|
|
|
Hardware
and consumables
|
$30
|
$25
|
$5
|
20%
|
Percentage of hardware and consumables product revenue
|
32%
|
37%
|
|
|
Services
|
$223
|
$202
|
$21
|
10%
|
Percentage of services product revenue
|
82%
|
61%
|
|
|
Total
product gross profit
|
$1,462
|
$1,006
|
$456
|
45%
|
Percentage of total product revenue
|
91%
|
81%
|
|
|
Software and royalty gross profit increased 55% or
approximately $430,000 for the year ended December 31, 2017 as
compared to the corresponding period in 2016, due primarily to higher
software and royalty product revenue of approximately $391,000
combined with lower cost of software and royalty revenue of
approximately $39,000. This relationship is reflective of
approximately $339,000 in license revenue with extremely low costs.
In addition to changes in costs of software and royalty product
revenue caused by revenue level fluctuations, costs of products can
vary as a percentage of product revenue from period to period
depending upon level of software customization and third-party
software license content included in product sales during a given
period.
Hardware and consumables gross profit increased
approximately $5,000 for the year ended December 31, 2017, as
compared to the 2016 period. This increase resulted
from higher sales of hardware and consumables in project solutions
of approximately $26,000
combined
with corresponding higher cost of hardware and consumables product
revenue of $21,000
for the
year ended December 31, 2017 as compared to the corresponding
period in 2016.
Services gross profit increased approximately
$21,000 during the year ended December 31, 2017, as compared to the
corresponding period in 2016, due to lower service
revenue of approximately $52,000 combined with lower cost of
service revenue of approximately $73,000 for the year ended
December 31, 2017 as compared to the corresponding period in
2016. This inverse relationship is cause by the recognition
of certain service revenues in the 12 months ended December 31,
2017 combined with the related costs of these revenues being
written off in 2015 due to significant doubts as to the
recoverability of such costs in the 2015
period.
Maintenance Gross Profit
Maintenance gross profit
|
Year
Ended
December
31,
2017
|
Year
Ended
December 31,
2016
|
|
|
|
|
|
|
|
Total
maintenance gross profit
|
$1,840
|
$1,736
|
$104
|
6%
|
Percentage of total maintenance revenue
|
69%
|
68%
|
|
|
Gross margins related
to maintenance revenue were 69% and 68% for the years ended
December 31, 2017 and 2016, respectively. The dollar increase of
approximately $104,000
for the
2017 year as compared to the corresponding 2016 period primarily
resulted from higher maintenance revenue of approximately $116,000
for the year ended December 31, 2017 as compared to the
corresponding period in 2016.
Operating Expense
|
Year Ended
December 31, 2017
|
Year Ended
December 31, 2016
|
|
|
|
|
|
|
|
General
and administrative
|
$4,192
|
$3,722
|
$470
|
13%
|
Percentage of total net revenue
|
98%
|
98%
|
|
|
Sales
and marketing
|
$2,816
|
$3,021
|
$(205)
|
(7)%
|
Percentage of total net revenue
|
66%
|
79%
|
|
|
Research
and development
|
$5,953
|
$5,332
|
$621
|
12%
|
Percentage of total net revenue
|
139%
|
140%
|
|
|
Depreciation
and amortization
|
$68
|
$129
|
$(61)
|
(47)%
|
Percentage of total net revenue
|
2%
|
3%
|
|
|
General and Administrative Expense
General
and administrative expense is comprised primarily of salaries and
other employee-related costs for executive, financial, and other
infrastructure personnel. General legal, accounting and consulting
services, insurance, occupancy and communication costs are also
included with general and administrative expense.
The
dollar increase of approximately $470,000 in general and
administrative expense for the year ended December 31, 2017, as
compared to the corresponding period in 2016, is comprised of the
following major components:
●
Increase
in personnel related expense of approximately $170,000 due to head
count increases;
●
Increase in
financing related expenses of approximately $160,000;
●
Increase in professional
fees including consulting services and contract services of
approximately $27,000 due primarily to decreases in audit fees of
$75,000 offset by increases in legal fees of approximately $6,000,
increases in various consulting, contract services and corporate
expenses of approximately $82,000 and increases in patent related
fees of approximately $14,000;
●
Decrease
in stock-based compensation expense of approximately $59,000;
and
●
Increase
in travel, insurances, licenses, dues, rent, and office related
costs of approximately $172,000.
We
continue to focus our efforts on achieving additional future
operating efficiencies by reviewing and improving upon existing
business processes and evaluating our cost structure. We believe
these efforts will allow us to continue to gradually decrease our
level of general and administrative expense expressed as a
percentage of total revenue.
Sales and Marketing Expense
Sales and marketing expense consists primarily of the salaries,
commissions, other incentive compensation, employee benefits and
travel expense of our sales, marketing, and business
development.
The dollar decrease in
sales and marketing expense of approximately
$205,000 during the year ended
December 31, 2017, as compared to the corresponding period in 2016,
is primarily comprised of the following major
components:
●
Decrease in personnel related expense of
approximately $45,000 due
primarily to decreases in headcount;
●
Decrease in professional services of approximately $194,000
resulting primarily from decreased utilization of sales
consultants;
●
Increase in contract services and office related expense of
approximately $18,000;
●
Decrease in our Mexico sales office related expense of
approximately $39,000 due primarily to lower contractor utilization
for the year ended December 31, 2017 as compared to the comparable
period in 2016 due to the completion of certain identity management
projects;
●
Increase
in travel and trade show expense of approximately $33,000 and
increases in advertising due and subscriptions and other selling
expense of approximately $26,000; and
●
Decrease
in stock-based compensation of approximately $4,000.
We
anticipate that the level of expense incurred for sales and
marketing during the year ended December 31, 2018 will increase as
we pursue large project solution opportunities.
Research and Development Expense
Research and development expense consists primarily of salaries,
employee benefits and outside contractors for new product
development, product enhancements, custom integration work and
related facility costs.
Research and
development expense increased approximately
$621,000 for the year ended
December 31, 2017, as compared to the corresponding period in 2016,
due primarily to the following major
components:
●
Decrease in personnel
expenditures of approximately $72,000 due to the full year
effect of several headcount changes combined with higher levels of
capitalized labor for the year ended December 31, 2017 as compared
to the comparable period in 2016;
●
Increase in contractor fees and contract services of approximately
$570,000;
●
Decrease in stock-based compensation of
approximately $4,000;
and
●
Increase in office related expense including communications,
engineering tools and supplies, dues and subscriptions and travel
of approximately $127,000.
Our level of expenditures in research and development reflects our
belief that to maintain our competitive position in markets
characterized by rapid rates of technological advancement, we must
continue to invest significant resources in new systems and
software as well as continue to enhance existing
products.
Depreciation and Amortization
During
the year ended December 31, 2017, depreciation and amortization
expense decreased approximately $61,000 as compared to the
corresponding period in 2016. The relatively small amount of
depreciation and amortization in both periods reflects the
relatively small property and equipment carrying
value.
Interest Expense (Income), Net
For
the year ended December 31, 2017, we recognized interest income of
$43,000 and interest expense of $634,000. For the year ended
December 31, 2016, we recognized interest income of $3,000 and
interest expense of $248,000.
Interest
expense for the year ended December 31, 2017 contains the following
components:
●
Approximately
$11,000 of amortization expense of deferred financing fees related
to the Lines of Credit;
●
Approximately
$198,000 of amortization expense of recognized beneficial
conversion feature related to the Lines of Credit borrowings;
and
●
Approximately
$425,000 related to coupon interest on our 8% Line of Credit
borrowings.
Interest
expense for the year ended December 31, 2016 contains the following
components:
●
Approximately
$48,000 of amortization expense of deferred financing fees related
to the Lines of Credit;
●
Approximately
$97,000 of amortization expense of recognized beneficial conversion
feature related to the Lines of Credit borrowings; and
●
Approximately
$102,000 related to coupon interest on our 8% Line of Credit
borrowings.
Other Income
For the year ended
December 31, 2017, we recognized other income of approximately
$125,000 and other expense of
$0. Other income for the year ended December 31, 2017 is
comprised of approximately $75,000 from the write off of
certain accrued expenses due the expiration of the legal statute of
limitations on such liabilities. Other income also includes $50,000
from the sale of one of the Company’s non-utilized
trademarks.
For the year ended
December 31, 2016, we recognized other income of approximately
$201,000 and other expense of
$0. Other income for the year ended December 31, 2016 is
comprised of approximately $201,000 from the write off of certain
accrued expenses due the expiration of the legal statute of
limitations on such liabilities.
Income Tax Expense
During
the year ended December 31, 2017, we recorded a net benefit of
approximately $124,000 from income taxes, as compared to an expense
of $21,000 for the year ended December 31, 2016, and expense of
$22,000 for the year ended December 31, 2015.
During
the years ended December 31, 2017 and 2016, our benefit for income
taxes of $124,000 and tax expense of $21,000, respectively. The tax
benefit reflects the reversal of a prior year accrual related to
foreign taxes which expired due to the expiration of the statute of
limitation on this foreign tax liability. The 2016 tax expense
relates to taxes on income generated in certain foreign
jurisdictions offset by research and development tax credits
generated in certain foreign jurisdictions.
We
have incurred consolidated pre-tax losses during the years ended
December 31, 2017 and 2016, and have incurred operating losses in
all prior periods. Management has determined that it is more likely
than not that a tax benefit from such losses will not be realized.
Accordingly, we did not record a benefit for income taxes for these
periods.
Comparison of the Six Months Ended June 30, 2018 to the Six Months
Ended June 30, 2017
Product
Revenue
|
Six Months Ended
June 30,
|
|
|
Net Product Revenue
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
Software
and royalties
|
$955
|
$508
|
$447
|
88%
|
Percentage
of total net product revenue
|
74%
|
74%
|
|
|
Hardware
and consumables
|
$122
|
$86
|
$36
|
42%
|
Percentage
of total net product revenue
|
10%
|
13%
|
|
|
Services
|
$202
|
$86
|
$116
|
135%
|
Percentage
of total net product revenue
|
16%
|
13%
|
|
|
Total
net product revenue
|
$1,279
|
$680
|
$599
|
88%
|
Software and
royalty revenue increased 88% or approximately $447,000 during the
six months ended June 30, 2018 as compared to the corresponding
period in 2017. This increase is attributable to higher
identification project related revenue of approximately $579,000
and higher law enforcement project related revenue of approximately
$78,000, offset by lower sales of boxed identity management
software sold through our distribution channel of approximately
$47,000 and lower royalty revenue of approximately
$163,000. The increase in
identification project related revenue and law enforcement project
revenue is reflective of additional software licenses sold into
existing identification projects caused by increased end-user
utilization. The decrease in boxed identity management software
sold through our distribution channel reflects lower procurement
from two of our channel partners and the decrease in royalty
revenue results primarily from revenue recognition timing
differences due to the adoption of ASC 606 – Revenue from
Contracts with Customers effective January 1, 2018 combined with
lower reported usage from certain customers.
Revenue
from the sale of hardware and consumables increased approximately
$36,000 during the six months ended June 30, 2018 as compared to
the corresponding period in 2017 due to an increase in project
related solutions containing hardware and consumables and a
decrease in replacement hardware procurement by our
customers.
Services
revenue is comprised primarily of software integration services,
system installation services and customer training. Such revenue
increased approximately $116,000 during the six months ended June
30, 2018 as compared to the corresponding period of 2017 due to an
increase in the service element of project related work completed
during the six months ended June 30, 2018.
We
believe that the period-to-period fluctuations of identity
management software revenue in project-oriented solutions are
largely due to the timing of government procurement with respect to
the various programs we are pursuing. Government procurement
initiatives, implementations and pilots are frequently delayed and
extended and we cannot predict the timing of such
initiatives.
During the six months ended June 30,
2018, we continued our efforts to move the Biometric Engine into
cloud and mobile markets, and expand our end-user market into
non-government sectors, including commercial, consumer and
healthcare applications. Our approach to the markets we serve
is to partner with larger integrators as resellers who have both
the infrastructure and resources to sell into the worldwide market.
We rely upon these partners for guidance as to when they expect
revenue for our products to begin to ramp. In the second quarter we saw additional customers
implement GoVerify ID®, our cloud based mobile biometric
authentication software as a service. Management believes that
additional implementations will occur throughout the remainder of
the year ended December 31, 2018, resulting in increased identities
under management.
Maintenance Revenue
|
Six Months Ended
June 30,
|
|
|
Maintenance Revenue
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
Total
maintenance revenue
|
$1,322
|
$1,309
|
$13
|
1%
|
Maintenance
revenue was approximately $1,322,000 for the six months ended June
30, 2018, as compared to approximately $1,309,000 for the
corresponding period in 2017. Identity management maintenance
revenue generated from identification software solutions was
approximately $675,000 for the six months ended June 30, 2018 as
compared to approximately $613,000 during the comparable period in
2017. Law enforcement maintenance revenue was approximately
$647,000 and $696,000 for the six months ended June 30, 2018 and
2017, respectively. The increase of $62,000 in identification
software maintenance revenue for the six months ended June 30, 2018
as compared to the corresponding period of 2017 reflects the
expansion of our installed base and the decrease of $49,000 in law
enforcement maintenance revenue reflects the expiration of certain
maintenance contracts.
We
anticipate growth of our maintenance revenue through the retention
of existing customers combined with the expansion of our installed
base resulting from the completion of project-oriented work;
however, we cannot predict the timing of this anticipated
growth.
Cost of Product Revenue
|
Six Months Ended
June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software
and royalties
|
$8
|
$17
|
$(9)
|
(53)%
|
Percentage
of software and royalty product revenue
|
1%
|
3%
|
|
|
Hardware
and consumables
|
$82
|
$55
|
$27
|
49%
|
Percentage
of hardware and consumables product revenue
|
67%
|
64%
|
|
|
Services
|
$75
|
$18
|
$57
|
317%
|
Percentage
of services product revenue
|
37%
|
21%
|
|
|
Total
product cost of revenue
|
$165
|
$90
|
$75
|
83%
|
Percentage
of total product revenue
|
13%
|
13%
|
|
|
The
cost of software and royalty product revenue decreased
approximately $9,000 despite higher software and royalty revenue
for the six months ended June 30, 2018 as compared to the
corresponding period in 2017 due to the 2018 period containing
significant software license revenue with no associated
customization costs.
The
cost of hardware and consumable product revenue increased
approximately $27,000 for the six months ended June 30, 2018 as
compared to the corresponding period in 2017 due primarily to
higher hardware and consumable product revenue of approximately
$36,000 during the 2018 period.
The
cost of services revenue increased approximately $57,000 during the
six months ended June 30, 2018 as compared to the corresponding
period in 2017 due primarily to higher service revenue of
approximately $116,000 combined with the write-off of approximately
$15,000 in non-recoverable project costs incurred due to
implementation difficulties combined with the composition of labor
resources utilized in the completion of the service element. In
addition to changes in costs of services product revenue caused by
revenue level fluctuations, costs of services can vary as a
percentage of service revenue from period to period depending upon
both the level and complexity of professional service resources
utilized in the completion of the service element.
Cost of Maintenance Revenue
Maintenance cost of revenue
|
Six Months Ended
June 30,
|
|
|
(dollars in thousands)
|
|
|
|
|
Total
maintenance cost of revenue
|
$390
|
$423
|
(33)
|
(8)%
|
Percentage of
total maintenance revenue
|
30%
|
32%
|
|
|
Cost
of maintenance revenue decreased approximately $33,000 during the
six months ended June 30, 2018 as compared to the corresponding
period in 2017. This decrease is reflective of lower maintenance
labor costs incurred during the six months ended June 30, 2018 as
compared to the corresponding period in 2017 due primarily to the
composition of engineering resources used in the provision of
maintenance services and reductions in headcount in our customer
support department.
Product
Gross Profit
|
Six
Months Ended
June
30,
|
|
|
Product
gross profit
|
|
|
|
|
(dollars
in thousands)
|
|
|
|
|
Software and
royalties
|
$947
|
$491
|
$456
|
93%
|
Percentage of
software and royalty product revenue
|
99%
|
97%
|
|
|
Hardware and
consumables
|
$40
|
$30
|
$10
|
33%
|
Percentage of
hardware and consumables product revenue
|
33%
|
35%
|
|
|
Services
|
$127
|
$68
|
$59
|
87%
|
Percentage of
services product revenue
|
63%
|
79%
|
|
|
Total product gross
profit
|
$1,114
|
$589
|
$525
|
89%
|
Percentage of total
product revenue
|
87%
|
87%
|
|
|
Software
and royalty gross profit increased 93% or approximately $456,000
for the six months ended June 30, 2018 from the corresponding
period in 2017 due primarily to higher software and royalty revenue
of approximately $447,000 combined with lower software and royalty
cost of revenue of $9,000 for the same period. In addition to
changes in costs of software and royalty product revenue caused by
revenue level fluctuations, costs of products can vary as a
percentage of product revenue from period to period depending upon
level of software customization and third -party software license
content included in product sales during a given
period.
Services
gross profit increased approximately $59,000 for the six months
ended June 30, 2018 as compared to the corresponding period in 2017
due to higher service revenue of approximately $116,000 for the six
months ended June 30, 2018 as compared to the corresponding period
in 2017, combined with higher costs of service revenue of
approximately $57,000 for the six months ended June 30, 2018 as
compared to the corresponding period in 2017. These higher costs
reflect the write-off of approximately $15,000 in non-recoverable
project costs incurred due to implementation
difficulties.
Maintenance Gross Profit
|
Six
Months Ended
June
30,
|
|
|
Maintenance gross profit
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
Total
maintenance gross profit
|
$932
|
$886
|
$46
|
5%
|
Percentage
of total maintenance revenue
|
70%
|
68%
|
|
|
Gross
profit related to maintenance revenue increased 5% or approximately
$46,000 for the six months ended June 30, 2018 as compared to the
corresponding period in 2017. This increase reflects higher
maintenance revenue of approximately $13,000 due to the expansion
of our installed base combined with lower cost of maintenance
revenue of approximately $33,000 due to headcount reductions in our
customer service department combined with lower maintenance labor
costs incurred during the same period due to the composition of
engineering resources used in the provision of maintenance
services.
Operating
Expense
|
Six
Months Ended
June
30,
|
|
|
Operating expense
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
General
and administrative
|
$2,190
|
$1,934
|
$256
|
13%
|
Percentage
of total net revenue
|
84%
|
97%
|
|
|
Sales
and marketing
|
$1,680
|
$1,463
|
$217
|
15%
|
Percentage
of total net revenue
|
65%
|
74%
|
|
|
Research and
development
|
$3,664
|
$3,096
|
$568
|
18%
|
Percentage
of total net revenue
|
141%
|
156%
|
|
|
Depreciation
and amortization
|
$24
|
$38
|
$(14)
|
(37)%
|
Percentage
of total net revenue
|
1%
|
2%
|
|
|
General and Administrative Expense
General and administrative expense is
comprised primarily of salaries and other employee-related costs
for executive, financial, and other infrastructure personnel.
General legal, accounting and consulting services, insurance,
occupancy and communication costs are also included with general
and administrative expense. The dollar increase of
approximately $256,000 during
the six months ended June 30, 2018 as compared to the corresponding
period in 2017 is comprised of the following major
components:
●
Decrease
in personnel related expense of approximately $13,000 due to
reductions in headcount;
●
Increases in professional services of
approximately $273,000, which
includes higher Board of Director fees of approximately $99,000 due
to additional members, higher patent-related fees of approximately
$16,000, higher auditing fees of approximately $141,000, higher
contractor fees of approximately $19,000, and higher general
corporate expense of approximately $11,000, offset by lower legal
fees of approximately $7,000 and lower investor relations fees of
approximately $6,000;
●
Increase
in travel, insurances, licenses, dues, rent, office related costs
and other of approximately $51,000;
●
Decrease
in financing expense of approximately $98,000; and
●
Increase
in stock-based compensation expense of approximately
$43,000.
We
continue to focus our efforts on achieving additional future
operating efficiencies by reviewing and improving upon existing
business processes and evaluating our cost structure. We believe
these efforts will allow us to continue to gradually decrease our
level of general and administrative expense expressed as a
percentage of total revenue.
Sales and Marketing
Sales
and marketing expense consists primarily of the salaries,
commissions, other incentive compensation, employee benefits and
travel expense of our sales, marketing, and business development
functions. The dollar increase of approximately $217,000 during the
six months ended June 30, 2018 as compared to the corresponding
period in 2017 is primarily comprised of the following major
components:
●
Increase
in personnel related expense of approximately $233,000 driven
primarily by headcount increases;
●
Decrease
in contractor and contract services of approximately $3,000
resulting from decreased utilization of certain sales consultants
of approximately $61,000, offset by increased marketing dues and
subscription expense and contract services of approximately
$58,000;
●
Decrease
in travel, trade show expense and office related expense of
approximately $30,000;
●
Increase in
stock-based compensation expense of approximately $13,000; and
●
Increase
in our Mexico sales office expense and other of approximately
$4,000.
Research and Development
Research
and development expense consists primarily of salaries, employee
benefits and outside contractors for new product development,
product enhancements, custom integration work and related facility
costs. Such expense increased approximately $568,000 for the six
months ended June 30, 2018 as compared to the corresponding period
in 2017 due primarily to the following major
components:
●
Increase
in personnel related expense of approximately $159,000 due to
headcount increases;
●
Increase
in contractor fees and contract services of approximately $313,000
for services related to the accelerated development of mobile
identity management applications;
●
Increase in stock
based-compensation expense of approximately $11,000; and
●
Increase
in rent, office related expense and engineering tools and supplies
of approximately $85,000.
Our
level of expenditures in research and development reflects our
belief that to maintain our competitive position in markets
characterized by rapid rates of technological advancement, we must
continue to invest significant resources in new systems and
software development as well as continue to enhance existing
products.
Depreciation and Amortization
During
the six months ended June 30, 2018 and 2017, depreciation and
amortization expense was approximately $24,000 and $38,000,
respectively. The relatively small amount of depreciation and
amortization reflects the relatively small property and equipment
carrying value. The decrease is reflective of the full depreciation
of certain fixed assets.
Interest Expense, Net
For the six months ended June 30, 2018, we
recognized interest expense of approximately $386,000 and interest
income of approximately $30,000. For the six months ended June 30,
2017, we recognized interest expense of approximately $266,000 and
interest income of approximately $2,000. Interest expense for the
six months ended June 30, 2018 is comprised of approximately $4,000
of amortization expense of deferred financing fees related to the
Goldman LOC, interest expense of approximately $263,000 of coupon
interest on debt outstanding under the Lines of Credit, and
approximately $119,000 related to the amortization of beneficial
conversion feature related to the Lines of
Credit.
Liquidity, Capital Resources and Going Concern
Historically,
our principal sources of cash have included customer payments from
the sale of our products, proceeds from the issuance of common and
preferred stock and proceeds from the issuance of debt, including
our former Lines of Credit. Our principal uses of cash have
included cash used in operations, payments relating to purchases of
property and equipment and repayments of borrowings. We expect that
our principal uses of cash in the future will be for product
development, including customization of identity management
products for enterprise and consumer applications, further
development of intellectual property, development of SaaS
capabilities for existing products as well as general working
capital and capital expenditure requirements. We expect that, as
our revenue grows, our sales and marketing and research and
development expense will continue to grow, albeit at a slower rate
and, as a result, we will need to generate significant net revenue
to achieve and sustain income from operations.
Series A Financing
On
September 18, 2017, the Company consummated the Series A Financing
and Preferred Stock Exchange. As a result of the Series A
Financing, the Company generated net proceeds to the Company of
approximately $10.9 million. As a result of the Preferred Stock
Exchange, the holders of all outstanding Exchanged Preferred,
agreed to cancel their Exchanged Preferred in exchange for the same
number of shares of Series A Preferred, resulting in the issuance
to the holders of Exchanged Preferred of an aggregate total of
20,021 shares of Series A Preferred.
Series C Financing
On
September 10, 2018, the Company offered and sold a total of 890
shares of Series C Preferred at a purchase price of $10,000 per
share, and on September 21, 2018, the Company sold an additional
110 shares of Series C Preferred as a purchase price of $10,000 per
share. The total gross proceeds to the Company from the Series C
Financing were approximately $10.0 million.
Lines of Credit
In March 2013, the Company and Neal Goldman, a
member of the Company’s Board of Directors
(“Goldman”), entered into a line of credit (the
“Goldman Line of
Credit”), as amended,
with available borrowings of up to $5.5 million, and a maturity
date, as amended, of December 31, 2018. Pursuant to the terms and
conditions of the Goldman Line of Credit, as amended, Goldman has
the right to convert the outstanding principal amount due under the
terms of the Goldman Line of Credit, plus any accrued but unpaid
interest due thereunder, into shares of the Company’s Common
Stock for $1.25 per share.
As consideration for the Goldman Line of Credit,
as amended, Goldman was granted warrants to purchase an aggregate
of 1,230,410 shares of the Company’s Common Stock (the
“Line
of Credit Warrants”). The
Goldman Line of Credit Warrants have exercise prices ranging
between $0.95 and $2.25 per share and 177,778 of these warrants
expired unexercised.
The
Company estimated the fair value of the Line of Credit Warrants
using the Black-Scholes option pricing model using the following
assumptions: term of two years, a risk-free interest rate of 2.58%,
a dividend yield of 0%, and volatility between 74% and 79%. The
Company recorded the fair value of the Line of Credit Warrants as a
deferred financing fee of approximately $580,000 to be amortized
over the life of the Goldman Line of Credit.
During
the years ended December 31, 2017 and 2016, the Company recorded an
aggregate of approximately $11,000 and $48,000, respectively in
deferred financing fee amortization expense which is recorded as a
component of interest expense in the Company’s consolidated
statements of operations.
The Company also entered into an unsecured line of
credit with Charles Crocker, a member of the Company’s Board
of Directors (“Crocker”), which, as amended, provides for
available borrowings of up to $500,000 (the
“Crocker LOC”). All amounts due under the terms of
the Crocker LOC, as amended, are convertible into shares of the
Company’s Common Stock for $1.25 per
share.
As the amendments to
the Goldman Line of Credit and the Crocker LOC
(“Lines
of Credit”) resulted in an
increase to the borrowing capacity of the Lines of Credit, the
Company adjusted the amortization period of any remaining
unamortized deferred costs and note discounts to the term of the
new arrangement.
The
Company evaluated the Lines of Credit and determined that the
instruments contain a contingent beneficial conversion feature,
i.e. an embedded conversion right that enables the holder to obtain
the underlying Common Stock at a price below market value. The
beneficial conversion feature is contingent as the terms of the
conversion do not permit the Company to compute the number of
shares that the holder would receive if the contingent event occurs
(i.e. future borrowings under the Lines of Credit). The Company has
considered the accounting for this contingent beneficial conversion
feature using the guidance in ASC 470, Debt. The guidance in ASC
470 states that a contingent beneficial conversion feature in an
instrument shall not be recognized in earnings until the
contingency is resolved. The beneficial conversion features of
future borrowings under the Lines of Credit will be measured
using the intrinsic value calculated at the date the contingency is
resolved using the conversion price and trading value of the
Company’s Common Stock at the date the Lines of Credit were
issued (commitment date). Pursuant to borrowings made during the
2015 year, the Company recognized approximately $146,000 in
beneficial conversion feature as debt discount. As a result of the
retirement of all amounts outstanding under the Lines of Credit in
2015, the Company recognized all remaining unamortized debt
discount of approximately $385,000 as a component of interest
expense during the three months ended March 31, 2015. As a result
of $2,650,000 in borrowings under the Lines of Credit during the
year ended December 31, 2016, the Company recorded approximately
$219,000 in debt discount attributable to the beneficial conversion
feature during the year ended December31, 2016. As a result of
additional borrowings of $3,350,000 under the Lines of Credit
during the year ended December 31, 2017, the Company recorded
approximately $302,000 in debt discount attributable to the
beneficial conversion feature during the year ended December 31,
2017. During the years ended December 31, 2017 and 2016, the
Company accreted approximately $198,000 and $97,000, respectively,
of debt discount as a component of interest expense.
In addition, on January 23, 2017, the Company and Crocker amended
the New Crocker LOC to extend the maturity date thereof to December
31, 2017.
On
May 10, 2017, Goldman and Crocker agreed to further extend the
maturity dates of the Lines of Credit to December 31,
2018.
As
of June 30, 2018, we had aggregate borrowings outstanding under our
Lines of Credit of $6,000,000 and related accrued unpaid interest
of approximately $791,000. These amounts were scheduled to become
due on December 31, 2018.
On September 10, 2018, the Company entered into
agreements (the “Exchange
Agreements”) with Goldman
and Crocker, pursuant to which Goldman and Crocker agreed to
exchange approximately $6.3 million and $0.6 million, respectively,
of outstanding debt (including accrued and unpaid interest) owed
under the terms of their respective Lines of Credit for an
aggregate of 6,896 shares of Series A Preferred (the
“Debt Exchange”). As a result of the Debt Exchange, all
indebtedness, liabilities and other obligations arising under the
Lines of Credit were terminated, cancelled and deemed satisfied in
full. As a result, no future
borrowings are available under the Lines of
Credit.
The
following table sets forth the Company’s activity under its
former Lines of Credit for the periods indicated:
Balance
outstanding under Lines of Credit as of December 31,
2015
|
$—
|
Borrowing
under Lines of Credit
|
2,650
|
Repayments
|
—
|
Balance
outstanding under Lines of Credit as of December 31,
2016
|
$2,650
|
Borrowings
under Lines of Credit
|
3,350
|
Repayments
|
—
|
Balance
outstanding under Lines of Credit as of December 31,
2017
|
$6,000
|
Borrowings
under Lines of Credit
|
—
|
|
(6,000)
|
Balance
outstanding under Lines of Credit as of October 4,
2018
|
$—
|
Going Concern and Management’s Plan
At
June 30, 2018, we had a working capital deficit of approximately
$5.3 million, as compared to a working capital deficit of
approximately $415,000 and $3.0 million at December 31, 2017 and
December 31, 2016, respectively. Our principal sources of liquidity
at June 30, 2018 consisted of cash of $2,213,000 and $672,000 of
trade accounts receivable. Our principal sources of liquidity at
December 31, 2017 consisted of cash and cash equivalents of
$7,317,000, compared to available borrowings under our Lines of
Credit of $3,350,000, and approximately $1,586,000 of cash and cash
equivalents at December 31, 2016.
Considering
our projected cash requirements, and assuming we are unable to
generate incremental revenue, our available cash may be
insufficient to satisfy our cash requirements for the next 12
months from the date of this filing. These factors raise
substantial doubt about our ability to continue as a going concern.
To address our working capital requirements, management may seek
additional equity and/or debt financing through the issuance of
additional debt and/or equity securities or may seek strategic or
other transactions intended to increase shareholder value. There
are currently no formal committed financing arrangements to support
our projected cash shortfall, including commitments to purchase
additional debt and/or equity securities, or other agreements, and
no assurances can be given that we will be successful in raising
additional debt and/or equity securities, or entering into any
other transaction that addresses our ability to continue as a going
concern.
In
view of the matters described in the preceding paragraph,
recoverability of a major portion of the recorded asset amounts
shown in the accompanying consolidated balance sheet is dependent
upon continued operations of the Company, which, in turn, is
dependent upon the Company’s ability to continue to raise
capital and generate positive cash flows from operations. However,
the Company operates in markets that are emerging and highly
competitive. There is no assurance that the Company will be able to
obtain additional capital, operate at a profit or generate positive
cash flows in the future.
The
consolidated financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset
amounts and classifications of liabilities that might be necessary
should the Company be unable to continue as a going
concern.
Operating Activities
Net
cash used in operating activities was $5,236,000 during the six
months ended June 30, 2018 as compared to net used in operating
activities of $8,703,000 and $7,911,000 during the years ended
December 31, 2017 and December 31, 2016,
respectively.
During
the six months ended June 30, 2018, net cash used in operating
activities consisted of net loss of $5,869,000 and a decrease in
working capital and other assets and liabilities of $230,000. Those
amounts were offset by approximately $863,000 of non-cash costs,
including $717,000 in stock-based compensation, $122,000 in debt
issuance cost amortization and beneficial conversion feature
amortization and $24,000 in depreciation and amortization. During
the six months ended June 30, 2018, we used cash of $102,000 from
increases in current assets and used cash of $128,000 through
reductions in current liabilities and deferred revenue, excluding
debt.
During
the year ended December 31, 2017, net cash used in operating
activities consisted of net loss of $10,069,000 and an increase in
operating cash from changes in assets and liabilities of $195,000.
We also incurred $1,171,000 in net non-cash costs including
$1,151,000 in stock based compensation, $209,000 in debt issuance
cost amortization and debt discount amortization, $15,000 in
provision for losses on accounts receivable and $68,000 in
depreciation and amortization offset by $272,000 of non-cash income
primarily from the write-off of certain accrued expenses due to the
expiration of the statute of limitations of $222,000 and $50,000
from the sale of one of the Company’s non-utilized
trademarks. During the year ended December 31, 2017, we used cash
of $282,000 from increases in current assets and generated
cash of $477,000 through increases in current liabilities and
deferred revenues, excluding debt.
During
the year ended December 31, 2016, net cash used in operating
activities consisted of net loss of $9,527,000 and an increase in
operating cash from changes in assets and liabilities of $383,000.
We also incurred $1,235,000 in net non-cash costs including
$1,162,000 in stock-based compensation, $145,000 in debt issuance
cost amortization and debt discount amortization, and $129,000 in
depreciation and amortization offset by $200,000 of non-cash income
primarily from the write-off of certain accrued expenses due to the
expiration of the statute of limitations. During the year ended
December 31, 2016, we generated cash of $35,000
from reductions in current assets and generated cash of
$348,000 through increases in current liabilities and deferred
revenues, excluding debt.
Investing Activities
Net cash used in
investing activities was $7,000
for the six months ended June 30, 2018 and net cash provided by
operating activities was $45,000 for the year ended
December 31, 2017, and net cash
used in investing activities was $49,000 for the year
ended December 31, 2016. For
the six months ended June 30, 2018, we used cash of $7,000 to fund
capital expenditures of leasehold improvements. For the years ended
December 31, 2017 and 2016, we
used cash to fund capital expenditures of computer equipment,
software and furniture and fixtures of $5,000 and $49,000,
respectively. This level of equipment
purchases resulted primarily from the replacement of older
equipment. For the year ended
December 31, 2017, we generated cash of $50,000 from the sale of
one of our non-utilized
trademarks.
Financing Activities
During the six months ended June 30, 2018, we
generated cash of approximately $149,000 from the exercise of
148,757 options resulting in the issuance of 148,757 shares of
Common Stock, as compared to $14,495,000 from financing activities
for the year ended December 31, 2017 and
$6,195,000 for
the year ended December 31, 2016. During the six months ended June
30, 2018, we used cash of approximately $25,000 for the payment of
dividends on our Series B Preferred stock. For the six months ended
June 30, 2017, we generated cash of $3,350,000 from borrowings
under our Lines of Credit and generated approximately $227,000 from
the exercise of 322,000 option resulting in the Issuance of 322,000
shares of Common Stock. For the six months ended June 30, 2017, we
used cash of approximately $25,000 for the payment of dividends on
our Series B Preferred stock. During the year ended December 31,
2017, we generated cash of $11,000,000 from the Series A Financing
offset by $63,000 in offering costs, generated $3,350,000 from
borrowings under the Lines of Credit and generated approximately
$259,000 from the exercise of 369,004 options resulting in the
issuance of 369,004 shares of Common Stock. We used cash of
approximately $51,000 for the payment of dividends on our Series B
Convertible Preferred Stock.
Subsequent
to the quarter ended June 30, 2018, in September 2018, we offered
and sold an aggregate of 1,000 shares of Series C Preferred at a
purchase price of $10,000 per share in the Series C Financing,
resulting in gross proceeds to the Company of approximately $10.0
million.
Debt
At June 30, 2018, the Company had $6,000,000 in outstanding debt
under the terms of the Lines of Credit, and $791,000 in accrued but unpaid
interest, as compared to $6,000,000 in outstanding debt and
$527,000 in related accrued but unpaid interest at December 31,
2017. As a result of the Debt Exchange consummated on September 10,
2018, the Lines of Credit and all indebtedness, liabilities and
other obligations arising thereunder were terminated, cancelled and
deemed satisfied in full. As a result, no future borrowings are
available under the Lines of Credit.
Contractual Obligations
Total
contractual obligations and commercial commitments as of June 30,
2018 are summarized in the following table (in
thousands):
|
|
|
|
|
|
|
|
Operating
lease obligations
|
$1,433
|
$274
|
$842
|
$317
|
$—
|
Advances
(including accrued interest of approximately $791,000) under
related party lines of credit
|
$6,791
|
$6,791
|
$—
|
$—
|
$—
|
Total
|
$8,224
|
$7,065
|
$842
|
$317
|
$—
|
Total
contractual obligations and commercial commitments as of December
31, 2017 are summarized in the following table (in
thousands):
|
|
|
|
|
|
|
|
Operating
lease obligations
|
$1,770
|
$607
|
$847
|
$316
|
$—
|
Advances
(including accrued interest of approximately $527,000) under
related party lines of credit
|
$6,527
|
$6,527
|
$—
|
$—
|
$—
|
Total
|
$8,297
|
$7,134
|
$847
|
$316
|
$—
|
Real Property Leases
Our
corporate headquarters are located in San Diego, California, where
we occupy 9,927 square feet of office space. This facility’s
lease was renewed in September 2017 through October 2018 at a cost
of approximately $30,000 per month. In addition to our corporate
headquarters, we also occupied the following spaces at June 30,
2018:
●
1,508
square feet in Ottawa, Province of Ontario, Canada, at a cost of
approximately $3,000 per month until the expiration of the lease on
March 31, 2021;
●
9,720
square feet in Portland, Oregon, at a cost of approximately $22,000
per month until the expiration of the lease on February 28, 2023;
and
●
304
square feet of office space in Mexico City, Mexico, at a cost of
approximately $3,000 per month until November 30,
2018.
In July 2018, the
Company entered in a new leasing arrangement for 8,511 square feet
of office space for its San Diego headquarters. The new lease
commences on November 1, 2018 and terminates on April 30, 2025.
Annual base rent over the lease term approximates $361,000 per
year.
Stock-based Compensation
Stock-based
compensation related to equity options and restricted stock has
been classified as follows in the accompanying consolidated
statements of operations (in thousands):
|
Six
Months Ended
June
30,
|
|
|
|
|
|
|
(unaudited)
|
|
|
Cost
of revenue
|
$11
|
$19
|
$20
|
General
and administrative
|
462
|
655
|
714
|
Sales
and marketing
|
123
|
220
|
224
|
Research
and development
|
112
|
200
|
204
|
|
|
|
|
Total
|
$708
|
$1,094
|
$1,162
|
Off-Balance Sheet Arrangements
At
June 30, 2018, we did not have any relationships with
unconsolidated entities or financial partnerships, such as entities
often referred to as structured finance, special purpose or
variable interest entities, which would have been established for
the purpose of facilitating off-balance sheet arrangements or other
contractually narrow or limited purposes. In addition, we did not
engage in trading activities involving non-exchange traded
contracts. As a result, we are not exposed to any financing,
liquidity, market or credit risk that could arise if we had engaged
in such relationships. We do not have relationships and
transactions with persons or entities that derive benefits from
their non-independent relationship with us or our related parties
except as disclosed elsewhere in this prospectus.
Recently Issued Accounting Pronouncements
From
time to time, new accounting pronouncements are issued by the FASB,
or other standard setting bodies, which are adopted by us as of the
specified effective date. See Note 2 to the consolidated
financial statements for the period ended June 30, 2018 for a
detailed discussion of recently issued accounting
pronouncements.
Impact of Inflation
The
primary inflationary factor affecting our operations is labor
costs, and we do not believe that inflation has materially affected
earnings during the past four years. Substantial increases in costs
and expenses, particularly labor and operating expenses, could have
a significant impact on our operating results to the extent that
such increases cannot be passed along to customers and end
users.
DIRECTORS AND EXECUTIVE
OFFICERS
The
Board of Directors and executive officers consist of the persons
named in the table below. Each director serves for a one-year term,
until his or her successor is elected and qualified, or until
earlier resignation or removal. Our bylaws provide that the
number of directors shall not be less than four, but no more than
ten. The directors and executive officers are as
follows:
Name
|
|
Age
|
|
Principal Occupation/Position Held With the Company
|
Mr. S. James Miller, Jr.
|
|
65
|
|
Chief Executive Officer and Chairman of the Board of
Directors
|
Mr. Wayne Wetherell
|
|
66
|
|
Senior Vice President of Administration, Chief Financial Officer,
Secretary and Treasurer
|
Mr. David Harding
|
|
49
|
|
Senior Vice President, Chief Technical Officer
|
Mr. Robert Brown
|
|
57
|
|
Vice President, Sales and Business Development
|
Mr. David Somerville
|
|
58
|
|
Senior Vice President, Sales and Marketing
|
Mr. David Carey
|
|
73
|
|
Director
|
Mr. Guy Steve Hamm
|
|
70
|
|
Director
|
Mr. David Loesch
|
|
74
|
|
Director
|
Mr. John Cronin
|
|
63
|
|
Director
|
Mr. Neal Goldman
|
|
74
|
|
Director
|
Mr. Charles Crocker
|
|
79
|
|
Director
|
Mr. Dana W. Kammersgard
|
|
63
|
|
Director
|
Mr. Charles Frischer
|
|
52
|
|
Director
|
Mr. Robert T. Clutterbuck
|
|
67
|
|
Director
|
S. James
Miller, Jr. has
served as our Chief Executive Officer since 1990 and Chairman of
the Board since 1996. He also served as our President from 1990
until 2003. From 1980 to 1990, Mr. Miller was an executive
with Oak Industries, Inc., a manufacturer of components for
the telecommunications industry. While at Oak Industries,
Mr. Miller served as a director and as Senior Vice President,
General Counsel, Corporate Secretary and Chairman/President of Oak
Industries’ Pacific Rim subsidiaries. He has a J.D. from the
University of San Diego School of Law and a B.A. from the
University of California, San Diego.
The
Nominating and Corporate Governance Committee believes that Mr.
Miller possesses substantial managerial expertise leading the
Company through its various stages of development and growth,
beginning in 1990 when Mr. Miller joined the Company as President
and Chief Executive Officer, and that such expertise is extremely
valuable to the Board of Directors and the Company as it executes
its business plan. In addition, the Board of Directors values the
input provided by Mr. Miller given his legal
experience.
Wayne
Wetherell has served as
our Senior Vice President, Administration and Chief Financial
Officer since May 2001 and additionally as our Secretary and
Treasurer since October 2005. From 1996 to May 2001, he
served as Vice President of Finance and Chief Financial Officer.
From 1991 to 1996, Mr. Wetherell was the Vice President and
Chief Financial Officer of Bilstein Corporation of America, a
manufacturer and distributor of automotive parts. From 1980 to 1990
Mr. Wetherell served in various financial roles culminating as
Director of Financial Planning and Analysis for Oak Industries,
Inc., a manufacturer of components for the telecommunications
industry traded on the NYSE. Mr. Wetherell holds a B.S.
degree in Management and a M.S. degree in Finance from San Diego
State University.
David Harding has served as our Sr.
Vice President and Chief Technology Officer since January 2006. Mr.
Harding has more than 25 years of technology implementation and
management experience, is responsible for strategic design,
technology infrastructure and core strategy from concept through
delivery. Before joining us, Mr. Harding was the Chief
Technology Officer at IC Solutions, Inc., where he was
responsible for all technology departments including the
development and management of software development, IT and quality
assurance, as well as their respective hardware, software and human
resource budgets from 2001 to 2003. He was the Chief Technology
Officer at Thirsty.com from 1999 to 2000, the Chief Technology
Officer at Fulcrum Point Technologies, Inc., from 1996 to
1999, and consultant to Access360, which is now part of IBM/Tivoli,
from 1995 to 1996.
Robert
Brown has served as our Vice
President – Sales and Business Development since June 2015.
Prior to joining the Company, Mr. Brown served since February 2010
as the principal of Black Diamond Group, a global consultancy
agency representing new technology companies in connection with
their relationship with Microsoft. Prior to Black Diamond
Group, Mr. Brown served as the Director of Business Development of
Ascend Communications. Mr. Brown is a graduate of Eastern
Washington University with a B.S. in Computer
Technology.
David
Somerville has served as our
Senior Vice President of Sales and Marketing since January 2018.
Mr. Somerville has spent over 20 years working in executive,
consulting, and advisory board positions for public and private
companies, supporting the world’s major service providers,
enterprises, and government agencies. Mr. Somerville leads our
Sales and Marketing efforts and is responsible for bringing our
industry leading, patented biometric platforms to mobile and
desktop users around the globe via strategic partnerships and
direct sales. Prior to joining the Company, Mr. Somerville held
senior executive sales and business development positions at
leading companies in the cybersecurity industry, including Norse
Networks Inc. from January 2017 to January 2018, Fortscale Inc.
from March 2016 to January 2017, Norse Corporation Inc. from
September 2014 to February 2016, Cloudmark Inc. (now Proofpoint
Inc.) from 2005 to March 2014, and Network Equipment Technologies,
where he has consistently achieved global market leadership
positions in the service provider, enterprise, and government
markets. From April 2014 to September 2014, he served as the
Principal at David Somerville Consulting. Mr. Somerville holds a
Bachelor of Science degree in communications and electronic
engineering with a minor in business studies from Edinburgh Napier
University, Scotland.
David
Carey was appointed to the
Board in February 2006. Mr. Carey is a former Executive
Director of the Central Intelligence Agency. Mr. Carey briefly
served on the Board of Cyberby, Inc., a public company, resigning
in October 2015 and currently is the Chairman of Proxy Boards for
Leonard DRS Technologies and OnPoint Consulting. In addition, he is
a member of the Proxy Board for Informatica Federal Operations,
Inc. as well as the Board of Trimpan, Inc. Mr. Carey also
serves on a number of Advisory Boards. In addition, Mr. Carey
consults with companies both independently and as an affiliate of
the Command Consulting Group. From April 2005 to August
of 2008, Mr. Carey served as Executive Director for Blackbird
Technologies, which provides state-of-the-art IT security
expertise, where he assisted the company with business development
and strategic planning. Prior to joining Blackbird Technologies,
Mr. Carey was Vice President, Information Assurance for Oracle
Corporation from September 2001 to April 2005. In
addition, Mr. Carey worked for the CIA for 32 years until
2001. During his career at the CIA, Mr. Carey held several
senior positions including that of Executive Director, often
referred to as the Chief Operating Officer, or No. 3 person in
the agency, from 1997 to 2001. Before assuming that position,
Mr. Carey was Director of the DCI Crime and Narcotics Center,
the Director of the Office of Near Eastern and South Asian
Analysis, and Deputy Director of the Office of Global Issues.
Mr. Carey is a graduate of Cornell University and the
University of Delaware.
The
Nominating and Corporate Governance Committee believes that Mr.
Carey’s experience as a former Executive Director of the CIA,
his experience dealing with IT security matters, and the extensive
contacts gained over his career working within the intelligence and
security community, provide the Board with specialized expertise
that assists the Company in the specific industries in which it
operates.
Guy Steve
Hamm was appointed to the
Board in October 2004. Mr. Hamm served as CFO of Aspen
Holding, a privately held insurance provider, from
December 2005 to February 2007. In 2003, Mr. Hamm retired
from PricewaterhouseCoopers, where he was a national
partner-in-charge of middle market. Mr. Hamm was instrumental
in growing the Audit Business Advisory Services
(“ABAS”) Middle Market practice at
PricewaterhouseCoopers, where he was responsible for $300 million
in revenue and more than 100 partners. Mr. Hamm is a
graduate of San Diego State University.
The
Nominating and Corporate Governance Committee believes that Mr.
Hamm’s experience in public accounting, together with his
management experience as a Chief Financial Officer, provide the
Audit Committee of the Board with the expertise needed to oversee
the Company’s finance and accounting professionals, and the
Company’s independent public accountants.
David
Loesch was appointed to
the Board in September 2001 after 29 years of service as
a Special Agent with the Federal Bureau of Investigations
(“FBI”). At the time of his retirement from the
FBI, Mr. Loesch was the Assistant Director in Charge of the
Criminal Justice Information Services Division of the FBI.
Mr. Loesch was awarded the Presidential Rank Award for
Meritorious Executive in 1998 and has served on the board of
directors of the Special Agents Mutual Benefit Association since
1996. He is also a member of the International Association of
Chiefs of Police and the Society of Former Special Agents of the
FBI, Inc. In 1999, Mr. Loesch was appointed by former
Attorney General Janet Reno to serve as one of 15 original members
of the Compact Council, an organization charged with promulgating
rules and procedures governing the use and exchange of criminal
history records for non-criminal justice use. Mr. Loesch
served in the United States Army as an Officer with the 101st
Airborne Division in Vietnam. He holds a Bachelor’s degree
from Canisius College and a Master’s degree in Criminal
Justice from George Washington University. Mr. Loesch continues to
work as a private consultant on criminal justice information
sharing and the use of biometrics to help identify criminals and
individuals of special concern.
The
Nominating and Corporate Governance Committee believes that Mr.
Loesch’s extensive service as a Special Agent with the FBI,
together with his knowledge of security issues relevant to the
Company’s products and markets, provides the Company and the
Board of Directors with relevant input regarding the industries in
which the Company competes, and the markets served by the
Company.
John
Cronin was appointed to
the Board in February 2012. Mr. Cronin is currently Managing
Director and Chairman of ipCapital Group, Inc.
(“ipCG”), an intellectual property consulting firm
Mr. Cronin founded in 1998. During his time with ipCG, Mr.
Cronin created both a unique ipCapital System(R) Methodology for
consulting, as well as a world-class licensing and transaction
process, and worked with over 700 companies, including more than
10% of the Fortune 500. Prior to forming ipCG, Mr. Cronin spent
over 17 years at IBM and became its top inventor with over 100
patents and 150 patent publications. He created and ran the IBM
Patent Factory, which was essential in helping IBM become number
one in US patents, and the team that contributed to the startup and
success of IBM’s licensing program. Additionally, Mr. Cronin
serves as a member of the Board of Directors at Vermont Electric
Power Company (“VELCO”), Armor Designs, Inc., Document Security
Systems, and Primal Fusion, Inc., and GraphOn and as a member of
the advisory board for innoPad, Inc. He holds a B.S. and a M.S.in
electrical engineering, and a B.A. degree in Psychology from the
University of Vermont.
The
Nominating and Corporate Governance Committee believes that Mr.
Cronin’s experience developing and extracting the value from
intellectual property, and his experience serving on, and advising,
boards of directors, will contribute to deliberations of our Board
of Directors, and assist the Company as it capitalizes on the
opportunities presented by its portfolio of intellectual property
assets.
Neal
Goldman was appointed to the Board in August 2012. Mr.
Goldman is currently president, chief compliance officer and a
director of Goldman Capital Management, Inc., an employee owned
investment advisor that he founded in 1985. Additionally, Mr.
Goldman is Chairman of Charles and Colvard, LTD, a specialty
jewelry company. Mr. Goldman also served as a member of the
Board of Directors and Compensation Committee for Blyth, Inc., a
New York Stock Exchange-listed designer and marketer of home
decorative and fragrance products.
Mr.
Goldman is the Company’s largest shareholder and has
significant investment experience. As a result, the
Nominating and Corporate Governance Committee believes that Mr.
Goldman can provide valuable guidance to the Board of Directors as
it seeks to build shareholder value.
Charles
Crocker was appointed to
the Board in September 2012. Mr. Crocker currently serves as
Chairman and CEO of Crocker Capital, a private investment company.
Mr. Crocker also serves as a director of Teledyne Technologies,
Inc. (NYSE:TDY), Bailard, Inc. and Mercator MedSystems. Beyond his
corporate duties, Mr. Crocker serves as a Trustee of the Mary A.
Crocker Trust, the Cypress Lawn Cemetery Association and the Fine
Arts Museums Foundation of San Francisco. Mr. Crocker received his
B.S. degree from Stanford University and M.B.A. from the University
of California, Berkley.
The
Nominating and Corporate Governance Committee believes that Mr.
Crocker’s significant experience serving on boards of
directors, together with his investment experience, assists the
Company’s Board of Directors in its deliberations and
contributes to the governance of the Board.
Dana
Kammersgard was appointed to
the Board in May of 2016. Mr. Kammersgard is currently the Executive Vice President, Cloud
Systems and Solutions for Seagate Technology, where he is
responsible for all storage systems related products and
strategies. Prior to joining Seagate Systems in 2015, he served as
the President, CEO and a director of Dot Hill System Corp.
(“Dot
Hill”) since March 2006.
He served as President of Dot Hill from August 2004 to March 2006.
From August 1999 to August 2004, Mr. Kammersgard served as Dot
Hill’s Chief Technical Officer. Mr. Kammersgard was a founder
of Artecon, where he served as a director from its inception in
1984 until the company’s merger with Box Hill Systems Corp.
in August 1999. At Artecon, Mr. Kammersgard served in various
positions, including Secretary and Senior Vice President of
Engineering from March 1998 until August 1999, and as Vice
President of Sales and Marketing from March 1997 until March 1998.
Prior to cofounding Artecon, Mr. Kammersgard was the Director of
Software Development at Calma, a division of General Electric
Company. Mr. Kammersgard holds a B.A. in chemistry from the
University of California, San Diego.
The
Nominating and Corporate Governance Committee believes that Mr.
Kammersgard’s engineering and technical experience, coupled
with his senior executive management experience with technology
companies, is valuable to the Company’s Board of Directors
and senior management given the technical issues and marketing
challenges facing the Company.
Charles
Frischer was appointed to the
Board in September of 2017. Mr. Frischer currently
works as self-employed private investor, a role he has occupied
since 2009, and serves as General Partner of LF Partners, LLC.
Previously, he served as a Principal at Zephyr Management, L.P.
from 2005 to 2008. Prior to that, he served as a Senior Vice
President at Capri Capital, where he originated commercial loans,
from 1995 to 2005, and as General Manager of Ericson Memorial
Studios from 1993 to 1994. Mr. Frischer holds a B.A. from Cornell
University.
The
Nominating and Corporate Governance Committee believes that Mr.
Frischer’s background with capital markets and public
companies is valuable to the Company’s Board of Directors and
senior management.
Robert T.
Clutterbuck was appointed to
the Board as a Series A Director in September of 2017. Mr.
Clutterbuck is the Founder, and has served as the Managing Director
and Portfolio Manager at Clutterbuck Capital Management LLC, since
2006. Mr. Clutterbuck gained more than 30 years of experience at
McDonald & Company Investments, Inc., where he specialized in
advising affluent clients, professionals and corporate executives
on investment management, financial planning, estate preservation
and wealth transfer strategies. During his time at McDonald &
Company, Mr. Clutterbuck served as Chairman and Chief Executive
Partner of Key Capital Partners, and as Chief Executive Officer of
McDonald Investments Inc. from 2000 to 2002. Prior to 2000, Mr.
Clutterbuck served in several senior management positions within
McDonald Investments Inc., including as Chief Financial Officer and
Executive Managing Director of McDonald & Co. Securities, Inc.,
as Treasurer of McDonald & Co. Investments, Inc., and as
President and Chief Operating Officer of McDonald & Co.
Securities, Inc. Currently, Mr. Clutterbuck serves as an
Independent Director of Westmoreland Resources GP, LLC (NYSE:
WMLP), a position he has held since January 6,
2015. Mr. Clutterbuck holds a
B.A. from Ohio Wesleyan University and an M.B.A from the University
of Pennsylvania Wharton School of Business.
The Nominating and Corporate Governance Committee
believes that Mr. Clutterbuck’s background with capital
markets and public companies is valuable to the Company’s
Board of Directors and senior management.
Section 16(a) Beneficial Ownership Reporting
Compliance
Section 16(a) of the Exchange Act requires
our directors and executive officers, and persons who beneficially
own more than 10% of a registered class of our equity securities,
to file with the SEC initial reports of ownership and reports of
changes in ownership of our Common Stock and other equity
securities. Such persons are required by SEC regulations to furnish
us with copies of all Section 16(a) forms they file.
To our knowledge, based solely on a
review of the copies of such reports furnished to us and written
representations that no other reports were required, during the
fiscal year ended December 31, 2017, all Section 16(a) filing
requirements were complied with in a timely
manner.
Code of Ethics
The Company has adopted a Code of Business Conduct
and Ethics policy that
applies to our directors and employees (including the
Company’s principal executive officer, principal financial
officer, principal accounting officer or controller, or persons
performing similar functions). The Company intends to promptly
disclose (i) the nature of any amendment to this code of ethics
that applies to our principal executive officer, principal
financial officer, principal accounting officer or controller, or
persons performing similar functions and (ii) the nature of any
waiver, including an implicit waiver, from a provision of this code
of ethics that is granted to one of these specified individuals,
the name of such person who is granted the waiver and the date of
the waiver on our website in the future. A copy of our
Code of Business Conduct and Ethics can be obtained from our
website at http://www.iwsinc.com.
Board Leadership Structure
Our
Board of Directors has discretion to determine whether to separate
or combine the roles of Chief Executive Officer and Chairman of the
Board. S. James Miller has served in both roles since 1996, and our
Board continues to believe that his combined role is most
advantageous to the Company and our stockholders, as Mr. Miller
possesses in-depth knowledge of the issues, opportunities and risks
facing us, our business and our industry and is best positioned to
fulfill the responsibilities of our Chief Executive Officer, as
well as the Chairman’s responsibility to develop meeting
agendas that focus the Board’s time and attention on the most
critical matters and to facilitate constructive dialogue among
Board members on strategic issues.
In
addition to Mr. Miller’s leadership, the Board maintains
effective independent oversight through a number of governance
practices, including open and direct communication with management,
input on meeting agendas, and regular executive
sessions.
Board Role in Risk Assessment
Management,
in consultation with outside professionals, as applicable,
identifies risks associated with the Company’s operations,
strategies and financial statements. Risk assessment is also
performed through periodic reports received by the Audit Committee
from management, counsel and the Company’s independent
registered public accountants relating to risk assessment and
management. Audit Committee members meet privately in executive
sessions with representatives of the Company’s independent
registered public accountants. The Board also provides risk
oversight through its periodic reviews of the financial and
operational performance of the Company.
Director Independence
Our
Board of Directors has determined that all of its members, other
than Mr. Miller, who serves as the Company’s Chief Executive
Officer, and Mr. Goldman, who beneficially owns
approximately 39.9% of the Company’s Common Stock, are
“independent” within the meaning of the NASDAQ Stock
Market Rules and SEC rules regarding independence.
Committees of the Board of Directors
Our
Board of Directors has an Audit Committee, a Compensation Committee
and a Nominating and Corporate Governance Committee, each of which
has the composition and responsibilities described
below.
Audit Committee
The
Audit Committee provides assistance to the Board of Directors in
fulfilling its legal and fiduciary obligations in matters involving
our accounting, auditing, financial reporting, internal control and
legal compliance functions by approving the services performed by
our independent accountants and reviewing their reports regarding
our accounting practices and systems of internal accounting
controls. The Audit Committee also oversees the audit efforts of
our independent accountants and takes those actions as it deems
necessary to satisfy it that the accountants are independent of
management. The Audit Committee currently consists of Messrs. Hamm
(Chairman), Carey and Loesch, each of whom is a non-management
member of our Board of Directors. Mr. Hamm is also our Audit
Committee financial expert, as currently defined under current SEC
rules. The Audit Committee met 4 times during the year ended
December 31, 2017. We believe that the composition of
our Audit Committee meets the criteria for independence under, and
the functioning of our Audit Committee complies with the applicable
NASDAQ Stock Market Rules and SEC rules and
regulations.
Compensation Committee
The
Compensation Committee determines our general compensation policies
and the compensation provided to our directors and officers. The
Compensation Committee also reviews and determines bonuses for our
officers and other employees. In addition, the Compensation
Committee reviews and determines equity-based compensation for our
directors, officers, employees and consultants and administers our
stock option plans. The Compensation Committee currently
consists of Messrs. Carey (Chairman), Cronin and Goldman, each of
whom is a non-management member of our Board of Directors. The
Compensation Committee met 4 times during the year ended December
31, 2017. Although Messrs. Carey and Cronin meet the criteria for
independence under the applicable NASDAQ Stock Market Rules and SEC
rules and regulations, Mr. Goldman is not considered independent
under such requirements.
Nominating and
Corporate Governance Committee
The
Nominating and Corporate Governance Committee is responsible for
making recommendations to the Board of Directors regarding
candidates for directorships and the size and composition of the
Board. In addition, the Nominating and Corporate Governance
Committee is responsible for overseeing our corporate governance
guidelines and reporting and making recommendations to the Board
concerning corporate governance matters. The Nominating and
Corporate Governance Committee currently consists of all the
nonemployee members of the Board. The Nominating and
Corporate Governance Committee met 4 times during the year
ended December 31, 2017.
Indemnification of Officers and Directors
To
the extent permitted by Delaware law, the Company will
indemnify its directors and officers against expenses and
liabilities they incur to defend, settle, or satisfy any civil
or criminal action brought against them on account
of their being or having been Company directors or officers
unless, in any such action, they are adjudged to have acted
with gross negligence or willful
misconduct.
Compensation Committee Interlocks and Insider
Participation
As
of December 31, 2017, the members of our Compensation Committee
were, and currently are, David Carey (Chairman), John Cronin and
Neal Goldman. None of the current or past members of our
Compensation Committee is or has been an officer or employee of our
company. None of our executive officers currently serves, or in the
past year has served, as a member of the compensation committee (or
other board committee performing equivalent functions or, in the
absence of any such committee, the entire board of directors) or
director of any entity that has one or more executive officers
serving on our Compensation Committee or our Board of
Directors.
Compensation Committee Report
The
Compensation Committee has reviewed and discussed with management
the Compensation Discussion and Analysis provisions to be included
in our Annual Report on Form 10-K for the year ended
December 31, 2017. Based on this review and discussion, the
Compensation Committee has recommended to the board of directors
that the Compensation Discussion and Analysis be included in our
Annual Report on Form 10-K for the year ended
December 31, 2017.
The Compensation Committee of the Board of Directors:
|
David Carey (Chairman)
John Cronin
Neal Goldman
|
Date:
March 19, 2018
Summary Compensation Table
The following table sets forth certain information
about the compensation paid or accrued during the years ended
December 31, 2017 and 2016 to our Chief Executive Officer and our
two most highly compensated executive officers who were serving as
executive officers at December 31, 2017 and 2016, and whose annual
compensation exceeded $100,000 during such year or would have
exceeded $100,000 during such year if the executive officer were
employed by the Company for the entire fiscal year (collectively
the “Named Executive
Officers”).
Name and Principal Position
|
Year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S.
James Miller, Jr.
|
2017
|
$380,076
|
$-
|
$174,125
|
$19,913
|
(3)
|
$574,114
|
Chairman of the Board and
Chief Executive Officer
|
2016
|
$368,938
|
$-
|
$174,185
|
$19,816
|
|
$562,939
|
|
|
|
|
|
|
|
Wayne
G. Wetherell
|
2017
|
$211,319
|
$-
|
$57,467
|
$11,715
|
(4)
|
$280,501
|
Senior Vice President
Chief Financial Officer, Secretary, and Treasurer
|
2016
|
$207,333
|
$-
|
$48,676
|
$11,787
|
|
$267,796
|
|
|
|
|
|
|
|
David
Harding
|
2017
|
$280,288
|
$-
|
$163,885
|
4,788
|
(5)
|
$448,961
|
Vice President and
Chief Technical Officer
|
2016
|
$242,955
|
$-
|
$150,807
|
$4,105
|
|
$397,867
|
(1)
|
|
All option awards were granted under the 1999 Plan.
|
|
|
|
(2)
|
|
The amounts presented in this column do not reflect the cash value
or realizable value of option grants to the named executive
officers during the year ended December 31, 2017. During the year
ended December 31, 2017, no named executive officer exercised an
option and therefore no value was realized during the reporting
period. The amounts reflect the grant date fair value of
the options awarded in the fiscal year ended December 31,
2017 and 2016, respectively, in accordance with the provisions
of FASB ASC Topic 718. We have elected to use the
Black-Scholes option-pricing model, which incorporates various
assumptions including volatility, expected life, and interest
rates. We are required to make various assumptions in the
application of the Black-Scholes option-pricing model and have
determined that the best measure of expected volatility is based on
the historical weekly volatility of our Common Stock. Historical
volatility factors utilized in our Black-Scholes computations range
from 58% to 103%. We have elected to estimate the expected life of
an award based upon the SEC approved “simplified
method” noted under the provisions of Staff Accounting
Bulletin No. 110. The expected term used by the Company during
the years ended December 31, 2017 and 2016 was 5.9 years. The
difference between the actual historical expected life and the
simplified method was immaterial. The interest rate used is the
risk-free interest rate and is based upon U.S. Treasury rates
appropriate for the expected term. Interest rates used in the
Company’s Black-Scholes calculations for the years ended
December 31, 2017 and 2016 was 2.6%. Dividend yield is zero, as we
do not expect to declare any dividends on our common shares in the
foreseeable future. In addition to the key assumptions used in the
Black-Scholes model, the estimated forfeiture rate at the time of
valuation is a critical assumption. We have estimated an annualized
forfeiture rate of 0% for corporate officers, 4.1% for members of
the Board of Directors and 6.0% for all other employees. We review
the expected forfeiture rate annually to determine if that percent
is still reasonable based on historical experience.
|
(3)
|
|
This amount includes premiums on life insurance and disability
insurance of $9,113 and matching 401(k) contributions of
$10,800.
|
|
|
|
(4)
|
|
This amount includes premiums on life insurance and disability
insurance of $3,077 and matching 401(k) contributions of
$8,638.
|
|
|
|
(5)
|
|
This amount includes premiums in life insurance and disability
insurance of $2,888 and matching 401(k) contributions of
$1,900.
|
Grants of Plan Based
Awards
There
were no grants of plan-based awards in 2017 to any Named Executive
Officer.
Outstanding Equity Awards at Fiscal
Year-End
The
following table sets forth information regarding unexercised
options, stock that has not vested and equity incentive awards held
by each of the Named Executive Officers outstanding as of
December 31, 2017:
|
|
|
|
Name
|
Number of
Securities
Underlying
Unexercised
Options:
Exercisable (#)
|
Number of
Securities
Underlying
Unexercised
Options:
Unexercisable (#)
|
Option
Exercise
Price
($)
|
|
Number of Shares That Have
Not Vested
(#)
|
Market Value of Shares That Have Not
Vested ($)
|
S.
James Miller, Jr.
|
100,000
|
—
|
$0.20
|
1/27/2019
|
—
|
$—
|
|
183,000
|
—
|
$0.73
|
1/29/2020
|
—
|
$—
|
|
225,000
|
—
|
$1.11
|
3/10/2021
|
—
|
$—
|
|
450,000
|
—
|
$0.92
|
2/2/2022
|
—
|
$—
|
|
100,000
|
—
|
$0.93
|
2/8/2023
|
—
|
$—
|
|
100,000
|
—
|
$1.93
|
10/29/2023
|
—
|
$—
|
|
50,000
|
-
|
$2.29
|
12/15/2024
|
—
|
$—
|
|
112,500
|
37,500
|
$1.73
|
9/14/2025
|
—
|
$—
|
|
125,000
|
175,000
|
$1.37
|
9/20/2026
|
—
|
$—
|
|
|
|
|
|
|
|
Wayne
G. Wetherell
|
60,000
|
—
|
$0.20
|
1/27/2019
|
—
|
$—
|
|
60,000
|
—
|
$0.73
|
1/29/2020
|
—
|
$—
|
|
100,000
|
—
|
$0.92
|
2/2/2022
|
—
|
$—
|
|
10,000
|
—
|
$1.93
|
10/29/2023
|
—
|
$—
|
|
10,000
|
-
|
$2.29
|
12/15/2024
|
—
|
$—
|
|
56,250
|
18,750
|
$1.73
|
9/14/2025
|
—
|
$—
|
|
31,250
|
43,750
|
$1.37
|
9/20/2026
|
—
|
$—
|
|
|
|
|
|
|
|
David
Harding
|
50,000
|
—
|
$0.20
|
1/27/2019
|
—
|
$—
|
|
80,000
|
—
|
$0.73
|
1/29/2020
|
—
|
$—
|
|
325,000
|
—
|
$0.92
|
2/2/2022
|
—
|
$—
|
|
100,000
|
—
|
$.93
|
2/8/2023
|
—
|
$—
|
|
75,000
|
—
|
$1.93
|
10/29/2023
|
—
|
$—
|
|
50,000
|
-
|
$2.29
|
12/15/2024
|
—
|
$—
|
|
93,752
|
31,248
|
$1.73
|
9/14/2025
|
—
|
$—
|
|
125,000
|
175,000
|
$1.37
|
9/20/2026
|
—
|
$—
|
Employment Agreements
S. James
Miller, Jr. On October 1, 2005, we entered into an
employment agreement with Mr. Miller pursuant to which
Mr. Miller serves as President and Chief Executive Officer,
which agreement is currently set to expire on December 31, 2018.
Historically, Mr. Miller’s employment agreement has been
amended annually to extend the expiration date. The agreement
provides for annual base compensation in the amount of $291,048,
which amount, as a result of cost-of-living adjustments, has
increased to $376,456. Under this agreement, we will reimburse
Mr. Miller for reasonable expenses incurred in connection with
our business. Under the terms of the agreement, Mr. Miller
will be entitled to the following severance benefits if we
terminate his employment without cause or in the event of an
involuntary termination: (i) a lump sum cash payment equal to
twenty-four months base salary; (ii) continuation of
Mr. Miller’s fringe benefits and medical insurance for a
period of three years; and (iii) immediate vesting of 50% of
Mr. Miller’s outstanding stock options and restricted
stock awards. In the event that Mr. Miller’s employment
is terminated within six months prior to or thirteen months
following a change of control (defined below), Mr. Miller is
entitled to the severance benefits described above, except that
100% of Mr. Miller’s outstanding stock options and
restricted stock awards will immediately vest.
Wayne
Wetherell. On October 1, 2005, we entered into an
employment agreement with Mr. Wetherell pursuant to which
Mr. Wetherell will serve as our Chief Financial Officer,
which, as amended, terminated on December 31, 2017. Mr.
Wetherell is paid a semi-monthly base salary of $8,369.
David
Harding. On
May 21, 2007, we entered into a
Change of Control and Severance Benefits Agreement with
Mr. David Harding, our Vice President and Chief Technical
Officer. This agreement was originally for a two-year term,
ending on May 21, 2009; however, the agreement has been
amended to extend the expiration date to December 31, 2018. Under
the terms of the agreement, Mr. Harding is paid a semi-monthly base
salary of $11,458, and is
entitled to the following severance benefits if we terminate his
employment without cause or in the event of an involuntary
termination: (i) a lump sum cash payment equal to six months
base salary; and continuation of Mr. Harding’s
medical and disability insurance for a period of six
months. In the event that Mr. Harding’s employment
is terminated within six months prior to or thirteen months
following a change of control (defined below), Mr. Harding is
entitled to the severance benefits described above, except that
100% of Mr. Harding’s outstanding stock options and
restricted stock awards will immediately vest.
For purposes of the above-referenced agreements,
termination for “cause” means the executive’s
commission of a criminal act or an act of fraud, embezzlement,
breach of trust or other act of gross misconduct; violations of
policies or rules of the Company; refusal to follow the direction
given by the Company from time to time or breach of any covenant or
obligation under the above-referenced agreements or other
agreements with the Company; neglect of duty; misappropriation,
concealment, or conversion of any money or property of the Company;
intentional damage or destruction of property of the Company;
reckless conduct which endangers the safety of other persons or
property during the course of employment or while on premises
leased or owned by the Company; or a breach of any obligation or
requirement set forth in the above-referenced agreements. A
“change in control” as used in these agreements
generally means the occurrence of any of the following events:
(i) the acquisition by any person or group of 50% or more of
our outstanding voting stock; (ii) the consummation of a
merger, consolidation, reorganization, or similar transaction other
than a transaction: (1) in which substantially all of the
holders of our voting stock hold or receive directly or indirectly
50% or more of the voting stock of the resulting entity or a parent
company thereof, in substantially the same proportions as their
ownership of the Company immediately prior to the transaction, or
(2) in which the holders of our capital stock immediately
before such transaction will, immediately after such transaction,
hold as a group on a fully diluted basis the ability to elect at
least a majority of the directors of the surviving corporation (or
a parent company); (iii) there is consummated a sale, lease,
exclusive license, or other disposition of all or substantially all
of the consolidated assets of us and our Subsidiaries, other than a
sale, lease, license, or other disposition of all or substantially
all of the consolidated assets of us and our Subsidiaries to an
entity, 50% or more of the combined voting power of the voting
securities of which are owned by our stockholders in substantially
the same proportions as their ownership of the Company immediately
prior to such sale, lease, license, or other disposition;
or (iv) individuals who, on the date the applicable
agreement was adopted by the Board, are Directors (the
“Incumbent
Board”) cease for any
reason to constitute at least a majority of the Directors;
provided,
however, that if the
appointment or election (or nomination for election) of any new
Director was approved or recommended by a majority vote of the
members of the Incumbent Board then still in office, such new
member shall, for purposes of the applicable agreement, be
considered as a member of the Incumbent Board.
Securities Authorized for Issuance Under Equity Compensation
Plans
The
following table provides information as of December 31, 2017
regarding equity compensation plans approved by our security
holders and equity compensation plans that have not been approved
by our security holders:
Plan Category
|
Number of securities to be issued
upon exercise of outstanding options, warrants
and rights
|
Weighted-
Average exercise price of outstanding options, warrants
and rights
|
Number of securities remaining available
for future issuance under equity compensation plans
(excluding securities reflected in
column) (a)
|
|
|
|
|
Equity compensation plans approved by security
holders:
|
|
|
|
1999
Stock Award Plan, as amended and restated
|
6,093,512
|
$1.23
|
100,265
|
|
|
|
|
Total
|
6,093,512
|
$1.23
|
100,265
|
Description of Equity Compensation Plans
1999 Stock Option Plan
The
1999 Plan was adopted by the Company’s Board of Directors on
December 17, 1999. Under the terms of the 1999 Plan, the Company
could, originally, issue up to 350,000 non-qualified or incentive
stock options to purchase Common Stock of the Company. During the
year ended December 31, 2014, the Company subsequently amended and
restated the 1999 Plan, whereby it increased the share reserve for
issuance to approximately 7.0 million shares of the Company’s
Common Stock. Subsequently, in February 2018, the Company amended
and restated the 1999 Plan, whereby it increased the share reserve
for issuance by an additional 2.0 million shares. The 1999
Plan prohibits the grant of stock option or stock appreciation
right awards with an exercise price less than fair market value of
Common Stock on the date of grant. The 1999 Plan also generally
prohibits the “re-pricing” of stock options or stock
appreciation rights, although awards may be bought-out for a
payment in cash or the Company’s stock. The 1999 Plan permits
the grant of stock-based awards other than stock options, including
the grant of “full value” awards such as restricted
stock, stock units and performance shares. The 1999 Plan permits
the qualification of awards under the plan (payable in either stock
or cash) as “performance-based compensation” within the
meaning of Section 162(m) of the Internal Revenue Code. The number
of options issued and outstanding and the number of options
remaining available for future issuance are shown in the table
below. The number of authorized shares available for issuance under
the plan at June 30, 2018 was 703,927.
Director Compensation
Each of our non-employee directors receives equity
compensation in the form of stock options that vest monthly during
the year of service for serving
on the Board of Directors. Board members who also serve on the
Audit Committee receive additional monthly compensation of
$458 for the Chairman and
$208 for the remaining members
of the Audit Committee. Board members who also serve on the
Compensation Committee receive additional monthly compensation of
$417 for the Chairman and
$208 for the remaining members
of the Compensation Committee. The members of the Board
of Directors are also eligible for reimbursement for their expenses
incurred in attending Board meetings in accordance with our
policies. For the fiscal year ended December 31, 2017 the total
amounts of compensation to non-employee directors (excluding
reimbursable expenses) was approximately $426,281, which amount was
paid $20,500 in cash with
the remainder paid in Stock
Options of the
Company.
Each
of our non-employee directors is also eligible to receive stock
option grants under the 1999 Plan. Options granted under the 1999
Plan are intended by us not to qualify as incentive stock options
under the Code.
The term of options granted under the 1999 Plan is
ten years. In the event of a merger of us with or into another
corporation or a consolidation, acquisition of assets or other
change-in-control transaction involving us, an equivalent option
will be substituted by the successor corporation;
provided,
however, that we may cancel
outstanding options upon consummation of the transaction by giving
at least thirty (30) days’
notice.
The
following table sets forth the compensation awarded to, earned by,
or paid to each person who served as a director during the year
ended December 31, 2017, other than a director who also served as
an executive officer:
|
Fees Earned or
Paid in Cash ($)
|
|
|
All Other Compensation ($)
|
|
Guy Steve
Hamm
|
$5,500
|
$—
|
$61,757
|
$—
|
$67,257
|
|
|
|
|
|
|
David
Carey
|
$7,500
|
$—
|
$61,757
|
$—
|
$69,257
|
|
|
|
|
|
|
David
Loesch
|
$2,500
|
$—
|
$61,757
|
$—
|
$64,257
|
|
|
|
|
|
|
John
Cronin
|
$2,500
|
$—
|
$61,757
|
$—
|
$64,257
|
|
|
|
|
|
|
Neal
Goldman
|
$2,500
|
$—
|
$61,757
|
$—
|
$64,257
|
|
|
|
|
|
|
Charles
Crocker
|
$—
|
$—
|
$61,757
|
$—
|
$61,757
|
|
|
|
|
|
|
Dana
Kammersgard
|
$—
|
$—
|
$35,239
|
$—
|
$35,239
|
|
|
|
|
|
|
Mr. Charles
Frischer
|
$—
|
$—
|
$—
|
$—
|
$—
|
|
|
|
|
|
|
Mr. Robert T.
Clutterbuck
|
$—
|
$—
|
$—
|
$—
|
$—
|
(1)
|
The amounts reflect the grant date fair value of options recognized
as compensation in 2017, in accordance with the provisions of FASB
ASC Topic 718, and thus may include amounts from awards granted
prior to 2017. Assumptions used in the calculation of these amounts
are included in Notes to the Consolidated Financial
|
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
As
of October 4, 2018, we had four classes of voting stock
outstanding: (i) Common Stock; (ii) Series A Preferred; (iii)
Series B Preferred; and (iv) Series C Preferred. The following
tables sets forth information regarding shares of Series A
Preferred, Series B Preferred, Series C Preferred and Common Stock
beneficially owned as of October 4, 2018 by:
(i)
|
Each of our officers and directors;
|
(ii)
|
All officer and directors as a group; and
|
(iii)
|
Each
person known by us to beneficially own five percent or more of the
outstanding shares of our Common Stock, Series A Preferred, Series
B Preferred and Series C Preferred. Percent ownership is calculated
based on 37,468 shares of Series A Preferred, 239,400 shares of
Series B Preferred, 1,000 shares of Series C Preferred and
96,727,726 shares Common Stock outstanding at October 4,
2018.
|
Unless
otherwise noted, the addresses of the individuals listed in the
below tables are 10815 Rancho Bernardo Road, Suite 310, San Diego,
California 92127.
Beneficial Ownership of Series A Preferred
Name, Address and Title (if applicable)
|
Series A Convertible
Preferred
Stock (2)
|
|
|
|
|
Directors and
Named Executive Officers: (1)
|
|
|
|
|
|
S.
James Miller, Jr., Chairman, Chief Executive
Officer
|
100
|
*
|
Neal
Goldman, Director
|
9,434
|
25.2%
|
Robert
T. Clutterbuck, Director
|
2,148
|
5.7%
|
Charles
Frischer, Director
|
3,105
|
8.3%
|
Charles
Crocker, Director
|
596
|
1.6%
|
Wayne
Wetherell, SVP of Administration, Chief Financial Officer,
Secretary
|
25
|
*
|
|
|
|
Total
beneficial ownership of directors and officers as a group (13
persons):
|
15,408
|
41.0%
|
|
|
|
5% Stockholders:
|
|
|
CF Special Situation Fund I, LP (3)
1360
East 9th
Street
Suite
1250
Cleveland,
OH 44114
|
5,605
|
15.0%
|
CAP 1 LLC (4)
14000 Quail Spring Parkway
Suite 2200
Oklahoma City, OK 73134
|
3,000
|
8.0%
|
Robert Leahy
322 Pilots Point
Mt. Pleasant, SC 29464
|
2,000
|
5.3%
|
* less than 1%
(1)
|
Each of the Company’s officers and directors who do not hold
shares of Series A Preferred were excluded from this
table.
|
(2)
|
Beneficial ownership is determined in accordance with the rules of
the SEC and generally includes voting or investment power with
respect to securities.
|
(3)
|
Mr. Robert T. Clutterbuck, Managing Partner of CF Special Situation
Fund I, LP, may be deemed to have voting and investment discretion
over the securities identified herein.
|
(4)
|
Mr. David Sackler, President of CAP I LLC, may be deemed to have
voting and investment discretion over the securities identified
herein.
|
Beneficial Ownership of Series B Preferred
Name, Address and Title (if applicable) (1)
|
Series B Convertible
Preferred
Stock (2)
|
|
Darrelyn
Carpenter
|
28,000
|
12%
|
Frederick
C. Orton
|
20,000
|
8%
|
Howard
Harrison
|
20,000
|
8%
|
Wesley
Hampton
|
16,000
|
7%
|
(1)
|
Each of the Company’s officers and directors who do not hold
shares of Series A Preferred were excluded from this
table.
|
(2)
|
Beneficial ownership is determined in accordance with the rules of
the SEC and generally includes voting or investment power with
respect to securities.
|
Beneficial Ownership of Series C Preferred
Name, Address and Title (if applicable)
(1)
|
Series C Convertible
Preferred
Stock
(2)
|
|
Blackwell Partners
LLC – Series A
(3)
c/o Nantahala
Capital Management, LLC
19 Old Kings
Highway South
Suite
200
Darien, CT
06820
|
128
|
12.8%
|
Geode Capital
Management LP
1 Post Office
Square, 20th Floor
Boston, MA
02109
|
100
|
10.0%
|
Nantahala Capital Partners Limited
Partnership (3)
c/o Nantahala
Capital Management, LLC
19 Old Kings
Highway South
Suite
200
Darien, CT
06820
|
54
|
5.4%
|
Nantahala Capital Partners II Limited
Partnership (3)
c/o Nantahala
Capital Management, LLC
19 Old Kings
Highway South
Suite
200
Darien, CT
06820
|
112
|
11.2%
|
Nantahala Capital Partners SI LP
(3)
c/o Nantahala
Capital Management, LLC
19 Old Kings
Highway South
Suite
200
Darien, CT
06820
|
397
|
39.7%
|
Shellback
Financial, LLC
16405
45th
Avenue North
Minneapolis, MN
55446
|
100
|
10.0%
|
Silver Creek CS SAV, L.L.C.
(3)
c/o Nantahala
Capital Management, LLC
19 Old Kings
Highway South
Suite
200
Darien, CT
06820
|
59
|
5.9%
|
(1)
|
Each of the Company’s officers and directors who do not hold
shares of Series C Preferred were excluded from this
table.
|
(2)
|
Beneficial ownership is determined in accordance with the rules of
the SEC and generally includes voting or investment power with
respect to securities.
|
|
|
(3)
|
Nantahala
Capital Management, LLC is a Registered Investment Adviser and has
been delegated the legal power to vote and/or direct the
disposition of securities on behalf of these entities as a General
Partner or Investment Manager and would be considered the
beneficial owner of such securities. The above shall not be deemed
to be an admission by the record owners that they are themselves
beneficial owners of these shares of Series C Preferred for
purposes of Section 13(d) of the Exchange Act or any other
purpose.
|
Beneficial Ownership of Common Stock
Name and Address
|
|
|
|
|
|
Directors and Named Executive
Officers:
(3)
|
|
|
S. James Miller, Jr., Chairman, Chief
Executive Officer (4)
|
2,502,287
|
2.5%
|
David Carey Director(5)
|
256,854
|
*
|
G. Steve Hamm, Director(6)
|
256,940
|
*
|
David Loesch, Director(7)
|
285,062
|
*
|
Neal Goldman, Director (8)
|
42,149,672
|
39.9%
|
John Cronin, Director(9)
|
217,354
|
*
|
Charles Crocker, Director(10)
|
1,243,465
|
1.3%
|
Dana W. Kammersgard, Director(11)
|
206,836
|
*
|
Robert T. Clutterbuck, Director(12)
|
2,389,635
|
2.4%
|
Charles Frischer,
Director (13)
|
3,364,521
|
3.4%
|
Wayne Wetherell, SVP of Administration, Chief
Financial Officer, Secretary(14)
|
686,351
|
*
|
David Harding, Chief Technical Officer
(15)
|
1,005,000
|
1.0%
|
Robert Brown, Vice President, Sales and Business
Development(16)
|
350,000
|
*
|
|
|
|
Total
beneficial ownership of directors and officers as a group (13
persons):
|
54,913,977
|
43.3%
|
* less than 1%
(1)
|
All entries exclude beneficial ownership of shares issuable
pursuant to options that have not vested or that are not otherwise
exercisable as of the date hereof, or which will not become vested
or exercisable within 60 days of October 4, 2018.
|
|
|
(2)
|
Percentages are rounded to nearest one-tenth of one percent.
Percentages are based on 96,727,726 shares of Common Stock
outstanding as of October 4, 2018. Options that are presently
exercisable or exercisable within 60 days of October 4, 2018 are
deemed to be beneficially owned by the stockholder holding the
options for the purpose of computing the percentage ownership of
that stockholder, but are not treated as outstanding for the
purpose of computing the percentage of any other
stockholder.
|
|
|
(3)
|
As of October 4, 2018, Mr. Somerville did not beneficially own any
shares of Company Common Stock, and has thus been excluded from
this table.
|
|
|
(4)
|
Includes 75,201 shares held jointly with spouse,
1,558,000 shares issuable upon exercise of stock options, each
exercisable within 60 days of October 4, 2018, and 88,841 shares
issuable upon the conversion of Series A Preferred, and 3,987
shares issuable upon the exercise of warrants.
|
|
|
(5)
|
Includes 155,168 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018.
|
|
|
(6)
|
Includes 157,668 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018.
|
|
|
(7)
|
Includes 155,168 shares issuable upon exercise of stock options,
each exercisable within 60 days of October 4, 2018.
|
|
|
(8)
|
Includes 8,347,320 shares issuable upon the conversion of Series A
Preferred and 127,668 shares issuable upon exercise of stock
options, each exercisable within 60 days of October 4, 2018. Mr.
Goldman exercises sole voting and dispositive power over 33,298,556
shares, and shared voting and dispositive power over 3,147,700
reported shares, of which 3,000,000 shares are owned by the Goldman
Family 2012 GST Trust and 147,700 shares are owed by The Neal and
Marlene Goldman Foundation, and 376,128 shares issuable upon the
exercise of warrants.
|
|
|
(9)
|
Includes 177,668 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018.
|
|
|
(10)
|
Includes 527,348 shares issuable upon the conversion of Series A
Preferred and 177,668 shares issuable upon exercise of
stock options exercisable within 60 days of October 4, 2018, and
23,763 shares issuable upon the exercise of warrants.
|
|
|
(11)
|
Includes 121,336 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018.
|
|
|
(12)
|
Includes 1,900,577 shares issuable upon the conversion of Series A
Preferred and 40,000 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018, and 85,642 shares
issuable upon the exercise of warrants.
|
|
|
(13)
|
Includes 2,747,342 shares issuable upon the conversion of Series A
Preferred and 40,000 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018, and 123,795 shares
issuable upon the exercise of warrants.
|
|
|
(14)
|
Includes 22,120 shares issuable
upon the conversion of Series A Preferred and 365,000 shares
issuable upon exercise of stock options exercisable within 60 days
of October 4, 2018, and 997 shares issuable upon the exercise of
warrants.
|
|
|
(15)
|
Includes 1,005,000 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018.
|
|
|
(16)
|
Includes 350,000 shares issuable upon exercise of stock options
exercisable within 60 days of October 4, 2018.
|
CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS
Lines of Credit
In March 2013, the Company and Neal Goldman, a
member of the Company’s Board of Directors
(“Goldman”), entered into a line of credit (the
“Goldman Line of
Credit”) with available
borrowings of up to $2.5 million. In March 2014, the Goldman Line
of Credit’s borrowing was increased to an aggregate total of
$3.5 million (the “Amendment”). Pursuant to the terms and conditions of
the Amendment, Goldman had the right to convert up to $2.5 million
of the outstanding balance of the Goldman Line of Credit into
shares of the Company’s Common Stock for $0.95 per share. Any
remaining outstanding balance was convertible into shares of
the Company’s Common Stock for $2.25 per
share.
As consideration for the initial Goldman Line of
Credit, the Company issued a warrant to Goldman, exercisable for
1,052,632 shares of the Company’s Common Stock (the
“Line
of Credit Warrant”). The
Goldman Line of Credit Warrant had a term of two years from the
date of issuance and an exercise price of $0.95 per share. As
consideration for entering into the Amendment, the Company issued
to Goldman a second warrant, exercisable for 177,778 shares of the
Company’s Common Stock (the “Amendment
Warrant”). The Amendment
Warrant expired on March 27, 2015 and had an exercise price of
$2.25 per share.
In April 2014, the Company and Goldman entered
into a further amendment to the Goldman Line of Credit to decrease
the available borrowings to $3.0 million (the
“Second
Amendment”). Contemporaneous with the execution
of the Second Amendment, the Company entered into a new unsecured
line of credit with Charles Crocker, a member of the
Company’s Board of Directors (“Crocker”), with available borrowings of up to
$500,000 (the “Crocker LOC”), which amount was convertible into
shares of the Company’s Common Stock for $2.25 per share. As
a result of these amendments, total available borrowings under the
Lines of Credit available to the Company remained unchanged at a
total of $3.5 million. In connection with the Second Amendment,
Goldman assigned and transferred to Crocker one-half of the
Amendment Warrant.
In December 2014, the Company and Goldman entered
into a further amendment to the Goldman Line of Credit to increase
the available borrowing to $5.0 million and extend the maturity
date of the Goldman Line of Credit to March 27, 2017 (the
“Third
Amendment”). Also, as a
result of the Third Amendment, Goldman had the right to convert up
to $2.5 million outstanding principal, plus any accrued but unpaid
interest (“Outstanding
Balance”) into shares of
the Company’s Common Stock for $0.95 per share, the next
$500,000 Outstanding Balance into shares of Common Stock for $2.25
per share and any remaining outstanding balance thereafter into
shares of Common Stock for $2.30 per share. The Third Amendment
also modified the definition of a “Qualified Financing”
to mean a debt or equity financing resulting in gross proceeds to
the Company of at least $5.0 million.
In
February 2015, as a result of the Series E Financing, the Company
issued 1,978 shares of Series E Preferred to Goldman to satisfy
$1,950,000 in principal borrowings under the Goldman Line of Credit
plus approximately $28,000 in accrued interest. As a result of the
Series E Financing, the Company’s borrowing capacity under
the Goldman Line of Credit was reduced to $3,050,000 with the
maturity date unchanged and the Crocker LOC was terminated in
accordance with its terms.
In March 2016, the Company and Goldman entered
into a fourth amendment to the Goldman Line of Credit (the
“Fourth
Amendment”) solely to (i)
increase available borrowings to $5.0 million; (ii) extend the
maturity date to June 30, 2017, and (iii) provide for the
conversion of the outstanding balance due under the terms of the
Goldman Line of Credit into that number of fully paid and
non-assessable shares of the Company’s Common Stock as is
equal to the quotient obtained by dividing the outstanding balance
by $1.25.
Contemporaneous with the execution of the Fourth
Amendment, the Company entered into a new $500,000 Line of Credit
(the “New Crocker
LOC”) with available
borrowings of up to $500,000 with Crocker, which replaced the
original Crocker LOC that terminated as a result of the
consummation of the Series E Financing. Similar to the Fourth
Amendment, the New Crocker LOC with Crocker originally matured
on June 30, 2017, and provides for the conversion of the
outstanding balance due under the terms of the New Crocker LOC into
that number of fully paid and non-assessable shares of the
Company’s Common Stock as is equal to the quotient obtained
by dividing the outstanding balance by $1.25.
On
December 27, 2016, in connection with the consummation of the
Series G Financing, the Company and Goldman agreed to enter
into the
Fifth Amendment (the “Line
of Credit Amendment”) to the Goldman
Line of Credit to provide the Company with the ability to borrow up
to $5.5 million under the terms of the Goldman Line of Credit. In
addition, the Maturity Date, as defined in the Goldman Line of
Credit was amended to be December 31, 2017. The Line of Credit
Amendment was executed on January 23, 2017.
In addition, on January 23, 2017, the Company and Crocker amended
the New Crocker LOC to extend the maturity date thereof to December
31, 2017.
On May 10, 2017, Goldman and Crocker agreed to
further extend the maturity dates of Lines of Credit to December
31, 2018.
The
following table sets forth the Company’s activity under its
Lines of Credit for the periods indicated:
Balance
outstanding under Lines of Credit as of December 31,
2015
|
$—
|
Borrowings
under Lines of Credit
|
2,650
|
Repayments
|
—
|
Balance
outstanding under Lines of Credit as of December 31,
2016
|
$2,650
|
Borrowings
under Lines of Credit
|
3,350
|
Repayments
|
—
|
Balance
outstanding under Lines of Credit as of December 31,
2017
|
$6,000
|
Borrowings
under Lines of Credit
|
—
|
|
(6,000)
|
Balance
outstanding under Lines of Credit as of October 4,
2018
|
$—
|
On September 10, 2018, the Company entered into
the Exchange Agreements with Goldman and Crocker, pursuant to which
Goldman and Crocker agreed to exchange approximately $6.3 million
and $0.6 million, respectively, of outstanding debt (including
accrued and unpaid interest) owed under the terms of their
respective Lines of Credit for an aggregate of 6,896 shares of
Series A Preferred. As a result of the Debt Exchange, all
indebtedness, liabilities and other obligations arising under the
Lines of Credit were terminated, cancelled and deemed satisfied in
full. As a result, no future
borrowings are available under the Lines of
Credit.
Review, Approval or Ratification of Transactions with Related
Persons
As
provided in the charter of our Audit Committee, it is our policy
that we will not enter into any transactions required to be
disclosed under Item 404 of the SEC’s Regulation S-K unless
the Audit Committee or another independent body of our Board of
Directors first reviews and approves the
transactions.
In
addition, pursuant to our Code of Ethical Conduct and Business
Practices, all employees, officers and directors of ours and our
subsidiaries are prohibited from engaging in any relationship or
financial interest that is an actual or potential conflict of
interest with us without approval. Employees, officers and
directors are required to provide written disclosure to the Chief
Executive Officer as soon as they have any knowledge of a
transaction or proposed transaction with an outside individual,
business or other organization that would create a conflict of
interest or the appearance of one.
Certain
legal matters in connection with this offering will be passed upon
for us by Disclosure Law Group, a Professional Corporation, of San
Diego, California.
Our consolidated
financial statements appearing in our Annual Report on Form 10-K
for the year ended December 31, 2017, and the effectiveness of
our internal control over financial reporting as of
December 31, 2017, have been audited by Mayer Hoffman McCann
P.C. of San Diego,
California, an independent
registered public accounting firm, as set forth in their reports
thereon. Such consolidated financial statements are included herein
in reliance upon such reports given on the authority of such firm
as experts in accounting and auditing.
WHERE
YOU CAN FIND
MORE INFORMATION
We are a public company and file annual, quarterly
and special reports, proxy statements and other information with
the SEC. You may read and copy any document we file at the
SEC’s public reference room at 100 F Street, NE, Washington,
D.C. 20549. You can request copies of these documents by writing to
the SEC and paying a fee for the copying cost. Please call the SEC
at 1-800-SEC-0330 for more information about the operation of the
public reference room. Our SEC filings are also available, at no
charge, to the public at the SEC’s web site
at http://www.sec.gov.
Index to Financial Statements
Reports of Independent Registered
Public Accounting Firm
|
F-1
|
Consolidated
Balance Sheets as of December 31, 2017 and 2016
|
F-3
|
Consolidated
Statements of Operations for the years ended December 31, 2017,
2016 and 2015
|
F-4
|
Consolidated Statements of
Comprehensive Loss for the years ended December 31, 2017, 2016 and
2015
|
F-5
|
Consolidated Statements of
Shareholders’ Equity (Deficit) for the years ended December
31, 2017, 2016 and 2015
|
F-6
|
Consolidated Statements of Cash
Flows for the years ended December 31, 2017, 2016 and
2015
|
F-8
|
Notes to Consolidated Financial
Statements
|
F-9
|
|
|
|
|
Condensed Consolidated Balance
Sheets as of June 30, 2018 (unaudited) and December 31,
2017
|
F-39
|
Condensed Consolidated Statements
of Operations for the three and six months ended June 30, 2018 and
2017 (unaudited)
|
F-40
|
Condensed Consolidated Statements
of Comprehensive Loss for the three and six months ended June 30,
2018 and 2017 (unaudited)
|
F-41
|
Condensed Consolidated Statements
of Cash Flows for the six months ended June 30, 2018 and 2017
(unaudited)
|
F-42
|
REPORT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
To the Board of
Directors and Shareholders of:
ImageWare Systems, Inc.
Opinion
on the Financial Statements
We have audited the
accompanying consolidated balance sheets of ImageWare Systems, Inc.
(“Company”) as of December 31, 2017 and 2016, and the
related consolidated statements of operations, comprehensive
loss, shareholders’ equity (deficit) and cash flows for each
of the three years in the period ended December 31, 2017, and the
related notes (collectively referred to as the “financial
statements”). In our opinion, the financial statements
present fairly, in all material respects, the financial position of
the Company as of December 31, 2017 and 2016, and the results of
its operations and its cash flows for each of the three years in
the period ended December 31, 2017, in conformity with accounting
principles generally accepted in the United States of
America.
We also have
audited, in accordance with the standards of the Public Company
Accounting Oversight Board (United States), the
Company’s internal control
over financial reporting as of December 31, 2017, based on criteria
established in the 2013 Internal
Control—Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) and
our report dated March 19, 2018, expressed an unqualified
opinion.
Going
Concern Uncertainty
The accompanying
financial statements have been prepared assuming that the Company
will continue as a going concern. As discussed in Note 1 to the
financial statements, the Company has incurred recurring operating
losses and is dependent on additional financing to fund operations.
These conditions raise substantial doubt about the Company’s
ability to continue as a going concern. Management’s plans in
regard to these matters are also described in Note 1 to the
financial statements. The financial statements do not include any
adjustments to reflect the possible future effects on the
recoverability and classification of assets or the amounts and
classification of liabilities that may result from the outcome of
this uncertainty.
Basis
for Opinion
These financial
statements are the responsibility of the Company’s
management. Our responsibility is to express an opinion on the
Company’s financial statements based on our audits. We are a
public accounting firm registered with the Public Company
Accounting Oversight Board (United States) ("PCAOB") and are
required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and
the PCAOB.
We conducted our
audits in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement, whether due to error or
fraud.
Our audits included
performing procedures to assess the risks of material misstatement
of the financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts
and disclosures in the financial statements. Our audits also
included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall
presentation of the financial statements. We believe that our
audits provide a reasonable basis for our opinion.
We have served as
the Company's auditor since 2011.
/s/ Mayer Hoffman
McCann P.C.
San Diego,
California
March 19,
2018
Report
of Independent Registered Public
Accounting Firm
To the Board of
Directors and Shareholders of:
ImageWare
Systems, Inc.
Opinion
on Internal Control over Financial Reporting
We have audited
ImageWare Systems,
Inc.’s (“Company”) internal control over
financial reporting as of December 31, 2017, based on criteria
established in Internal
Control—Integrated Framework (2013) issued by the
Committee of Sponsoring Organizations of the Treadway Commission
(COSO criteria). In our opinion, the Company maintained, in
all material respects, effective internal control over financial
reporting as of December 31, 2017, based on the COSO
criteria.
We also have
audited, in accordance with the standards of the Public Company
Accounting Oversight Board (United States) (“PCAOB”),
the consolidated balance sheets of the Company as of December 31,
2017 and 2016, and the related consolidated statements of
operations, comprehensive loss, shareholders’ equity
(deficit) and cash flows for each of the three years in the period
ended December 31, 2017, and our report dated March 19, 2018,
expressed an unqualified opinion on those financial statements, and
included an explanatory paragraph relating to the uncertainty of
the Company’s ability to continue as a going
concern.
Basis
for Opinion
The Company’s
management is responsible for maintaining effective internal
control over financial reporting, and for its assessment of the
effectiveness of internal control over financial reporting,
included in the accompanying Management’s Report on Internal Control
over Financial Reporting. Our responsibility is to express
an opinion on the Company’s internal control over financial
reporting based on our audit. We are a public accounting firm
registered with the PCAOB and are required to be independent with
respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.
We conducted our
audit in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control over
financial reporting was maintained in all material respects. Our
audit of internal control over financial reporting included
obtaining an understanding of internal control over financial
reporting, assessing the risk that a material weakness exists, and
testing and evaluating the design and operating effectiveness of
internal control based on the assessed risk. Our audit also
included performing such other procedures as we considered
necessary in the circumstances. We believe that our audit provides
a reasonable basis for our opinion.
Definition
and Limitations of Internal Control over Financial
Reporting
A company’s
internal control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with accounting principles generally
accepted in the United States of America. A company’s
internal control over financial reporting includes those policies
and procedures that (1) pertain to the maintenance of records that,
in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as
necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that
receipts and expenditures of the company are being made only in
accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a
material effect on the financial statements.
Because of its
inherent limitations, internal control over financial reporting may
not prevent or detect misstatements. Also, projections of any
evaluation of effectiveness to future periods are subject to the
risk that controls may become inadequate because of changes in
conditions, or that the degree of compliance with the policies or
procedures may deteriorate.
/s/ Mayer Hoffman
McCann P.C.
San Diego,
California
March 19,
2018
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
|
|
|
ASSETS
|
|
|
Current
Assets:
|
|
|
Cash
|
$7,317
|
$1,586
|
Accounts
receivable, net of allowance for doubtful accounts of $15 and $1 at
December 31, 2017 and 2016, respectively.
|
458
|
287
|
Inventory,
net
|
79
|
23
|
Other
current assets
|
163
|
135
|
Total
Current Assets
|
8,017
|
2,031
|
|
|
|
Property
and equipment, net
|
43
|
93
|
Other
assets
|
35
|
34
|
Intangible
assets, net of accumulated amortization
|
93
|
106
|
Goodwill
|
3,416
|
3,416
|
Total Assets
|
$11,604
|
$5,680
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
|
|
|
|
|
|
Current
Liabilities:
|
|
|
Accounts
payable
|
$457
|
$425
|
Deferred
revenue
|
1,016
|
1,045
|
Accrued
expenses
|
658
|
945
|
Accrued
interest payable to related parties
|
527
|
102
|
Convertible
lines of credit to related parties, net of discount
|
5,774
|
2,528
|
Total
Current Liabilities
|
8,432
|
5,045
|
|
|
|
Pension
obligation
|
2,024
|
1,895
|
Total
Liabilities
|
10,456
|
6,940
|
|
|
|
Shareholders’
Equity (Deficit):
|
|
|
Preferred
stock, authorized 4,000,000 shares:
|
|
|
Series
A Convertible Redeemable Preferred Stock, $0.01 par value;
designated 31,021 shares, 31,021 shares and 0 shares issued and
outstanding at December 31, 2017 and 2016, respectively;
liquidation preference $31,021 and $0 at December 31, 2017 and
2016, respectively.
|
|
-
|
Series
B Convertible Redeemable Preferred Stock, $0.01 par value;
designated 750,000 shares, 389,400 shares issued, and 239,400
shares outstanding at December 31, 2017 and 2016; liquidation
preference $620 at December 31, 2017 and 2016.
|
2
|
2
|
Series
E Convertible Redeemable Preferred Stock, $0.01 par value;
designated 12,000 shares, 0 shares and 12,000 shares issued and
outstanding at December 31, 2017 and December 31, 2016,
respectively; liquidation preference $0 and $12,000 at December 31,
2017 and December 31, 2016, respectively.
|
-
|
-
|
Series
F Convertible Redeemable Preferred Stock, $0.01 par value;
designated 2,000 shares, 0 shares and 2,000 shares issued and
outstanding at December 31, 2017 and December 31, 2016,
respectively; liquidation preference $0 and $2,000 at December 31,
2017 and December 31, 2016, respectively.
|
-
|
-
|
Series
G Convertible Redeemable Preferred Stock, $0.01 par value;
designated 6,120 shares, 0 shares and 6,021 shares issued and
outstanding at December 31, 2017 and December 31, 2016,
respectively; liquidation preference $0 and $6,021 at December 31,
2017 and December 31, 2016, respectively.
|
-
|
-
|
Common
Stock, $0.01 par value, 150,000,000 shares authorized; 94,174,540
and 91,853,499 shares issued at December 31, 2017 and 2016,
respectively, and 94,167,836 and 91,846,795 shares outstanding at
December 31, 2017 and 2016, respectively.
|
941
|
917
|
Additional
paid-in capital
|
172,414
|
156,195
|
Treasury
stock, at cost 6,704 shares
|
(64)
|
(64)
|
Accumulated
other comprehensive loss
|
(1,664)
|
(1,543)
|
Accumulated
deficit
|
(170,481)
|
(156,767)
|
Total
Shareholders’ Equity (Deficit)
|
1,148
|
(1,260)
|
Total Liabilities and Shareholders’ Equity
(Deficit)
|
$11,604
|
$5,680
|
The
accompanying notes are an integral part of these consolidated
financial statements.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
|
|
|
|
|
|
Revenues:
|
|
|
|
Product
|
$1,614
|
$1,249
|
$2,192
|
Maintenance
|
2,679
|
2,563
|
2,577
|
|
4,293
|
3,812
|
4,769
|
Cost of revenues:
|
|
|
|
Product
|
152
|
243
|
1,117
|
Maintenance
|
839
|
827
|
827
|
Gross
profit
|
3,302
|
2,742
|
2,825
|
|
|
|
|
Operating expenses:
|
|
|
|
General
and administrative
|
4,192
|
3,722
|
3,437
|
Sales
and marketing
|
2,816
|
3,021
|
2,791
|
Research
and development
|
5,953
|
5,332
|
4,643
|
Depreciation
and amortization
|
68
|
129
|
164
|
|
13,029
|
12,204
|
11,035
|
Loss
from operations
|
(9,727)
|
(9,462)
|
(8,210)
|
|
|
|
|
Interest
expense, net
|
591
|
245
|
447
|
Other
income, net
|
(125)
|
(201)
|
(145)
|
Loss
before income taxes
|
(10,193)
|
(9,506)
|
(8,512)
|
|
|
|
|
Income
tax expense (benefit)
|
(124)
|
21
|
22
|
Net
loss
|
$(10,069)
|
$(9,527)
|
$(8,534)
|
Preferred
dividends
|
(2,400)
|
(1,347)
|
(1,065)
|
Preferred
stock exchange
|
(1,245)
|
—
|
—
|
Net
loss available to common shareholders
|
$(13,714)
|
$(10,874)
|
$(9,599)
|
|
|
|
|
Basic and diluted loss per common share — see Note
2:
|
|
|
|
Net
loss
|
$(0.11)
|
$(0.10)
|
$(0.09)
|
Preferred
dividends
|
(0.03)
|
(0.02)
|
(0.01)
|
Preferred
stock exchange
|
(0.01)
|
—
|
—
|
Basic
and diluted loss per share available to common
shareholders
|
$(0.15)
|
$(0.12)
|
$(0.10)
|
Basic
and diluted weighted-average shares outstanding
|
92,816,723
|
94,426,783
|
93,786,079
|
The
accompanying notes are an integral part of these consolidated
financial statements.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
|
|
|
|
|
|
|
|
|
|
Net
loss
|
$(10,069)
|
$(9,527)
|
$(8,534)
|
Other
comprehensive income (loss):
|
|
|
|
Reduction (increase)
in additional minimum pension liability
|
(15)
|
(347)
|
332
|
Foreign
currency translation adjustment
|
(106)
|
(1)
|
67
|
Comprehensive
loss
|
$(10,190)
|
$(9,875)
|
$(8,135)
|
The
accompanying notes are an integral part of these consolidated
financial statements.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(DEFICIT)
(In thousands, except share amounts)
|
Series
A Convertible,
Redeemable
Preferred
|
Series
B Convertible,
Redeemable
Preferred
|
Series
E
Convertible,
Preferred
|
Series
F
Convertible,
Preferred
|
Series
G
Convertible,
Preferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
December 31, 2014
|
-
|
$-
|
239,400
|
$2
|
-
|
$-
|
-
|
$-
|
-
|
$-
|
93,513,854
|
$934
|
(6,704)
|
$(64)
|
$135,982
|
$(1,594)
|
$(136,294)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of
Series E Convertible Redeemable Preferred Stock for cash, net of
issuance costs
|
-
|
-
|
-
|
-
|
10,022
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
9,955
|
-
|
-
|
9,955
|
Conversion of
related party debt into Series E Convertible Redeemable Preferred
Stock
|
-
|
-
|
-
|
-
|
1,978
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,978
|
-
|
-
|
1,978
|
Issuance of
Common Stock in payment of Series E Preferred
dividends
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
478,664
|
5
|
-
|
-
|
769
|
-
|
(774)
|
-
|
Issuance of
Common Stock pursuant to cashless warrant
exercises
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
45,376
|
1
|
-
|
-
|
(1)
|
-
|
-
|
-
|
Issuance of
Common Stock pursuant to option exercises
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
39,705
|
-
|
-
|
-
|
33
|
-
|
-
|
33
|
Recognition of
beneficial conversion feature on convertible
debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
146
|
-
|
-
|
146
|
Warrants
modified in lieu of cash as compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
80
|
-
|
-
|
80
|
Stock-based
compensation expense
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
960
|
-
|
-
|
960
|
Reduction in
minimum pension liability
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
332
|
-
|
332
|
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
67
|
-
|
67
|
Dividends on
preferred stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(291)
|
(291)
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(8,534)
|
(8,534)
|
The
accompanying notes are an integral part of these consolidated
financial statements.
|
Series
A Convertible,
Redeemable
Preferred
|
Series
B Convertible,
Redeemable
Preferred
|
Series
E
Convertible,
Preferred
|
Series
F
Convertible,
Preferred
|
Series
G
Convertible,
Preferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
December 31, 2015
|
-
|
$-
|
239,400
|
$2
|
12,000
|
$-
|
-
|
$-
|
-
|
$-
|
94,077,599
|
$940
|
(6,704)
|
$(64)
|
$149,902
|
$(1,195)
|
$(145,893)
|
$3,692
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of
Series F Convertible Redeemable Preferred Stock for cash, net of
issuance costs
|
-
|
-
|
-
|
-
|
-
|
-
|
2,000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,979
|
-
|
-
|
1,979
|
Issuance of
Series GF Convertible Redeemable Preferred Stock for cash, net of
issuance costs
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,625
|
-
|
-
|
-
|
-
|
-
|
1,614
|
-
|
-
|
1,614
|
Issuance of
Series G Convertible Redeemable Preferred Stock in exchange for
Common Stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4,396
|
-
|
(3,383,830
|
) (34)
|
-
|
-
|
31
|
-
|
-
|
(3)
|
Issuance of
Common Stock pursuant to cashless warrant
exercises
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
144,459
|
1
|
-
|
-
|
(1)
|
-
|
-
|
-
|
Issuance of
Common Stock pursuant to option exercises
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
12,626
|
-
|
-
|
-
|
3
|
-
|
-
|
3
|
Recognition of
beneficial conversion feature on convertible
debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
219
|
-
|
-
|
219
|
Stock-based
compensation expense
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,162
|
-
|
-
|
1,162
|
Additional
minimum pension liability
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(347)
|
-
|
(347)
|
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1)
|
-
|
(1)
|
Dividends on
preferred stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,002,645
|
10
|
-
|
-
|
1,286
|
-
|
(1,347)
|
(51)
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(9,527)
|
(9,527)
|
The
accompanying notes are an integral part of these consolidated
financial statements.
IMAGEWARE SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(DEFICIT)
(In thousands, except share amounts)
(continued)
|
Series
A Convertible,
Redeemable
Preferred
|
Series
B Convertible,
Redeemable
Preferred
|
Series
E
Convertible,
Preferred
|
Series
F
Convertible,
Preferred
|
Series
G
Convertible,
Preferred
|
|
|
|
Compre-hensive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
December 31, 2016
|
-
|
$-
|
239,400
|
$2
|
12,000
|
$-
|
2,000
|
$-
|
6,021
|
$-
|
91,853,499
|
$917
|
(6,704)
|
$(64)
|
$156,195
|
$(1,543)
|
$ (156,767)
|
$(1,260)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of
Series A Convertible Redeemable Preferred Stock for cash, net of
issuance costs
|
11,000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
10,937
|
-
|
-
|
10,937
|
Issuance of
Series A Convertible Redeemable Preferred Stock in exchange for
preferred shares
|
20,021
|
-
|
-
|
-
|
(12,000)
|
-
|
(2,000)
|
-
|
(6,021)
|
-
|
-
|
-
|
-
|
-
|
1,245
|
-
|
(1,245)
|
-
|
Issuance of
common stock warrants as compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
57
|
-
|
-
|
57
|
Issuance of
Common Stock pursuant to option exercises
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
369,004
|
4
|
-
|
-
|
255
|
-
|
-
|
259
|
Recognition of
beneficial conversion feature on convertible
debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
302
|
-
|
-
|
302
|
Stock-based
compensation expense
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,094
|
-
|
-
|
1,094
|
Additional
minimum pension liability
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(15)
|
-
|
(15)
|
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(106)
|
-
|
(106)
|
Dividends on
preferred stock
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,952,037
|
20
|
-
|
-
|
2,329
|
-
|
(2,400)
|
(51)
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(10,069)
|
(10,069)
|
Balance at
December 31, 2017
|
31,021
|
$-
|
239,400
|
$2
|
-
|
$-
|
-
|
$-
|
-
|
$-
|
94,174,540
|
$941
|
(6,704)
|
$(64)
|
$172,414
|
$(1,664)
|
$(170,481)
|
$1,148
|
The
accompanying notes are an integral part of these consolidated
financial statements.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
|
|
Cash flows from operating activities
|
|
|
|
Net
loss
|
$(10,069)
|
$(9,527)
|
$(8,534)
|
Adjustments
to reconcile net loss to net cash used by operating
activities:
|
|
|
|
Depreciation
and amortization
|
68
|
129
|
164
|
Amortization
of debt discounts and debt issuance costs
|
209
|
145
|
438
|
Stock-based
compensation
|
1,094
|
1,162
|
960
|
Write
down of capitalized labor inventory to net realizable
value
|
—
|
—
|
281
|
Provision
for losses on accounts receivable
|
15
|
—
|
—
|
Gain
from sale of trademark
|
(50)
|
—
|
—
|
Reduction
in accrued expenses from expiration of statute of
limitations
|
(222)
|
(200)
|
—
|
Warrants
modified/issued in lieu of cash as compensation for
services
|
57
|
—
|
80
|
Change
in assets and liabilities
|
|
|
|
Accounts
receivable
|
(186)
|
62
|
(83)
|
Inventory
|
(56)
|
23
|
589
|
Other
assets
|
(40)
|
(50)
|
17
|
Accounts
payable
|
32
|
227
|
(261)
|
Accrued
expenses
|
359
|
94
|
(76)
|
Deferred
revenue
|
(29)
|
(13)
|
(768)
|
Pension
obligation
|
115
|
37
|
10
|
|
|
|
|
Total
adjustments
|
1,366
|
1,616
|
1,351
|
|
|
|
|
Net
cash used by operating activities
|
(8,703)
|
(7,911)
|
(7,183)
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
Purchase
of property and equipment
|
(5)
|
(49)
|
(87)
|
Proceeds from
sale of trademark
|
50
|
—
|
—
|
Net
cash provided by (used by) investing activities
|
45
|
(49)
|
(87)
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
Proceeds
from line of credit
|
3,350
|
2,650
|
400
|
Proceeds
from exercise of stock options
|
259
|
3
|
33
|
Proceeds
from issuance of preferred stock, net of issuance
costs
|
10,937
|
3,593
|
9,955
|
Dividends
paid to preferred stockholders
|
(51)
|
(51)
|
(51)
|
|
|
|
|
Net
cash provided by financing activities
|
14,495
|
6,195
|
10,337
|
|
|
|
|
Effect
of exchange rate changes on cash
|
(106)
|
(1)
|
67
|
Net
increase (decrease) in cash
|
5,731
|
(1,766)
|
3,134
|
Cash
at beginning of year
|
1,586
|
3,352
|
218
|
Cash
at end of year
|
$7,317
|
$1,586
|
$3,352
|
Supplemental
disclosure of cash flow information:
|
|
|
|
Cash
paid for interest
|
$—
|
$—
|
$1
|
Cash
paid for income taxes
|
$—
|
$—
|
$—
|
Summary
of non-cash investing and financing activities:
|
|
|
|
Conversion
of related party lines of credit balances into Series E
Preferred
|
$—
|
$—
|
$1,978
|
Beneficial
conversion feature of related party lines of credit
|
$302
|
$219
|
$146
|
Accrued
unpaid dividends on Series E Preferred
|
$—
|
$—
|
$240
|
Stock
dividends on Convertible Preferred Stock
|
$2,349
|
$1,296
|
$1,014
|
Issuance
of Common Stock pursuant to cashless warrant exercises
|
$—
|
$1
|
$1
|
Exchange
of Common Stock for Series G Preferred
|
$—
|
$34
|
$—
|
Reduction
(increase) in additional minimum pension
liability
|
$(15)
|
$(347)
|
$332
|
Preferred
stock exchange
|
$1,245
|
$—
|
$—
|
The
accompanying notes are an integral part of these consolidated
financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2017, 2016 AND 2015
1. DESCRIPTION OF BUSINESS AND OPERATIONS
Overview
As
used herein, “we,” “us,” “our,”
“ImageWare,” “ImageWare Systems,”
“Company” or “our Company” refers to
ImageWare Systems, Inc. and all of its subsidiaries. ImageWare
Systems, Inc. is incorporated in the state of Delaware. The Company
is a pioneer and leader in the emerging market for biometrically
enabled software-based identity management solutions. Using those
human characteristics that are unique to us all, the Company
creates software that provides a highly reliable indication of a
person’s identity. The Company’s “flagship”
product is the patented IWS Biometric Engine®. The
Company’s products are used to manage and issue secure
credentials, including national IDs, passports, driver licenses and
access control credentials. The Company’s products also
provide law enforcement with integrated mug shot, fingerprint
LiveScan and investigative capabilities. The Company also provides
comprehensive authentication security software using biometrics to
secure physical and logical access to facilities or computer
networks or internet sites. Biometric technology is now an integral
part of all markets the Company addresses and all of the products
are integrated into the IWS Biometric Engine.
Recent Developments
Creation of Series A
Convertible Preferred Stock
On September 15, 2017, the Company filed the
Certificate of Designations, Preferences, and Rights of the Series
A Convertible Preferred Stock with the Delaware Division of
Corporations, designating 31,021 shares of the Company’s
preferred stock, par value $0.01 per share, as Series A Convertible
Preferred Stock (“Series A
Preferred”). See Note
12, Equity, below, for a description of the Series A
Preferred.
Series A Financing and Preferred Stock Exchange
On September 18, 2017, the Company offered and
sold a total of 11,000 shares of Series A Preferred at a purchase
price of $1,000 per share (the “Series A
Financing”), which amount
includes an aggregate total of 875 shares of Series A Preferred
issuable to Neal Goldman, a member of the Board, and S. James
Miller, the Company’s Chief Executive Officer and member of
the Board, in connection with cash advances of $875,000 previously
made to the Company. The net proceeds to the Company from the
Series A Financing were approximately $10.9 million. Concurrently
with the Series A Financing, the Company entered into Exchange
Agreements with holders of all outstanding shares of the
Company’s Series E Convertible Preferred Stock, all
outstanding shares of Series F Convertible Preferred Stock, and all
outstanding shares of Series G Convertible Preferred Stock
(collectively, “Exchanged
Preferred”), pursuant to
which the holders thereof agreed to cancel their Exchanged
Preferred in exchange for the same number of shares of Series A
Preferred (the “Preferred Stock
Exchange”). As a result
of the Preferred Stock Exchange, the Company issued to the holders
of Exchanged Preferred an aggregate total of 20,021 shares of
Series A Preferred.
The
Company evaluated the Preferred Stock Exchange and determined that
the Exchanged Preferred was both an induced conversion and an
extinguishment transaction. Using the guidance in ASC 260-10-S99-2,
Earnings Per Share – SEC Materials – SEC Staff
Announcement: The Effect on the Calculations of Earnings Per Share
for a Period That Includes the Redemption or Induced Conversion of
Preferred Stock and ASC 470-50, Debt – Modifications and
Extinguishments, the Company recorded the fair value differential
of the Exchanged Preferred as adjustments within
Shareholders’ Deficit and in the computation of Net Loss
Available to Common Shareholders in the computation of basic and
diluted loss per share. The Company utilized the services of an
independent third-party valuation firm to perform the computation
of the fair value of the Exchanged Preferred. Based on the fair
value using these methodologies, the Company recorded approximately
$1,245,000 in fair value differential as adjustments within
Shareholders’ Deficit in the Company’s Consolidated
Balance Sheet for the year ended December 31, 2017 and in the
computation of basic and diluted loss per share in the
Company’s Consolidated Statement of Operations for the year
ended December 31, 2017.
As
a result of the Preferred Stock Exchange, on October 19, 2017, the
Company filed Certificates of Elimination with the Delaware
Secretary of State to eliminate the Exchanged
Preferred.
Liquidity,
Going Concern and Management’s Plan
Historically, our
principal sources of cash have included customer payments from the
sale of our products, proceeds from the issuance of common and
preferred stock and proceeds from the issuance of debt, including
our Lines of Credit (defined below). Our principal uses of cash
have included cash used in operations, product development and
payments relating to purchases of property and equipment. We expect
that our principal uses of cash in the future will be for product
development including customization of identity management products
for enterprise and consumer applications, further development of
intellectual property, development of Software-as-a-Service
(“SaaS”)
capabilities for existing products as well as general working
capital and capital expenditure requirements. Management expects
that, as our revenues grow, our sales and marketing and research
and development expenses will continue to grow, albeit at a slower
rate and, as a result, we will need to generate significant net
revenues to achieve and sustain income from
operations.
At
December 31, 2017, we had a working capital deficit of
approximately $415,000, compared to a working capital deficit of
approximately $3,014,000 at December 31, 2016. Our principal
sources of liquidity at December 31, 2017 consisted of
approximately $7,317,000 of cash, compared to available borrowings
under our Lines of Credit of $3,350,000, and approximately
$1,586,000 in cash at December 31, 2016.
Considering our projected cash requirements, and
assuming we are unable to generate incremental revenue, our
available cash may be insufficient to satisfy our cash requirements
for the next twelve months from the date of this filing. These
factors raise substantial doubt about our ability to continue as a
going concern. To address our working capital requirements,
management may seek additional equity and/or debt financing through
the issuance of additional debt and/or equity securities or may
seek strategic or other transactions intended to increase
shareholder value. There are currently no formal committed
financing arrangements to support our projected cash shortfall,
including commitments to purchase additional debt and/or equity
securities, or other agreements, and no assurances can be given
that we will be successful in raising additional debt and/or equity
securities, or entering into any other transaction that addresses
our ability to continue as a going concern.
In
view of the matters described in the preceding paragraph,
recoverability of a major portion of the recorded asset amounts
shown in the accompanying consolidated balance sheet is dependent
upon continued operations of the Company, which, in turn, is
dependent upon the Company’s ability to continue to raise
capital and generate positive cash flows from operations. However,
the Company operates in markets that are emerging and highly
competitive. There is no assurance that the Company will be able to
obtain additional capital, operate at a profit or generate positive
cash flows in the future.
The
consolidated financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset
amounts and classifications of liabilities that might be necessary
should the Company be unable to continue as a going
concern.
2. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Principles of Consolidation
The consolidated financial statements include the
accounts of the Company and its wholly owned subsidiaries. The
Company’s wholly-owned subsidiaries are: XImage Corporation,
a California Corporation; ImageWare Systems ID Group, Inc. a
Delaware corporation (formerly Imaging Technology Corporation);
I.W. Systems Canada Company, a Nova Scotia unlimited liability
company; ImageWare Digital Photography Systems, Inc., LLC a Nevada
limited liability company (formerly Castleworks LLC); Digital
Imaging International GmbH, a company formed under German laws;
and Image Ware Mexico
S de RL de CV, a company formed under Mexican laws.
All significant intercompany
transactions and balances have been eliminated.
Operating Cycle
Assets
and liabilities related to long-term contracts are included in
current assets and current liabilities in the accompanying
consolidated balance sheets, although they will be liquidated in
the normal course of contract completion which may take more than
one operating cycle.
Use of Estimates
The preparation of the consolidated financial
statements in conformity with accounting principles generally
accepted in the United States of America
(“U.S.
GAAP”) requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the consolidated
financial statements, and the reported amounts of revenue and
expense during the reporting period. Significant estimates include
the allowance for doubtful accounts receivable, inventory carrying
values, deferred tax asset valuation allowances, accounting for
loss contingencies, recoverability of goodwill and acquired
intangible assets and amortization periods, assumptions used in the
Black-Scholes model to calculate the fair value of share based
payments, assumptions used to compute the fair value of the
Exchanged Preferred, revenue and cost of revenues recognized under
the percentage of completion method and assumptions used in the
application of fair value methodologies to calculate the fair value
of pension assets and obligations. Actual results could differ from
estimates.
Accounts Receivable
In
the normal course of business, the Company extends credit without
collateral requirements to its customers that satisfy pre-defined
credit criteria. Accounts receivable are recorded net of an
allowance for doubtful accounts. Accounts receivable are considered
delinquent when the due date on the invoice has passed. The Company
records its allowance for doubtful accounts based upon its
assessment of various factors. The Company considers historical
experience, the age of the accounts receivable balances, the credit
quality of its customers, current economic conditions and other
factors that may affect customers’ ability to pay to
determine the level of allowance required. Accounts
receivable are written off against the allowance for doubtful
accounts when all collection efforts by the Company have been
unsuccessful.
Inventories
Finished
goods inventories are stated at the lower of cost, determined using
the average cost method, or net realizable value. See Note
6.
Property, Equipment and Leasehold Improvements
Property
and equipment, consisting of furniture and equipment, are stated at
cost and are being depreciated on a straight-line basis over the
estimated useful lives of the assets, which generally range from
three to five years. Maintenance and repairs are charged to expense
as incurred. Major renewals or improvements are capitalized. When
assets are sold or abandoned, the cost and related accumulated
depreciation are removed from the accounts and the resulting gain
or loss is recognized. Expenditures for leasehold improvements are
capitalized. Amortization of leasehold improvements is computed
using the straight-line method over the shorter of the remaining
lease term or the estimated useful lives of the
improvements.
Fair Value of Financial Instruments
For
certain of the Company’s financial instruments, including
accounts receivable, accounts payable, accrued expenses, deferred
revenues and lines of credit payable to related parties, the
carrying amounts approximate fair value due to their relatively
short maturities.
Revenue Recognition
The
Company recognizes revenue from the following major revenue
sources:
●
Long-term
fixed-price contracts involving significant
customization;
●
Fixed-price
contracts involving minimal customization;
●
Sales
of computer hardware and identification media; and
●
Post-contract customer support
(“PCS”).
The Company’s revenue recognition policies
are consistent with U.S. GAAP including the Financial Accounting
Standards Board (“FASB”) Accounting Standards Codification
(“ASC”) 985-605, “Software Revenue
Recognition,” ASC 605-35
“Revenue Recognition,
Construction-Type and Production-Type Contracts,” “Securities and Exchange
Commission Staff Accounting Bulletin 104,” and ASC 605-25 “Revenue Recognition, Multiple
Element Arrangements.”
Accordingly, the Company recognizes revenue when all of the
following criteria are met: persuasive evidence of an arrangement
exists, delivery has occurred or services have been rendered, the
fee is fixed or determinable, and collectability is reasonably
assured.
The Company recognizes revenue and profit as work
progresses on long-term, fixed-price contracts involving
significant amount of hardware and software customization using the
percentage of completion method based on costs incurred to date
compared to total estimated costs at completion. The primary
components of costs incurred are third party software and direct
labor cost including fringe benefits. Revenues recognized in excess
of amounts billed are classified as current assets under
“Costs and estimated earnings in excess of billings on
uncompleted contracts.” Amounts billed to customers in excess
of revenues recognized are classified as current liabilities under
“Billings in excess of costs and estimated earnings on
uncompleted contracts.” Revenue from contracts for which the
Company cannot reliably estimate total costs or there are not
significant amounts of customization are recognized upon
completion. For contracts that require significant amounts of
customization that the Company accounts for under the completed
contract method of revenue recognition, the Company defers revenue
recognition until customer acceptance is received. For contracts
containing either extended or dependent payment terms, revenue
recognition is deferred until such time as payment has been
received by the Company. The Company also generates non-recurring
revenue from the licensing of its software. Software license
revenue is recognized upon the execution of a license agreement,
upon deliverance, when fees are fixed and determinable, when
collectability is probable, when all other significant obligations
have been fulfilled and the Company has
obtained vendor specific objective evidence
(“VSOE”) of the fair
value of the undelivered element. VSOE of fair value for customer
support services is determined by reference to the price the
customer pays for such element when sold separately; that is, the
renewal rate offered to customers. In those instances when
objective and reliable evidence of fair value exists for the
undelivered items but not for the delivered items, the residual
method is used to allocate the arrangement consideration. Under the
residual method, the amount of arrangement consideration allocated
to the delivered items equals the total arrangement consideration
less the aggregate fair value of the undelivered
items. The Company also
generates revenue from the sale of computer hardware and
identification media. Revenue for these items is recognized upon
delivery of these products to the customer. The Company’s
revenue from periodic maintenance agreements is generally
recognized ratably over the respective maintenance periods provided
no significant obligations remain and collectability of the related
receivable is probable. Pricing of maintenance contracts is
consistent period to period and calculated as a percentage of the
software or hardware revenue. Amounts collected in advance for
maintenance services are included in current liabilities under
“Deferred revenue.” Sales tax collected from customers
is excluded from revenue.
Goodwill
The Company accounts for its intangible assets
under the provisions of ASC 350, “Intangibles - Goodwill and
Other.” In accordance
with ASC 350, intangible assets with a definite life are analyzed
for impairment under ASC 360-10-05 “Property, Plant and
Equipment” and intangible
assets with an indefinite life are analyzed for impairment under
ASC 360 annually, or more often if circumstances dictate. The
Company performs its annual goodwill impairment test in the fourth
quarter of each year, or if required, at the end of each fiscal
quarter. In accordance with ASC 350, goodwill, or the
excess of cost over fair value of net assets acquired is tested for
impairment using a fair value approach at the “reporting
unit” level. A reporting unit is the operating segment, or a
business one level below that operating segment (referred to as a
component) if discrete financial information is prepared and
regularly reviewed by management at the component level. The
Company’s reporting unit is at the entity level. The Company
recognizes an impairment charge for any amount by which the
carrying amount of a reporting unit’s goodwill exceeds its
fair value. The Company uses fair value methodologies to establish
fair values.
The
Company did not record any goodwill impairment charges for the
years ended December 31, 2017, 2016 or 2015.
Intangible and Long-Lived Assets
Intangible
assets are carried at their cost less any accumulated
amortization. Any costs incurred to renew or extend the
life of an intangible or long-lived asset are reviewed for
capitalization. The Company evaluates long-lived assets for
impairment whenever events or changes in circumstances indicate
their net book value may not be recoverable. When such factors and
circumstances exist, the Company compares the projected
undiscounted future cash flows associated with the related asset or
group of assets over their estimated useful lives against their
respective carrying amount. Impairment, if any, is based on the
excess of the carrying amount over the fair value, based on market
value when available, or discounted expected cash flows, of those
assets and is recorded in the period in which the determination is
made. The Company’s management currently believes there is no
impairment of its long-lived assets. There can be no assurance,
however, that market conditions will not change or demand for the
Company’s products under development will continue. Either of
these could result in future impairment of long-lived
assets.
Concentration of Credit Risk
Financial
instruments which potentially subject the Company to concentrations
of credit risk consist principally of cash and trade accounts
receivable. The Company places its cash with high quality financial
institutions and at times during the years ended December 31, 2017
and 2016 exceeded the FDIC insurance limits of $250,000. Sales are
typically made on credit and the Company generally does not require
collateral. The Company performs ongoing credit evaluations of its
customers’ financial condition and maintains an allowance for
doubtful accounts. The Company considers historical experience, the
age of the accounts receivable balances, the credit quality of its
customers, current economic conditions and other factors that may
affect customers’ ability to pay to determine the level of
allowance required. Accounts receivable are presented net of an
allowance for doubtful accounts of approximately $15,000 and $1,000
at December 31, 2017 and 2016, respectively.
For
the year ended December 31, 2017 one customer accounted for
approximately 25% or $1,089,000 of total revenues and had trade
receivables of approximately $201,000 as of the end of the
year. For the year ended December 31, 2016 two customers
accounted for approximately 30% or $1,162,000 of total revenues and
had trade receivables of $78,000 as of the end of the year. For the
year ended December 31, 2015, two customers accounted for
approximately 37% or $1,753,000 of total revenues and $78,000 trade
receivables as of the end of the year.
Stock-Based Compensation
At
December 31, 2017, the Company had one stock-based compensation
plan for employees and nonemployee directors, which authorize the
granting of various equity-based incentives including stock options
and restricted stock.
The Company estimates the fair value of its stock
options using a Black-Scholes option-pricing model, consistent with
the provisions of ASC 718, “Compensation – Stock
Compensation.” The fair
value of stock options granted is recognized to expense over the
requisite service period. Stock-based compensation expense for all
share-based payment awards is recognized using the straight-line
single-option method. Stock-based compensation expense is reported
in operating expenses based upon the departments to which
substantially all of the associated employees report and credited
to additional paid-in-capital. Stock-based compensation expense
related to equity options was approximately $1,094,000, $1,162,000
and $744,000 for the years ended December 31, 2017, 2016 and 2015,
respectively.
ASC
718 requires the use of a valuation model to calculate the fair
value of stock-based awards. The Company has elected to use the
Black-Scholes option-pricing model, which incorporates various
assumptions including volatility, expected life, and interest
rates. The Company is required to make various assumptions in the
application of the Black-Scholes option-pricing model. The Company
has determined that the best measure of expected volatility is
based on the historical weekly volatility of the Company’s
Common Stock. Historical volatility factors utilized in the
Company’s Black-Scholes computations for options granted
during the years ended December 31, 2017, 2016 and 2015 ranged from
58% to 103%. The Company has elected to estimate the expected life
of an award based upon the SEC approved “simplified
method” noted under the provisions of Staff Accounting
Bulletin No. 110. The expected term used by the Company during the
years ended December 31, 2017, 2016 and 2015 was 5.17 years. The
difference between the actual historical expected life and the
simplified method was immaterial. The interest rate used is the
risk-free interest rate and is based upon U.S. Treasury rates
appropriate for the expected term. Interest rates used in the
Company’s Black-Scholes calculations for the years ended
December 31, 2017, 2016 and 2015 averaged 2.6%. Dividend yield is
zero as the Company does not expect to declare any dividends on the
Company’s common shares in the foreseeable
future.
In
addition to the key assumptions used in the Black-Scholes model,
the estimated forfeiture rate at the time of valuation is a
critical assumption. The Company has adopted the provisions of ASU
2016-09 and will continue to use an estimated annualized forfeiture
rate of approximately 0% for corporate officers, 4.1% for members
of the Board of Directors and 6.0% for all other employees. The
Company reviews the expected forfeiture rate annually to determine
if that percent is still reasonable based on historical
experience.
Restricted
stock units are recorded at the grant date fair value with
corresponding compensation expense recorded ratably over the
requisite service period.
Income Taxes
Current
income tax expense or benefit is the amount of income taxes
expected to be payable or refundable for the current year. A
deferred income tax asset or liability is computed for the expected
future impact of differences between the financial reporting and
tax bases of assets and liabilities and for the expected future tax
benefit to be derived from tax credits and loss carryforwards.
Deferred tax assets are reduced by a valuation allowance when, in
the opinion of management, it is more likely than not that some
portion or all of the deferred tax assets will not be
realized.
Foreign Currency Translation
The
financial position and results of operations of the Company’s
foreign subsidiaries are measured using the foreign
subsidiary’s local currency as the functional currency.
Revenues and expenses of such subsidiaries have been translated
into U.S. dollars at weighted-average exchange rates
prevailing during the period. Assets and liabilities have been
translated at the rates of exchange on the balance sheet date. The
resulting translation gain and loss adjustments are recorded
directly as a separate component of shareholders’ equity,
unless there is a sale or complete liquidation of the underlying
foreign investments. The Company translates foreign currencies of
its German, Canadian and Mexican subsidiaries. The cumulative
translation adjustment, which is recorded in accumulated other
comprehensive loss, decreased approximately $106,000 for the year
ended December 31, 2017, decreased approximately $1,000 for the
year ended December 31, 2016 and increased approximately $67,000
for the year ended December 31, 2015.
Comprehensive Loss
Comprehensive loss consists of net gains and
losses affecting shareholders’ equity that, under generally
accepted accounting principles, are excluded from net loss. For the
Company, the only items are the cumulative translation adjustment
and the additional minimum liability related to the Company’s
defined benefit pension plan, recognized pursuant to ASC 715-30,
“Compensation - Retirement
Benefits - Defined Benefit Plans – Pension.”
Advertising Costs
The
Company expenses advertising costs as incurred. The Company
incurred approximately $45,000 in advertising expenses during the
year ended December 31, 2017, $24,000 in advertising expenses
during the year ended December 31, 2016, and $12,000 during the
year ended December 31, 2015.
Loss Per Share
Basic
loss per common share is calculated by dividing net loss available
to common shareholders for the period by the weighted-average
number of common shares outstanding during the period. Diluted loss
per common share is calculated by dividing net loss available to
common shareholders for the period by the weighted-average number
of common shares outstanding during the period, adjusted to
include, if dilutive, potential dilutive shares consisting of
convertible preferred stock, convertible notes payable, stock
options and warrants, calculated using the treasury stock and
if-converted methods. For diluted loss per share
calculation purposes, the net loss available to common shareholders
is adjusted to add back any preferred stock dividends in the
consolidated statement of operations for the respective
periods.
(Amounts in thousands, except share and per share
amounts)
|
|
|
|
|
|
Numerator
for basic and diluted loss per share:
|
|
|
|
Net
loss
|
$(10,069)
|
$(9,527)
|
$(8,534)
|
Preferred
dividends
|
(2,400)
|
(1,347)
|
(1,065)
|
Preferred
stock exchange
|
(1,245)
|
—
|
—
|
Net
loss available to common shareholders
|
$(13,714)
|
$(10,874)
|
$(9,599)
|
|
|
|
|
Denominator
for basic loss per share — weighted-average shares
outstanding
|
92,816,723
|
94,426,783
|
93,786,079
|
Effect
of dilutive securities
|
—
|
—
|
—
|
Denominator
for diluted loss per share — weighted-average shares
outstanding
|
92,816,723
|
94,426,783
|
93,786,079
|
|
|
|
|
Basic and diluted loss per share:
|
|
|
|
Net
loss
|
$(0.11)
|
$(0.10)
|
$(0.09)
|
Preferred
dividends
|
(0.03)
|
(0.02)
|
(0.01)
|
|
(0.01)
|
—
|
—
|
Net
loss available to common shareholders
|
$(0.15)
|
$(0.12)
|
$(0.10)
|
The
following potential dilutive securities have been excluded from the
computations of diluted weighted-average shares outstanding as
their effect would have been antidilutive:
Potential Dilutive Securities:
|
Common Share Equivalents at December 31, 2017
|
Common Share Equivalents at December 31, 2016
|
Common Share Equivalents at December 31, 2015
|
Convertible
lines of credit
|
5,221,964
|
2,201,903
|
—
|
Convertible
redeemable preferred stock – Series A
|
26,974,783
|
—
|
—
|
Convertible
redeemable preferred stock – Series B
|
46,029
|
46,029
|
46,029
|
Convertible
redeemable preferred stock – Series E
|
—
|
6,315,789
|
6,442,105
|
Convertible
redeemable preferred stock – Series F
|
—
|
1,333,333
|
—
|
Convertible
redeemable preferred stock – Series G
|
—
|
4,014,000
|
—
|
Stock
options
|
6,093,512
|
6,506,843
|
5,376,969
|
Warrants
|
230,000
|
175,000
|
450,000
|
Total
Potential Dilutive Securities
|
38,566,288
|
20,592,897
|
12,315,103
|
Recently Issued Accounting Standards
From time to time, new accounting pronouncements
are issued by the Financial Accounting Standards Board (the
“FASB”), or other standard setting bodies, which
are adopted by us as of the specified effective date. Unless
otherwise discussed, the Company’s management believes the
impact of recently issued standards not yet effective will not have
a material impact on the Company’s consolidated financial
statements upon adoption.
FASB ASU No. 2014-09.
In May 2014, FASB issued Accounting
Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with
Customers, which requires an
entity to recognize the amount of revenue to which it expects to be
entitled for the transfer of promised goods or services to
customers. ASU No. 2014-09 will replace most existing revenue
recognition guidance in U.S. GAAP when it becomes effective. In
July 2015, the FASB finalized a one-year deferral of the effective
date of the new standard. For public entities, the deferral results
in the new revenue standard being effective for fiscal years, and
interim periods within those fiscal years, beginning after December
15, 2017. The core principle of the new guidance is that an entity
should recognize revenue to depict the transfer of promised goods
or services to customers in an amount that reflects the
consideration to which the entity expects to be entitled in
exchange for those goods or services. Calendar year-end public
companies are therefore required to apply the revenue guidance
beginning in their 2018 interim and annual financial statements.
The standard permits the use of either the retrospective or
modified retrospective transition method. We have adopted this
standard using the modified retrospective transition method during
the first fiscal quarter in 2018.
In preparation for
adoption of the standard, we have analyzed each of our revenue
streams:
●
Long-term
fixed-price contracts involving significant
customization;
●
Fixed-price
contracts involving minimal customization;
●
Software
licensing;
●
Sales
of computer hardware and identification media; and
●
Post-contract customer support
(“PCS”).
Analysis
of the above revenue streams in preparation for the adoption of the
standard resulted in the identification of one of our revenue
contracts requiring the customer to make a fixed payment for a
one-year minimum royalty. Under current GAAP, we recognized the
royalty revenue over the one year. Under the new standard, we will
recognize the minimum royalty fee upon contract
renewal.
Revenue
recognition related to our other arrangements for software
licenses, hardware and identification media, professional services
and maintenance will remain substantially unchanged.
The
Company is still evaluating the effect the standard will have on
its financial statement disclosures.
FASB ASU No.
2016-01. In January 2016, the
FASB issued ASU 2016-01, “Financial
Instruments—Overall – Recognition and Measurement of
Financial Assets and Financial Liabilities.” The
amendments in this ASU address certain aspects of recognition,
measurement, presentation, and disclosure of financial instruments
and apply to all entities that hold financial assets or owe
financial liabilities. The amendments in this ASU also simplify the
impairment assessment of equity investments without readily
determinable fair values by requiring assessment for impairment
qualitatively at each reporting period. That impairment assessment
is similar to the qualitative assessment for long-lived assets,
goodwill, and indefinite-lived intangible assets. This ASU is
effective for fiscal years beginning after December 15, 2017,
including interim periods within those fiscal years, with earlier
application permitted for financial statements that have not been
issued. An entity should apply the amendments by means of a
cumulative-effect adjustment to the balance sheet as of the
beginning of the fiscal year of adoption. We have adopted the
provisions of this ASU for our fiscal year beginning January 1,
2018 and the adoption of this standard did not have a significant
impact on our consolidated financial statements.
FASB ASU No.
2016-02. In February 2016, the
FASB issued ASU No. 2016-02, “Leases.”This guidance will result in key changes
to lease accounting and will aim to bring leases onto balance
sheets to give investors, lenders, and other financial statement
users a more comprehensive view of a company's long-term financial
obligations as well as the assets it owns versus leases. The new
leasing standard will be effective for fiscal years beginning after
December 15, 2018, and for interim periods within those fiscal
years. The Company is currently evaluating the impact this guidance
will have on our consolidated financial statements and anticipates
commencement of adoption planning in the fourth fiscal quarter of
2018.
FASB ASU No.
2016-08. In March 2016, the
FASB issued Accounting Standards Update No.
2016-08, Revenue from Contracts with
Customers (Topic 606): Principal versus Agent Considerations
(Reporting Revenue Gross versus Net) (“ASU 2016-08”). ASU 2016-08 clarifies
the implementation guidance on principal versus agent
considerations. The guidance includes indicators to assist an
entity in determining whether it controls a specified good or
service before it is transferred to the customers. This guidance is
effective for fiscal years beginning after December 15, 2017
including interim periods within those fiscal years. We have
adopted the provisions this ASU in conjunction with our adoption of
ASU 2014-09, Revenue from Contracts with
Customers.
FASB ASU No.
2016-10. In April 2016, the
FASB issued Accounting Standards Update No.
2016-10, Revenue from Contracts with
Customers (Topic 606): Identifying Performance Obligations and
Licensing (“ASU
2016-10”). ASU 2016-10 provides further implementation
guidance on identifying performance obligations and also improves
the operability and understandability of the licensing
implementation guidance. This guidance is effective for fiscal
years beginning after December 15, 2017 including interim periods
within those fiscal years. We have adopted the provisions this ASU
in conjunction with our adoption of ASU 2014-09,
Revenue from
Contracts with Customers.
FASB ASU No.
2016-13. In June 2016, the FASB
issued Accounting Standard Update No. 2016-13, Financial
Instruments—Credit Losses (Topic 326): Measurement of Credit
Losses on Financial Instruments. ASU No. 2016-13 changes the impairment model
for most financial assets and certain other instruments. For trade
and other receivables, held-to-maturity debt securities, loans and
other instruments, entities will be required to use a new
forward-looking “expected loss” model that will replace
today’s “incurred loss” model and generally will
result in the earlier recognition of allowances for losses. For
available-for-sale debt securities with unrealized losses, entities
will measure credit losses in a manner similar to current practice,
except that the losses will be recognized as an allowance. This
guidance is effective for fiscal years beginning after December 15,
2019 including interim periods within those fiscal years. The
Company is currently evaluating the potential impact of adoption of
this standard on its consolidated financial
statements.
FASB ASU No.
2016-15. In August 2016, the
FASB issued Accounting Standards Update No.
2016-15, Statement
of Cash Flows (Topic 230) Classification
of Certain Cash Receipts and Cash
Payments. ASU
2016-15 eliminates the diversity in practice related to the
classification of certain cash receipts and payments for debt
prepayment or extinguishment costs, the maturing of a zero-coupon
bond, the settlement of contingent liabilities arising from a
business combination, proceeds from insurance settlements,
distributions from certain equity method investees and beneficial
interests obtained in a financial asset securitization. ASU 2016-15
designates the appropriate cash flow classification, including
requirements to allocate certain components of these cash receipts
and payments among operating, investing and financing
activities. This guidance
is effective for fiscal years beginning after December 15, 2017
including interim periods within those fiscal years.
The
retrospective transition method, requiring adjustment to all
comparative periods presented, is required unless it is
impracticable for some of the amendments, in which case those
amendments would be prospectively as of the earliest date
practicable. We have adopted
the provisions of this ASU for our fiscal year beginning January 1,
2018 and the adoption of this standard did not have a significant
impact on our consolidated financial
statements.
FASB ASU No. 2017-04.
In January 2017, the FASB issued ASU
No. 2017-04, Intangibles – Goodwill
and Other (Topic 350): Simplifying the Test for Goodwill
Impairment. The amendments of this
ASU eliminate step 2 from the goodwill impairment test. The annual,
or interim test is performed by comparing the fair value of a
reporting unit with its carrying amount. The amendments of this ASU
also eliminate the requirements for any reporting unit with a zero
or negative carrying amount to perform a qualitative assessment and
if it fails that qualitative test, to perform step 2 of the
goodwill impairment test. ASU No. 2017-04 is effective for fiscal
years beginning after December 15, 2019. The Company is currently evaluating the potential
impact of adoption of this standard on its consolidated financial
statements.
FASB ASU No.
2017-09. In May 2017,
the FASB issued ASU
No. 2017-09, “Scope
of Modification Accounting,” to reduce
diversity in practice and provide clarity regarding existing
guidance in ASC 718, “Stock
Compensation.” The amendments
in this updated guidance clarify that an entity should apply
modification accounting in response to a change in the terms and
conditions of an entity’s share-based payment awards unless
three newly specified criteria are met. This guidance is effective
for fiscal years beginning after December 15, 2017, including
interim periods within that reporting
period. We have adopted
the provisions of this ASU for our fiscal year beginning January 1,
2018 and the adoption of this standard did not have a significant
impact on our consolidated financial
statements.
FASB ASU No. 2017-11.
In July 2017, the FASB issued ASU No
2017-11, “Earnings Per Share (Topic
260); Distinguishing Liabilities from Equity (Topic 480);
Derivatives and Hedging (Topic 815): (Part I) Accounting for
Certain Financial Instruments with Down Round Features, (Part II)
Replacement of the Indefinite Deferral.” The ASU applies to issuers of financial
instruments with down-round features. It amends (1) the
classification of such instruments as liabilities or equity by
revising the guidance in ASC 815 on the evaluation of whether
instruments or embedded features with down-round provisions must be
accounted for as derivative instruments and (2) the guidance on
recognition and measurement of the value transferred upon the
trigger of a down-round feature for equity-classified instruments
by revising ASC 260. The ASU is effective for public business
entities for fiscal years, and interim periods within those fiscal
years, beginning after December 15, 2018. For all other
organizations, the amendments are effective for fiscal years
beginning after December 15, 2019, and interim periods within
fiscal years beginning after December 15, 2020. Early adoption is
permitted. The Company is
currently evaluating the potential impact of this updated guidance
on its consolidated financial
statements.
3. FAIR VALUE ACCOUNTING
The Company accounts for fair value measurements
in accordance with ASC 820, “Fair Value Measurements and
Disclosures,” which
defines fair value, establishes a framework for measuring fair
value in generally accepted accounting principles, and expands
disclosures about fair value measurements.
ASC
820 establishes a fair value hierarchy that prioritizes the inputs
to valuation techniques used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3
measurements). The three levels of the fair value hierarchy under
ASC 820 are described below:
|
Level
1
|
Unadjusted
quoted prices in active markets that are accessible at the
measurement date for identical, unrestricted assets or
liabilities.
|
|
|
|
|
Level
2
|
Applies
to assets or liabilities for which there are inputs other than
quoted prices included within Level 1 that are observable for the
asset or liability such as quoted prices for similar assets or
liabilities in active markets; quoted prices for identical assets
or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in
which significant inputs are observable or can be derived
principally from, or corroborated by, observable market
data.
|
|
|
|
|
Level
3
|
Prices
or valuation techniques that require inputs that are both
significant to the fair value measurement and unobservable
(supported by little or no market activity).
|
The
following table sets forth the Company’s financial assets and
liabilities measured at fair value by level within the fair value
hierarchy. As required by ASC 820, assets and liabilities are
classified in their entirety based on the lowest level of input
that is significant to the fair value measurement.
|
Fair Value at December 31, 2017
|
($ in thousands)
|
|
|
|
|
Assets:
|
|
|
|
|
Pension
assets
|
$1,806
|
$1,806
|
$—
|
$—
|
Totals
|
$1,806
|
$1,806
|
$—
|
$—
|
|
Fair Value at December 31, 2016
|
($ in thousands)
|
|
|
|
|
Assets:
|
|
|
|
|
Pension
assets
|
$1,645
|
$1,645
|
$—
|
$—
|
Totals
|
$1,645
|
$1,645
|
$—
|
$—
|
The
Company’s pension assets are classified within Level 1 of the
fair value hierarchy because they are valued using market prices.
The pension assets are primarily comprised of the cash surrender
value of insurance contracts. All plan assets are managed in a
policyholder pool in Germany by outside investment managers. The
investment objectives for the plan are the preservation of capital,
current income and long-term growth of capital.
The
Company monitors the activity within each level and any changes
with the underlying valuation techniques or inputs utilized to
recognize if any transfers between levels are
necessary. That determination is made, in part, by
working with outside valuation experts for Level 3 instruments and
monitoring market related data and other valuation inputs for Level
1 and Level 2 instruments.
4. INTANGIBLE ASSETS AND GOODWILL
The Company has intangible assets in the form of
trademarks, trade names and patents. The carrying amount of the
Company’s trademarks and trade names was $0 as of December
31, 2017 and 2016, respectively, which include accumulated
amortization of $347,000 as of December 31, 2017 and 2016.
Amortization expense related to trademarks and tradenames was $0,
$0 and $15,000 for the years ended December 31, 2017, 2016 and
2015, respectively. All intangible assets are amortized over their
estimated useful lives with no estimated residual values. Any costs
incurred by the Company to renew or extend the life of intangible
assets will be evaluated under ASC No. 350, Intangibles – Goodwill
and Other, for proper
treatment.
The
carrying amounts of the Company’s patent intangible assets
were $93,000 and $105,000 as of December 31, 2017 and 2016,
respectively, which includes accumulated amortization of $566,000
and $554,000 as of December 31, 2017 and 2016,
respectively. Amortization expense for patent intangible
assets was $12,000 for the years ended December 31, 2017, 2016 and
2015. Patent intangible assets are being amortized on a
straight-line basis over their remaining life of approximately 8.5
years. There was no impairment of the Company’s intangible
assets during the years ended December 31, 2017, 2016 and
2015.
The
Company annually, or more frequently if events or circumstances
indicate a need, tests the carrying amount of goodwill for
impairment. The Company performs its annual impairment test in the
fourth quarter of each year. A two-step impairment test is used to
first identify potential goodwill impairment and then measure the
amount of goodwill impairment loss, if any. The first step was
conducted by determining and comparing the fair value, employing
the market approach, of the Company’s reporting unit to the
carrying value of the reporting unit. The Company continues to have
only one reporting unit, Identity Management. Based on the results
of this impairment test, the Company determined that its goodwill
was not impaired during the years ended December 31,
2017, 2016 and 2015.
The
estimated acquired intangible amortization expense for the next
five fiscal years is as follows:
Fiscal Year Ended December 31,
|
Estimated Amortization
Expense
($ in thousands)
|
2018
|
$12
|
2019
|
12
|
2020
|
12
|
2021
|
12
|
2022
|
12
|
Thereafter
|
33
|
Totals
|
$93
|
5. RELATED PARTIES
Lines of Credit with Related Parties
In March 2013, the Company and Neal Goldman, a
member of the Company’s Board of Directors
(“Goldman”), entered into a line of credit (the
“Goldman Line of
Credit”) with available
borrowings of up to $2.5 million. In March 2014, the Goldman Line
of Credit’s borrowing was increased to an aggregate total of
$3.5 million (the “Amendment”). Pursuant to the terms and conditions of
the Amendment, Goldman had the right to convert up to $2.5 million
of the outstanding balance of the Goldman Line of Credit into
shares of the Company’s Common Stock for $0.95 per share. Any
remaining outstanding balance was convertible into shares of
the Company’s Common Stock for $2.25 per
share.
As consideration for the initial Goldman Line of
Credit, the Company issued a warrant to Goldman, exercisable for
1,052,632 shares of the Company’s Common Stock (the
“Line
of Credit Warrant”). The
Goldman Line of Credit Warrant had a term of two years from the
date of issuance and an exercise price of $0.95 per
share. As consideration for entering into the Amendment,
the Company issued to Goldman a second warrant, exercisable for
177,778 shares of the Company’s Common Stock (the
“Amendment
Warrant”). The Amendment
Warrant expired on March 27, 2015 and had an exercise price of
$2.25 per share.
The
Company estimated the fair value of the Line of Credit Warrant
using the Black-Scholes option pricing model using the following
assumptions: term of two years, a risk-free interest rate of 2.58%,
a dividend yield of 0%, and volatility of 79%. The Company recorded
the fair value of the Line of Credit Warrant as a deferred
financing fee of approximately $580,000 to be amortized over the
life of the Goldman Line of Credit. The Company estimated the fair
value of the Amendment Warrant using the Black-Scholes option
pricing model using the following assumptions: term on one year, a
risk-free interest rate of 2.58%, a dividend yield of 0% and
volatility of 74%. The Company recorded the fair value of the
Amendment Warrant as an additional deferred financing fee of
approximately $127,000 to be amortized over the life of the Goldman
Line of Credit.
During
the years ended December 31, 2017 and 2016, the Company recorded an
aggregate of approximately $11,000 and $48,000, respectively in
deferred financing fee amortization expense which is recorded as a
component of interest expense in the Company’s consolidated
statements of operations.
In April 2014, the Company and Goldman entered
into a further amendment to the Goldman Line of Credit to decrease
the available borrowings to $3.0 million (the
“Second
Amendment”). Contemporaneous with the execution
of the Second Amendment, the Company entered into a new unsecured
line of credit with Charles Crocker, a member of the
Company’s Board of Directors (“Crocker”), with available borrowings of up to
$500,000 (the “Crocker LOC”), which amount was convertible into
shares of the Company’s Common Stock for $2.25 per share. As
a result of these amendments, total available borrowings under the
Lines of Credit available to the Company remained unchanged at a
total of $3.5 million. In connection with the Second Amendment,
Goldman assigned and transferred to Crocker one-half of the
Amendment Warrant.
In December 2014, the Company and Goldman entered
into a further amendment to the Goldman Line of Credit to increase
the available borrowing to $5.0 million and extend the maturity
date of the Goldman Line of Credit to March 27, 2017 (the
“Third
Amendment”). Also, as a
result of the Third Amendment, Goldman had the right to convert up
to $2.5 million outstanding principal, plus any accrued but unpaid
interest (“Outstanding
Balance”) into shares of
the Company’s Common Stock for $0.95 per share, the next
$500,000 Outstanding Balance into shares of Common Stock for $2.25
per share and any remaining outstanding balance thereafter into
shares of Common Stock for $2.30 per share. The Third Amendment
also modified the definition of a “Qualified Financing”
to mean a debt or equity financing resulting in gross proceeds to
the Company of at least $5.0 million.
In
February 2015, as a result of the Series E Financing, the Company
issued 1,978 shares of Series E Preferred to Goldman to satisfy
$1,950,000 in principal borrowings under the Goldman Line of Credit
plus approximately $28,000 in accrued interest. As a result of the
Series E Financing, the Company’s borrowing capacity under
the Goldman Line of Credit was reduced to $3,050,000 with the
maturity date unchanged and the Crocker LOC was terminated in
accordance with its terms.
In March 2016, the Company and Goldman entered
into a fourth amendment to the Goldman Line of Credit (the
“Fourth
Amendment”) solely to (i)
increase available borrowings to $5.0 million; (ii) extend the
maturity date to June 30, 2017, and (iii) provide for the
conversion of the outstanding balance due under the terms of the
Goldman Line of Credit into that number of fully paid and
non-assessable shares of the Company’s Common Stock as is
equal to the quotient obtained by dividing the outstanding balance
by $1.25.
Contemporaneous with the execution of the Fourth
Amendment, the Company entered into a new $500,000 Line of Credit
(the “New Crocker
LOC”) with available
borrowings of up to $500,000 with Crocker, which replaced the
original Crocker LOC that terminated as a result of the
consummation of the Series E Financing. Similar to the
Fourth Amendment, the New Crocker LOC with Crocker originally
matured on June 30, 2017, and provides for the conversion of
the outstanding balance due under the terms of the New Crocker LOC
into that number of fully paid and non-assessable shares of the
Company’s Common Stock as is equal to the quotient obtained
by dividing the outstanding balance by $1.25.
On December 27,
2016, in connection with the consummation of the Series G
Financing, the Company and Holder agreed to enter into the Fifth
Amendment (the “Line
of Credit Amendment”) to the Goldman
Line of Credit to provide the Company with the ability to borrow up
to $5.5 million under the terms of the Goldman Line of Credit. In
addition, the Maturity Date, as defined in the Goldman Line of
Credit was amended to be December 31, 2017. The Line of Credit
Amendment was executed on January 23, 2017.
In addition, on January 23, 2017, the Company and Crocker amended
the New Crocker LOC to extend the maturity date thereof to December
31, 2017.
On May 10, 2017, Goldman and Crocker agreed to
further extend the maturity dates of Lines of Credit to December
31, 2018.
As the
aforementioned amendments to the Lines of Credit resulted in an
increase to the borrowing capacity of the Lines of Credit, the
Company adjusted the amortization period of any remaining
unamortized deferred costs and note discounts to the term of the
new arrangement.
The
Company evaluated the Lines of Credit and determined that the
instruments contain a contingent beneficial conversion feature,
i.e. an embedded conversion right that enables the holder to obtain
the underlying Common Stock at a price below market value. The
beneficial conversion feature is contingent as the terms of the
conversion do not permit the Company to compute the number of
shares that the holder would receive if the contingent event occurs
(i.e. future borrowings under the Line of Credit). The Company has
considered the accounting for this contingent beneficial conversion
feature using the guidance in ASC 470, Debt. The guidance in ASC
470 states that a contingent beneficial conversion feature in an
instrument shall not be recognized in earnings until the
contingency is resolved. The beneficial conversion features of
future borrowings under the Line of Credit will be measured
using the intrinsic value calculated at the date the contingency is
resolved using the conversion price and trading value of the
Company’s Common Stock at the date the Lines of Credit were
issued (commitment date). Pursuant to borrowings made during the
2015 year, the Company recognized approximately $146,000 in
beneficial conversion feature as debt discount. As a result of the
retirement of all amounts outstanding under the Lines of Credit in
2015, the Company recognized all remaining unamortized debt
discount of approximately $385,000 as a component of interest
expense during the three months ended March 31, 2015. As a result
of $2,650,000 in borrowings under the Lines of Credit during the
year ended December 31, 2016, the Company recorded approximately
$219,000 in debt discount attributable to the beneficial conversion
feature during the year ended December 31, 2016. During the year
ended December 31, 2016, the Company accreted approximately $97,000
of debt discount as a component of interest expense. At December
31, 2016, unamortized note discount was approximately $122,000. As
a result of an additional $3,350,000 in borrowings under the Lines
of Credit during the year ended December 31, 2017, the Company
recorded approximately $302,000 in debt discount attributable to
the beneficial conversion feature during the year ended December
31, 2017. During the year ended December 31, 2017, the Company
accreted approximately $198,000 of debt discount which is
classified as a component of interest expense. At December 31,
2017, unamortized note discount was approximately
$226,000.
The
following table sets forth the Company’s activity under its
Lines of Credit for the periods indicated:
Balance
outstanding under Lines of Credit as of December 31,
2015
|
$—
|
Borrowing
under Lines of Credit
|
2,650
|
Repayments
|
—
|
Balance
outstanding under Lines of Credit as of December 31,
2016
|
$2,650
|
Borrowings
under Lines of Credit
|
3,350
|
Repayments
|
—
|
Balance
outstanding under Lines of Credit as of December 31,
2017
|
$6,000
|
Series A Preferred Stock
A member of the
Company's Board of Directors and certain members of management
participated in the Series A Preferred Stock financing on the same
terms as all other participants. Management purchased an aggregate
of 125 shares for $125,000 and our Board Member purchased 855
shares for $855,000.
6. INVENTORY
Inventories of
$79,000 as of December 31, 2017
were comprised of work in process of $53,000 representing direct
labor costs on in-process projects and finished goods of
$26,000 net of reserves for
obsolete and slow-moving items of $3,000.
Inventories of $23,000 as of December 31, 2016 were comprised of
work in process of $19,000 representing direct labor costs on
in-process projects and finished goods of $4,000 net of reserves
for obsolete and slow-moving items of $3,000.
Appropriate consideration is given to obsolescence, excessive
levels, deterioration and other factors in evaluating net
realizable value and required reserve levels.
7. PROPERTY AND EQUIPMENT
Property
and equipment at December 31, 2017 and 2016, consists
of:
($ in thousands)
|
|
|
|
|
|
Equipment
|
$946
|
$935
|
Leasehold
improvements
|
11
|
11
|
Furniture
|
102
|
101
|
|
1,059
|
1,047
|
Less
accumulated depreciation
|
(1,016)
|
(954)
|
|
$43
|
$93
|
Total
depreciation expense for the years ended December 31, 2017, 2016
and 2015 was approximately $56,000, $117,000 and $137,000,
respectively.
8. ACCRUED EXPENSES
Principal
components of accrued expenses consist of:
($ in thousands)
|
|
|
|
|
|
Compensated
absences
|
$273
|
$313
|
Wages,
payroll taxes and sales commissions
|
38
|
28
|
Customer
deposits
|
40
|
198
|
Royalties
|
72
|
147
|
Pension
and employee benefit plans
|
5
|
7
|
Professional
services
|
100
|
—
|
Income
and sales taxes
|
27
|
161
|
Dividends
|
34
|
27
|
Other
|
69
|
64
|
|
$658
|
$945
|
9. LINES OF CREDIT
Outstanding
lines of credit consist of the following:
|
|
|
Lines
of Credit with Related Parties
|
|
|
8%
convertible lines of credit. Face value of advances under lines of
credit $6,000 at December 31, 2017 and $2,650 at December 31, 2016.
Discount on advances under lines of credit is $226 at December 31,
2017 and $122 at December 31, 2016. Maturity date is December
31, 2018.
|
$5,774
|
$2,528
|
|
|
|
Total
lines of credit to related parties
|
5,774
|
2,528
|
Less
current portion
|
(5,774)
|
(2,528)
|
Long-term
lines of credit to related parties
|
$—
|
$—
|
For a more detailed discussion of the Company’s Lines of
Credit, see Note 5, Related Parties.
10. INCOME TAXES
The Company accounts for income taxes in
accordance with ASC 740, Accounting for Income
Taxes, (ASC 740). Deferred
income taxes are recognized for the tax consequences related to
temporary differences between the carrying amount of assets and
liabilities for financial reporting purposes and the amounts used
for tax purposes at each year-end, based on enacted tax laws and
statutory tax rates applicable to the periods in which the
differences are expected to affect taxable income. A valuation
allowance is established when necessary based on the weight of
available evidence, if it is considered more likely than not that
all or some portion of the deferred tax assets will not be
realized. Income tax expense is the sum of current income tax plus
the change in deferred tax assets and liabilities. The
Company has established a valuation allowance against its deferred
tax asset due to the uncertainty surrounding the realization of
such asset.
ASC
740 requires a company to first determine whether it is
more-likely-than-not (defined as a likelihood of more than fifty
percent) that a tax position will be sustained based on its
technical merits as of the reporting date, assuming that taxing
authorities will examine the position and have full knowledge of
all relevant information. A tax position that meets this
more-likely-than-not threshold is then measured and recognized at
the largest amount of benefit that is greater than fifty percent
likely to be realized upon effective settlement with a taxing
authority. The amount accrued for uncertain tax
positions was zero at December 31, 2017, 2016 and 2015,
respectively.
The
Company’s uncertain position relative to unrecognized tax
benefits and any potential increase in these liabilities relates
primarily to the allocations of revenue and costs among the
Company’s global operations and the impact of tax rulings
made during the period affecting its tax positions. The
Company’s existing tax position could result in liabilities
for unrecognized tax benefits. The Company recognizes interest
and/or penalties related to uncertain tax positions in income tax
expense. The amount of interest and penalties accrued as of
December 31, 2017 and 2016 was approximately $10,000 and $12,000,
respectively.
Significant
judgment is required in evaluating the Company’s uncertain
tax positions and determining the Company’s provision for
income taxes. No assurance can be given that the final tax outcome
of these matters will not be different from that which is reflected
in the Company’s historical income tax provisions and
accruals. The Company adjusts these items in light of changing
facts and circumstances. To the extent that the final tax outcome
of these matters is different than the amounts recorded, such
differences will impact the provision for income taxes in the
period in which such determination is made.
The
significant components of the income tax provision are as
follows:
($ in thousands)
|
|
Current
|
|
|
|
Federal
|
$—
|
$—
|
$—
|
State
|
—
|
—
|
—
|
Foreign
|
(124)
|
21
|
22
|
|
|
|
|
Deferred
|
|
|
|
Federal
|
—
|
—
|
—
|
State
|
—
|
—
|
—
|
Foreign
|
—
|
—
|
—
|
|
|
|
|
|
$(124)
|
$21
|
$22
|
The
principal components of the Company’s deferred tax assets at
December 31, 2017, 2016 and 2015 are as follows:
($ in thousands)
|
|
|
|
|
|
|
|
Net
operating loss carryforwards
|
$13,734
|
$17,829
|
$15,948
|
Intangible
and fixed assets
|
(28)
|
102
|
220
|
Stock
based compensation
|
1,954
|
2,324
|
1,861
|
Reserves
and accrued expenses
|
38
|
8
|
8
|
Other
|
—
|
—
|
—
|
|
15,698
|
20,263
|
18,037
|
Less
valuation allowance
|
(15,698)
|
(20,263)
|
(18,037)
|
|
|
|
|
Net
deferred tax assets
|
$—
|
$—
|
$—
|
A
reconciliation of the provision for income taxes to the amount
computed by applying the statutory income tax rates to loss before
income taxes is as follows:
|
|
|
|
|
|
|
|
Amounts
computed at statutory rates
|
$(3,423)
|
$(3,239)
|
$(2,902)
|
State
income tax, net of federal benefit
|
(497)
|
(462)
|
(262)
|
Expiration
of net operating loss carryforwards
|
688
|
1,082
|
695
|
Non-deductible
interest
|
250
|
49
|
149
|
Tax
Act – federal rate change
|
7,276
|
—
|
—
|
Foreign
taxes
|
143
|
362
|
413
|
Other
|
4
|
3
|
5
|
Net
change in valuation allowance on deferred tax assets
|
(4,565)
|
2,226
|
1,924
|
|
|
|
|
|
$(124)
|
$21
|
$22
|
The
Company has established a valuation allowance against its deferred
tax assets due to the uncertainty surrounding the realization of
such assets.
On December 22,
2017 the 2017 Tax Cuts and Jobs Act (the “Act”) was enacted into laws and
the new legislation reduces the corporate tax rate to 21% effective
January 1, 2018. Consequently, the Company remeasured the deferred
tax assets and recorded a decrease in federal tax assets and
valuation allowance of approximately $7,276,000. The Company
believes that the one-time transition tax does not apply because
there were no post-1986 earnings and profits previously deferred
from US income taxes.
At
December 31, 2017, 2016 and 2015, the Company had federal and state
net operating loss carryforwards, a portion of which may be
available to offset future taxable income for tax purposes. The
federal net operating loss carryforwards expire at various dates
from 2022 through 2037. The state net operating loss carryforwards
expire at various dates from 2030 through 2037.
The Internal Revenue Code (the “Code”) limits the availability of certain tax
credits and net operating losses that arose prior to certain
cumulative changes in a corporation’s ownership resulting in
a change of control of the Company. The Company’s use of its
net operating loss carryforwards and tax credit carryforwards will
be significantly limited because the Company believes it underwent
“ownership changes,” as defined under Section 382 of
the Internal Revenue Code, in 1991, 1995, 2000, 2003, 2004, 2011
and 2012, though the Company has not performed a study to determine
the limitation. The Company has reduced its deferred tax assets to
zero relating to its federal and state research credits because of
such limitations. The Company continues to disclose the tax effect
of the net operating loss carryforwards at their original amount in
the table above as the actual limitation has not yet been
quantified. The Company has also established a full valuation
allowance for substantially all deferred tax assets due to
uncertainties surrounding its ability to generate future taxable
income to realize these assets. Since substantially all deferred
tax assets are fully reserved, future changes in tax benefits will
not impact the effective tax rate. Management periodically
evaluates the recoverability of the deferred tax assets. If it is
determined at some time in the future that it is more likely than
not that deferred tax assets will be realized, the valuation
allowance would be reduced accordingly at that
time.
Tax returns for
the years 2013 through 2017 are subject to examination by taxing
authorities.
11. COMMITMENTS AND CONTINGENCIES
Employment Agreements
The
Company has employment agreements with its Chief Executive Officer
and its Chief Technical Officer. The Company may terminate the
agreements with or without cause. Subject to the conditions and
other limitations set forth in each respective employment
agreement, each executive will be entitled to the following
severance benefits if the Company terminates the executive’s
employment without cause or in the event of an involuntary
termination (as defined in the employment agreements) by the
Company or by the executive:
Under
the terms of the agreement, the Chief Executive Officer will be
entitled to the following severance benefits if we terminate his
employment without cause or in the event of an involuntary
termination: (i) a lump sum cash payment equal to twenty-four
months’ base salary; (ii) continuation of fringe benefits and
medical insurance for a period of three years; and (iii) immediate
vesting of 50% of outstanding stock options and restricted stock
awards. In the event that the Chief Executive Officer’s
employment is terminated within six months prior to or thirteen
months following a change of control (as defined in the employment
agreements), the Chief Executive Officer is entitled to the
severance benefits described above, except that 100% of the Chief
Executive Officer’s outstanding stock options and restricted
stock awards will immediately vest.
Under
the terms of the employment agreement with our Chief Technical
Officer, this executive will be entitled to the following severance
benefits if we terminate his employment without cause or in the
event of an involuntary termination: (i) a lump sum cash payment
equal to six months of base salary; and (ii) continuation of their
fringe benefits and medical insurance for a period of six months.
In the event that his employment is terminated within six months
prior to or thirteen months following a change of control (as
defined in the employment agreements), he is entitled to the
severance benefits described above, except that 100% of his
outstanding stock options and restricted stock awards will
immediately vest.
The
employment agreements for the Company’s Chief Executive
Officer and Chief Technical Officer were amended to extend the term
of each executive officer's employment agreement until December 31,
2018.
Litigation
There
is no action, suit, proceeding, inquiry or investigation before or
by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the executive
officers of the Company or any of our subsidiaries, threatened
against or affecting the Company, our Common Stock, any of our
subsidiaries or of the Company’s or our subsidiaries’
officers or directors in their capacities as such, in which an
adverse decision could have a material adverse effect.
Leases
The
Company’s corporate headquarters are located in San Diego,
California where we occupy 9,927 square feet of office space. This
facility’s lease was renewed in September 2017 through
October 2018 at a cost of approximately $30,000 per month. In
addition to our corporate headquarters, we also occupied the
following spaces at December 31, 2017:
●
1,508
square feet in Ottawa, Province of Ontario, Canada, at a cost of
approximately $3,000 per month until the expiration of the lease on
March 31, 2021. This lease was renewed in April 2016 for a
five-year period ending on March 31, 2021. Renewal terms were
substantially unchanged from the existing lease;
●
9,720
square feet in Portland, Oregon, at a cost of approximately $21,000
per month until the expiration of the lease on December 31, 2021.
This lease was renewed in September 2017 resulting in an additional
1,675 feet, an increase from approximately $18,000 to approximately
$21,000 per month and the extension of the term from October 2018
to December 2021; and
●
304 square feet of office space in Mexico City,
Mexico, at a cost of approximately $3,000 per month
until November 30, 2018.
At
December 31, 2017, future minimum lease payments are as
follows:
($ in thousands)
|
|
2018
|
$607
|
2019
|
284
|
2020
|
291
|
2021
|
272
|
2022
|
270
|
Thereafter
|
46
|
Total
|
$1,770
|
Rental
expense incurred under operating leases for the years ended
December 31, 2017, 2016 and 2015 was approximately $545,000,
$492,000 and $477,000, respectively.
12. EQUITY
The
Company’s Certificate of Incorporation, as amended, authorize
the issuance of two classes of stock to be designated “Common
Stock” and “Preferred Stock”. The Preferred Stock
may be divided into such number of series and with the rights,
preferences, privileges and restrictions as the Board of Directors
may determine.
Series A Convertible Preferred Stock
On
September 15, 2017, the Company filed the Certificate of
Designations of the Series A Preferred with the Delaware Secretary
of State, designating 31,021 shares of the Company’s
preferred stock, par value $0.01 per share, as Series A Preferred.
Shares of Series A Preferred accrue dividends at a rate of 8% per
annum if the Company chooses to pay accrued dividends in cash, and
10% per annum if the Company chooses to pay accrued dividends in
shares of Common Stock. Each share of Series A Preferred has a
liquidation preference of $1,000 per share and is convertible, at
the option of the holder, into that number of shares of the
Company’s Common Stock equal to the Liquidation Preference,
divided by $1.15. Each holder of the Series A Preferred is entitled
to vote on all matters, together with the holders of Common Stock,
on an as converted basis.
Holders of Series A Preferred may elect to convert
shares of Series A Preferred into Conversion Shares at any time. In
the event the volume-weighted average price
(“VWAP”) of the Company’s Common Stock is at
least $2.15 per share for at least 20 consecutive trading days, the
Company may elect to convert one-half of the shares of Series A
Preferred issued and outstanding, on a pro-rata basis, into
Conversion Shares, or, if the VWAP of the Company’s Common
Stock is at least $2.15 for 80 consecutive trading days, the
Company may convert all issued and outstanding shares of Series A
Preferred into Conversion Shares. In addition, in the event of a
Change of Control, the Company will have the option to redeem all
issued and outstanding shares of Series A Preferred for 115% of the
Liquidation Preference per share.
On
September 18, 2017, the Company offered and sold a total of 11,000
shares of Series A Preferred at a purchase price of $1,000 per
share. The total net proceeds to the Company from the Series A
Financing were approximately $10.9 million.
Concurrently with the Series A Financing, the
Company entered into Exchange Agreements with holders of all
outstanding shares of the Company's Series E Convertible Preferred
Stock, all outstanding shares of the Company's Series F Convertible
Preferred Stock and all outstanding shares of the Company's Series
G Convertible Preferred Stock (collectively
“Exchanged
Preferred”) pursuant to
which the holders thereof agreed to cancel their respective shares
of Exchanged Preferred in exchange for shares of Series A
Preferred. As a result of the Preferred Stock Exchange, the Company
issued to the holders of the Exchanged Preferred an aggregate total
of 20,021 shares of Series A Preferred.
The Company evaluated the Preferred Stock Exchange
and determined that the Preferred Stock Exchange was both an
induced conversion and an extinguishment transaction. Using the
guidance in ASC 260-10-S99-2, Earnings Per Share – SEC
Materials – SEC Staff Announcement: The Effect on the
Calculations of Earnings Per Share for a Period That Includes the
Redemption or Induced Conversion of Preferred Stock and
ASC 470-50, Debt – Modifications and
Extinguishments, the Company
recorded the fair value differential of the Exchanged Preferred as
adjustments within Shareholders’ Deficit and in the
computation of Net Loss Available to Common Shareholders in the
computation of basic and diluted loss per share. The Company
utilized the services an independent third-party valuation firm to
perform the computation of the fair value of the Exchanged
Preferred. Based on the fair value using these methodologies, the
Company recorded approximately $1,245,000 in fair value
differential as adjustments within Shareholders’ Deficit in
the Company’s Consolidated Balance Sheet for the year ended
December 31, 2017 and in the computation of basic and diluted loss
per share in the Company’s Consolidated Statement of
Operations for the year ended December 31,
2017.
The Company had 31,021 shares and 0 shares of
Series A Preferred outstanding as of December 31, 2017 and December
31, 2016, respectively. At December 31, 2017, the
Company had cumulative undeclared dividends of $0. There
were no conversions of Series A Preferred into Common Stock during
the year ended December 31, 2017. During the year ended
December 31, 2017, the Company issued the
holders of Series A Preferred 585,058 shares of Common Stock as
payment of dividends due.
Series B Convertible Redeemable Preferred Stock
The Company had 239,400 shares of Series B
Convertible Redeemable Preferred Stock (“Series B
Preferred”) outstanding
as of December 31, 2017 and 2016. At December 31, 2017 and 2016,
the Company had cumulative undeclared dividends of approximately
$8,000 ($0.03 per share). There were no conversions of Series B
Preferred into Common Stock during the years ended December 31,
2017, 2016 and 2015. The Company paid dividends of approximately
$51,000 to the holders of our Series B Preferred in 2017, 2016 and
2015.
Series E Convertible Preferred Stock
On
January 29, 2015, the Company filed the Certificate of Designations
of the Series E Preferred Stock with the Delaware Secretary of
State, designating 12,000 shares of the Company’s preferred
stock, par value $0.01 per share, as Series E Preferred. Shares of
Series E Preferred accrue dividends at a rate of 8% per annum if
the Company chooses to pay accrued dividends in cash, and 10% per
annum if the Company chooses to pay accrued dividends in shares of
Common Stock. Each share of Series E Preferred has a liquidation
preference of $1,000 per share and is convertible, at the option of
the holder, into that number of shares of the Company’s
Common Stock equal to the Liquidation Preference, divided by $1.90.
The Series E Preferred shall be subordinate to and rank junior to
the Company's Series A Preferred, Series B Preferred and all
indebtedness of the Company. Each holder of the Series E Preferred
is entitled to vote on all matters, together with the holders of
Common Stock, on an as converted basis.
Any time after the six-month period following the
issuance date, in the event the arithmetic average of the closing
sales price of the Company’s Common Stock is or was at least
$2.85 for twenty (20) consecutive trading days, the Company may
redeem all or a portion of the Series E Preferred outstanding upon
thirty (30) calendar day's prior written notice (the
“Company's Redemption
Notice”) in cash at a
price per share of Series E Preferred equal to 110% of the
liquidation preference amount plus all accrued and unpaid
dividends. Also, simultaneous with the occurrence of a
change of control transaction, the Company, at its option, shall
have the right to redeem all or a portion of the outstanding Series
E Preferred in cash at a price per share of Series E Preferred
equal to 110% of the liquidation preference amount plus all accrued
and unpaid dividends.
In
February 2015, the Company consummated a registered direct offering
conducted without an underwriter or placement agent. In connection
therewith, the Company issued 12,000 shares of Series E Preferred
to certain investors at a price of $1,000 per share, with each
share convertible into 526.32 shares of the Company’s Common
Stock at $1.90 per share.
On December 29, 2016, the Company filed Amendment
No. 1 to the Certificate of Designations, Preferences and Rights of
the Series E Convertible Preferred Stock (the
“Series E
Amendment”) with the
Delaware Division of Corporations. The Series E Amendment made the
following changes to the Certificate of Designations, Preferences
and Rights of the Series E Convertible Preferred Stock: (i) the
Company may only make dividend payments in cash received from
positive cash flow from operations; (ii) beginning on July 1, 2017,
in the event the Company pays accrued dividend payments in shares
of Common Stock for more than four consecutive quarterly periods,
holders of shares of Series E Preferred will have the right to
immediately appoint two designees to the Company’s Board of
Directors (the “ Director Appointment
Provision ”); (iii)
dividend payments incurred on December 31, 2016 and March 31, 2017
may be paid in shares of Common Stock, without triggering the
Director Appointment Provision; and (iv) the term Permitted
Indebtedness (as defined in the Series E Certificate of
Designations) was revised to cover permitted borrowings of up to
$6.0 million.
The
Company had 0 shares of Series E Preferred outstanding as of
December 31, 2017 as a result of the Preferred Stock Exchange, and
12,000 shares of Series E Preferred outstanding at December 31,
2016. At December 31, 2017 and December 31, 2016, the
Company had cumulative undeclared dividends of $0. There
were no conversions of Series E Preferred into Common Stock during
the years ended December 31, 2017 and 2016. For the year ended
December 31, 2017, the Company has issued the holders of Series E
Preferred 822,122 shares of Common Stock as payment of dividends
due. With the payment of the quarterly dividends due September 30,
2017 to the holders of Series E Preferred in shares of Common
Stock, the Director Appointment Provision became effective as of
that date resulting in the Company adding two Board members as of
September 15, 2017.
Series F Convertible Preferred Stock
In September 2016, we filed the Certificate of
Designations, Preferences, and Rights of the Series F Convertible
Preferred Stock (the “Certificate of
Designations”) with the
Delaware Division of Corporations, designating 2,000 shares of our
preferred stock as Series F Convertible Preferred Stock
(“Series F
Preferred”). Shares of
Series F Preferred rank junior to shares of Series A Preferred,
Series B Preferred and Series E Preferred, as well as our existing
indebtedness, and accrue dividends at a rate of 10% per annum,
payable on a quarterly basis in shares of Common
Stock.
Each share of Series F Preferred has a liquidation
preference of $1,000 per share (“Liquidation
Preference”), and is
convertible, at the option of the holder, into that number of
shares of the Company’s Common Stock equal to the Series F
Liquidation Preference, divided by $1.50 (the
“Series F Conversion
Shares”).
Any
time after the six-month period following the issuance date, in the
event the arithmetic average of the closing sales price of the
Company’s Common Stock is or was at least $2.50 for twenty
(20) consecutive trading days, the Company may redeem all or a
portion of the Series F Preferred outstanding upon thirty (30)
calendar days prior written notice in cash at a price per share of
Series F Preferred equal to 110% of the Series F Liquidation
Preference, plus all accrued and unpaid dividends. Also,
simultaneous with the occurrence of a Change of Control transaction
(as defined in the Certificate of Designations), the Company, at
its option, shall have the right to redeem all or a portion of the
outstanding Series F Preferred in cash at a price per share of
Series F Preferred equal to 110% of the Liquidation Preference
Amount plus all accrued and unpaid dividends.
In September 2016, the Company offered and sold
2,000 shares of Series F Preferred for $1,000 per share (the
“Series F
Financing”), resulting in
gross proceeds to the Company of $2,000,000 net of issuance costs
of approximately $21,000.
The Company had 0 shares of Series F Preferred
outstanding as of December 31, 2017 as a result of
the Preferred Stock Exchange, and 2,000 shares of Series F
Preferred at December 31, 2016. At December 31, 2017 and December 31,
2016, the Company had cumulative undeclared dividends of $0. There
were no conversions of Series F Preferred into Common Stock during
the years ended December 31, 2017 and 2016. For the year ended
December 31, 2017, the Company has issued the holders of Series F
Preferred 135,855 shares of Common Stock as payment of dividends
due.
Series G Convertible Preferred Stock
In December 27, 2016, the Company filed the
Certificate of Designations, Preferences, and Rights of the Series
G Convertible Preferred Stock with the Delaware Division of
Corporations, designating 6,120 shares of the Company’s
preferred stock, par value $0.01 per share, as Series G Convertible
Preferred Stock (“Series G
Preferred”). Shares of
Series G Preferred rank junior to the Company’s Series A
Preferred, Series B Preferred, Series E Preferred, Series F
Preferred as well as the Company’s existing indebtedness, and
accrue dividends at a rate of 10% per annum, payable on a quarterly
basis in shares of the Company’s Common Stock. Each share of
Series G Preferred has a liquidation preference of $1,000 per share
(“Series G Liquidation
Preference”), and is
convertible, at the option of the holder, into that number of
shares of the Company’s Common Stock equal to the Series G
Liquidation Preference, divided by $1.50.
Any
time after the six-month period following the issuance date, in the
event the arithmetic average of the closing sales price of the
Company’s Common Stock is or was at least $2.50 for twenty
(20) consecutive trading days, the Company may redeem all or a
portion of the Series G Preferred outstanding upon thirty (30)
calendar days prior written notice in cash at a price per share of
Series G Preferred equal to 110% of the Series G Liquidation
Preference, plus all accrued and unpaid dividends. Also,
simultaneous with the occurrence of a Change of Control transaction
(as defined in the Certificate of Designations), the Company, at
its option, shall have the right to redeem all or a portion of the
outstanding Series G Preferred in cash at a price per share of
Series G Preferred equal to 110% of the Liquidation Preference
Amount plus all accrued and unpaid dividends.
On December 29, 2016, the Company accepted
subscription forms from certain accredited investors to purchase a
total of 1,625 shares of Series G Preferred for $1,000 per share
(the “Series G
Financing”), resulting in
gross proceeds to the Company of $1,625,000, net of issuance cost
of approximately $11,000. In addition, the Company also received
executed exchange agreements from the Investors pursuant to which
the Company exchanged an aggregate total of 3,383,830 shares of
Common Stock held by the Investors for an aggregate total of 4,396
shares of Series G Preferred.
The
Company had 0 shares of Series G Preferred outstanding as of
December 31, 2017 as a result of the Preferred Stock Exchange, and
6,021 shares of Series G Preferred at December 31,
2016. At December 31, 2017 and December 31, 2016, the
Company had cumulative undeclared dividends of $0. There
were no conversions of Series G Preferred into Common Stock during
the years ended December 31, 2017 and 2016. For the year ended
December 31, 2017, the Company has issued the holders of Series G
Preferred 409,002 shares of Common Stock as payment of dividends
due.
Common Stock
The
following table summarizes outstanding Common Stock activity for
the following periods:
|
|
|
|
Shares
outstanding at December 31, 2014
|
93,507,150
|
Shares issued pursuant to payment of stock dividend on Series E
Preferred
|
478,664
|
Shares issued pursuant to cashless warrants exercised
|
45,376
|
Shares issued pursuant to option exercises
|
39,705
|
Shares
outstanding at December 31, 2015
|
94,070,895
|
Shares issued pursuant to payment of stock dividend on Series E
Preferred
|
950,362
|
Shares issued pursuant to payment of stock dividend on Series F
Preferred
|
48,513
|
Shares issued pursuant to payment of stock dividend on
Series G Preferred
|
3,770
|
Shares issued pursuant to cashless warrants exercised
|
144,459
|
Shares issued pursuant to option exercises
|
12,626
|
Exchange of common shares for Series G
Preferred
|
(3,383,830)
|
Shares
outstanding at December 31, 2016
|
91,846,795
|
Shares issued pursuant to payment of stock dividend on Series A
Preferred
|
585,058
|
Shares issued pursuant to payment of stock dividend on Series E
Preferred
|
822,122
|
Shares issued pursuant to payment of stock dividend on
Series F Preferred
|
135,855
|
Shares issued pursuant to payment of stock dividend on
Series G Preferred
|
409,002
|
Shares issued pursuant to option exercises
|
369,004
|
Shares
outstanding at December 31, 2017
|
94,167,836
|
Warrants
As of December 31, 2017, warrants to purchase
230,000 shares
of Common Stock at prices ranging from $0.80 to $1.17 were
outstanding. All warrants are exercisable as of December 31, 2017
and expire as of September 11, 2019, with the exception of an
aggregate of 150,000 warrants, which become exercisable only upon
the attainment of specified events.
The
following table summarizes warrant activity for the following
periods:
|
|
Weighted-
Average
Exercise
Price
|
|
|
|
Balance
at December 31, 2014
|
977,778
|
$1.22
|
Granted
|
—
|
$0.00
|
Expired
/ Canceled
|
(419,444)
|
$1.86
|
Exercised
|
(108,334)
|
$1.01
|
Balance
at December 31, 2015
|
450,000
|
$0.67
|
Exercised
|
(275,000)
|
$0.55
|
Balance
at December 31, 2016
|
175,000
|
$0.84
|
Granted
|
80,000
|
$1.13
|
Expired
/ Canceled
|
(25,000)
|
$1.10
|
Exercised
|
—
|
$—
|
Balance
at December 31, 2017
|
230,000
|
$0.91
|
During
the year ended December 31, 2017, the Company issued an aggregate
of 80,000 warrants to certain members of the Company’s
advisory board. The Company determined the grant date fair value of
these warrants using the Black-Scholes option valuation model and
recorded approximately $57,000 in expense for the year ended
December 31, 2017. The Company used the following assumptions in
the application of the Black-Scholes option valuation model: an
exercise price ranging between $1.09 and $1.17, a term of 2.0
years, a risk-free interest rate of 2.58%, a dividend yield of 0%
and volatility of 59%. Such expense is recorded in the
Company’s consolidated statement of operations as a component
of general and administrative expense. There were no warrants
exercised during the twelve months ended December 31, 2017 and
25,000 warrants expired unexercised during the 2017 year. The
intrinsic value of warrants outstanding as of December 31, 2017 was
approximately $155,000.
13. STOCK-BASED
COMPENSATION
Stock Options
As of December 31, 2017, the Company had one
active stock-based compensation plan: the 1999 Stock Option Plan
(the “1999 Plan”).
1999 Plan
The 1999 Plan was adopted by the Company’s
Board of Directors on December 17, 1999. Under the terms of the
1999 Plan, the Company could, originally, issue up to 350,000
non-qualified or incentive stock options to purchase Common Stock
of the Company. During the year ended December 31, 2014, the
Company subsequently amended and restated the 1999 Plan whereby it
increased the share reserve for issuance to approximately 7.0
million shares of the Company’s Common Stock. The
1999 Plan prohibits the grant of stock option or stock appreciation
right awards with an exercise price less than fair market value of
Common Stock on the date of grant. The 1999 Plan also generally
prohibits the “re-pricing” of stock options or stock
appreciation rights, although awards may be bought-out for a
payment in cash or the Company’s stock. The 1999 Plan permits
the grant of stock-based awards other than stock options, including
the grant of “full value” awards such as restricted
stock, stock units and performance shares. The 1999 Plan permits
the qualification of awards under the plan (payable in either stock
or cash) as “performance-based compensation” within the
meaning of Section 162(m) of the Internal Revenue Code. The number
of options issued and outstanding and the number of options
remaining available for future issuance are shown in the table
below. On July 1, 2014, the Company began soliciting written
consents from its shareholders to approve an amendment to the
Company’s 1999 Stock Option Plan to increase the number of
shares authorized for issuance thereunder from approximately 4.0
million to approximately 7.0 million (the
“Amendment”). As
of July 21, 2014, the Company had received written consents
approving the Amendment from over 50% of the Company’s
stockholders. As such, the Amendment was approved. The number of
authorized shares available under the plan for issuance at December
31, 2017 was 6,193,777. The number of available shares under the
plan for issuance at December 31, 2017 was
100,265.
A
summary of the activity under the Company’s stock option
plans is as follows:
|
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term (Years)
|
Balance
at December 31, 2014
|
4,057,296
|
$1.06
|
6.8
|
Granted
|
2,110,000
|
$1.63
|
—
|
Expired/Cancelled
|
(750,622)
|
$1.86
|
—
|
Exercised
|
(39,705)
|
$0.87
|
—
|
|
|
|
|
Balance
at December 31, 2015
|
5,376,969
|
$1.17
|
6.9
|
Granted
|
1,264,000
|
$1.34
|
—
|
Expired/Cancelled
|
(121,500)
|
$1.29
|
—
|
Exercised
|
(12,626)
|
$0.21
|
—
|
Balance
at December 31, 2016
|
6,506,843
|
$1.21
|
6.6
|
Granted
|
112,500
|
$1.39
|
—
|
Expired/Cancelled
|
(156,827)
|
$1.67
|
—
|
Exercised
|
(369,004)
|
$0.70
|
—
|
Balance
at December 31, 2017
|
6,093,512
|
$1.23
|
5.8
|
At
December 31, 2017, a total of 6,093,512 options were outstanding of
which 5,051,016 were exercisable at a weighted average price of
$1.19 per share with a remaining weighted average contractual term
of approximately 5.3 years. The Company expects that, in
addition to the 5,051,016 options that were exercisable as of
December 31, 2017, another 1,042,496 will ultimately vest resulting
in a combined total of 6,093,512. Those 6,093,512 shares
have a weighted average exercise price of $1.23 and an aggregate
intrinsic value of approximately $2,595,000 as of December 31,
2017. Stock-based compensation expense related to equity options
was approximately $1,094,000, $1,162,000 and $744,000 for the years
ended December 31, 2017, 2016 and 2015, respectively.
The weighted-average
grant-date fair value per share of options granted to employees
during the years ended December 31, 2017, 2016 and 2015 was
$0.77, $0.82 and $1.18,
respectively. At December 31, 2017, the total remaining
unrecognized compensation cost related to unvested stock options
amounted to approximately $847,000, which will be
amortized over the weighted-average remaining requisite service
period of 1.3 years.
During
the year ended December 31, 2017, there were 369,004 options
exercised for cash resulting in the issuance of 369,004 shares of
the Company’s Common Stock and proceeds of approximately
$259,000. During the year ended December 31, 2016,
there were 12,626 options exercised for cash resulting in the
issuance of 12,626 shares of the Company’s Common Stock and
proceeds of approximately $3,000.
The intrinsic value of options exercised during
the years ended December 31, 2017 and 2016 was approximately
$177,000 and $11,000, respectively. The intrinsic value of options
exercisable at December 31, 2017 and 2016 was approximately
$2,388,000 and $1,679,000,
respectively. The intrinsic value of options that vested
during 2017 was approximately $207,000. The aggregate intrinsic
value for all options outstanding as of December 31, 2017 and 2016
was approximately $2,595,000 and $1,744,000,
respectively.
In September 2015, the Company issued an aggregate
of 144,000 options to purchase shares of the Company’s Common
Stock to certain members of the Company’s Board of Directors
in return for their service from January 1, 2016 through December
31, 2016. Such options vest at the rate of 12,000 options per month
on the last day of each month during the 2016 year. The options
have an exercise price of $1.73 per share and a term of 10 years.
Pursuant to this issuance, the Company recorded compensation
expense of approximately $178,000 the twelve months ended December
31, 2016 based on the grant-date fair value of the options
determined using the Black-Scholes option-valuation
model.
In
May 2016, the Company issued an aggregate of 16,000 options to
purchase shares of the Company’s Common Stock to a new member
of the Company’s Board of Directors in return for their
service from May 2016 through December 31, 2016. Such options vest
at the rate of 2,000 options per month on the last day of each
month during the 2016 year. The options have an exercise price of
$1.29 per share and a term of 10 years. Pursuant to this issuance,
the Company recorded compensation expense of approximately $12,000
for the twelve months ended December 31, 2016 based on the
grant-date fair value of the options determined using the
Black-Scholes option-valuation model.
In
September 2016, the Company issued an aggregate of 168,000 options
to purchase shares of the Company’s Common Stock to certain
members of the Company’s Board of Directors in return for
their service from January 1, 2017 through December 31, 2017. Such
options vested at the rate of 14,000 options per month on the last
day of each month during the 2017 year. The options have an
exercise price of $1.37 per share and a term of 10 years. The
Company began recognition of compensation based on the grant-date
fair value ratably over the 2017 requisite service period and
recorded approximately $140,000 in expense. Such expense is
recorded in the Company’s consolidated statement of
operations as a component of general and administrative
expense.
Restricted Stock Awards
There
were no restricted stock awards issued during the years ended
December 31, 2017 and 2016.
In
December 2014, the Company issued 94,116 shares of its Common Stock
to certain members of the Company’s Board of Directors as
compensation for services to be rendered through December
2015. Such shares vested monthly over the 12 months of
2015 with any unvested shares being forfeitable should the Board
members’ service be terminated during 2015. For the year
ended December 31, 2015, the Company recorded approximately
$216,000 as compensation expense related to this stock
issuance.
Stock-based Compensation
Stock-based
compensation related to equity options and restricted stock has
been classified as follows in the accompanying consolidated
statements of operations (in thousands):
|
|
|
|
|
|
Cost
of revenues
|
$19
|
$20
|
$15
|
General
and administrative
|
655
|
714
|
618
|
Sales
and marketing
|
220
|
224
|
171
|
Research
and development
|
200
|
204
|
156
|
|
|
|
|
Total
|
$1,094
|
$1,162
|
$960
|
Common Stock Reserved for Future Issuance
The
following table summarizes the Common Stock reserved for future
issuance as of December 31, 2017:
|
|
Convertible
preferred stock – Series A and Series B
|
27,020,812
|
Convertible
lines of credit
|
5,221,964
|
Stock options outstanding
|
6,093,512
|
Warrants
outstanding
|
230,000
|
Authorized for future grant under stock option
plans
|
100,265
|
14. EMPLOYEE BENEFIT PLAN
During 1995, the Company adopted a defined
contribution 401(k) retirement plan (the “Plan”). All U.S. based employees aged 21 years
and older are eligible to become participants after the completion
of 60 day's employment. The Plan provides for annual contributions
by the Company of 50% of employee contributions not to exceed 8% of
employee compensation. Effective April 1, 2009, the Plan
was amended to provide for Company contributions on a discretionary
basis. Participants may contribute up to 100% of the annual
contribution limitations determined by the Internal Revenue
Service.
Employees
are fully vested in their share of the Company’s
contributions after the completion of five years of
service. In 2015, the Company authorized contributions of
approximately $119,000 for the 2015 plan year of which $83,000 were
paid prior to December 31, 2015. In 2016, the Company authorized
contributions of approximately $150,000 for the 2016 plan year of
which $111,000 were paid prior to December 31, 2016. In 2017,
the Company authorized contributions of approximately $154,000 for
the 2017 plan year of which $115,000 were paid prior to December
31, 2017.
15. PENSION PLAN
One
of the Company’s dormant foreign subsidiaries maintains a
defined benefit pension plan that provides benefits based on length
of service and final average earnings. The following table sets
forth the benefit obligation, fair value of plan assets, and the
funded status of the Company’s plan; amounts recognized in
the Company’s consolidated financial statements; and the
assumptions used in determining the actuarial present value of the
benefit obligations as of December 31:
($ in thousands)
|
|
|
|
Change in benefit obligation:
|
|
|
|
Benefit
obligation at beginning of year
|
$3,540
|
$3,068
|
$3,488
|
Service
cost
|
—
|
—
|
—
|
Interest
cost
|
64
|
75
|
70
|
Actuarial
(gain) loss
|
(167)
|
542
|
(123)
|
Effect
of exchange rate changes
|
473
|
(114)
|
(356)
|
Effect
of curtailment
|
—
|
—
|
—
|
Benefits
paid
|
(80)
|
(31)
|
(11)
|
Benefit
obligation at end of year
|
3,830
|
3,540
|
3,068
|
|
|
|
|
Change
in plan assets:
|
|
|
|
Fair
value of plan assets at beginning of year
|
1,645
|
1,557
|
1,654
|
Actual
return of plan assets
|
7
|
142
|
40
|
Company
contributions
|
12
|
28
|
34
|
Benefits
paid
|
(80)
|
(31)
|
—
|
Effect
of exchange rate changes
|
222
|
(51)
|
(171)
|
Fair
value of plan assets at end of year
|
1,806
|
1,645
|
1,557
|
Funded
status
|
(2,024)
|
(1,895)
|
(1,511)
|
Unrecognized
actuarial loss (gain)
|
1,629
|
1,831
|
1,413
|
Unrecognized
prior service (benefit) cost
|
—
|
—
|
—
|
Additional
minimum liability
|
(1,629)
|
(1,831)
|
(1,413)
|
Unrecognized
transition (asset) liability
|
—
|
—
|
—
|
Net
amount recognized
|
$(2,024)
|
$(1,895)
|
$(1,511)
|
|
|
|
|
Plan
Assets
|
|
|
|
Pension
plan assets were comprised of the following asset categories at
December 31,
|
|
|
|
Equity
securities
|
5.7%
|
5.7%
|
5.0%
|
Debt
securities
|
86.7%
|
87.2%
|
89.3%
|
Other
|
7.6%
|
7.1%
|
5.7%
|
Total
|
100%
|
100%
|
100%
|
|
|
|
|
Components
of net periodic benefit cost are as follows:
|
|
|
|
Service
cost
|
$—
|
$—
|
$—
|
Interest
cost on projected benefit obligations
|
64
|
75
|
70
|
Expected
return on plan assets
|
(70)
|
(63)
|
(61)
|
Amortization
of prior service costs
|
—
|
—
|
—
|
Amortization
of actuarial loss
|
104
|
73
|
80
|
Net
periodic benefit costs
|
$98
|
$85
|
$89
|
|
|
|
|
The
weighted average assumptions used to determine net periodic benefit
cost for the years ended December 31, were
|
|
|
|
Discount
rate
|
1.9%
|
1.7%
|
2.4%
|
Expected
return on plan assets
|
3.2%
|
4.0%
|
4.0%
|
Rate
of pension increases
|
2.0%
|
2.0%
|
2.0%
|
Rate
of compensation increase
|
N/A
|
N/A
|
N/A
|
|
|
|
|
The
following discloses information about the Company’s defined
benefit pension plan that had an accumulated benefit obligation in
excess of plan assets as of December 31,
|
|
|
|
Projected
benefit obligation
|
$3,830
|
$3,540
|
$3,068
|
Accumulated
benefit obligation
|
$3,830
|
$3,540
|
$3,068
|
Fair
value of plan assets
|
$1,806
|
$1,645
|
$1,557
|
As
of December 31, 2017, the following benefit payments are expected
to be paid as follows (in thousands):
2018
|
$86
|
2019
|
$87
|
2020
|
$88
|
2021
|
$103
|
2022
|
$105
|
2023
— 2027
|
$676
|
The
Company made contributions to the plan of approximately $12,000
during year 2017, $28,000 during year 2016 and approximately
$34,000 during 2015.
The
investment objectives for the plan are the preservation of capital,
current income and long-term growth of capital. The Company’s
pension assets are classified within Level 1 of the fair value
hierarchy, as defined under ASC 820, because they are valued using
market prices. The pension assets are primarily comprised of the
cash surrender value of insurance contracts. All plan assets are
managed in a policyholder pool in Germany by outside investment
managers. The measurement date used to determine the benefit
information of the plan was January 1, 2018.
16. ACCUMULATED OTHER COMPREHENSIVE LOSS
Accumulated other comprehensive income is the
combination of the additional minimum liability related to the
Company’s defined benefit pension plan, recognized pursuant
to ASC 715-30, “Compensation - Retirement
Benefits - Defined Benefit Plans – Pension” and the accumulated gains or losses from
foreign currency translation adjustments. The Company translates
foreign currencies of its German, Canadian and Mexican subsidiaries
into U.S. dollars using the period end exchange rate. Revenue and
expenses were translated using the weighted-average exchange rates
for the reporting period. All items are shown net of
tax.
As
of December 31, 2017, 2016 and 2015, the components of accumulated
other comprehensive loss were as follows:
($ in thousands)
|
|
|
|
|
|
|
|
Additional
minimum pension liability
|
$(1,353)
|
$(1,338)
|
$(991)
|
Foreign
currency translation adjustment
|
(311)
|
(205)
|
(204)
|
Ending
balance
|
$(1,664)
|
$(1,543)
|
$(1,195)
|
17. QUARTERLY INFORMATION (UNAUDITED)
The
following table sets forth selected quarterly financial data for
2017, 2016 and 2015 (in thousands, except share and per share
data):
|
2017 (by quarter)
|
|
1
|
2
|
3
|
4
|
|
|
|
|
|
Revenues
|
$928
|
$1,060
|
$1,084
|
$1,221
|
Cost
of sales
|
262
|
250
|
231
|
248
|
Operating
expenses
|
3,290
|
3,240
|
3,136
|
3,363
|
Loss
from operations
|
(2,624)
|
(2,430)
|
(2,283)
|
(2,390)
|
Interest
expense (income), net
|
100
|
164
|
178
|
149
|
Other
expense (income), net
|
-
|
(50)
|
(75)
|
-
|
Income
tax expense (benefit)
|
3
|
3
|
4
|
(134)
|
Net
loss
|
$(2,727)
|
$(2,547)
|
$(2,390)
|
$(2,405)
|
|
|
|
|
|
Net
loss per share:
|
|
|
|
|
Net
loss
|
(0.03)
|
(0.03)
|
(0.03)
|
(0.03)
|
Preferred
dividends
|
(0.01)
|
-
|
-
|
-
|
Preferred
stock exchange
|
-
|
-
|
(0.01)
|
-
|
Basic
loss per share to common shareholders
|
(0.04)
|
(0.03)
|
(0.04)
|
(0.03)
|
Basic
weighted-average shares outstanding
|
91,864,174
|
92,539,230
|
93,197,689
|
93,642,074
|
|
|
|
1
|
2
|
3
|
4
|
|
|
|
|
|
Revenues
|
$1,043
|
$996
|
$848
|
$925
|
Cost
of Sales
|
279
|
275
|
232
|
284
|
Operating
expenses
|
3,028
|
2,995
|
2,955
|
3,226
|
Loss
from Operations
|
(2,264)
|
(2,274)
|
(2,339)
|
(2,585)
|
Interest
expense (income), net
|
11
|
36
|
89
|
109
|
Other
expense (income), net
|
(1)
|
(200)
|
-
|
-
|
Income
tax expense (benefit)
|
3
|
4
|
3
|
11
|
Net
loss
|
$(2,277)
|
$(2,114)
|
$(2,431)
|
$(2,705)
|
|
|
|
|
|
Net
loss per share:
|
|
|
|
|
Net
loss
|
$(0.03)
|
$(0.02)
|
$(0.03)
|
$(0.03)
|
Preferred
dividends
|
$(0.00)
|
$(0.01)
|
$(0.00)
|
$(0.00)
|
Basic
loss per share to common shareholders
|
$(0.03)
|
$(0.03)
|
$(0.03)
|
$(0.03)
|
Basic
weighted-average shares outstanding
|
94,073,367
|
94,298,567
|
94,550,721
|
94,779,243
|
|
|
|
1
|
2
|
3
|
4
|
|
|
|
|
|
Revenues
|
$991
|
$1,695
|
$1,181
|
$902
|
Cost
of Sales
|
286
|
798
|
321
|
539
|
Operating
expenses
|
2,641
|
2,660
|
2,813
|
2,921
|
Loss
from Operations
|
(1,936)
|
(1,763)
|
(1,953)
|
(2,558)
|
Interest
expense (income), net
|
437
|
(2)
|
1
|
11
|
Other
expense (income), net
|
(46)
|
—
|
(99)
|
—
|
Income
tax expense (benefit)
|
3
|
6
|
3
|
10
|
Net
loss
|
$(2,330)
|
$(1,767)
|
$(1,858)
|
$(2,579)
|
|
|
|
|
|
Net
loss per share:
|
|
|
|
|
Net
loss
|
$(0.03)
|
$(0.02)
|
$(0.02)
|
$(0.03)
|
Preferred
dividends
|
$(0.00)
|
$(0.00)
|
$(0.00)
|
$(0.00)
|
Basic
loss per share to common shareholders
|
$(0.03)
|
$(0.02)
|
$(0.02)
|
$(0.03)
|
Basic
weighted-average shares outstanding
|
93,515,640
|
93,674,349
|
93,876,339
|
94,070,895
|
18. SUBSEQUENT
EVENTS
On February 8,
2018, the Company filed with the Secretary of State of the State of
Delaware a Certificate of Amendment to its Certificate of
Incorporation, as amended, to increase the authorized number of
shares of its Common Stock to 175,000,000 from 150,000,000
shares.
On January 4, 2018,
the Company amended its 1999 Stock Option Plan to increase the
number of shares authorized for issuance thereunder from
approximately 6.2 million to 8.2 million
Subsequent to
December 31, 2017, the Company issued an aggregate of 1,289,000
options to purchase Common Stock at an exercise price of $1.75 per
share as follows: (i) 414,000 options issued to certain members of
the Board of Directors, (ii) 650,000 options issued to certain
members of senior management and (iii) 225,000 options issued to
certain employees. In addition, the Company issued
61,669 shares of Common Stock pursuant to the exercise of 61,669
options resulting in cash proceeds to the Company of approximately
$65,000.
IMAGEWARE SYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE
SHEETS
(In Thousands, except for share and per share data)
|
|
|
|
|
|
ASSETS
|
|
|
Current
Assets:
|
|
|
Cash
|
$2,213
|
$7,317
|
Accounts
receivable, net of allowance for doubtful accounts of $15 at June
30, 2018 and December 31, 2017.
|
672
|
458
|
Inventory,
net
|
19
|
79
|
Other
current assets
|
203
|
163
|
Total
Current Assets
|
3,107
|
8,017
|
|
|
|
Property
and equipment, net
|
31
|
43
|
Other
assets
|
35
|
35
|
Intangible
assets, net of accumulated amortization
|
87
|
93
|
Goodwill
|
3,416
|
3,416
|
Total Assets
|
$6,676
|
$11,604
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
|
|
|
|
|
|
Current
Liabilities:
|
|
|
Accounts
payable
|
$390
|
$457
|
Deferred
revenue
|
552
|
1,016
|
Accrued
expense
|
781
|
658
|
Accrued
interest payable to related parties
|
791
|
527
|
Convertible
lines of credit to related parties, net of discount
|
5,871
|
5,774
|
Total
Current Liabilities
|
8,385
|
8,432
|
|
|
|
Pension
obligation
|
2,039
|
2,024
|
Total
Liabilities
|
10,424
|
10,456
|
|
|
|
Shareholders’
Equity (Deficit):
|
|
|
Preferred
stock, authorized 4,000,000 shares:
|
|
|
Series
A Convertible Preferred Stock, $0.01 par value; designated 31,021
shares, 30,571 shares and 31,021 shares issued and outstanding at
June 30, 2018 and December 31, 2017, respectively; liquidation
preference $30,571 and $31,021 at June 30, 2018 and December 31,
2017, respectively.
|
—
|
—
|
Series
B Convertible Redeemable Preferred Stock, $0.01 par value;
designated 750,000 shares, 389,400 shares issued and 239,400 shares
outstanding at June 30, 2018 and December 31, 2017; liquidation
preference $620 at June 30, 2018 and at December 31,
2017.
|
2
|
2
|
Common
Stock, $0.01 par value, 175,000,000 shares authorized; 95,835,859
and 94,174,540 shares issued at June 30, 2018 and December 31,
2017, respectively, and 95,829,155 and 94,167,836 shares
outstanding at June 30, 2018 and December 31, 2017,
respectively.
|
957
|
941
|
Additional
paid-in capital
|
174,749
|
172,414
|
Treasury
stock, at cost 6,704 shares
|
(64)
|
(64)
|
Accumulated
other comprehensive loss
|
(1,649)
|
(1,664)
|
Accumulated
deficit
|
(177,743)
|
(170,481)
|
Total
Shareholders’ Equity (Deficit)
|
(3,748)
|
1,148
|
Total Liabilities and Shareholders’ Equity
(Deficit)
|
$6,676
|
$11,604
|
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, except share and per share amounts)
(Unaudited)
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|
|
|
|
|
Revenue:
|
|
|
|
|
Product
|
$1,182
|
$407
|
$1,279
|
$680
|
Maintenance
|
703
|
653
|
1,322
|
1,309
|
|
1,885
|
1,060
|
2,601
|
1,989
|
Cost of revenue:
|
|
|
|
|
Product
|
139
|
36
|
165
|
90
|
Maintenance
|
167
|
214
|
390
|
423
|
Gross
profit
|
1,579
|
810
|
2,046
|
1,476
|
|
|
|
|
|
Operating expense:
|
|
|
|
|
General
and administrative
|
987
|
965
|
2,190
|
1,934
|
Sales
and marketing
|
816
|
702
|
1,680
|
1,463
|
Research
and development
|
1,865
|
1,556
|
3,664
|
3,096
|
Depreciation
and amortization
|
11
|
17
|
24
|
38
|
|
3,679
|
3,240
|
7,558
|
6,531
|
Loss
from operations
|
(2,100)
|
(2,430)
|
(5,512)
|
(5,055)
|
|
|
|
|
|
Interest
expense, net
|
184
|
164
|
356
|
264
|
Other
income, net
|
—
|
(50)
|
—
|
(50)
|
Loss
before income taxes
|
(2,284)
|
(2,544)
|
(5,868)
|
(5,269)
|
Income
tax expense
|
—
|
3
|
1
|
7
|
Net
loss
|
(2,284)
|
(2,547)
|
(5,869)
|
(5,276)
|
Preferred
dividends
|
(720)
|
(514)
|
(1,489)
|
(1,021)
|
Net
loss available to common shareholders
|
$(3,004)
|
$(3,061)
|
$(7,358)
|
$(6,297)
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per common share - see Note 3:
|
|
|
|
|
Net
loss
|
$(0.02)
|
$(0.03)
|
$(0.06)
|
$(0.06)
|
Preferred
dividends
|
(0.01)
|
(0.00)
|
(0.02)
|
(0.01)
|
Basic
and diluted loss per share available to common
shareholders
|
$(0.03)
|
$(0.03)
|
$(0.08)
|
$(0.07)
|
Basic
and diluted weighted-average shares outstanding
|
95,161,570
|
92,539,230
|
94,749,904
|
92,203,567
|
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In Thousands)
(Unaudited)
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|
|
|
|
|
Net
loss
|
$(2,284)
|
$(2,547)
|
$(5,869)
|
$(5,276)
|
Other
comprehensive income (loss):
|
|
|
|
|
Foreign
currency translation adjustment
|
43
|
(61)
|
15
|
(78)
|
Comprehensive
loss
|
$(2,241)
|
$(2,608)
|
$(5,854)
|
$(5,354)
|
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
IMAGEWARE SYSTEMS,
INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
(Unaudited)
|
Six Months Ended
June 30,
|
|
|
|
Cash flows from operating activities
|
|
|
Net
loss
|
$(5,869)
|
$(5,276)
|
Adjustments
to reconcile net loss to net cash used by operating
activities:
|
|
|
Depreciation
and amortization
|
24
|
38
|
Amortization
of debt issuance costs and beneficial conversion
feature
|
122
|
97
|
Provision
for losses on accounts receivable
|
—
|
15
|
Stock-based
compensation
|
708
|
550
|
Warrants
issued in lieu of cash as compensation for services
|
9
|
—
|
Gain
from sale of trademark
|
—
|
(50)
|
Change
in assets and liabilities
|
|
|
Accounts receivable
|
(118)
|
(60)
|
Inventory
|
60
|
(30)
|
Other assets
|
(44)
|
(21)
|
Accounts payable
|
(67)
|
(82)
|
Deferred revenue
|
(464)
|
(438)
|
Accrued expense
|
389
|
192
|
Pension obligation
|
14
|
60
|
Total
adjustments
|
633
|
271
|
Net
cash used in operating activities
|
(5,236)
|
(5,005)
|
|
|
|
Cash flows from investing activities
|
|
|
Purchase
of property and equipment
|
(7)
|
(1)
|
Proceeds
received from sale of trademark
|
—
|
50
|
Net
cash provided by (used in) investing activities
|
(7)
|
49
|
|
|
|
Cash flows from financing activities
|
|
|
Proceeds
from exercised stock options
|
149
|
227
|
Proceeds
from lines of credit, net
|
—
|
3,350
|
Dividends
paid
|
(25)
|
(25)
|
Net
cash provided by financing activities
|
124
|
3,552
|
|
|
|
Effect
of exchange rate changes on cash
|
15
|
(78)
|
|
|
|
Net
decrease in cash
|
(5,104)
|
(1,482)
|
|
|
|
Cash
at beginning of period
|
7,317
|
1,586
|
|
|
|
Cash
at end of period
|
$2,213
|
$104
|
|
|
|
Supplemental
disclosure of cash flow information:
|
|
|
Cash
paid for interest
|
$—
|
$—
|
Cash
paid for income taxes
|
$—
|
$—
|
Summary
of non-cash investing and financing activities:
|
|
|
Beneficial
conversion feature on
convertible related party lines of credit
|
$21
|
$281
|
Stock
dividend on Convertible Redeemable Preferred Stock
|
$1,464
|
$996
|
Conversion
of Convertible Preferred Stock into Common Stock
|
$4
|
$—
|
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1. ORGANIZATION AND DESCRIPTION OF
BUSINESS
Overview
As
used in this Quarterly Report, “we,” “us,”
“our,” “ImageWare,” “ImageWare
Systems,” “Company” or “our Company”
refers to ImageWare Systems, Inc. and all of its subsidiaries.
ImageWare Systems, Inc. is incorporated in the state of Delaware.
The Company is a pioneer and leader in the emerging market for
biometrically enabled software-based identity management solutions.
Using those human characteristics that are unique to us all, the
Company creates software that provides a highly reliable indication
of a person’s identity. The Company’s
“flagship” product is the patented IWS Biometric
Engine®. The Company’s products are used to manage and
issue secure credentials, including national IDs, passports, driver
licenses and access control credentials. The Company’s
products also provide law enforcement with integrated mug shot,
fingerprint LiveScan and investigative capabilities. The Company
also provides comprehensive authentication security software using
biometrics to secure physical and logical access to facilities or
computer networks or internet sites. Biometric technology is now an
integral part of all markets the Company addresses, and all the
products are integrated into the IWS Biometric
Engine.
Liquidity, Going Concern and Management’s Plan
Historically, our principal sources of cash have
included customer payments from the sale of our products, proceeds
from the issuance of common and preferred stock and proceeds from
the issuance of debt, including our Lines of Credit (defined
below). Our principal uses of cash have included cash used in
operations, product development, and payments relating to purchases
of property and equipment. We expect that our principal uses of
cash in the future will be for product development, including
customization of identity management products for enterprise and
consumer applications, further development of intellectual
property, development of Software-as-a-Service
(“SaaS”) capabilities for existing products as
well as general working capital and capital expenditure
requirements. Management expects that, as our revenue grows, our
sales and marketing and research and development expense will
continue to grow, albeit at a slower rate and, as a result, we will
need to generate significant net revenue to achieve and sustain
income from operations.
Going Concern
At
June 30, 2018, we had a working capital deficit of approximately
$5,278,000. Our principal sources of liquidity at June 30, 2018
consisted of approximately $2,213,000 of cash and $672,000 of trade
accounts receivable.
Considering
our projected cash requirements, and assuming we are unable to
generate incremental revenue, our available cash will be
insufficient to satisfy our cash requirements for the next twelve
months from the date of this filing. These factors raise
substantial doubt about our ability to continue as a going concern.
To address our working capital requirements, management intends to
seek additional equity and/or debt financing through the issuance
of additional debt and/or equity securities, or may seek strategic
or other transactions intended to increase shareholder value. There
are currently no formal committed financing arrangements to support
our projected cash shortfall, including commitments to purchase
additional debt and/or equity securities, or other agreements, and
no assurances can be given that we will be successful in raising
additional debt and/or equity securities, or entering into any
other transaction that addresses our ability to continue as a going
concern.
In
view of the matters described in the preceding paragraph,
recoverability of a major portion of the recorded asset amounts
shown in the accompanying consolidated balance sheet is dependent
upon continued operations of the Company, which, in turn, is
dependent upon the Company’s ability to continue to raise
capital and generate positive cash flows from operations. However,
the Company operates in markets that are emerging and highly
competitive. There is no assurance that the Company will be able to
obtain additional capital, operate at a profit or generate positive
cash flows in the future.
These
condensed consolidated financial statements do not include any
adjustments relating to the recoverability and classification of
recorded asset amounts and classifications of liabilities that
might be necessary should the Company be unable to continue as a
going concern.
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF
PRESENTATION
Basis of Presentation
The accompanying
condensed consolidated balance sheet as of December 31, 2017, which
has been derived from audited financial statements, and the
unaudited interim condensed consolidated financial statements have
been prepared by the Company in accordance with accounting
principles generally accepted in the United States of America
(“GAAP”)
and the rules and regulations of the Securities and Exchange
Commission (“SEC”)
related to a quarterly report on Form 10-Q. Certain information and
note disclosures normally included in annual financial statements
prepared in accordance with GAAP have been condensed or omitted
pursuant to those rules and regulations, although the Company
believes that the disclosures made are adequate to make the
information not misleading. The interim financial statements
reflect all adjustments, which, in the opinion of management, are
necessary for a fair statement of the results for the periods
presented. All such adjustments are of a normal and recurring
nature. These unaudited condensed consolidated financial statements
should be read in conjunction with the Company’s audited
financial statements for the year ended December 31, 2017, which
are included in the Company’s Annual Report on Form 10-K for
the year ended December 31, 2017 that was filed with the SEC on
March 19, 2018.
Operating
results for the three and six months ended June 30, 2018 are not
necessarily indicative of the results that may be expected for the
year ended December 31, 2018, or any other future
periods.
Certain prior period amounts have been
reclassified to conform with current period presentation.
These reclassifications have no impact on net
loss.
Significant Accounting
Policies
Principles of Consolidation
The
consolidated financial statements include the accounts of the
Company and its wholly owned subsidiaries. The Company’s
wholly-owned subsidiaries are: XImage Corporation, a California
Corporation; ImageWare Systems ID Group, Inc., a Delaware
corporation (formerly Imaging Technology Corporation); I.W. Systems
Canada Company, a Nova Scotia unlimited liability company;
ImageWare Digital Photography Systems, LLC, a Nevada limited
liability company (formerly Castleworks LLC); Digital Imaging
International GmbH, a company formed under German laws; and Image
Ware Mexico S de RL de CV, a company formed under Mexican laws. All
significant intercompany transactions and balances have been
eliminated.
Use of Estimates
The
preparation of the consolidated financial statements in conformity
with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
consolidated financial statements, and the reported amounts of
revenue and expense during the reporting period. Significant
estimates include the evaluation of our ability to continue as a
going concern, the allowance for doubtful accounts receivable,
deferred tax asset valuation allowances, recoverability of
goodwill, assumptions used in the Black-Scholes model to calculate
the fair value of share based payments, fair value of Exchanged
Preferred (defined below), assumptions used in the application of
revenue recognition policies and assumptions used in the
application of fair value methodologies to calculate the fair value
of pension assets and obligations. Actual results could differ from
estimates.
Accounts Receivable
In
the normal course of business, the Company extends credit without
collateral requirements to its customers that satisfy pre-defined
credit criteria. Accounts receivable are recorded net of an
allowance for doubtful accounts. Accounts receivable are considered
delinquent when the due date on the invoice has passed. The Company
records its allowance for doubtful accounts based upon its
assessment of various factors. The Company considers historical
experience, the age of the accounts receivable balances, the credit
quality of its customers, current economic conditions and other
factors that may affect customers’ ability to pay to
determine the level of allowance required. Accounts receivable
are written off against the allowance for doubtful accounts when
all collection efforts by the Company have been
unsuccessful.
Inventories
Finished goods inventories are stated at the lower
of cost, determined using the average cost method, or net
realizable value. See Note 4, “Inventory,” below.
Fair Value of Financial Instruments
For
certain of the Company’s financial instruments, including
accounts receivable, accounts payable, accrued expense, deferred
revenue and lines of credit payable to related parties, the
carrying amounts approximate fair value due to their relatively
short maturities.
Revenue Recognition
Effective January 1, 2018, we adopted Accounting
Standards Codification (“ASC”), Topic 606, Revenue from Contracts with
Customers (“ASC 606”), using the modified retrospective
transition method.
In
accordance with ASC 606, revenue is recognized when control of the
promised goods or services is transferred to our customers, in an
amount that reflects the consideration we expect to be entitled to
in exchange for those goods or services.
The
core principle of the standard is that we should recognize revenue
to depict the transfer of promised goods or services to customers
in an amount that reflects the consideration to which we expect to
be entitled in exchange for those goods or services. To achieve
that core principle, we apply the following five step
model:
1.
Identify
the contract with the customer;
2.
Identify
the performance obligation in the contract;
3.
Determine
the transaction price;
4.
Allocate
the transaction price to the performance obligations in the
contract; and
5.
Recognize
revenue when (or as) each performance obligation is
satisfied.
At
contract inception, we assess the goods and services promised in a
contract with a customer and identify as a performance obligation
each promise to transfer to the customer either: (i) a good or
service (or a bundle of goods or services) that is distinct or (ii)
a series of distinct goods or services that are substantially the
same and that have the same pattern of transfer to the customer. We
recognize revenue only when we satisfy a performance obligation by
transferring a promised good or service to a customer.
Determining
the timing of the satisfaction of performance obligations as well
as the transaction price and the amounts allocated to performance
obligations requires judgement.
We
disclose disaggregation of our customer revenue by classes of
similar products and services as follows:
●
Software licensing and
royalties;
●
Sales of computer hardware and identification
media;
●
Post-contract customer
support.
Software licensing and royalties
Software licenses
consist of revenue from the sale of software for identity
management applications. Our software licenses are functional
intellectual property and typically provide customers with the
right to use our software in perpetuity as it exists when made
available to the customer. We recognize revenue from software
licensing at a point in time upon delivery, provided all other
revenue recognition criteria are met.
Royalties
consist of revenue from usage-based arrangements and guaranteed
minimum-based arrangements. We recognize revenue for royalty
arrangements at the later of (i) when the related sales occur, or
(ii) when the performance obligation to which some or all of the
royalty has been allocated has been satisfied.
Computer hardware and identification media
We
generate revenue from the sale of computer hardware and
identification media. Revenue for these items is recognized upon
delivery of these products to the customer, provided all other
revenue recognition criteria are met.
Services
Services
revenue is comprised primarily of software customization services,
software integration services, system installation services and
customer training. Revenue is generally recognized upon completion
of services and customer acceptance provided all other revenue
recognition criteria are met.
Post-contract customer support (“PCS”)
Post contract customer support consists of
maintenance on software and hardware for our identity management
solutions. We recognize PCS revenue from periodic maintenance
agreements. Revenue is generally recognized ratably over the
respective maintenance periods provided no significant obligations
remain. Costs related to such contracts are expensed as
incurred.
Arrangements with multiple performance obligations
A
performance obligation is a promise in a contract to transfer a
distinct good or service to the customer. In addition to selling
software licenses, hardware and identification media, services and
post-contract customer support on a standalone basis, certain
contracts include multiple performance obligations. For such
arrangements, we allocate revenue to each performance obligation
based on our best estimate of the relative standalone selling
price. The standalone selling price for a performance obligation is
the price at which we would sell a promised good or service
separately to a customer. The primary methods used to estimate
standalone selling price are as follows: (i) the expected cost-plus
margin approach, under which we forecast our expected costs of
satisfying a performance obligation and then add an appropriate
margin for that distinct good or service and (ii) the percent
discount off of list price approach.
Contract costs
We recognize an
asset for the incremental costs of obtaining a contract with a
customer if we expect the benefit of those costs to be longer than
one year. We apply a practical expedient to expense costs as
incurred for costs to obtain a contract when the amortization
period is one year or less.
Other items
We
do not offer rights of return for our products and services in the
normal course of business.
Sales
tax collected from customers is excluded from revenue.
The adoption of ASC
606 as of January 1, 2018 resulted in a cumulative positive
adjustment to beginning accumulated deficit and accounts receivable
of approximately $95,000. For the three and six months ended June
30, 2018, the adoption of ASC 606 resulted in a reduction in
royalty revenue of approximately $28,000 and $56,000, respectively.
The following table sets forth our disaggregated revenue for the
three months and six months ended June 30, 2018 and
2017:
|
Three
Months Ended
June
30,
|
Six
Months Ended
June
30,
|
Net
Revenue
|
|
|
|
|
(dollars
in thousands)
|
|
|
|
|
|
|
|
|
|
Software and
royalties
|
$871
|
$319
|
$955
|
$508
|
Hardware and
consumables
|
122
|
39
|
122
|
86
|
Services
|
189
|
49
|
202
|
86
|
Maintenance
|
703
|
653
|
1,322
|
1,309
|
Total
revenue
|
$1,885
|
$1,060
|
$2,601
|
$1,989
|
Customer Concentration
For the three
months ended June 30, 2018, two customers accounted for
approximately 60% or $1,133,000 of our total revenue and had trade
receivables at June 30, 2018 of $213,000. For the six
months ended June 30, 2018, one customer accounted for
approximately 43% or $1,121,000 of our total revenue and had trade
receivables at June 30, 2018 of $0.
For the three
months ended June 30, 2017, one customer accounted for
approximately 17% or $184,000 of our total revenue and had trade
receivables at June 30, 2017 of $0. For the six months
ended June 30, 2017, one customer accounted for approximately 19%
or $368,000 of our total revenue and had trade receivables at June
30, 2017 of $0.
Recently Issued Accounting Standards
From time to time, new accounting pronouncements
are issued by the Financial Accounting Standards Board
(“FASB”), or other standard setting bodies, which
are adopted by us as of the specified effective date. Unless
otherwise discussed, the Company’s management believes the
impact of recently issued standards not yet effective will not have
a material impact on the Company’s consolidated financial
statements upon adoption.
FASB ASU No.
2016-02. In February 2016, the
FASB issued ASU No. 2016-02, “Leases.” This
guidance will result in key changes to lease accounting and will
aim to bring leases onto balance sheets to give investors, lenders,
and other financial statement users a more comprehensive view of a
company’s long-term financial obligations as well as the
assets it owns versus leases. The new leasing standard will be
effective for fiscal years beginning after December 15, 2018, and
for interim periods within those fiscal years. The Company is
currently evaluating the impact this guidance will have on our
consolidated financial statements and anticipates commencement of
adoption planning in the third fiscal quarter of
2018.
FASB ASU No.
2016-13. In June 2016, the FASB
issued Accounting Standard Update No. 2016-13, Financial
Instruments—Credit Losses (Topic 326): Measurement of Credit
Losses on Financial Instruments. ASU No. 2016-13 changes the impairment model
for most financial assets and certain other instruments. For trade
and other receivables, held-to-maturity debt securities, loans and
other instruments, entities will be required to use a new
forward-looking “expected loss” model that will replace
today’s “incurred loss” model and generally will
result in the earlier recognition of allowances for losses. For
available-for-sale debt securities with unrealized losses, entities
will measure credit losses in a manner similar to current practice,
except that the losses will be recognized as an allowance. This
guidance is effective for fiscal years beginning after December 15,
2019 including interim periods within those fiscal years. The
Company is currently evaluating the potential impact of adoption of
this standard on its consolidated financial
statements.
FASB ASU No.
2017-04. In January 2017,
the FASB issued ASU No. 2017-04, Intangibles – Goodwill
and Other (Topic 350): Simplifying the Test for Goodwill
Impairment. The amendments of this
ASU eliminate step 2 from the goodwill impairment test. The annual,
or interim test is performed by comparing the fair value of a
reporting unit with its carrying amount. The amendments of this ASU
also eliminate the requirements for any reporting unit with a zero
or negative carrying amount to perform a qualitative assessment and
if it fails that qualitative test, to perform step 2 of the
goodwill impairment test. ASU No. 2017-04 is effective for fiscal
years beginning after December 15, 2019. The Company is currently evaluating the
potential impact of adoption of this standard on its consolidated
financial statements.
FASB ASU No.
2017-07. Effective January
1, 2018, we adopted ASU No. 2017-07, Compensation –
Retirement Benefits (Topic 715): Improving the Presentation of
Periodic Pension Cost and Net Periodic Postretirement Benefit
Cost issued by the FASB, which
requires employers to present the service cost component of net
periodic benefit cost in the same income statement line item(s) as
other employee compensation costs arising from services rendered
during the period. The adoption of this standard did not have a
material effect on our consolidated financial
statements.
FASB ASU No. 2017-11.
In July 2017, the FASB issued ASU No
2017-11, “Earnings Per Share (Topic
260); Distinguishing Liabilities from Equity (Topic 480);
Derivatives and Hedging (Topic 815): (Part I) Accounting for
Certain Financial Instruments with Down Round Features, (Part II)
Replacement of the Indefinite Deferral.” The
ASU applies to issuers of financial instruments with down-round
features. It amends (1) the classification of such instruments as
liabilities or equity by revising the guidance in ASC 815 on the
evaluation of whether instruments or embedded features with
down-round provisions must be accounted for as derivative
instruments and (2) the guidance on recognition and measurement of
the value transferred upon the trigger of a down-round feature for
equity-classified instruments by revising ASC 260. The ASU is
effective for public business entities for fiscal years, and
interim periods within those fiscal years, beginning after December
15, 2018. For all other organizations, the amendments are effective
for fiscal years beginning after December 15, 2019, and interim
periods within fiscal years beginning after December 15, 2020.
Early adoption is permitted. The Company is
currently evaluating the potential impact of this updated guidance
on its consolidated financial statements.
FASB ASU No. 2018-07.
In June 2018, the FASB issued
ASU 2018-07, “Shared-Based Payment Arrangements with
Nonemployees” (Topic
505), which simplifies the accounting for share-based
payments granted to nonemployees for goods and services. Under the
ASU, most of the guidance on such payments to nonemployees will be
aligned with the requirements for share-based payments granted to
employees. Under the ASU 2018-07, the measurement of
equity-classified nonemployee share-based payments will be fixed on
the grant date, as defined in ASC 718, and will use the term
nonemployee vesting period, rather than requisite service period.
The amendments in this update are effective for fiscal years
beginning after December 15, 2018, including interim periods within
those fiscal years. Early adoption is permitted if financial
statements have not yet been issued. The Company is currently
evaluating the impact of the adoption
of ASU 2018-07 on the Company’s financial
statements.
NOTE 3. NET LOSS PER COMMON SHARE
Basic
loss per common share is calculated by dividing net loss available
to common shareholders for the period by the weighted-average
number of common shares outstanding during the period. Diluted loss
per common share is calculated by dividing net loss available to
common shareholders for the period by the weighted-average number
of common shares outstanding during the period, adjusted to
include, if dilutive, potential dilutive shares consisting of
convertible preferred stock, convertible related party lines of
credit, stock options and warrants, calculated using the treasury
stock and if-converted methods. For diluted loss per share
calculation purposes, the net loss available to common shareholders
is adjusted to add back any preferred stock dividends and any
interest on convertible debt reflected in the condensed
consolidated statement of operations for the respective
periods.
The
table below presents the computation of basic and diluted loss per
share:
(Amounts in thousands except share and per share
amounts)
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|
|
|
|
|
Numerator
for basic and diluted loss per share:
|
|
|
|
|
Net
loss
|
$(2,284)
|
$(2,547)
|
$(5,869)
|
$(5,276)
|
Preferred
dividends
|
(720)
|
(514)
|
(1,489)
|
(1,021)
|
|
|
|
|
|
Net
loss available to common shareholders
|
$(3,004)
|
$(3,061)
|
$(7,358)
|
$(6,297)
|
|
|
|
|
|
Denominator
for basic and dilutive loss per share – weighted-average
shares outstanding
|
95,161,570
|
92,539,230
|
94,749,904
|
92,203,567
|
|
|
|
|
|
Net
loss
|
$(0.02)
|
$(0.03)
|
$(0.06)
|
$(0.06)
|
Preferred
dividends
|
(0.01)
|
(0.00)
|
(0.02)
|
(0.01)
|
|
|
|
|
|
Basic
and diluted loss per share available to common
shareholders
|
$(0.03)
|
$(0.03)
|
$(0.08)
|
$(0.07)
|
The following potential dilutive securities have
been excluded from the computations of diluted weighted-average
shares outstanding, as their effect would have been
antidilutive:
Potential
Dilutive securities
|
Three and
Six Months Ended
June
30,
|
|
|
|
|
|
|
Related party lines
of credit
|
5,432,579
|
5,016,236
|
Convertible
redeemable preferred stock
|
26,629,507
|
11,709,151
|
Stock
options
|
7,341,093
|
6,171,555
|
Warrants
|
270,000
|
175,000
|
Total potential
dilutive securities
|
39,673,179
|
23,071,942
|
NOTE 4. SELECT BALANCE SHEET DETAILS
Inventory
Inventories of $19,000 as of June 30, 2018 were comprised of work
in process of $1,000 representing direct labor costs on in-process
projects and finished goods of $18,000 net of reserves for obsolete
and slow-moving items of $3,000.
Inventories of $53,000 as of June 30, 2017 were comprised of work
in process of $47,000 representing direct labor costs on in-process
projects and finished goods of $6,000 net of reserves for obsolete
and slow-moving items of $3,000.
Intangible Assets
The
carrying amounts of the Company’s patent intangible assets
were $87,000 and $93,000 as of June 30, 2018 and December 31, 2017,
respectively, which includes accumulated amortization of $572,000
and $566,000 as of June 30, 2018 and December 31, 2017,
respectively. Amortization expense for patent intangible
assets was $2,000 and $7,000 for the three and six months ended
June 30, 2018 and 2017, respectively. Patent intangible assets are
being amortized on a straight-line basis over their remaining life
of approximately 7.7 years.
The
estimated acquired intangible amortization expense for the next
five fiscal years is as follows:
Fiscal Year Ended December 31,
|
Estimated
Amortization
Expense
($ in
thousands)
|
2018
(six months)
|
$6
|
2019
|
12
|
2020
|
12
|
2021
|
12
|
2022
|
12
|
Thereafter
|
33
|
Totals
|
$87
|
Goodwill
The
Company annually, or more frequently if events or circumstances
indicate a need, tests the carrying amount of goodwill for
impairment. A two-step impairment test is used to first
identify potential goodwill impairment and then measure the amount
of goodwill impairment loss, if any. The first step was conducted
by determining and comparing the fair value, employing the market
approach, of the Company’s reporting unit to the carrying
value of the reporting unit. The Company continues to have only one
reporting unit, Identity Management. Based on the results of this
impairment test, the Company determined that its goodwill was not
impaired as of June 30, 2018 and December 31, 2017.
NOTE 5. LINES OF CREDIT WITH RELATED
PARTIES
Outstanding
lines of credit consist of the following:
($ in thousands)
|
|
|
Lines
of Credit with Related Parties
|
|
|
8%
convertible lines of credit. Face value of advances under lines of
credit $6,000 at June 30, 2018 and December 31, 2017. Discount on
advances under lines of credit is $129 at June 30, 2018
and $226 at December 31, 2017. Maturity date is December 31,
2018.
|
$5,871
|
$5,774
|
|
|
|
Total
lines of credit to related parties
|
5,871
|
5,774
|
Less
current portion
|
(5,871)
|
(5,774)
|
Long-term
lines of credit to related parties
|
$—
|
$—
|
Lines of Credit
In March 2013, the Company and Neal Goldman, a
member of the Company’s Board of Directors
(“Goldman”), entered into a line of credit (the
“Goldman Line of
Credit”) with available
borrowings of up to $2.5 million. In March 2014, the Goldman Line
of Credit’s borrowing was increased to an aggregate total of
$3.5 million (the “Amendment”). Pursuant to the terms and conditions of
the Amendment, Goldman had the right to convert up to $2.5 million
of the outstanding balance of the Goldman Line of Credit into
shares of the Company’s Common Stock for $0.95 per share. Any
remaining outstanding balance was convertible into shares of
the Company’s Common Stock for $2.25 per
share.
As consideration for the initial Goldman Line of
Credit, the Company issued a warrant to Goldman, exercisable for
1,052,632 shares of the Company’s Common Stock (the
“Line
of Credit Warrant”). The
Line of Credit Warrant had a term of two years from the date of
issuance and an exercise price of $0.95 per share. As
consideration for entering into the Amendment, the Company issued
to Goldman a second warrant, exercisable for 177,778 shares of the
Company’s Common Stock (the “Amendment
Warrant”). The Amendment
Warrant expired on March 27, 2015 and had an exercise price of
$2.25 per share.
The
Company estimated the fair value of the Line of Credit Warrant
using the Black-Scholes option pricing model using the following
assumptions: term of two years, a risk-free interest rate of 2.58%,
a dividend yield of 0%, and volatility of 79%. The Company recorded
the fair value of the Line of Credit Warrant as a deferred
financing fee of approximately $580,000 to be amortized over the
life of the Goldman Line of Credit. The Company estimated the fair
value of the Amendment Warrant using the Black-Scholes option
pricing model using the following assumptions: term of one year, a
risk-free interest rate of 2.58%, a dividend yield of 0% and
volatility of 74%. The Company recorded the fair value of the
Amendment Warrant as an additional deferred financing fee of
approximately $127,000 to be amortized over the life of the Goldman
Line of Credit.
During
the three and six months ended June 30, 2018, the Company recorded
an aggregate of approximately $2,000 and $4,000 in deferred
financing fee amortization expense, respectively. During the three
and six months ended June 30, 2017, the Company recorded an
aggregate of approximately $3,000 and $8,000 in deferred financing
fee amortization expense, respectively. Such expense is recorded as
a component of interest expense in the Company’s condensed
consolidated statements of operations.
In April 2014, the Company and Goldman entered
into a further amendment to the Goldman Line of Credit to decrease
the available borrowings to $3.0 million (the
“Second
Amendment”). Contemporaneous with the execution
of the Second Amendment, the Company entered into a new unsecured
line of credit with Charles Crocker, a member of the
Company’s Board of Directors (“Crocker”), with available borrowings of up to
$500,000 (the “Crocker LOC”), which amount was convertible into
shares of the Company’s Common Stock for $2.25 per share. As
a result of these amendments, total available borrowings under the
lines of credit available to the Company remained unchanged an
aggregate of $3.5 million. In connection with the Second Amendment,
Goldman assigned and transferred to Crocker one-half of the
Amendment Warrant.
In December 2014, the Company and Goldman entered
into a further amendment to the Goldman Line of Credit to increase
the available borrowing to $5.0 million and extend the maturity
date of the Goldman Line of Credit to March 27, 2017 (the
“Third
Amendment”). Also, as a
result of the Third Amendment, Goldman had the right to convert up
to $2.5 million of outstanding principal, plus any accrued but
unpaid interest (“Outstanding
Balance”) into shares of
the Company’s Common Stock for $0.95 per share, the next
$500,000 Outstanding Balance into shares of Common Stock for $2.25
per share, and any remaining outstanding balance thereafter into
shares of Common Stock for $2.30 per share. The Third Amendment
also modified the definition of a “Qualified Financing”
to mean a debt or equity financing resulting in gross proceeds to
the Company of at least $5.0 million.
In
February 2015, as a result of the Series E Financing, the Company
issued 1,978 shares of Series E Preferred to Goldman to satisfy
$1,950,000 in principal borrowings under the Goldman Line of
Credit, plus approximately $28,000 in accrued interest. As a result
of the Series E Financing, the Company’s borrowing capacity
under the Goldman Line of Credit was reduced to $3,050,000 with the
maturity date unchanged and the Crocker LOC was terminated in
accordance with its terms.
In March 2016, the Company and Goldman entered
into a fourth amendment to the Goldman Line of Credit (the
“Fourth
Amendment”) solely to (i)
increase available borrowings to $5.0 million; (ii) extend the
maturity date to June 30, 2017, and (iii) provide for the
conversion of the outstanding balance due under the terms of the
Goldman Line of Credit into that number of fully paid and
non-assessable shares of the Company’s Common Stock as is
equal to the quotient obtained by dividing the outstanding balance
by $1.25.
Contemporaneous with the execution of the Fourth
Amendment, the Company entered into a new $500,000 line of credit
with Crocker (the “New Crocker
LOC”) with available
borrowings of up to $500,000, which replaced the original Crocker
LOC that terminated as a result of the consummation of the Series E
Financing. Similar to the Fourth Amendment, the New Crocker
LOC originally matured on June 30, 2017, and provided for the
conversion of the outstanding balance due under the terms of the
New Crocker LOC into that number of fully paid and non-assessable
shares of the Company’s Common Stock as is equal to the
quotient obtained by dividing the outstanding balance by
$1.25.
On December 27, 2016, in connection with the
consummation of the Series G Financing, the Company and Goldman
agreed to enter into the Fifth
Amendment (the “Line
of Credit Amendment”) to the Goldman
Line of Credit to provide the Company with the ability to borrow up
to $5.5 million under the terms of the Goldman Line of Credit. In
addition, the Maturity Date, as defined in the Goldman Line of
Credit, was amended to be December 31, 2017. The Line of Credit
Amendment was executed on January 23, 2017.
In addition, on January 23, 2017, the Company and Crocker amended
the New Crocker LOC to extend the maturity date thereof to December
31, 2017.
On May 10, 2017,
Goldman and Crocker agreed to further extend the maturity dates of
the Goldman Line of Credit and the New Crocker Line of Credit
(collectively, the “Lines
of Credit”) to December
31, 2018.
As the aforementioned amendments to the Lines of Credit resulted in
an increase to the borrowing capacity of the Lines of Credit, the
Company adjusted the amortization period of any remaining
unamortized deferred costs and note discounts to the term of the
new arrangement.
The
Company evaluated the Lines of Credit and determined that the
instruments contain a contingent beneficial conversion feature,
i.e. an embedded conversion right that enables the holder to obtain
the underlying Common Stock at a price below market value. The
beneficial conversion feature is contingent, as the terms of the
conversion do not permit the Company to compute the number of
shares that the holder would receive if the contingent event occurs
(i.e. future borrowings under the Line of Credit). The Company has
considered the accounting for this contingent beneficial conversion
feature using the guidance in ASC 470, Debt. The guidance in ASC
470 states that a contingent beneficial conversion feature in an
instrument shall not be recognized in earnings until the
contingency is resolved. The beneficial conversion features of
future borrowings under the Line of Credit will be measured
using the intrinsic value calculated at the date the contingency is
resolved using the conversion price and trading value of the
Company’s Common Stock at the date the Lines of Credit were
issued (commitment date).
The Company incurred no additional borrowings
under the Lines of Credit during the six months ended June 30,
2018. During the three and six months ended June 30, 2018, the
Company incurred approximately $130,000 and $263,000, respectively,
in accrued unpaid interest under the terms of the Lines of Credit.
As a result of this interest accrual, during the three and six
months ended June 30, 2018, the Company recorded an additional
$10,000 and $21,000, respectively, in debt discount attributable to
beneficial conversion feature. During the three and six months
ended June 30, 2018, the Company accreted approximately
$59,000 and $119,000, respectively, of debt discount. During the
three and six months ended June 30, 2017, the Company recorded
approximately $156,000 and $281,000, respectively in debt discount
attributable to beneficial conversion feature and accreted
approximately $55,000 and $90,000, respectively, of debt
discount. Such expense is
recorded as a component of interest expense in the Company’s
condensed consolidated statements of
operations.
NOTE 6. EQUITY
The
Company’s Certificate of Incorporation, as amended,
authorizes the issuance of two classes of stock to be designated
“Common Stock” and “Preferred Stock.” The
Preferred Stock may be divided into such number of series and with
the rights, preferences, privileges and restrictions as the Board
of Directors may determine.
Series A Convertible Preferred Stock
On September 15, 2017, the Company filed the
Certificate of Designations of the Series A Preferred with the
Delaware Secretary of State, designating 31,021 shares of the
Company’s preferred stock, par value $0.01 per share, as
Series A Preferred. Shares of Series A Preferred accrue dividends
at a rate of 8% per annum if the Company chooses to pay accrued
dividends in cash, and 10% per annum if the Company chooses to pay
accrued dividends in shares of Common Stock. Each share of Series A
Preferred has a liquidation preference of $1,000 per share and is
convertible, at the option of the holder, into that number of
shares of the Company’s Common Stock equal to the Liquidation
Preference, divided by $1.15 (“Conversion
Shares”). Each holder of
the Series A Preferred is entitled to vote on all matters, together
with the holders of Common Stock, on an as converted
basis.
Holders of Series A Preferred may elect to convert
shares of Series A Preferred into Conversion Shares at any time. In
the event the volume-weighted average price
(“VWAP”) of the Company’s Common Stock is at
least $2.15 per share for at least 20 consecutive trading days, the
Company may elect to convert one-half of the shares of Series A
Preferred issued and outstanding, on a pro-rata basis, into
Conversion Shares, or, if the VWAP of the Company’s Common
Stock is at least $2.15 for 80 consecutive trading days, the
Company may convert all issued and outstanding shares of Series A
Preferred into Conversion Shares. In addition, in the event of a
Change of Control, the Company will have the option to redeem all
issued and outstanding shares of Series A Preferred for 115% of the
Liquidation Preference per share.
On
September 18, 2017, the Company offered and sold a total of 11,000
shares of Series A Preferred at a purchase price of $1,000 per
share. The total net proceeds to the Company from the Series A
Financing were approximately $10.9 million.
Concurrently with the Series A Financing, the
Company entered into Exchange Agreements with holders of all
outstanding shares of the Company’s Series E Convertible
Preferred Stock, all outstanding shares of the Company’s
Series F Convertible Preferred Stock and all outstanding shares of
the Company's Series G Convertible Preferred Stock (collectively,
the “Exchanged
Preferred”), pursuant to
which the holders thereof agreed to cancel their respective shares
of Exchanged Preferred in exchange for shares of Series A Preferred
(the “Preferred Stock
Exchange”). As a result
of the Preferred Stock Exchange, the Company issued to the holders
of the Exchanged Preferred an aggregate total of 20,021 shares of
Series A Preferred.
The Company evaluated the Preferred Stock Exchange
and determined that the Preferred Stock Exchange was both an
induced conversion and an extinguishment transaction. Using the
guidance in ASC 260-10-S99-2, Earnings Per Share – SEC
Materials – SEC Staff Announcement: The Effect on the
Calculations of Earnings Per Share for a Period That Includes the
Redemption or Induced Conversion of Preferred Stock and
ASC 470-50, Debt – Modifications and
Extinguishments, the Company
recorded the fair value differential of the Exchanged Preferred as
adjustments within Shareholders’ Deficit and in the
computation of Net Loss Available to Common Shareholders in the
computation of basic and diluted loss per share. The Company
utilized the services of an independent third-party valuation firm
to perform the computation of the fair value of the Exchanged
Preferred. Based on the fair value using these methodologies, the
Company recorded approximately $1,245,000 in fair value
differential as adjustments within Shareholders’ Deficit in
the Company’s Condensed Consolidated Balance Sheet for the
year ended December 31, 2017.
The Company had 30,571 shares and 31,021 shares of
Series A Preferred outstanding as of June 30, 2018 and December 31,
2017, respectively. At June 30, 2018 and December 31, 2017,
the Company had cumulative undeclared dividends of $0.
During the six months ended June 30, 2018 certain holders of Series
A Preferred converted 450 shares of Series A Preferred into 391,304
shares of the Company’s Common Stock. The Company issued the
holders of Series A Preferred 472,562 and 648,696 shares of Common
Stock on March 31, 2018 and June 30, 2018, respectively, as payment
of dividends due on that date.
Series B Convertible Preferred Stock
The Company had 239,400 shares of Series B
Convertible Preferred stock (“Series B
Preferred”) outstanding
as of June 30, 2018 and December 31, 2017. At June 30, 2018 and
December 31, 2017, the Company had cumulative undeclared dividends
of approximately $8,000. There were no conversions of Series B
Preferred into Common Stock during the six months ended June 30,
2018 and 2017.
Common Stock
On February 8,
2018, the Company filed with the Secretary of the State of Delaware
a Certificate of Amendment to its Certificate of Incorporation, as
amended, to increase the authorized number of shares of its Common
Stock to 175,000,000 from 150,000,000 shares.
The
following table summarizes Common Stock activity for the six months
ended June 30, 2018:
|
|
Shares
outstanding at December 31, 2017
|
94,167,836
|
Shares
issued as payment of stock dividend on Series A
Preferred
|
1,121,258
|
Shares
issued pursuant to conversion of Series A Preferred
|
391,304
|
Shares
issued pursuant to option exercises
|
148,757
|
Shares
outstanding at June 30, 2018
|
95,829,155
|
Warrants
The
following table summarizes warrant activity for the following
periods:
|
|
Weighted- Average
Exercise Price
|
Balance
at December 31, 2017
|
230,000
|
$0.91
|
Granted
|
40,000
|
1.46
|
Expired/Canceled
|
—
|
—
|
Exercised
|
—
|
—
|
Balance
at June 30, 2018
|
270,000
|
$1.00
|
As
of June 30, 2018, warrants to purchase 270,000 shares of Common
Stock at an exercise prices ranging from $0.80 to $1.46 were
outstanding. All warrants are exercisable as of June 30, 2018
except for an aggregate of 150,000 warrants, which become
exercisable only upon the attainment of specified events and 20,000
warrants which become exercisable on June 7, 2019. Such warrants
expire at various dates through June 6, 2020. The intrinsic value
of warrants outstanding at June 30, 2018 was approximately
$44,000.
In June 2018, the
Company issued warrants to purchase 40,000 shares of Common Stock
at an exercise price of $1.46 per share to a member of the
Company’s Advisory Board. Such warrants have a two-year term
with 50% immediately exercisable and the remaining 50% exercisable
after one-year. Pursuant to this
issuance, the Company recorded compensation expense of
approximately $9,000 during the three months ended June 30, 2018
based on the grant-date fair value of the warrants determined using
the Black-Scholes option-valuation model.
Stock-Based Compensation
The
1999 Plan was adopted by the Company’s Board of Directors on
December 17, 1999. Under the terms of the 1999 Plan, the Company
could, originally, issue up to 350,000 non-qualified or incentive
stock options to purchase Common Stock of the Company. During the
year ended December 31, 2014, the Company subsequently amended and
restated the 1999 Plan, whereby it increased the share reserve for
issuance to approximately 7.0 million shares of the Company’s
Common Stock. Subsequently, in February 2018, the Company amended
and restated the 1999 Plan, whereby it increased the share reserve
for issuance by an additional 2.0 million shares. The 1999
Plan prohibits the grant of stock option or stock appreciation
right awards with an exercise price less than fair market value of
Common Stock on the date of grant. The 1999 Plan also generally
prohibits the “re-pricing” of stock options or stock
appreciation rights, although awards may be bought-out for a
payment in cash or the Company’s stock. The 1999 Plan permits
the grant of stock-based awards other than stock options, including
the grant of “full value” awards such as restricted
stock, stock units and performance shares. The 1999 Plan permits
the qualification of awards under the plan (payable in either stock
or cash) as “performance-based compensation” within the
meaning of Section 162(m) of the Internal Revenue Code. The number
of options issued and outstanding and the number of options
remaining available for future issuance are shown in the table
below. The number of authorized shares available for issuance under
the plan at June 30, 2018 was 703,927.
The Company estimates the fair value of its stock
options using a Black-Scholes option-valuation model, consistent
with the provisions of ASC No. 718, Compensation – Stock
Compensation. The fair value of
stock options granted is recognized to expense over the requisite
service period. Stock-based compensation expense is reported in
general and administrative, sales and marketing, engineering and
customer service expense based upon the departments to which
substantially all of the associated employees report and credited
to additional paid-in capital. Stock-based compensation expense
related to equity options was approximately $275,000 and $548,000
for the three and six months ended June 30, 2018, respectively.
Stock-based compensation expense related to equity options was
approximately $240,000 and $480,000 for the three and six months
ended June 30, 2017, respectively. Stock-based compensation expense
related to options to purchase shares of the Company’s Common
Stock issued to certain members of the Company’s Board of
Directors in return for their service (disclosed more fully below)
was approximately $98,000 and $160,000 for the three and six months
ended June 30, 2018, respectively. Stock-based compensation expense
related to options to purchase shares of the Company’s Common
Stock issued to certain members of the Company’s Board of
Directors in return for their service was approximately $35,000 and
$70,000 for the three and six months ended June 30, 2017,
respectively.
ASC No. 718 requires the use of a valuation model
to calculate the fair value of stock-based awards. The Company has
elected to use the Black-Scholes option-valuation model, which
incorporates various assumptions including volatility, expected
life, and interest rates. The Company is required to make various
assumptions in the application of the Black-Scholes
option-valuation model. The Company has determined that the best
measure of expected volatility is based on the historical weekly
volatility of the Company’s Common Stock. Historical
volatility factors utilized in the Company’s Black-Scholes
computations for the six months ended June 30, 2018 and 2017 ranged
from 51% to 84%. The Company has elected to estimate the expected
life of an award based upon the SEC approved “simplified
method” noted under the provisions of Staff Accounting
Bulletin No. 110. The expected term used by the Company during the
six months ended June 30, 2018 and 2017 was 5.17 years. The
difference between the actual historical expected life and the
simplified method was immaterial. The interest rate used is
the risk-free interest rate and is based upon U.S. Treasury rates
appropriate for the expected term. The interest rate used
in the Company’s Black-Scholes calculations for the six
months ended June 30, 2018 and 2017 was 2.6%. Dividend yield is
zero, as the Company does not expect to declare any dividends on
the Company’s Common Stock in the foreseeable
future.
In
addition to the key assumptions used in the Black-Scholes model,
the estimated forfeiture rate at the time of valuation is a
critical assumption. The Company has estimated an annualized
forfeiture rate of approximately 0% for corporate officers, 4.1%
for members of the Board of Directors and 6.0% for all other
employees. The Company reviews the expected forfeiture rate
annually to determine if that percent is still reasonable based on
historical experience.
A
summary of the activity under the Company’s stock option
plans is as follows:
|
|
Weighted-Average
Exercise Price
|
Balance
at December 31, 2017
|
6,093,512
|
$1.23
|
Granted
|
1,455,500
|
$1.71
|
Expired/Cancelled
|
(59,162)
|
$1.39
|
Exercised
|
(148,757)
|
$1.00
|
Balance
at June 30, 2018
|
7,341,093
|
$1.33
|
The
intrinsic value of options exercisable at June 30, 2018 was
approximately $742,000. The aggregate intrinsic value for all
options outstanding as of June 30, 2018 was approximately
$744,000. The
weighted-average grant-date per share fair value of options granted
during the three and six months ended June 30, 2018 was $0.75 and
$0.97, respectively. The weighted-average grant-date per share fair
value of options granted during the three and six months ended June
30, 2017 was $0.53 and $0.56, respectively. At
June 30, 2018, the total remaining unrecognized compensation cost
related to unvested stock options amounted to approximately
$1,515,000, which will be recognized over a weighted-average period
of 2.3 years.
In
January 2018, the Company issued an aggregate of 324,000 options to
purchase shares of the Company’s Common Stock to certain
members of the Company’s Board of Directors in return for
their service on the Board from January 1, 2018 through December
31, 2018. Such options vest at the rate of 27,000 options per month
on the last day of each month during the 2018 year. The options
have an exercise price of $1.75 per share and a term of 10 years.
Pursuant to this issuance, the Company recorded compensation
expense of $98,000 and $160,000 during the three and six months
ended June 30, 2018 based on the grant-date fair value of the
options determined using the Black-Scholes option-valuation
model.
Stock-based
compensation related to equity options, including options granted
to certain members of the Company’s Board of Directors, has
been classified as follows in the accompanying condensed
consolidated statements of operations (in thousands):
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|
|
|
|
|
Cost
of revenue
|
$5
|
$5
|
$11
|
$10
|
General
and administrative
|
246
|
165
|
462
|
329
|
Sales
and marketing
|
63
|
55
|
123
|
110
|
Research
and development
|
58
|
50
|
112
|
101
|
|
|
|
|
|
Total
|
$372
|
$275
|
$708
|
$550
|
NOTE 7. FAIR VALUE ACCOUNTING
The Company accounts for fair value measurements
in accordance with ASC 820, “Fair Value Measurements and
Disclosures,” which
defines fair value, establishes a framework for measuring fair
value in generally accepted accounting principles, and expands
disclosures about fair value measurements.
ASC
820 establishes a fair value hierarchy that prioritizes the inputs
to valuation techniques used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (Level 1 measurements)
and the lowest priority to unobservable inputs (Level 3
measurements). The three levels of the fair value hierarchy under
ASC 820 are described below:
Level
1
|
Unadjusted
quoted prices in active markets that are accessible at the
measurement date for identical, unrestricted assets or
liabilities.
|
Level
2
|
Applies
to assets or liabilities for which there are inputs other than
quoted prices included within Level 1 that are observable for the
asset or liability such as quoted prices for similar assets or
liabilities in active markets; quoted prices for identical assets
or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in
which significant inputs are observable or can be derived
principally from, or corroborated by, observable market
data.
|
Level
3
|
Prices
or valuation techniques that require inputs that are both
significant to the fair value measurement and unobservable
(supported by little or no market activity).
|
The
following table sets forth the Company’s financial assets and
liabilities measured at fair value by level within the fair value
hierarchy. As required by ASC 820, assets and liabilities are
classified in their entirety based on the lowest level of input
that is significant to the fair value measurement.
|
Fair Value at June 30, 2018
|
($ in thousands)
|
|
|
|
|
Assets:
|
|
|
|
|
Pension
assets
|
$1,754
|
$1,754
|
$—
|
$—
|
Totals
|
$1,754
|
$1,754
|
$—
|
$—
|
|
Fair Value at December 31, 2017
|
($ in thousands)
|
|
|
|
|
Assets:
|
|
|
|
|
Pension
assets
|
$1,806
|
$1,806
|
$—
|
$—
|
Totals
|
$1,806
|
$1,806
|
$—
|
$—
|
NOTE 8. RELATED PARTY TRANSACTIONS
Lines of Credit
The Company has certain Lines of Credit extended
by certain members of the Company’s Board of Directors. For a
more detailed discussion of the Company’s Lines of Credit,
see Note 5, “Lines of
Credit.” As of June
30, 2018, the Company had borrowed $5,500,000
under the terms of the Goldman LOC and $500,000 under the terms of
the New Crocker LOC. Each of Messrs. Goldman and Crocker are
members of the Board of Directors of the
Company.
Series A Financing
Messrs. Miller and Goldman, Wayne Wetherell, the Company’s
Chief Financial Officer, Robert T. Clutterbuck and Charles
Frischer, two directors appointed as members of the Company’s
Board of Directors in connection with the Series A Financing during
2017, purchased an aggregate of 1,450 Series A Preferred in
connection with the Series A Financing resulting in gross proceeds
of $1,450,000 to the Company. Messrs. Goldman, Clutterbuck and
Frischer also exchanged an aggregate 11,364 shares of Series E
Preferred, Series F Preferred and Series G Preferred for 11,364
shares of Series A Preferred in connection with the Series A
Financing.
NOTE 9. CONTINGENT LIABILITIES
Employment Agreements
The
Company has employment agreements with its Chief Executive Officer
and its Chief Technical Officer. The Company may terminate the
agreements with or without cause. Subject to the conditions and
other limitations set forth in each respective employment
agreement, each executive will be entitled to the following
severance benefits if the Company terminates the executive’s
employment without cause or in the event of an involuntary
termination (as defined in the employment agreements) by the
Company or by the executive:
Under
the terms of the agreement, the Chief Executive Officer will be
entitled to the following severance benefits if we terminate his
employment without cause or in the event of an involuntary
termination: (i) a lump sum cash payment equal to twenty-four
months’ base salary; (ii) continuation of fringe benefits and
medical insurance for a period of three years; and (iii) immediate
vesting of 50% of outstanding stock options and restricted stock
awards. In the event that the Chief Executive Officer’s
employment is terminated within six months prior to or thirteen
months following a change of control (as defined in the employment
agreements), the Chief Executive Officer is entitled to the
severance benefits described above, except that 100% of the Chief
Executive Officer’s outstanding stock options and restricted
stock awards will immediately vest.
Under
the terms of the employment agreement with our Chief Technical
Officer, this executive will be entitled to the following severance
benefits if we terminate his employment without cause or in the
event of an involuntary termination: (i) a lump sum cash payment
equal to six months of base salary; and (ii) continuation of their
fringe benefits and medical insurance for a period of six months.
In the event that his employment is terminated within six months
prior to or thirteen months following a change of control (as
defined in the employment agreements), he is entitled to the
severance benefits described above, except that 100% of his
outstanding stock options and restricted stock awards will
immediately vest.
Effective
September 15, 2017, the employment agreements for the
Company’s Chief Executive Officer and Chief Technical Officer
were amended to extend the term of each executive officer’s
employment agreement until December 31, 2018.
Litigation
There
is no action, suit, proceeding, inquiry or investigation before or
by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the executive
officers of the Company or any of our subsidiaries, threatened
against or affecting the Company, our Common Stock, any of our
subsidiaries or of the Company’s or our subsidiaries’
officers or directors in their capacities as such, in which an
adverse decision could have a material adverse effect.
Leases
The
Company’s corporate headquarters are located in San Diego,
California, where we occupy 9,927 square feet of office space. This
facility’s lease was renewed in September 2017 through
October 2018 at a cost of approximately $30,000 per month. In
addition to our corporate headquarters, we also occupied the
following spaces at June 30, 2018:
●
1,508
square feet in Ottawa, Province of Ontario, Canada, at a cost of
approximately $3,000 per month until the expiration of the lease on
March 31, 2021;
●
9,720
square feet in Portland, Oregon, at a cost of approximately $22,000
per month until the expiration of the lease on February 28, 2023;
and
●
304
square feet of office space in Mexico City, Mexico, at a cost of
approximately $3,000 per month until November 30,
2018.
At
June 30, 2018, future minimum lease payments are as
follows:
($ in thousands)
|
|
2018
(six months)
|
$274
|
2019
|
282
|
2020
|
289
|
2021
|
271
|
2022
|
271
|
Thereafter
|
46
|
Total
|
$1,433
|
Rental
expense incurred under operating leases for the six months ended
June 30, 2018 and 2017 was approximately $348,000 and $256,000,
respectively.
In July 2018, the
Company entered in a new leasing arrangement for 8,511 square feet
of office space for its San Diego headquarters. The new lease
commences on November 1, 2018 and terminates on April 30, 2025.
Annual base rent over the lease term approximates $361,000 per year
(which is not included in the future minimum lease payment totals
above).
NOTE 10. SUBSEQUENT EVENTS
As described in
Note 9, in July 2018, the Company
entered into a new lease for 8,511 square feet of office space for
the Company’s corporate headquarters in San Diego California.
This facilities lease commences on November 1, 2018 and runs
through April 30, 2025. Approximate annual rent over the life of
the lease approximates $361,000.
PROSPECTUS
11,031,000 SHARES
COMMON STOCK
, 2018
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM
14. OTHER EXPENSES OF ISSUANCE AND
DISTRIBUTION
The
following table sets forth an estimate of the fees and expenses
payable by us in connection with the issuance and distribution of
the securities being registered hereunder. All the amounts shown
are estimates, except for the SEC registration fees.
|
|
SEC
registration fee
|
$1,324
|
Legal fees and
expenses
|
50,000
|
Accounting fees and
expenses
|
15,000
|
Printing and miscellaneous fees and
expenses
|
5,000
|
Total
|
$71,324
|
ITEM 15. INDEMNIFICATION OF OFFICERS AND
DIRECTORS
Our Certificate of Incorporation, as amended
(“Charter”) and bylaws contain provisions relating to
the limitation of liability and indemnification of directors and
officers. Our Charter provides that a director will not be
personally liable to us or our stockholders for monetary damages
for breach of fiduciary duty as a director, except for
liability:
●
for any breach of
the director’s duty of loyalty to us or our
stockholders;
●
for acts or
omissions not in good faith or that involve intentional misconduct
or a knowing violation of law;
●
under Section 174
of the Delaware General Corporation Law (the “DGCL”); or
●
for any transaction
from which the director derived any improper personal
benefit.
Our
Charter also provides that if the DGCL is amended to authorize
corporate action further eliminating or limiting the personal
liability of directors, then the liability of our directors will be
eliminated or limited to the fullest extent permitted by the
DGCL.
Our bylaws provide that we will indemnify our
directors and officers to the fullest extent not prohibited by the
DGCL; provided,
however, that we may limit
the extent of such indemnification by individual contracts with our
directors and executive officers; and provided, further, that we
are not required to indemnify any director or executive officer in
connection with any proceeding (or part thereof) initiated by such
person or any proceeding by such person against us or our
directors, officers, employees or other agents
unless:
●
such
indemnification is expressly required to be made by
law;
●
the proceeding was
authorized by the Board of Directors; or
●
such
indemnification is provided by us, in our sole discretion, pursuant
to the powers vested in us under the DGCL.
Our
bylaws provide that we shall advance, prior to the final
disposition of any proceeding, promptly following request therefor,
all expenses by any director or executive officer in connection
with any such proceeding upon receipt of any undertaking by or on
behalf of such person to repay said amounts if it should be
determined ultimately that such person is not entitled to be
indemnified under Article 8 of our bylaws or otherwise.
Notwithstanding the foregoing, unless otherwise determined, no
advance shall be made by us if a determination is reasonably and
promptly made by the Board of Directors by a majority vote of a
quorum of directors who were not parties to the proceeding, or if
such a quorum is not obtainable, or even if obtainable, a quorum of
disinterested directors so directs, by independent legal counsel in
a written opinion, that the facts known to the decision-making
party at the time such determination is made demonstrate clearly
and convincingly that such person acted in bad faith or in a manner
that such person did not believe to be in or not opposed to our
best interests.
Our
bylaws also authorize us to purchase insurance on behalf of any
person required or permitted to be indemnified pursuant to Article
8 of our bylaws.
Section
145(a) of the DGCL authorizes a corporation to indemnify any person
who was or is a party, or is threatened to be made a party, to a
threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other
than an action by or in the right of the corporation), by reason of
the fact that the person is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of
the corporation as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other
enterprise, against expenses (including attorneys’ fees),
judgments, fines and amounts paid in settlement actually and
reasonably incurred by the person in connection with such action,
suit or proceeding, if the person acted in good faith and in a
manner the person reasonably believed to be in, or not opposed to,
the best interests of the corporation and, with respect to any
criminal action or proceeding, had no reasonable cause to believe
the person’s conduct was unlawful.
Section
145(b) of the DGCL provides in relevant part that a corporation may
indemnify any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action or suit
by or in the right of the corporation to procure a judgment in its
favor by reason of the fact that the person is or was a director,
officer, employee or agent of the corporation, or is or was serving
at the request of the corporation as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust
or other enterprise against expenses (including attorneys’
fees) actually and reasonably incurred by the person in connection
with the defense or settlement of such action or suit if the person
acted in good faith and in a manner the person reasonably believed
to be in or not opposed to the best interests of the corporation
and except that no indemnification shall be made in respect of any
claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or the court in which such action
or suit was brought shall determine upon application that, despite
the adjudication of liability but in view of all the circumstances
of the case, such person is fairly and reasonably entitled to
indemnity for such expenses which the Court of Chancery or such
other court shall deem proper.
The
DGCL also provides that indemnification under Section 145(d) can
only be made upon a determination that indemnification of the
present or former director, officer or employee or agent is proper
in the circumstances because such person has met the applicable
standard of conduct set forth in Section 145(a) and
(b).
Section
145(g) of the DGCL also empowers a corporation to purchase and
maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation, or is or
was serving at the request of the corporation as a director,
officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against any liability
asserted against such person and incurred by such person in any
such capacity, or arising out of such person’s status as
such, whether or not the corporation would have the power to
indemnify such person against such liability under Section 145 of
the DGCL.
Section
102(b)(7) of the DGCL permits a corporation to provide for
eliminating or limiting the personal liability of one of its
directors for any monetary damages related to a breach of fiduciary
duty as a director, as long as the corporation does not eliminate
or limit the liability of a director for acts or omissions which
(1) which breached the director’s duty of loyalty to the
corporation or its stockholders, (2) which were not in good faith
or which involve intentional misconduct or knowing violation of
law, (3) under Section 174 of the DGCL; or (4) from which the
director derived an improper personal benefit.
We
have obtained directors’ and officers’ insurance to
cover our directors and officers for certain
liabilities.
ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES
Set
forth below is information regarding all securities sold by us
within the last three years which were not registered under the
Securities Act. Also included is the consideration received by us
for such securities and information relating to the section of the
Securities Act, or rule of the SEC, under which exemption from
registration was claimed.
On
September 7, 2016, we sold and issued 2,000 shares of our Series F
Preferred at a price of $1,000 per share to an accredited investor
in a private placement transaction, resulting in gross proceeds of
$2.0 million. In addition, we agreed to file a registration
statement to register the shares of Common Stock issuable upon the
conversion of the shares of Series F Preferred.
On
December 29, 2016, we sold and issued 1,625 shares of our Series G
Preferred at a price of $1,000 per share to certain accredited
investors in a private placement transaction, resulting in gross
proceeds of approximately $1.63 million. In addition, we also
received executed Exchange Agreements from the accredited investors
pursuant to which we exchanged an aggregate of approximately 3.3
million shares of Common Stock held by the accredited investors for
an aggregate of approximately 4,400 additional shares of Series G
Preferred.
On
September 18, 2017, we entered into Exchange Agreements with
holders of all outstanding shares of Series E Preferred, all
outstanding shares of Series F Preferred and all outstanding shares
of Series G Preferred, pursuant to which we cancelled their
respective shares of preferred stock in exchange for the same
number of shares of Series A Preferred. As a result, we issued to
the holders an aggregate of 20,021 shares of Series A
Preferred.
In
September 2018, we sold and issued an aggregate of 1,000 shares of
our Series C Preferred at a price of $10,000 per share to certain
accredited investors in private placement transactions, resulting
in gross proceeds of approximately $10.0 million. In addition, we
agreed to file a registration statement to register the shares of
Common Stock issuable upon the conversion of the shares of Series C
Preferred as well as those shares of Common Stock issuable as
payment of accrued dividends on shares of Series C Preferred
purchased by the accredited investors.
On September 10, 2018, we entered into Exchange Agreements with
Neal Goldman and Charles Crocker, pursuant to which Messrs. Goldman
and Crocker exchanged approximately $6.3 million and $0.6 million,
respectively, of outstanding debt (including accrued and unpaid
interest) owed under the terms of their respective lines of credit
for the issuance of an aggregate of 6,896 shares of Series A
Preferred.
On September 10, 2018, we granted warrants to
purchase an aggregate of 1,493,856 shares of Common Stock with an
exercise price of $0.01 per share to all holders of our Series A
Preferred as a special dividend. Holders of our Series A Preferred
received warrants to purchase 39.87 shares of Common Stock for
every share of Series A Preferred held. Each warrant was
exercisable immediately upon issuance; provided,
however, that the warrants may
only be exercised concurrently with the conversion of shares
of Series A Preferred held by the holders into shares of Common
Stock. In addition, each warrant expires on the earliest to occur
of (i) the conversion of all Series A Preferred held by the holders
into Common Stock, (ii) our redemption of all outstanding shares of
Series A Preferred held by the holders, (iii) the warrant no longer
representing the right to purchase any shares of Common Stock, and
(iv) the tenth anniversary of the date of
issuance.
We
believe that each of the offers, sales and issuances of securities
described in Item 15 were exempt from registration under the
Securities Act pursuant to Regulation D under the Securities Act or
pursuant to Section 4(a)(2) of the Securities Act regarding
transactions not involving a public offering. The recipients of
securities in each of these transactions represented their
intention to acquire the securities for investment only and not
with a view to or for sale in connection with any distribution
thereof and appropriate legends were affixed to the stock
certificates and instruments issued in such transactions. All
recipients had adequate access, through their relationships with
us, to information about us.
ITEM 16. EXHIBITS
|
|
Agreement and Plan of Merger, dated October 27, 2005 (incorporated
by reference to Annex A to the Company’s Definitive Proxy
Statement on Schedule 14A, filed November 15, 2005).
|
|
|
Certificate of Incorporation (incorporated by reference to Annex B
to the Company’s Definitive Proxy Statement on Schedule 14A,
filed November 15, 2005).
|
|
|
Certificate of Amendment to Certificate of Incorporation
(incorporated by reference to Exhibit 3.1 to the Company's Current
Report on Form 8-K, filed October 14, 2011).
|
|
|
Amended
and Restated Bylaws (incorporated by reference to Exhibit 3.2 to
the Company’s Current Report on Form 8-K, filed February 16,
2017).
|
|
|
Certificate of Designations, Preferences and Rights of the Series E
Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K, filed
February 2, 2015).
|
|
|
Certificate of Designations, Preferences and Rights of the Series F
Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K, filed
September 9, 2016).
|
|
|
Certificate of Designations, Preferences and Rights of the Series G
Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K, filed
December 30, 2016).
|
|
|
Amendment No. 1 to the Certificate of Designations, Preferences and
Rights of the Series E Convertible Preferred Stock (incorporated by
reference to Exhibit 3.2 to the Company’s Current Report on
Form 8-K, filed December 30, 2016).
|
|
|
Certificate of Designations, Preferences and Rights of the Series A
Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K, filed
September 19, 2017).
|
|
|
Certificate of Elimination of the Series E Convertible Preferred
Stock, Series F Convertible Preferred Stock and Series G
Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K, filed
October 19, 2017).
|
|
|
Certificate of Amendment to Certificate of Incorporation
(incorporated by reference to Exhibit 3.1 to the Company’s
Current Report on Form 8-K, filed February 13, 2018).
|
|
|
Certificate of Designations, Preferences, and Rights of Series C
Convertible Preferred Stock (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K, filed
September 13, 2018)
|
|
|
Amendment No. 1 to the Certificate of Designations, Preferences,
and Rights of Series A Convertible Preferred Stock (incorporated by
reference to Exhibit 3.2 to the Company’s Current Report on
Form 8-K, filed September 13, 2018)
|
|
|
Form of Amendment to Warrant, dated March 21, 2012, (incorporated
by reference to Exhibit 4.16 to the Company's Annual Report on Form
10-K, filed April 4, 2012).
|
|
|
Form of Warrant, dated September 10, 2018 (incorporated by
reference to Exhibit 3.3 to the Company’s Current Report on
Form 8-K, filed September 13, 2018)
|
5.1*
|
|
Opinion of Disclosure Law Group, a Professional
Corporation
|
|
|
Employment Agreement, dated September 27, 2005, between the Company
and S. James Miller (incorporated by reference to Exhibit 10.1 to
the Company’s Current Report on Form 8-K, filed September 30,
2005).
|
|
|
Form of Indemnification Agreement entered into by the Company with
its directors and executive officers (incorporated by reference to
Exhibit 10.4 to the Company’s Registration Statement on Form
SB-2 (No. 333-93131), filed December 20, 1999, as
amended).
|
|
|
Amended and Restated 1999 Stock Plan Award (incorporated by
reference to Appendix B of the Company’s Definitive Proxy
Statement on Schedule 14A, filed November 21, 2007).
|
|
|
Form of Stock Option Agreement (incorporated by reference to
Exhibit 10.2 to the Company’s Current Report on Form 8-K,
filed July 14, 2005).
|
|
|
2001 Equity Incentive Plan (incorporated by reference to Exhibit
10.2 to the Company’s Quarterly Report on Form 10-QSB, filed
November 14, 2001).
|
|
|
Securities Purchase Agreement, dated September 25, 2007, by and
between the Company and certain accredited investors (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report
on Form 8-K, filed September 26, 2007).
|
|
|
Office Space Lease between I.W. Systems Canada Company and GE
Canada Real Estate Equity, dated July 25, 2008 (incorporated by
reference to Exhibit 10.39 to the Company’s Annual Report on
Form 10-K, filed February 24, 2010).
|
|
|
Form of Securities Purchase Agreement, dated August 29, 2008 by and
between the Company and certain accredited investors (incorporated
by reference to Exhibit 10.40 to the Company’s Annual Report
on Form 10-K, filed February 24, 2010).
|
|
|
Change of Control and Severance Benefits Agreement, dated September
27, 2008, between Company and Charles Aubuchon (incorporated by
reference to Exhibit 10.41 to the Company’s Annual Report on
Form 10-K, filed February 24, 2010).
|
|
|
Change of Control and Severance Benefits Agreement, dated September
27, 2008, between Company and David Harding (incorporated by
reference to Exhibit 10.42 to the Company’s Annual Report on
Form 10-K, filed February 24, 2010).
|
|
|
First Amendment to Employment Agreement, dated September 27, 2008,
between the Company and S. James Miller (incorporated by reference
to Exhibit 10.43 to the Company’s Annual Report on Form 10-K,
filed February 24, 2010).
|
|
|
Form of Convertible Note dated November 14, 2008 (incorporated by
reference to Exhibit 10.45 to the Company’s Annual Report on
Form 10-K, filed February 24, 2010).
|
|
|
Second Amendment to Employment Agreement, dated April 6, 2009,
between the Company and S. James Miller (incorporated by reference
to Exhibit 10.50 to the Company’s Annual Report on Form 10-K,
filed February 24, 2010).
|
|
|
Office Space Lease between the Company and Allen W. Wooddell, dated
July 25, 2008 (incorporated by reference to Exhibit 10.54 to the
Company’s Annual Report on Form 10-K, filed February 24,
2010).
|
|
|
Third Amendment to Employment Agreement, dated December 10, 2009,
between the Company and S. James Miller (incorporated by reference
to Exhibit 10.60 to the Company’s Annual Report on Form 10-K,
filed February 24, 2010).
|
|
|
Securities Purchase Agreement, dated December 12, 2011, by and
between the Company and certain accredited investors (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report
on Form 8-K, filed December 21, 2011).
|
|
|
Note Exchange Agreement, dated December 12, 2011, by and between
the Company and certain accredited investors (incorporated by
reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K, filed December 21, 2011).
|
|
|
Fourth Amendment to Employment Agreement, dated March 10, 2011,
between the Company and S. James Miller, (incorporated by reference
to Exhibit 10.40 to the Company’s Annual Report on Form 10-K,
filed January 17, 2012).
|
|
|
Fifth Amendment to Employment Agreement, dated January 31, 2012,
between the Company and S. James Miller, Jr., (incorporated by
reference to Exhibit 10.44 to the Company’s Annual Report on
Form 10-K, filed April 4, 2012.
|
|
|
Employment Agreement, dated January 1, 2013, between the Company
and Wayne Wetherell (incorporated by reference to Exhibit 10.1 to
the Company's Current Report on Form 8-K, filed March 7,
2013).
|
|
|
Employment Agreement, dated January 1, 2013, between the Company
and David Harding (incorporated by reference to Exhibit 10.1 to the
Company's Current Report on Form 8-K, filed March 7,
2013).
|
|
|
Convertible Promissory Note dated March 27, 2013 issued by the
Company to Neal Goldman (incorporated by reference to Exhibit 10.41
to the Company's Annual Report on Form 10-K, filed April 1,
2013).
|
|
|
Amendment to Convertible Promissory Note, dated March 12, 2014
(incorporated by reference to Exhibit 10.1 to the Company's Current
Report on Form 8-K, filed March 13, 2014).
|
|
|
Note Exchange Agreement, dated January 29, 2015 (incorporated by
reference to the Company’s Current Report on Form 8-K, filed
February 2, 2015).
|
|
|
Sixth
Amendment to Employment Agreement, by and between S. James Miller
and the Company, dated November 1, 2013 (incorporated by reference
to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed
November 7, 2013).
|
|
|
Seventh Amendment to Employment Agreement, by and between S. James
Miller, Jr. and the Company, dated January 9, 2015 (incorporated by
reference to the Company’s Current Report on Form 8-K, filed
January 15, 2015).
|
|
|
Second Amendment to Employment Agreement, by and between Wayne
Wetherell and the Company, dated January 9, 2015 (incorporated by
reference to the Company’s Current Report on Form 8-K, filed
January 15, 2015).
|
|
|
Second
Amendment to Employment Agreement, by and between David E. Harding
and the Company, dated January 9, 2015 (incorporated by reference
to the Company’s Current Report on Form 8-K, filed January
15, 2015).
|
|
|
Amendment
No. 3 to Convertible Promissory Note, dated December 8, 2014
(incorporated by reference to the Company’s Current Report on
Form 8-K, filed December 10, 2014).
|
|
|
Third
Amendment to Employment Agreement, by and between Wayne Wetherell
and the Company, dated December 14, 2015 (incorporated by reference
to Exhibit 10.2 to the Company's Current Report on Form 8-K, filed
December 21, 2015).
|
|
|
Third
Amendment to Employment Agreement, by and between David E. Harding
and the Company, dated December 14, 2015 (incorporated by reference
to Exhibit 10.3 to the Company's Current Report on Form 8-K, filed
December 21, 2015).
|
|
|
Eighth
Amendment to Employment Agreement, by and between S. James Miller
and the Company, dated December 14, 2015 (incorporated by reference
to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed
December 21, 2015).
|
|
|
Amendment No. 4 to Convertible Promissory Note, dated March 8, 2016
(incorporated by reference to the Company's Current Report on Form
8-K, filed March 10, 2017).
|
|
|
Convertible Promissory Note, dated March 9, 2016 (incorporated by
reference to the Company's Current Report on Form 8-K, filed March
10, 2017).
|
|
|
Form of Securities Purchase Agreement, dated September 7, 2016
(incorporated by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K, filed September 9, 2016).
|
|
|
Amendment No. 5 to Convertible Promissory Note, dated January 23,
2017 (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 10-K, filed January 26,
2017).
|
|
|
Form of Subscription Agreement for Series G Convertible Preferred
Stock (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K, filed December 30,
2016).
|
|
|
Form of Exchange Agreement (incorporated by reference to Exhibit
10.2 to the Company’s Current Report on Form 8-K, filed
December 30, 2016).
|
|
|
Ninth Amendment to Employment Agreement, by and between James
Miller, Jr. and the Company, dated October 20, 2016 (incorporated
by reference to Exhibit 10.3 to the Company’s Current Report
on Form 8-K, filed December 30, 2016).
|
|
|
Fourth
Amendment to Employment Agreement, by and between Wayne Wetherell
and the Company, dated October 20, 2016 (incorporated by reference
to Exhibit 10.4 to the Company’s Current Report on Form 8-K,
filed December 30, 2016).
|
|
|
Fourth Amendment to Employment Agreement, by and between David E.
Harding and the Company, dated October 20, 2016 (incorporated by
reference to Exhibit 10.5 to the Company’s Current Report on
Form 8-K, dated December 30, 2016).
|
|
|
Amendment No. 2 to Convertible Promissory Note, dated May 10, 2017
(incorporated by reference to Exhibit 10.1 to the Company’s
Quarterly Report on Form 10-Q, filed May 12, 2017).
|
|
|
Amendment No. 6 to Convertible Promissory Note, dated May 10, 2017
(incorporated by reference to Exhibit 10.2 to the Company’s
Quarterly Report on Form 10-Q, filed May 12, 2017).
|
|
|
Form of Subscription Agreement for Series A Convertible Preferred
Stock (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K, filed September 19,
2017).
|
|
|
Form of Exchange Agreement (incorporated by reference to Exhibit
10.2 to the Company’s Current Report on Form 8-K, filed
September 19, 2017).
|
|
|
Fifth Amendment to Employment Agreement, by and between David E.
Harding and the Company, dated February 7, 2018 (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on
Form 8-K, dated February 13, 2018).
|
|
|
Tenth Amendment to Employment Agreement, by and between James
Miller, Jr. and the Company, dated February 8, 2018 (incorporated
by reference to Exhibit 10.2 to the Company’s Current Report
on Form 8-K, dated February 13, 2018).
|
|
|
Form of Securities Purchase Agreement for Series C Convertible
Preferred Stock (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K, filed September 13,
2018)
|
|
|
Form of Registration Rights Agreement (incorporated by reference to
Exhibit 10.2 to the Company’s Current Report on Form 8-K,
filed September 13, 2018)
|
|
|
Placement Agency Agreement, by and between the Company and
Northland Capital Markets (incorporated by reference to Exhibit
10.3 to the Company’s Current Report on Form 8-K, filed
September 13, 2018)
|
|
|
Form of Exchange Agreement (incorporated by reference to Exhibit
10.4 to the Company’s Current Report on Form 8-K, filed
September 13, 2018)
|
|
|
List of Subsidiaries (incorporated by referenced to Exhibit 21.1 to
the Company’s Annual Report on Form 10-K filed February 24,
2010).
|
23.1*
|
|
Consent of Disclosure Law Group, a Professional Corporation
(included in Exhibit 5.1)
|
|
|
Consent of Independent Registered Public Accounting Firm
– Mayer Hoffman McCann P.C., filed
herewith.
|
|
|
Power of Attorney (located on signature page)
|
*
|
To be filed by amendment.
|
ITEM 17. UNDERTAKINGS
(a) The undersigned registrant hereby undertakes:
(1) To
file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration
Statement:
(i) To
include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933, as amended;
(ii) To
reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form
of prospectus filed with the SEC pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than
20% change in the maximum aggregate offering price set forth in the
“Calculation of Registration Fee” table in the
effective registration statement.
(iii) To include any material information
with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such
information in the registration
statement; provided,
however, that paragraphs
(a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply
if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or
furnished to the SEC by the registrant pursuant to Section 13
or Section 15(d) of the Exchange Act that are incorporated by
reference in the registration statement, or is contained in a form
of prospectus filed pursuant to Rule 424(b) that is part of the
registration statement.
(2) That, for the purpose of determining any
liability under the Securities Act of 1933, as amended, each such
post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the
initial bona
fide offering
thereof.
(3) To
remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the
termination of the offering.
(4) That,
for the purpose of determining liability under the Securities Act
of 1933, as amended, to any purchaser:
(i)
If the Registrant is relying on Rule 430B:
(A) Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) shall
be deemed to be part of the registration statement as of the date
the filed prospectus was deemed part of and included in the
registration statement; and
(B) Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5),
or (b)(7) as part of a registration statement in reliance on Rule
430B relating to an offering made pursuant to Rule 415(a)(1)(i),
(vii), or (x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933, as amended, shall
be deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first used
after effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As provided
in Rule 430B,for liability purposes of the issuer and any person
that is at that date an underwriter, such date shall be deemed to
be a new effective date of the registration statement relating to
the securities in the registration statement to which that
prospectus relates, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.
Provided, however, that no statement made in a registration
statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by
reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a
time of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement or
prospectus that was part of the registration statement or made in
any such document immediately prior to such effective date;
or
(ii) If
the registrant is subject to Rule 430C, each prospectus filed
pursuant to Rule 424(b) as part of a registration statement
relating to an offering, other than registration statements relying
on Rule 430B or other than prospectuses filed in reliance on Rule
430A, shall be deemed to be part of and included in the
registration statement as of the date it is first used after
effectiveness. Provided, however, that no statement made in a
registration statement or prospectus that is part of the
registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a
purchaser with a time of contract of sale prior to such first use,
supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of
first use.
(5) That,
for the purpose of determining liability of the registrant under
the Securities Act of 1933, as amended, to any purchaser in the
initial distribution of the securities: The undersigned registrant
undertakes that in a primary offering of securities of the
undersigned registrant pursuant to this registration statement,
regardless of the underwriting method used to sell the securities
to the purchaser, if the securities are offered or sold to such
purchaser by means of any of the following communications, the
undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such
purchaser:
(i) Any
preliminary prospectus or prospectus of the undersigned registrant
relating to the offering required to be filed pursuant to
Rule 424;
(ii) Any
free-writing prospectus relating to the offering prepared by or on
behalf of the undersigned registrant or used or referred to by the
undersigned registrant;
(iii) The
portion of any other free-writing prospectus relating to the
offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the
undersigned registrant; and
(iv) Any
other communication that is an offer in the offering made by the
undersigned registrant to the purchaser.
Insofar
as indemnification for liabilities arising under the Securities Act
of 1933, as amended, may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in
the opinion of the SEC such indemnification is against public
policy as expressed in the Act and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant
will, unless in the opinion of its counsel the matter has been
settled by controlling precedent submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be governed
by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act
of l933, the registrant has duly caused this Registration Statement
to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of San Diego, California on October
10, 2018.
|
IMAGEWARE SYSTEMS, INC.
|
|
|
|
|
|
By:
|
/s/ S. James
Miller, Jr.
|
|
|
|
S.
James Miller, Jr.
|
|
|
|
Chief
Executive Officer, President
|
|
KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints S. James Miller, Jr. as his
or her true and lawful attorney-in-fact and agent, with full power
of substitution and resubstitution, for him and in his or her name,
place, and stead, in any and all capacities, to (i) act on,
sign and file with the Securities and Exchange Commission any and
all amendments (including post-effective amendments) to this
registration statement together with all schedules and exhibits
thereto and any subsequent registration statement filed pursuant to
Rule 462(b) under the Securities Act of 1933, as amended, together
with all schedules and exhibits thereto, (ii) act on, sign and
file such certificates, instruments, agreements and other documents
as may be necessary or appropriate in connection therewith,
(iii) act on and file any supplement to any prospectus
included in this registration statement or any such amendment or
any subsequent registration statement filed pursuant to Rule 462(b)
under the Securities Act of 1933, as amended, and (iv) take
any and all actions which may be necessary or appropriate to be
done, as fully for all intents and purposes as he or she might or
could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent, or his or her substitute or
substitutes, may lawfully do or cause to be done by virtue
hereof.
Pursuant
to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in
the capacities and on the dates indicated.
Signature
|
|
Title(s)
|
|
Date
|
|
|
|
/s/ S. James
Miller, Jr.
S.
James Miller, Jr.
|
|
President,
Chief Executive Officer and Chairman
(Principal
Executive Officer)
|
|
October
10, 2018
|
|
|
|
/s/ Wayne
Wetherell
Wayne
Wetherell
|
|
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
|
|
October
10, 2018
|
|
|
|
/s/ David
Loesch
David
Loesch
|
|
Director
|
|
October
10, 2018
|
|
|
|
/s/ Steve
Hamm
Steve
Hamm
|
|
Director
|
|
October
10, 2018
|
|
|
|
/s/ David
Carey
David
Carey
|
|
Director
|
|
October
10, 2018
|
|
|
|
|
|
/s/ John
Cronin
John
Cronin
|
|
Director
|
|
October
10, 2018
|
/s/ Neal
Goldman
Neal
Goldman
|
|
Director
|
|
October
10, 2018
|
|
|
|
/s/ Charles
Crocker
Charles
Crocker
|
|
Director
|
|
October
10, 2018
|
|
|
|
/s/ Dana
Kammersgard
Dana
Kammersgard
|
|
Director
|
|
October
10, 2018
|
|
|
|
/s/ Charles
Frischer
Charles
Frischer
|
|
Director
|
|
October
10, 2018
|
|
|
|
/s/ Robert
Clutterbuck
Robert
Clutterbuck
|
|
Director
|
|
October
10, 2018
|
|
|
|